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ABSTRACT 
 
Background 
Introduction of nationwide breast and cervical screening programmes in Poland (2006) created an 
unprecedented opportunity to explore the predictors of breast and cervical cancer prophylactic 
behaviours in a society unexposed to population screening. The study aims to add to the body of 
knowledge on predictors that could be common for other countries in a similar geo-political 
situation, aiming to introduce nationwide breast and cervical screening programmes.  
 
Methods 
A data subset (N=4,290) from a large representative survey (N=7,948) on cancer knowledge and 
prophylaxis, conducted by the Cancer Oncology Institute in Warsaw close to the introduction of 
nationwide breast and cervical cancer screening, was used in this thesis. Behaviours and 
knowledge were described and logistic regression used to identify predictors of mammography 
and cytology uptake. 
 
Results 
Women’s level of cancer knowledge was evenly distributed (49.2% low and 50.8% high scores). 
However, knowledge on cervical cancer was lower than for breast. Higher knowledge was linked 
to higher education, better material conditions, cancer diagnosis, or practicing any type of the 
studied prophylaxis and lower levels of knowledge was associated with being aged 18-24 or ≥70  
y.o., being widowed, and living in village. Even though 93% (N=3,970) of respondents were 
aware of the need for breast self-examination (BSE), only 32.3% regularly practiced BSE. 
Majority (92.3%, N=3,943) knew that mammography can allow early cancer detection but only 
52.5% ≥ 50 y.o. (32.1% all ages) declared ever having it. Similarly, 90.7% (N=3,871) knew that 
cytology allows early detection of cancer and 78.8% have ever undertaken it cytology but only 
53.6% had it done every 1-3 years. Up to 4% indicated test unavailability of either test as the 
reason for non-attendance. The most common barriers included: feeling of no need for such test 
(37.9-44.9%) and lack of referral (28.7%-39.2%). Women with the highest education levels, the 
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ones living in cities above 100,000 inhabitants, or with highest cancer knowledge were the most 
likely to ever get screened for breast and cervical cancers. Additionally BSE was found to predict 
mammography whilst cytology was also predicted by: household size, marital status, having a 
family member or a friend with cancer. 
 
Conclusions 
Low screening uptake could be reflective of the fact that there was no nationally available 
screening but only a small proportion reported non-attendance due to unavailability of tests. This 
suggests that the uptake was driven by other factors (e.g., cancer knowledge, education) than 
population screening availability. Particular attention should be paid to the provision of cancer 
related knowledge. A follow up study is recommended to assess whether women’s knowledge 
and screening behaviours improved since the conduct of this survey. 
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STRUCTURE OF THE THESIS 
 
The objectives of the introductory chapter are to: present a rationale for the thesis, its aims and 
objectives and a brief overview of methodology  
 
The second chapter of the thesis provides the background for this study describing topics relevant 
to cancer screening and its uptake during and where relevant beyond the study period (2006). The 
study rationale is supported by a review of the literature on the historical context of health care 
system in relation to cancer screening, inequalities in health outcomes related to cancer screening, 
breast and cervical cancer epidemiology, as well as topics covered by the questionnaire such as: 
women’s knowledge of breast and cervical cancer, screening behaviours, cues to take up 
screening and various theories related to practicing cancer screening behaviours. 
 
The third chapter describes the methodology of the study design and profile of the collected data 
is discussed in detail followed by chapter 4 that discusses the overall study results. Finally, 
chapter 5 provides a summary of the findings, discusses study strengths and limitations and 
provides conclusions and recommendations.  
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GLOSSARY  
 
o Barriers – physical or structural concerns or perceived emotions related to behaviours that 
might interfere with the uptake of breast or cervical cancer screening (Champion, 1999) 
o Cervical screening – term cervical screening used throughout this thesis relates to early 
detection of pre-cancerous lesions using a Papanicolaou smear (Pap) – a screening tool 
detecting cervical abnormalities. 
o Breast screening – term breast screening refers to mammography, an X-ray technique used to 
screen the breast tissue in order to identify changes of breast tissue that might be suggestive 
of cancerous or pre-cancerous cells. 
o Coverage of screening – the proportion of individuals eligible for screening within a 
population invited for screening in a specified time period (Jepson et al., 2000). 
o Cues to action – term cues to action refers to anything that prompts an individual to think or 
act upon a specific health related issue (i.e. TV commercials prompting to take a specific 
action or having a family member suffering from a specific condition) (Witte, 2001). 
o Determinants – factors significantly influencing the screening uptake (e.g., individual’s 
characteristics, type of screening and methods involved, other) (Jepson et al., 2000) 
o  “Grey literature” – a body of material not available through the usual publication channels 
(Auger, 1994). It can include government reports, and non-profit organisation reports, 
academic papers; conference abstracts posters and papers, PowerPoint presentations, 
conference proceedings, evaluation reports, guidelines and others 
o Health literacy – ability to process and understand basic health information necessary to take 
appropriate health decisions (National Network of Libraries of Medicine, 2013).  
o Human Papilloma Virus (HPV) – epitheliotropic agent that may induces benign skin and 
mucous membrane papillomas. More than 100 HPV (types) have been identified with a 
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subset of them being sexually transmitted. Several of its types have a strong relationship with 
development of cervical cancer. HPV DNA is found in majority or all cervical cancers 
(DeVita Jr et al., 2011a). 
o Nulliparity – a state without offspring  
o Opportunistic screening – is done through disease testing of symptom free individuals when 
they visit a healthcare professional for reasons different than the condition screened for 
(Australian Population Health Development Principal Committee Screening Subcommittee, 
2008) 
o Population based screening – systematically targets all individuals meeting screening target 
criteria defined by protocols, policy, and other governing documentation. All screening 
activities are planned and coordinated as well as monitored and evaluated with careful 
consideration for appropriate resource use (Australian Population Health Development 
Principal Committee Screening Subcommittee, 2008) 
o Secondary data – is data that has been collected for a different purpose from the research 
activity they were used (Olsen, 2008, Vogt and Johnson, 2011). In this study term secondary 
data refers to the sub-sample of data that was generated as a part of a study: Knowledge 
about cancer and health prophylaxis 
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CHAPTER 1 INTRODUCTION TO THE STUDY 
 
Non-communicable diseases such as cancers account for most of the global burden of disease 
(World Health Organization (WHO), 2011). In 2008 about 12.7 million cancer cases and 7.6 
million cancer deaths were registered worldwide (Ferlay et al., 2010). It is expected that the 
number of deaths due to cancer will rise to 21.4 million cases and 13.5 million deaths by 2030 
(American Cancer Society, 2011). However, up to about 40% of all cancer deaths could be 
avoided by the implementation of disease prevention programmes, disease monitoring, decrease 
in the use of substances such as tobacco or alcohol, improvement of diet and physical activity, 
and the elimination of environmental carcinogens (WHO, 2007a, WHO, 2013, Cancer Research 
UK (CRUK), 2013).  
 
Breast and cervical cancers are the most common cancers in women worldwide (Mauad et al., 
2009, WHO, 2011, Nilaweera et al., 2012)  with WHO’s most recent (2008) worldwide estimates 
of 458,000 deaths due to breast cancer and 275,000 due cervical cancer (GLOBOCAN, 2008a). 
About 20-60% of breast and cervical cancer deaths could be avoided with the help of cancer 
screening programmes (Centers for Disease Control and Prevention (CDC), 2008, NHS Cancer 
Screening Programmes, 2008) and the use of vaccinations such as against Human Papilloma 
virus (WHO, 2007b). Three quarters of all cancer deaths worldwide occur in low and middle 
income countries (WHO, 2007b) including middle income countries from former Soviet bloc 
such as for example Estonia, Hungary, Poland, Romania, or Burlgaria (Gottret and Schieber, 
2006) where there are often no population based cancer screening programmes or they are still in 
their very early stages. For example Romania and Bulgaria are yet to introduce population based 
breast and cervical screening programmes (OECD, 2012) but Poland and Estonia have already 
started the implementation of both screening types in response to high mortality rates in 
comparison to countries with existing population based screening programmes (i.e. Finland, UK)  
(Ministerstwo Zdrowia, 2005a,b, Social Minister’s regulation [Estonia], 2007, Ministerstwo 
Zdrowia, 2012). 
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Despite the progress in research on health inequalities, limited evidence exists regarding the way 
in which the patient’s decision to take up (or not) the opportunity of cancer screening is formed 
and what factors have the strongest influence on participation in such prophylactic initiatives 
(House of Commons Health Committee, 2009). This can be seen especially in countries with a 
complicated historic and political past where nationwide and cost free prophylaxis is not 
available or is in its early stages, as it is the case of Poland (for example see Dowling et al., 2010). 
Knowledge, behavioural factors and individual characteristics are frequently identified in an 
attempt to explain health related behaviours (please see sections 2.6-2.7). The goal of this thesis 
is to explore knowledge, behaviours and other factors that might influence uptake of cervical and 
breast cancer screening in Poland, at the time of their introduction in 2006. The knowledge 
gained through this study will help to evaluate some of the screening challenges (e.g. barriers to 
screening) and behavioural screening predictors (e.g., reasons for lack of uptake, practice of BSE) 
in Poland and contribute to knowledge that could be used in countries aiming to introduce 
nationwide disease preventative programmes (e.g., Bulgaria or Romania).  
 
1.1. Study rationale 
 
In 2008, in Poland there were more than 140,000 new cancer cases and 92,000 cancer deaths 
(GLOBOCAN, 2008b). It has been estimated that every fourth Pole will develop a neoplasm 
during their lifetime and every fifth will die due to that reason (Polski Komitet Zwalcznia 
Raka) i ii
Barot, 2012
. Breast cancer prevalence in Poland equals to 425.6 cases per 100,000 people and 
cervical cancer to 164.6 per 100,000 people (Lutz et al., 2003). In most of the developed world 
prevention and effective treatment are the main methods in the fight against cancer ( ). 
However, some groups of people may have limited or unequal access to relevant preventative 
measures which could contribute to health inequalities (Van der Meer and Mackenbach, 1998) 
and in case of cancer morbidity this could mean a higher risk of premature mortality especially 
                                                 
 
i http://www.um.torun.pl/torun/baza/pierwsza.php?status=1&news_id=6394 
ii http://www.diagnosis.pl/polski-komitet-zwalczania-raka-5183.html 
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amongst the more disadvantaged populations i.e. communities living in post-Soviet states that 
often experience a lower standard of care but also lack nationally available disease screening (see 
Vrdoljak et al., 2011). Various researchers noted that a significant disparity in the public’s health 
still exists between Western and Central/Eastern Europe (Ádany et al., 2011, Carlson, 1998, 
Sagan et al., 2011) also affecting outcomes related to breast and cervical cancers (Jemal et al., 
2010, Autier et al., 2010). It has been stipulated that as collapsing communism forced post-Soviet 
states to open their markets to capitalism, the structure and welfare of the Eastern European 
societies changed considerably and in some cases worsened (Szaflarski and Cubbins, 2004). This 
worsening scenario was also observed in the context of health care provision as in many 
countries it was split between public and private sectors meaning that some people were not able 
to afford private health services (Sotiropoulos et al., 2003, Cerami, 2008). 
 
Political and socio-economic factors can influence not only accessibility of healthcare but also 
screening uptake and the general health of the country’s population (International Agency for 
Research on Cancer (IARC) Working Group on the Evaluation of Cancer-Preventive Strategies, 
2005; Steptoe and Wardle, 2001) specifically in a country like Poland affected in the past by 
turbulent external (World Wars I & II) and internal challenges (transition from communism). 
Such major changes could result in the country’s authorities and women themselves having a 
different understanding of, and approach to, health prophylaxis compared to countries that did not 
suffer changes of such magnitude (Mackenbach et al., 2008). Familiarity with screening 
predictors could help to inform interventions aiming to ascertain desired levels of uptake, 
especially those targeted at groups of women less likely to participate (Chumworathayi, 2012; 
Everett et al., 2011). As stated previously, breast and cervical cancers are amongst the leading 
causes of female mortality around the world but the majority of countries in Western and 
Northern Europe have seen a significant decrease in mortality due to these neoplasms since the 
1970’s (e.g., reduction in mortality of breast cancer ranged: 11%-45% and reduction in mortality 
of cervical cancer ranged 0.3%-15.6%) which have not been observed in Poland and other 
countries in Central and Eastern Europe (Arbyn et al., 2009; Autier et al., 2010). This decrease in 
Western European countries follows the first introductions of nationwide screening programmes. 
The beginning of these changing trends can be observed around the time of the national roll-out 
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of the screening and it has not been noted for the countries without such initiatives (for examples 
of the relevant mortality trends please refer to Autier et al., 2010 and Arbyn et al., 2009). Such 
initiatives may be not only of country’s attempt to decrease cancer mortality but also could raise 
women’s awareness of cancer risks and potentially lead to change of health behaviours. 
Whenever appropriate, information available for other European countries that began breast and 
cervical screening many years ago (e.g. UK, Finland, Norway) is discussed in this thesis. Such 
contextualisation of screening has been used before (see for example a policy brief prepared by 
Holland et al., 2006 for WHO) to gain a wider overview of the screening situation as well as 
facilitate learning from past experiences of other countries.  
 
In accordance with the Act of 1 July 2005 (Ministerstwo Zdrowia, 2005a) that followed the 
guidance of the European Code against Cancer Poland began a programme National Programme 
for Cancer Control to be implemented in the years 2006-2015 (Ministerstwo Zdrowia, 2005b). 
The adoption of the above legislation gave a guarantee of stable state funding for this programme 
with the aim of developing cancer prevention strategies, increasing early detection and the 
availability of treatments in line with the current level of medical advances. This is anticipated to 
lead to approximately 10% lower cancer incidence and improvements in the cancer treatment 
techniques to those comparable in Western and Northern Europe with a 50% five year survival 
rate in women and 40% in men by 2015 (Opolskie Centrum Onkologii, 2013, Ministerstwo 
Zdrowia, 2005b).  
 
The programme focuses in particular on: development of primary prevention of cancer (i.e. 
smoking cessation and improvements in nutrition); implementation of population based screening 
programmes (i.e. breast cancer, cervical cancer, colorectal cancer etc.); improvement of access to 
early cancer detection methods; modernisation of diagnostic and therapeutic equipment and 
procedures for high quality diagnosis and cancer treatment, standardization of the treatment 
procedures; promotion of combination therapy methods; development and promotion of modern 
methods of rehabilitation and palliative care; limitation of long term consequences of cancer 
treatment; improvement of the operations of cancer data collection, improvements in education of 
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health professionals and society about of knowledge about the prevention; and early detection 
and treatment of cancer (Ministerstwo Zdrowia, 2005a,b). 
In 2006, following the objectives of the National Programme for Cancer Control, Poland 
introduced nationwide population-based and state funded breast and cervical screening 
programmes. The programmes’ roll out was initiated in 2007 with the aim to reduce mortality 
and improve the health of the population, and at the same time to decrease the gap between health 
outcomes in Poland and Western Europe. However, a nationwide and cost free screening 
programme may not be effective in achieving its objectives if the population that the programme 
is aiming at does not, or only a small proportion of it, participate in it (Mauad et al., 2009). 
Health behaviours, such as attendance to prophylactic cancer screening tests in transitional 
regions such as Poland may be influenced by different factors than in the Western European 
countries. It has been previously noted that women from Eastern European populations from 
post-Soviet states developed a different way of perceiving their own health, worse prioritisation 
of their health needs leading to lower self-rated health to those reported in Western societies 
(Szaflarski and Cubbins, 2004). The citizens of many of those post-Soviet states remain 
insufficiently involved in their health care (Fister and McKee, 2005) and this may be particularly 
relevant for initiatives such as screening that require individuals to take a decision to attend it.  
 
Since the 1950’s many researchers have tried to explain and predict behaviour by constructing 
theoretical frameworks (see section 2.7.) to identify its determinants (Noar and Zimmerman, 
2005; Ogden, 2003; Taylor et al., 2006). Health behaviours are complex and subject to variability 
between not only populations of different countries but also within regions or even groups with 
different socio-economic status (Adler and Newman, 2002; Whitehead, 1992; Mladovsky et al., 
2009; Palencia et al., 2010). They have been found to comprise some of the following 
components: knowledge, past behaviours and experiences, cues to action, health beliefs, attitudes, 
and many other factors that can be used as predictors for health related behaviours amongst the 
target screening populations (Noar and Zimmerman, 2005; Day et al., 2010; Ogden, 2003; Taylor 
et al., 2006). Many of these factors have been used in theoretical models aiming to predict or 
influence health behaviours such as screening uptake (sections 2.6-2.7). 
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Various international and multi-ethnic studies have been conducted on the factors that may 
influence the level of uptake of breast and cervical cancer screening such as women’s knowledge, 
behaviours, attitudes, cues to action and other factors related to screening have been carried out in 
the past (for example Fylan, 1998; Austin, et al., 2002; McCaffery et al., 2003; Elmore et al., 
2005; Thomas et al., 2005; Jepson et al., 2000; Thomas et al., 2005; Weller and Campbell, 2009; 
Byrd et al., 2007). However, only a few studies examining the Polish population have been 
found, and their data either did not take into account both breast and cervical screening or the 
sample was small and purposive (for example: Chojnacka-Szawłowska, 1998; Zych, et al., 2006; 
Gronwald et al., 2006 described in more detail in chapter 2).  
 
Understanding the predictors of behaviour is particularly important for population-based disease 
screening initiatives which are often very costly, labour intense, and if not taken up by the target 
population, ineffective and burdensome for governments (Jepson et al., 2000). Identification of 
factors that may affect screening uptake in Polish society can help to generate evidence needed 
for improving population health, by gaining an understanding of which factors need to be 
particularly paid attention to in order to design screening programmes for this specific 
population. The results of this study will provide a basis for making inferences not only about 
cancer screening predictors in Poland but also for countries with a similar geo-political 
background that are still yet to introduce nationwide cancer screening initiatives. Romania or 
Bulgaria can serve as examples of such countries. Autier et al. (2010) noted that even though 
many countries saw a significant decrease in breast cancer mortality between 1989 and 2006, 
Bulgaria experienced only a small decrease (-0.8%) and Romania conversely experienced a 
significant increase of 17% (Autier et al., 2010). Similar trends were shown for the years 1970-
2004 with regards to cervical cancer mortality, as in Romania mortality rose by 0.4% annual 
percentage of change and in Bulgaria by 3.5% (not significant statistically after 1988) (Arbyn et 
al., 2009). 
 
The study is timely as to-date no nationally representative studies exploring Polish women’s 
knowledge and behaviours related to breast and cervical cancer and their prophylaxis exist. 
Despite the fact that the Polish screening programme has now been rolled out nationally, only 
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31%-39.8% of Polish women have taken up mammography and 76.7% cytology (Central 
Statistical Office of Poland, 2012c; Madej et al., 2010). The data analysed and described in this 
study was collected immediately before the nationwide rollout of cervical and breast screening 
programmes in Poland providing a unique opportunity to study elements of screening behaviour 
amongst women in a society with a difficult historical and political past (that made transition to 
democracy less than 25 years ago). This thesis explores factors that have been suggested by the 
scientific community as those having potential to influence the uptake of cancer screening 
initiatives such as: type of cancer, cancer screening knowledge, current and past screening 
behaviours, and various socio-demographic and economic characteristics (Jepson et al., 2000 or 
Consedine et al., 2004).  
 
1.2. Aim of the study 
 
The aim of this study was to identify which factors may serve as potential predictors of the 
uptake of breast and cervical cancer prophylaxis and assess the levels of knowledge and 
behaviours related to screening behaviours in Poland on the brink of the introduction of 
centralised and nationwide screening programmes for breast and cervical cancer detection. The 
study also aimed to assess different socio-demographic and socio-economic circumstances as 
potential facilitators or barriers to screening.  
 
1.3. Research questions 
 
The questions that this thesis will answer are: 
1. What were Polish women’s knowledge levels related to breast and cervical cancers and 
their prophylaxis and how did their knowledge relate to known evidence of prophylaxis? 
2. Did Polish women practice positive breast and cervical screening behaviours 
(mammography, cytology, and BSE)?  
3. Which factors did Polish women consider as barriers to attending breast and cervical 
screening? 
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4. What factors (e.g., socio-demographics, socio-economics, cancer and cancer screening 
knowledge) can be considered predictors of breast and cervical cancer screening 
behaviours in Poland? 
 
1.4. Objectives 
 
The specific objectives were to: 
- Identify and characterise socio-demographic and socio-economic factors associated with 
uptake of the screening services by Polish women in relation to knowledge, behaviours, 
and other factors on the brink of the introduction of a national screening programmes for 
breast and cervical cancer detection 
- Explore and describe the knowledge, behaviours, past experiences and other factors (i.e. 
motivators/cues to action) relating to cervical and breast cancers and their screening 
among Polish women 
- Explore and identify potential cancer screening behaviour predictors 
- Explore and identify potential cancer screening behaviour barriers 
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1.5. Research methodology 
 
Data described in this thesis was extracted from a large nationally representative survey 
conducted in Poland in 2006: Wiedza o nowotworach i profilaktyce -Knowledge about cancer 
and health prophylaxis. It was carried out by the Social Research Laboratory (Pracownia Badań 
Społecznych-PBS DGA) for the Epidemiology Division at the Cancer Oncology Institute in 
Warsaw, Poland. The structured questionnaire was completed at women’s homes with the help of 
trained nurses (interviewers). It collected data relevant to respondents’ knowledge, behaviours 
and past experiences related to all cancer types and general health prophylaxis. In this thesis, only 
the data from sections of the questionnaire relevant to breast and cervical neoplasms and their 
prophylaxis, answered by women, were extracted and analysed in a quantitative  way (secondary 
data analysis). Further details of the methodology used to collect the data have been given in 
chapter 3. 
 
1.6. Summary 
 
Chapter one has given the introduction and orientation of the study, the research problem, aims 
and objectives, an overview of the methodology and the further outlay of the research report. The 
next chapter will provide a review of literature on the topics relating to the study.  
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CHAPTER 2 LITERATURE REVIEW 
 
2.1. Introduction  
 
2.1.1. Aims of the literature review 
 
The main aim of this review was to examine the literature on the factors with a potential to affect 
the uptake of breast and cervical cancer screening with particular focus on screening in Poland. It 
was also intended to provide a conceptual framework for the analysis of the study results and 
further definition of the research questions (section 1.3). Topics discussed in this chapter covered 
relevant literature on: breast and cervical cancer epidemiology and predictors of breast and 
cervical screening. The review also explored the role of health care system in Poland and its 
historical changes. It provided broader background for understanding the existing and future 
challenges of introducing screening in countries without centralised and population based 
screening, especially those that transitioned from communism to democracy and as a result 
experienced many economic, political, and social changes (e.g., Bulgaria or Romania). 
 
The following topics were covered: 
 
• Health care system in Poland and its historical context  
• Epidemiology of breast and cervical cancer 
• Breast and cervical cancer prevention and detection 
• Determinants of breast and cervical cancer screening 
• Knowledge, behaviours, cues to action and other factors related to breast and cervical 
cancer screening 
• Concepts, constructs, and theories associated with screening behaviour  
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2.1.2. Methods used to identify the relevant literature 
 
The main body of literature concerning the investigation of breast and cervical cancer screening 
and factors affecting their uptake consisted predominantly of peer reviewed articles found in 
electronic databases such as PubMed, PsychINFO, ISI Web of Science, and EMBASE with 
Medline, ERIC, CINAHL and Google Scholar. Some of the terms used to search for the relevant 
literature included but were not limited to a combination of terms: “access”, “attitudes”, 
“awareness”, “beliefs”, “behaviour/behavior”, “behavioural/behavioral theory”, “breast”, 
“cancer”, “cancer screening”, “cervical”, “cervix”, “determinants”, “health”, “health belief 
theories”, “health belief model”, “income”, “inequities”, “inequalities”, “knowledge”, 
“perceptions”, “Poland”, “Polish”, “predictors”, “screening”, “socio-economic”, “uptake”, 
(including searches that mapped onto related subjects in particular databases). To ensure that the 
relevant literature was identified also search terms in Polish were employed (following the logic 
of the searches conducted in English). 
 
Additionally, a search for “grey” or otherwise not listed literature (i.e. reports, conference 
abstracts, government and health services’ documents) was employed with help of the freely 
available search engines such as Google (.com, .co.uk, and .pl), WHO and other governmental 
websites. Also several additional publications and information leaflets were obtained directly 
from Polish health care centres, through personal contacts or gleaned from the reference sections 
of identified material. Main searches for relevant publications were done in English and Polish. 
However, if a relevant article was identified through the main search, also articles in other 
languages, spoken by the researcher, were taken into consideration (i.e. articles in Spanish or 
French). Even though no specific time cut-off points were selected for the searches it was 
intended to review publications relatively recent to the conduct of the survey analysed in this 
thesis (2006) and which were later supplemented with more recent publications.  
 
Throughout this work, where appropriate, the information on breast and cervical screening is put 
in context of countries that have extensive experience of both types of the screening (i.e. UK 
with nationwide screening from the late 1980’s). It was not intended to make direct comparisons 
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with Poland but merely to provide context to screening initiatives by highlighting the challenges 
and identify the potential benefits that the national screening programme could achieve in 
Poland. 
 
2.2. Historical background of the health care system in Poland 
 
Poland is the largest (312,679 square kilometres) amongst Central Eastern European countries 
with a population of 38.5 million people. It has a democratic parliament composed of upper and 
lower houses that are elected every four years and a president and prime minister heading the 
government elected every 5 years (Sagan et al., 2011). Territorial administration is divided into 
three levels: the top level - województwo (voivodship or region) (please see figure 7), the middle 
level - powiat (district), and the lowest level - gmina (municipality) (Sagan et al., 2011).  
 
Even though Poland is now a democratic republic it has not always been this way. Since the end 
of World War II, Poland remained under Soviet influence and followed the same health 
imperatives as the rest of the Soviet world, providing free generally available health services 
(both primary and secondary care) (Balabanova and McKee, 2002) and therefore it faced the 
same advantages and disadvantages. For example McKee (2004) noted that in the 1920-1950s, 
Russia’s health situation was a legacy from imperial times and that Lenin’s political commitment 
incorporated a goal to control epidemics and improve health care. Provision of basic health 
services to a widely spread population noticeably improved health outcomes as it helped to 
control and even eradicate some endemic diseases (i.e. smallpox) (McKee, 2004). This brought 
many beneficial changes to the people of the Soviet Union and its satellite states such as Poland.  
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Figure 1 Regional division of the territory of Poland (16 voivodships)iii
 
 
 
However, at the beginning of the 1990’s, after the fall of the Soviet-style model Poland and 
many other post-Soviet countries had to undergo a full transition to a freely elected parliament 
with a market economy and experienced a number of fundamental reforms of many sectors, 
including health care (Sagan et al., 2011; Kuszewski and Gericke, 2005). Changes of such 
magnitude created conditions for instability in public health in most of the affected countries of 
the Central and Eastern Europe (Carlson, 1998; Fister and McKee, 2005; Jenkins et al., 2005). 
Health care improvements such as the development of new vaccinations and use of advanced 
technologies and training of highly qualified specialists in the West were financially challenging 
and impossible to match by the falling economy of the Soviet world (McKee, 2004). The health 
                                                 
 
iii Source: d-maps.com (free maps) http://d-maps.com/carte.php?num_car=18758&lang=en 
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improvements previously implemented could not be supported by the socialistic system (McKee, 
2004) and unstable economic growth contributed to income and social inequalities linked with 
increased morbidity and mortality (Jenkins et al., 2005). Western Europe was advantageous in 
comparison to post-communist countries in all above aspects (Carlson, 1998). Inequalities in 
socio-economic spheres of life increased but the information on inequalities in healthcare 
utilisation is still limited (Plug et al., 2012; Balabanova and McKee, 2002). 
 
Poland was the first country among the Central and Eastern European countries to reintroduce 
democracy after over 40 years of communism (Kuszewski and Gericke, 2005). It provided 
universal free health care (Siemashko system) prior to its transition from communism in 1989. 
The early 1990’s brought an economic shock and many government resources had to be 
restructured (Łoś, 2006). In 1991 a new structure of health care organisation was introduced, and 
the Independent Public Health Care Facilities - SPZOZ – (Samodzielny Publiczny Zakład Opieki 
Zdrowotnej) became the bodies responsible for buying medical services, administering and 
managing public health funds (Golinowska and Kozierkiewicz, 2008).  
 
In 1997, Polish Constitution guaranteed that every Polish person has the right to health care 
financed from public funds (Golinowska and Kozierkiewicz, 2008); but as Poland was 
undergoing serious economic changes it also faced two major reforms of the national health 
system (Ministerstwo Zdrowia, 2001-2003). In 1999, a new reform of Polish health care was 
implemented, and sixteen new regional Health Funds with one additional occupational health 
fund for uniformed public employees (i.e. army, police and others) were formed (Golinowska 
and Kozierkiewicz, 2008). The funds, according to the Law of Universal Health Insurance, were 
responsible for the management of health services by signing contracts with health care units. 
Citizens could freely choose their health provider independently of their habitual residence 
(Golinowska and Kozierkiewicz, 2008). 
 
The reform was widely criticised by patients, medical communities, and politicians (from the 
parties opposing those in power) (Golinowska and Kozierkiewicz, 2008) as it influenced the free 
access to health services (Łoś, 2006) by diminishing accessibility to conceptually free health care 
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resulting from the lack of clearly defined scope and type of available services (Golinowska and 
Kozierkiewicz, 2008). Even though the government worked to solve the challenges associated 
with the implementation of this reform (e.g. improving administration of and access to the health 
services), the lack of relatively quick visible health care improvements, financial problems of the 
regional funds, and high prices in private health care caused patients to mistrust towards the 
health care sector (Golinowska and Kozierkiewicz, 2008; Kuszewski and Gericke, 2005). This 
led to wide spread criticism and an unfavourable image reinforced by the mass media 
(Golinowska and Kozierkiewicz, 2008; Kuszewski and Gericke, 2005). As a result of these 
problems the funds merged once again in the second health care reform in 2003 to form a single 
National Health Fund (NHF) (Kuszewski and Gericke, 2005). Since then due to rising 
employment and fast economic growth the financial problems of Polish health care have 
decreased (Kuszewski and Gericke, 2005). However, some hospitals were still in debt and the 
financial situation of the Polish health system was delicate in 2005 (Sagan et al., 2011). 
Privatisation of public hospitals was proposed in order to overcome the financial problems. This 
proposal has been widely opposed by society due to fears of creating deeper inequities and 
inequalities in health care access amongst poorer and or more disadvantaged layers of the society 
(Sagan et al., 2011). However, privatization is taking place and as Sagan et al. (2011) noted the 
results of this will only be possible to assess with time (Sagan et al., 2011). 
 
Since the last reforms Polish health care is divided between public and private financing. Both 
public and private health care are still often financed by both formal and informal payments i.e. 
gifts prior or after the treatment (Lewis, 2007; Kuszewski and Gericke, 2005). Those informal 
payments are considered a legacy of post-Soviet societies (Allin et al., 2006), as the medical 
professionals used to supplement their low salaries by either working at several establishments or 
accepting such informal payments as an expression of patient’s gratitude (Golinowska and 
Kozierkiewicz, 2008). Such informal payments could be a factor strengthening the disparities in 
access to and quality of care between the different socio-economic layers of Polish society, as 
well as slowing down the needed improvements (Chawla et al., 1998).  
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Since Poland became a member of the European Union in 2004 it started actively working 
towards meeting European guidelines on the improvement of accessibility, the level of modern 
treatments available, and creating nationwide disease preventative initiatives, such as screening 
programmes for the most common cancers and circulatory system disorders (Ministerstwo 
Zdrowia, 2005b; Ministerstwo Zdrowia, 2012). These nationwide programmes focus on disease 
prevention and health promotion and are fully funded by the state through mandatory income tax 
contributions (Kuszewski and Gericke, 2005; Ministerstwo Zdrowia, 2001-2003). Through the 
implementation of successful population screening, cancer education and decrease of preventable 
environmental risk factors, they aim to limit the rising incidence of breast cancer and improve 
detection of cervical cancers improving outcomes of these cancers in Poland (Ministerstwo 
Zdrowia, 2005b). Studies such as the survey analysed in this thesis help to uncover and 
understand which factors may predict or act as barriers or motivators to achieving desired 
screening uptake levels and therefore serve to inform the relevant policies. 
 
2.3. Breast cancer epidemiology 
 
2.3.1. Incidence and mortality  
 
Breast cancer is a type of cancer originating in the milk ducts (ductal breast cancer) or lobules 
(lobular breast cancer) of breast tissue. It may be invasive or non-invasive. In rare cases, breast 
cancer can originate in other types of breast tissue (Sandeep et al., 2012). It is the most common 
cancer in women, accounting for about 23% new female cancers diagnosed each year around the 
world (Madej et al., 2010; GLOBOCAN, 2008a). The incidence of breast cancer is rising around 
the world (IAEA, 2011) as well as in Poland and other post-Soviet states (Autier et al., 2010). 
These rising trends have been mostly associated with lifestyle ‘westernisation’ (e.g., dietary 
change, physical inactivity, Hormone Replacement Therapy (HRT) exposure, late parity etc) 
(IAEA, 2011) and improving detection rates related to screening (Autier et al., 2010). The crude 
annual incidence of breast cancer in the world in 2008 has been estimated as 89.1 per 100,000 
population and in Poland, as 48.9 per 100,000 population with population of over 38 million 
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(Central Statistical Office of Poland, 2012a; GLOBOCAN, 2008a). Age standardised mortality 
rates from this cancer in 2008 in Poland were 14.7 per 100,000 people (GLOBOCAN, 2008a).  
 
Table 1 below shows changes of breast cancer mortality between 1987-9 and 2004-6 in many 
countries in Europe. Decline in mortality is seen in some countries at the time of the introduction 
of national screening. For example in England and Wales mortality decline began in 1989 after 
the introduction of breast screening programmes available nationally for women aged 50-64 
(Autier et al., 2010; CRUK, 2012). It decreased from 41.9% in 1987-9 to 28.1% in 2004-6. Other 
countries (e.g., Norway, Iceland, Luxembourg, and Ireland) also saw similar decreases in 
mortality (Autier et al., 2010). However, countries in Eastern Europe (without centralised 
screening) such as Poland, did not observe similar decline or the data needed to assess these 
trends was unavailable (Olsen et al., 2013; Autier et al., 2010). Therefore the development and 
implementation of national breast screening in Eastern Europe countries such as Poland were 
suggested as having the potential to bring measurable benefits to the screened population as 
earlier detection could mean earlier and more successful treatment resulting in decreased 
mortality (Autier et al., 2010).  
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Table 1 Changes in breast cancer mortality between 1989 and 2006 in European countries ranked according to overall decline in 
mortality (reproduced from Autier et al. 2010) 
   Mortality change for all ages (%) 
Mortality change 1989-2006 by age group 
(%)      
 Mean mortality* For 1989-2006    Annual change Overall change  
Country 1987-9 2004-6 Annual Overall 
Year for 
start of 
decline 
Annual 
change 
1999-
2006 
 <50 50-69 ≥70 <50 50-69 ≥70 
cause of 
death data 
quality§ 
Iceland 33.1 23.5 −3.4 −44.5 1995 1.1   −8.1 −2.5 −3.1 −76.3 −35.0 −41.5 High 
England and 
Wales 41.9 28.1 −2.5 −34.9 1989 −2.0   −3.2 −3.0 −1.5 −42.1 −40.1 −22.6 High 
Luxembourg 36.3 22.9 −2.4 −34.1 1988 −2.8   −5.3 −2.5 −1.3 −60.0 −34.9 −19.9 Medium 
Scotland 39.3 29 −2.1 −29.9 1990 −1.4   −2.9 −2.7 −0.7 −39.1 −37.2 −11.9 High 
Northern 
Ireland 37 28.1 −2.0 −29.2 1991 −1.2   −3.8 −2.6 0 −48.2 −36.2 −0.7 High 
Austria 31.8 24.5 −1.8 −26.8 1990 −1.6   −4.0 −1.7 −1.1 −50.3 −25.3 −16.9 Medium 
Spain 23.7 18.9 −1.8 −26.8 1992 −2.2   −3.4 −2.1 −0.3 −44.7 −30.3 −4.6 Medium 
Ireland 40.3 30.5 −1.8 −26.4 1991 −2.3   −3.2 −1.9 −1.0 −42.7 −27.2 −15.7 High 
Netherlands 39 30.1 −1.7 −25.1 1993 −2.7   −1.7 −1.9 −1.4 −25.3 −27.8 −20.9 Medium 
Norway 27.4 21.5 −1.6 −24.3 1995 −2.2   −2.5 −1.5 −1.4 −35.2 −22.6 −20.8 Medium 
Italy 29.7 23.2 −1.5 −22.8 1991 −1.6   −2.7 −1.7 −0.7 −36.7 −24.9 −11.0 Medium 
Switzerland 30.5 24 −1.5 −22.7 1985 −1.1   −2.2 −1.2 −1.7 −30.9 −18.5 −24.7 Medium 
Germany 31.3 26.2 −1.4 −21.3 1999 −1.5   −3.5 −1.3 −0.5 −45.5 −20.2 −8.9 Medium 
Denmark 40.5 32 −1.4 −20.8 1995 −2.6   −3.8 −1.7 0.1 −48.5 −25.7 1.3 Medium 
Belgium 37.5 29.7 −1.3 −20.3 1986 −2.4   −2.7 −1.5 −0.4 −36.7 −22.0 −7.2 Medium 
Portugal 23.9 NA −1.1 −17.8 1992 −0.9   −2.7 −1.4 0.4 −36.9 −21.5 6.5 Low 
Czech Republic 30.6 26.4 −1.1 −17.8 1994 −1.2   −3.7 −1.7 0.5 −47.2 −25.5 8.6 Medium 
Slovenia 30.7 26.3 −1.0 −16.1 1993 −2.1   −4.1 −1.1 0.5 −51.3 −17.3 9.1 High 
Sweden 25.6 22 −1.0 −16.0 1972 −0.6   −2.6 −1.0 −0.3 −35.7 −15.9 −4.3 Medium 
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   Mortality change for all ages (%) 
Mortality change 1989-2006 by age group 
(%)      
 Mean mortality* For 1989-2006    Annual change Overall change  
Country 1987-9 2004-6 Annual Overall 
Year for 
start of 
decline 
Annual 
change 
1999-
2006 
 <50 50-69 ≥70 <50 50-69 ≥70 
cause of 
death data 
quality§ 
Finland 24.5 21.4 −0.7 −11.7 1990 −1.5   −2.3 −0.7 0 −32.6 −10.8 0.1 High 
Hungary 32.4 29 −0.7 −11.4 1994 −3.1   −2.4 −0.5 −0.1 −34.4 −8.3 −2.4 High 
France 28.5 25.6 −0.7 −10.7 1994 −1.4   −0.9 −0.9 −0.1 −14.3 −14.9 −1.6 Medium 
Poland 21.5 21.1 −0.4 −5.9 None −0.1   −2.5 −0.3 0.8 −34.5 −4.3 14.6 Low 
Slovakia 23.6 23.4 −0.1 −1.5 2000 −3.2   −2.1 −0.1 1.1 −30.7 −1.9 20.5 High 
Bulgaria 21.3 22.2 0 −0.8 1988 0.8   −1.7 0.1 0.9 −25.5 2.3 16.2 Medium 
Lithuania 22.9 23.2 0 −0.7 None −1.1   −2.7 −0.3 2.7 −37.0 −4.3 58.1 High 
Greece 21.9 22.2 0.1 1.4 NR 0.2   −3.0 −1.1 3.5 −40.6 −17.8 80.2 Low 
Estonia 20.9 23.6 0.5 9.6 NR −3.1   −2.0 0.6 2.2 −29.0 11.4 44.9 High 
Latvia 22.5 25.1 0.6 11.4 NR 0   −0.9 0.6 2.2 −13.7 10.2 43.6 High 
Romania 19.9 23.1 0.9 16.6 NR 0   −1.1 0.8 2.8 −17.6 14.3 59.3 High 
Summary statistics 
Median 30.1 24 −1.2 −19.0 NR −1.5   −2.7 −1.4 −0.1 −36.8 −20.8 −2.0 NR 
Minimum 19.9 18.9 −3.4 −44.5 NR −3.2   −8.1 −3.0 −3.1 −76.3 −40.1 −41.5 NR 
Maximum 41.9 32 0.9 16.6 NR 1.1   −0.9 0.8 3.5 −13.7 14.3 80.2 NR 
NA= not available; NR=not relevant. 
*Age adjusted (European standard) rate per 100 000 women. 
†Data for 2004-5 for Spain, Hungary, Slovakia, and Estonia; data for 2004 for Belgium; data for 2006 for Italy; 2003 was the last year of data for Portugal. 
§Quality of information on cause of death according to WHO (Autier et al., 2010). 
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Figure 2 Percentage changes in breast cancer mortality in Europe during 1989-2006 
according to the mean breast cancer mortality in 1987-9 (reproduced from Autier et al. 
2010) 
 
Key: 
AT=Austria; BE=Belgium; BG=Bulgaria; CH=Switzerland; CZ=Czech Republic; DE=Germany; DK=Denmark; 
EL=Greece; EE=Estonia; ES=Spain; EW=England and Wales; FI=Finland; FR=France; HU=Hungary; 
IC=Iceland; IE=Republic of Ireland; IT=Italy; LT=Lithuania; LU=Luxemburg; LV=Latvia; NI=Northern Ireland; 
NL=Netherlands; NO=Norway; PL=Poland; PT=Portugal; RO=Romania; SC=Scotland; SE=Sweden; 
SI=Slovenia; SK=Slovakia 
 
Figure 2 depicts the changes in breast cancer mortality between years 1987 and 2006 
(presented numerically in table 1). Countries with centralised and population based screening 
such as England and Wales, Iceland, Scotland, Northern Ireland, and others experienced a 
much more pronounced decrease of breast cancer mortalities than the countries which did not 
have such initiatives (e.g. Poland, Bulgaria, Estonia, Romania, etc). Also, the countries in 
Eastern Europe have lower mortality making the difference between the countries even more 
contrasting. However, WHO noted in a recent report (2012) on world health statistics that 
currently only 34 countries worldwide (including UK) record high-quality data on the 
mortality cause and lower mortality rates may be due to potential underreporting or 
insufficient quality of data in those countries (WHO, 2012c).  
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In order to provide greater detail on breast cancer mortality rates in Poland and complement 
the evidence reported by Autier et al. (2010) above, the data from online WHO Cancer 
Mortality Database (WHO, 2012b) was compared with the United Kingdom, a Western 
European country that had both types of screening programmes since the late 1980’s (breast 
screening for women 50-64 once every three years and cervical screening for women aged 25 
to 64 every three to five years) (Cancer Research UK, 2009; NHS Cancer Screening 
Programmes, 2008). These comparisons were done for three age groups: 20-44, 45-69, and 70 
and over to take into consideration the fact that as there was no population-based screening in 
Poland and some women from age groups other than the target screening population could 
have been screened during ad hoc screening actions. The breast and cervical cancer mortality 
trends showed mirroring trends of breast cancer mortality in Poland and the UK for the 
youngest age group (20-44) and a narrowing gap for the remaining age groups but mainly due 
to rising mortality in Poland. The figures below (Figures 3-5) depict that around the time of 
the introduction of national cancer screening in the UK (1988) mortality started rapidly 
decreasing.  
 
Figure 3 Comparison of breast cancer mortality trends 1959-2010 between Poland and 
the United Kingdom (standardized rates per 100,000 population) for women aged 20-44 
(data was sourced from online Cancer Mortality Database, WHO, 2012)  
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Figure 4 Comparison of breast cancer mortality trends 1959-2010 between Poland and 
the United Kingdom (standardized rates per 100,000 population) for women aged 45-69 
(data was sourced from online Cancer Mortality Database, WHO, 2012) 
 
The decline in mortality was especially notable in the 45-69 age group (from 91.5 per 100,000 
in 1989, through 62.0 per 100,000 in 2000, to 45.9 per 100,000 in 2010). However, no such 
decrease can be observed in Poland before the introduction of nationwide screening in 2006 
and after the introduction the decrease was only from 44.6 per 100,000 in 2006, to 41.6 per 
100,000 in 2010. In the 20-44 age group the most pronounced decrease was seen in both 
countries from 1989 (in the UK: from 10.3 per 100,000 in 1989 to 5.7 per 100,000 in 2010; in 
Poland: from 6.7 per 100,000 in 1989, to 3.5 per 100,000 in 2010).  
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Figure 5 Comparison of breast cancer mortality trends 1959-2010 between Poland and 
the United Kingdom (standardized rates per 100,000 population) for women aged 70 or 
over (data was sourced from Cancer Mortality Database, WHO, 2012 available online) 
 
Mortality among women aged 70 or over differed between the two countries as there was 
some decrease in mortality in the UK (from 195.8 per 100,000 in 1989, through 164.6 per 
100,000 in 2000, to 154.7 per 100,000 in 2010) and in Poland an increase can be seen (from 
80.3 per 100,000 in 1989, through 90.6 per 100,000 in 2000, to 95.3 per 100,000 in 2010). 
However, neither age group 20-44 nor over 70 were included in the nationwide breast 
screening. Increasing mortality trends in Poland could be associated with ‘westernisation’ of 
the lifestyle (e.g., increase of highly caloric foods, decrease of physical activity, later parity 
etc) (International Atomic Energy Agency (IAEA), 2011; Autrier et al., 2010) (for risk factors 
see section 2.3.2). Poland has been indicated by WHO (2012) as one of the countries with low 
quality data (WHO, 2012c). Therefore, lower mortality in Poland than in the UK presented 
above (for cervical cancer mortality trends please see section 2.4.1.) recorded before the 
1970’s may be related to underreporting or insufficient quality data that is often seen in post-
Soviet states (Anderson et al., 1994) rather than actual low mortality from these cancers. 
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2.3.2. Risk factors 
 
Breast cancer incidence and mortality vary greatly around the world with higher rates 
presenting in the more developed countries (Key et al., 2001; Parkin and Fernández, 2006). 
Even though, the aetiology of breast cancer is unknown, numerous factors have been 
described previously as being associated with increased or decreased risk of cancer 
development (Jardines et al., 2011). Those risk factors have been divided into: hereditary, 
endocrine, reproductive, environmental and life-style factors (e.g., diet, physical activity, toxic 
substance exposure) (Garcia-Solis and Aceves, 2005) which are described in more detail 
below. Where appropriate the evidence available prior to 2006 is highlighted and any 
information that came into light since then discussed. The reviewed publications were 
assessed by exploring several characteristics that are widely considered as quality indicators 
(Greenhalgh, 1997; Guyatt et al., 2008; Hemingway and Brereton 2009; York: Centre for 
Reviews and Dissemination, 2008). The following characteristics contributed to strengthening 
of the evidence: study size, representativeness of the included subjects or studies for literature 
reviews/meta-analyses (inclusion/exclusion criteria), rigour of data collection and data 
analysis, smaller or less severe number of biases/study limitations, and journal quality (e.g., 
high impact factor) (Greenhalgh, 1997; Guyatt et al., 2008; Hemingway and Brereton 2009; 
York: Centre for Reviews and Dissemination, 2008). The characteristics that contributed to 
weakening of the evidence were characteristics inverse to items that increased the study 
quality. The overall strength of evidence depended on the quality and number of studies 
discussed in each of the sections. The strength of evidence obtained from the review of the 
literature was assessed for each of the sub-sections and displayed as ranging from one (‘♦‘) 
for the lowest level of quality of evidence to the highest number of four points (‘♦♦♦♦‘) for 
the highest quality of available evidence. The categories were described as ‘♦’- unclear 
evidence or evidence coming from studies with small very specific populations, ‘♦♦’- mixed 
evidence with majority of publications indicating at least some level of association, ‘♦♦♦’- 
studies providing strong evidence indicating existence of association, ‘♦♦♦♦’- studies 
providing very strong evidence indicating at association (for detail please see tables 2 and 5).  
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2.3.2.1. GENDER AND AGE  
 
Gender is indisputably one of the most important risk factors for the occurrence of breast 
cancer, as less than 1% of new breast cancers are observed in the male population (Walker, 
2009). Another of the most widely known risk factors for the development of breast cancer is 
increasing age (Martin and Boyd, 2008; Benson et al.; 2009, CDC, 2010). Breast cancer risk 
increases with age, doubling with every decade of life until the menopause (i.e. approximately 
around the fifth decade of woman’s life). In European countries median age at the beginning 
of menopause ranges from 50.1 to 52.8 years, in Americas from 43.8 to 53 years, and in Asia 
from 42.1 to 49.5 years (Palacios et al., 2010). Polish women have been found to experience 
menopause at median age 50.3-52.9 years (Szwejser and Szostek, 2012; Kaczmarek, 2007, 
Kaczmarek and Szwed, 2001; Chmara-Pawlinska and Szwed, 2004). After menopause the risk 
decreases and flattens reaching a plateau in women aged 80 years or over (Benson et al., 2009; 
Dixon, 2012; Key et al., 2001; McPherson et al., 2000; Walker, 2009).  
 
Increasing age as a risk factor for breast cancer has also been widely studied, not only by the 
scientific community, but also by governments and other policy makers, in order to inform the 
formation and implementation of screening services for women from specific age groups (for 
example: Canadian Task Force on Preventive Health Care et al., 2011 or U.S. Preventive 
Services Task Force, 2009). In 2011, the Canadian Task Force reviewed the existing evidence 
to provide recommendations on screening for breast cancer in women aged 40–74 years that 
were assumed to be an average risk group. They also concluded that according to the existing 
evidence of the relative risk of death from breast cancer mammographic screening 
recommendations should be made for women aged 50–69 years and 70–74 years every two to 
three years and not for women aged 40–49 years, as the absolute benefit for them is lower due 
to lower risk in comparison to their older counterparts (Canadian Task Force on Preventive 
Health Care et al., 2011). There was no sufficient data for those over 75 years old (Canadian 
Task Force on Preventive Health Care et al., 2011). Further information on mammography and 
screening age can be found in the section 2.5.1.  
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2.3.2.2. FAMILY HISTORY AND GENETIC FACTORS 
 
Family history of breast cancer has been established by many different studies as a strong risk 
factor for breast cancer (Pharoah et al., 1997; Easton, 2002). For example an increase of breast 
cancer risk has been seen especially amongst first degree relatives (e.g., mother daughter, 
father, son, and sibling) of pre-menopausal breast cancer patients. The risk was found to be 9 
times higher in women with bilateral cancer and a first degree relative affected by it, in 
comparison to a 5 fold risk for bilateral breast cancer patients who did not have a first degree 
relative affected by breast cancer (Walker, 2009). The level of that risk differs between 
individuals and also depends on the number and type of relatives affected, as well as the age at 
which they developed the disease. Pharoah et al. (1997) summarised the available published 
evidence on family history as a risk factor and for age specific risks. Relative risk (RR) for 
women with any relative affected by breast cancer was 1.9 (95% CI, 1.7-2.0); for a first-
degree relative 2.1 (95% CI 2.0-2.2) (i.e. mother, RR=2.0 (95% CI 1.8-2.1); sister, RR=2.3 
(95% CI 2.1-2.4); daughter, RR=1.8 (95% CI 1.6-2.0); mother and sister, RR=3.6 (95% CI 
2.5-5.0); and a second-degree relative (grand parent, grandchild, uncle, aunt), RR=1.5 (95% 
CI 1.4-1.6) (Pharoah et al., 1997). Also, later studies confirmed that family history is strongly 
associated with breast cancer. For example Virnig et al. (2010) conducted a structured 
literature review on the incidence of ductal carcinoma in situ (DCIS), commissioned by the 
National Institutes of Health Office of Medical Applications of Research in the US. They 
found that breast cancer in a first degree relative or another family member is associated with 
increased odds ratio (OR) of DCIS (pooled OR=1.97, 95% CI=1.10- 3.52) (Virnig et al., 2010; 
National Collaborating Centre for Primary Care, 2006). 
 
This familial predisposition to breast cancer has been linked so far in about 10% - 25% of 
cases to two main gene mutations BRCA1 and BRCA2, the most prominent amongst families 
with high risk (Key et al., 2001; McPherson et al., 2000; Antoniou and Easton, 2006; Edlich et 
al., 2006). These genetic mutations are linked to DNA repair mechanisms and account for 
approximately 3/4 of hereditary breast cancer cases (Benson et al., 2009). Both of the 
mentioned mutations have been found in large proportions (46.9%-67%) of Polish families 
with high risk of breast cancer (families with more than one relative with breast cancer) 
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(Gorski et al., 2004; Rogozinska-Szczepka et al., 2004; Ratajska et al., 2008). Often members 
of the families that suffer from breast cancer also experience increased occurrence of other 
cancers (i.e. ovarian, prostatic, and colon) that are attributable to the same genetic mutation 
(Key et al., 2001; Liede et al., 2004; McPherson et al., 2000). In fact BRCA1 or BRCA2 
mutations have been attributed to 11% to 40% lifetime ovarian cancer risk (Simard et al., 
1994; Antoniou et al., 2003; Chen and Parmigiani, 2007). It has been suggested that women 
with the increased risk of breast cancer should stay particularly breast aware and potentially 
consider prophylactic mastectomy (National Collaborating Centre for Primary Care (NCCPC), 
2006; Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology, 2006). 
For information on screening methods and recommendations please refer to section 2.5.1. 
 
2.3.2.3. AGE AT MENARCHE, MENOPAUSE, AND OTHER REPRODUCTIVE FACTORS 
 
Reproductive factors and the risk of breast cancer have been explored by many researchers. 
An increased risk has been observed in women who experience early menarche (younger than 
12 years old) and late menopause (after age of 55 years old) as those factors link to the 
prolonged exposure of the woman’s body to oestrogens (Key et al., 2001; Walker, 2009; 
Lacey et al., 2013; Okobia and Bunker, 2005; Collaborative Group on Hormonal Factors in 
Breast Cancer, 2012). Those who had their menopause after the age of 55 had double the 
likelihood of developing breast cancer of women with menopause at 45 years of age (Kelsey, 
1993; Key et al., 2001; McPherson et al., 2012; McPherson et al., 2000; Clavel-Chapelon and 
Gerber, 2002; Walker, 2009). A literature review by Velie et al. (2005) reported that the 
majority of studies show modest inverse breast cancer risk relationship with younger age at 
menarche but some of them showed that this effect is more pronounced in premenopausal 
women. The authors indicated that the breast cancer risk decrease for each year of delayed 
menarche was estimated to be 9% in premenopausal and 4% in post menopausal women 
(Velie et al., 2005). The association of the increased breast cancer and the above described 
factors has been linked to the prolonged exposure of the woman’s body to oestrogens known 
to have a negative effect on breast cancer risk (Key et al., 2001; Walker, 2009; Lacey et al., 
2013; Okobia and Bunker, 2005). 
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Older age at first childbirth (over 30 years old) and nulliparity were also found to increase the 
risk of breast cancer (Key et al., 2001; McPherson et al., 2000; Clavel-Chapelon and Gerber, 
2002; Velie et al., 2005; Schonfeld et al., 2011; Hoskins et al., 2005; Kobayashi et al., 2012). 
Schonfeld et al. (2011) showed that the overall aggregated hazard ratio (HR) for nulliparous 
women was 1.27 (95% CI 1.21-1.34) when compared with parous women (Schonfeld et al., 
2011). Velie et al. (2005) noted that the increased risk in nulliparous women was not observed 
until 40 years of age (Velie et al., 2005). A 50% risk reduction was observed for women who 
had a first full-term birth before the age of 20 (Kobayashi et al., 2012). However, first delivery 
after the age of 35 showed an increase of risk by 22% (Kobayashi et al., 2012). Velie et al. 
(2005) reported that there was a risk increase after first full-term pregnancy that peaked at 5 
years post-partum which later transformed into long term protection that was attained at 15 
years after delivery (Velie et al., 2005). This long term protection was observed to increase 
with the number of full term pregnancies (Velie et al., 2005; Kelsey, 1993; Ma et al., 2006; 
Kobayashi et al., 2012; Redondo et al., 2012). 
 
2.3.2.4. USE OF EXOGENOUS HORMONES  
 
Similarly as for reproductive factors, the use of exogenous hormones may result in prolonged 
exposure to oestrogen and evidence exists that the use of exogenous hormone therapy such as 
oral contraceptives (OC) and hormone replacement therapy (HRT) may increase breast cancer 
(Gadducci et al., 2005). However, this association has not been equivocal across the studies 
(Medard and Ostrowska, 2007; Althuis et al., 2004).  
 
Oral contraception 
Several reviews found that during the use of oral contraception and within 5-10 years after 
cessation there was 25% increase in the RR of breast cancer but after that time the risk was 
that of non-users (Key et al., 2001; Collaborative Group on Hormonal Factors in Breast 
Cancer, 1996; Cibula et al., 2010). Ever having used OC was significantly associated with 
increased breast cancer risk in women with first degree relatives affected by breast cancer 
(RR, 3.3; 95% CI 1.6-6.7), but not among those with second degree relatives (RR, 1.2; 95% 
CI, 0.8-2.0) (Grabrick et al., 2000). Key et al. (2001) noted that the use of combined OC was 
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linked to a larger number of localised cancers but they hypothesised that it was due to more 
frequent monitoring of the OC users (Key et al., 2001). They also suggested that due to the 
rarity of breast cancer in young women, the use of OC would not significantly increase the 
risk but it can have such potential in older women (Key et al., 2001). Later the Clinical 
Effectiveness Unit (CEU) (2011) review of the existing published evidence on benefits and 
risks of OC confirmed earlier findings by Key et al. by noting that there is approximately 24% 
increase in the risk of breast cancer increasing rapidly after OC initiation and decreasing to 
that of non users after OC is stopped (CEU, 2011). They noted that the evidence to date is 
unclear as to whether confounding variables played a role in the estimation of these risks, but 
also highlighted that women may be informed by their physicians that OC use has not been 
found to be associated with increase of long-term risk (CEU, 2011). It has been estimated that 
in Poland 5.1%-12% of women use this method of contraception (Center for Reproductive 
Rights, 2003; Binkowska et al., 2005). 
 
Hormone replacement therapy 
HRT use has been found to have an association with increased risk of breast cancer 
(McPherson et al., 2012; Steinberg et al., 1991; La Vecchia et al., 1995; Walker, 2009) and in 
Poland, at the time of data collection approximately 30.5%-33.8% of women aged 50 and 
older have ever received HRT (Mogilnaya et al., 2005; Zolnierczuk-Kieliszek et al., 2006). 
McPherson et al. (2000) found that current users of HRT and users in the past 4 years had their 
RR of developing breast cancer increased by a factor of 1.023 (1.011-1.036) for every year of 
therapy (McPherson et al., 2000). The level of the increase corresponds to the delay of 
menopause and in those who never used the treatment the increase factor was 1.028 
(1.021-1.034) for every year after menopause. The risk was higher in users of combined 
therapy that included oestrogen and progestogen. McPherson et al. (2000) found however that 
use of HRT did not increase the risk of breast cancer mortality, although subsequently the 
increased risk of developing breast cancer due to HRT use was later confirmed by many 
studies (Beral and Million Women Study Collaborators, 2003; Narod, 2011; Krolik and 
Milnerowicz, 2012; Shantakumar et al., 2007). It was found that current users of HRT were at 
a higher risk of breast cancers than those who never received such treatment. The risk also 
increased with the duration of use (Beral and Million Women Study Collaborators, 2003). 
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Current and longer than 5 years use was shown to produce a moderately elevated risk (RR 1.2-
1.50) (Humphrey, 2002) but 2 years after cessation of treatment this risk increase was found to 
return again to the levels comparable to risk levels of never users (Narod, 2011). Similarly as 
in case of the OC use, the risk of breast cancer is higher for combined formulations of 
oestrogen and progesterone than for those with oestrogen only (Narod, 2011). A recent 
Cochrane Review provided further evidence that at a mean of 11 years’ follow-up combined 
HRT was significantly associated with the increased risk of breast cancer (RR 1.25, 95% CI 
1.08-1.45) (Marjoribanks et al., 2012).  
 
2.3.2.5. RADIATION EXPOSURE 
 
Radiation exposure can vary greatly from none, through to one off, or very small doses (i.e. 
dental X-rays) to frequent or high dose exposures (i.e. atomic bomb survivors, oncologic 
patients in radiotherapy) (Key et al., 2001; McPherson et al., 2000). Higher risk of breast 
cancer was observed among women exposed to ionizing radiation and diagnostic X-rays 
(McPherson et al., 2000; Key et al., 2001; Ron, 2003; Pijpe et al., 2012; Gronwald et al., 
2008). Preston et al. (2002) pooled results from 8 cohort studies that explored breast cancer 
incidence rates following radiation exposure and found a linear relationship between the dose 
level and the increased risk, but they also highlighted the importance of age as well as age at 
exposure (Preston et al., 2002).  
 
In a later study, Heyes et al. (2009) also found some risk to be associated with mammography 
but they concluded that the benefits outweigh the risks and suggested that caution needs to be 
exercised in those with high familial risk (Heyes et al., 2009). However, the other studies 
confirmed that exposure to diagnostic radiation can cause an increased risk of breast cancer, 
especially amongst women with BRCA1 and BRCA2 gene mutations as (Pijpe et al., 2012; 
Gronwald et al., 2008). Mammography earlier than at 30 years of age in women with either of 
these mutations was linked with higher breast cancer risk (HR 1.43, 95% CI, 0.85-2.40) (Pijpe 
et al., 2012). In a Polish study Gronwald et al. (2008) found that in BRCA1/2 mutation carriers 
with breast cancer OR of having chest X-rays under 30 years of age was 1.8 (95% CI, 1.2–2.9) 
in comparison to affected non-carriers (Gronwald et al., 2008). The level of the risk increase 
was found to be associated with the dose of radiation (Pijpe et al., 2012). 
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2.3.2.6. DIET AND OTHER LIFESTYLE FACTORS 
 
A number of studies pointed towards an association between various lifestyle and 
environmental exposures as having an influence on the level of risk of breast cancer. For 
example factors such as diet, level of physical activity, and other lifestyle factors, have been 
widely discussed as those that could possibly be modified in order to decrease breast cancer 
risks.  
Dietary factors 
Typical Polish cuisine consists of foods that were influenced by many neighbouring countries 
and past occupants (Weichselbaum et al., 2005). Traditional foods include cabbage/sauerkraut, 
pickles, different meats (with pork being the preferred meat type) potatoes, bread and cereal-
based dishes (Weichselbaum et al., 2005). Polish society consume diets with relatively high 
energy levels (on average 3,000 kcal in comparison to recommended 2,000 kcal per day), high 
in fats (especially of animal origin), low in fibre and high in alcohol (Gawęcki and 
Hryniewiecki, 2007). Some authors noted that due to such dietary patterns a significant 
proportion (1/3 according to Gawęcki and Hryniewiecki) of the Polish population suffers from 
conditions related to incorrect nutritional habits such as circulatory disorders, obesity, diabetes 
mellitus type 2, neoplasms, osteoporosis etc (Gawęcki and Hryniewiecki, 2007; Kunachowicz 
et al., 1998; Zatonski et al., 2008). 
 
The role of diet and especially fat, fruit and vegetable consumption, as well as alcohol and 
tobacco intake in cancer aetiology has been suggested by the scientific community, in part 
because of the large international variation in cancer rates and the antioxidant properties of 
selected nutrients such as the influence on for example inflammatory and immune response as 
well as metabolic detoxification (Romieu, 2011; Vera-Ramirez et al., 2013; Kapiszewska, 
2006). Other protective elements of cancer preventive foods include folic acid, vitamin D, 
selenium, vitamin B12, chlorophyll and antioxidants found commonly in plants (Kapiszewska, 
2006; Divisi et al., 2006; Fernandez et al., 2006; Demetriou et al., 2012).  
 
Studies exploring the potential effects of foods with a high fat content have reported 
contradicting evidence in relation to breast cancer risk. For example fat intake and its 
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influence on risk of breast cancer was studied in the late 1990’s and a link was not found 
(Hunter et al., 1996; McPherson et al., 2000). However, in later studies, a high-fat diet was 
found to be significantly related to the increased risk of breast cancer (Schulz et al., 2008; Di 
Pietro et al., 2007; Prentice et al., 2006). Wang et al. (2008) reported that overall high fat 
consumption in lowest vs. highest intake quartile resulted in higher breast cancer risk (adjusted 
OR=1.35, 95% CI=1.10–1.65, Ptrend<0.01) (Wang et al., 2008). Thiebaut et al. (2007) showed 
that postmenopausal women in the highest quintile of percent energy from fat intake were 
more likely to have invasive breast cancer OR=1.11 (95% CI=1.00 to 1.24; Ptrend=0.017) 
(Thiebaut et al., 2007). Other studies also pointed towards evidence that a higher content of 
body fat is a risk factor for breast cancer in postmenopausal women (Inumaru et al., 2011; 
Rohan et al., 2013) but likely a protective factor in premenopausal women (Inumaru et al., 
2011; Berstad et al., 2010; Pathak and Whittemore, 1992). A recent study by Rohan et al. 
(2013) reported that anthropometric indices of obesity (95% CI 1.97, 1.45–2.68), waist 
circumference (95% CI 1.97, 1.46–2.65), and waist-hip ratio (95% CI 1.91, 1.41–2.58) were 
all associated with higher risk of breast cancer (Rohan et al., 2013). The mechanisms of this 
association of high fat intake and the increased risk of breast cancer have been attributed to 
high density energy that can cause weight gain, or fluctuations in sex hormones which then 
can impact other factors such as sex hormone levels at different stages of woman’s life 
(Romieu, 2011) and especially in postmenopausal women (Jevtic et al., 2010; Gonzalez, 2006; 
McPherson et al., 2000). It has been estimated that between 2003 and 2005 22.4 % of Polish 
women aged 20-74 years old were obese and 27.9 % overweight (Ministerstwo Zdrowia. 
Departament Polityki Zdrowotnej, 2007-2009). 
 
Not only the quantity but also quality (type) of fat intake has been shown to have an influence 
on the cancer risk. For example, monounsaturated fat consumption was reported to be 
significantly associated with lower risk of breast cancer (OR=0.52; 95% CI, 0.30-0.92) 
(Garcia-Segovia et al., 2006). In particular intake of ≥8.8 g/day olive oil resulted in lower odds 
of developing breast cancer (OR=0.27, 95% CI 0.17-0.42) (Garcia-Segovia et al., 2006). Fatty 
trans acids have been found to be associated with the increased risk of breast cancer in a study 
by Chajès et al. (2008) with a large sample of women (n=19,934). The odds ratio of the 
highest versus lowest quintile between the trans-monounsaturated fatty acids palmitoleic acid 
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and elaidic acid was OR=1.75 (95% CI 1.08-2.83). Nonetheless the researchers noted that 
their study results could be subject to chance and other studies to bias (Chajes et al., 2008). 
Other researchers reported similar findings that women consuming more hydrogenated fats 
(OR=1.58, 95% CI=1.20-2.10) or vegetable/corn oil with high content of linoleic acid 
(OR=1.30, 95% CI=1.06-1.58) had higher OR of having breast cancer in comparison to 
women using olive/canola oil high in oleic acid (Wang et al., 2008). A relatively recent meta-
analysis confirmed the previous findings and concluded that a link exists (irrespective of 
country of origin) between olive oil consumption and lower odds of any cancer type (log 
OR=-0.41, 95% CI, -0.53-0.29) and log OR=-0.45 (95% CI, 0.78-0.12) for breast cancer 
(Psaltopoulou et al., 2011). Even though in Poland since 1990’s consumption of plant based 
oils increased and animal fats decreased, the daily consumption of fatty trans acids is much 
higher than in the rest of Europe (2.8–6.9g vs. 1.2-6.7g) being much higher than the 
recommended 2g per day (Cichosz and Czeczot, 2012; Instytut Żywności i Żywienia) 
 
Lower breast cancer incidence in women on a low fat diet has been hypothesised to be linked 
directly not only with the amount of consumed fat but also with lower weight and higher 
consumption of fruit and vegetables, as antioxidants and fibre could play a protective role 
against breast cancer (Romieu, 2011; Pal et al., 2012). The influence of fruit and vegetables on 
cancers has been studied for the past 30 years (Key, 2011) and the negative correlation 
between a diet high in fruit and vegetables and various cancers has been well established (Pal 
et al., 2012; Giacosa et al., 2012). However, their association with breast cancer has been 
inconsistent throughout the studies (Fung et al., 2005; Masala et al., 2012).  
 
At the time of the data collection analysed in this thesis several reviews, meta-analyses and 
other studies noted lower breast cancer risk as well as cancer survival amongst those with 
higher vegetable and fruit consumption (Gandini et al., 2000; Maizes, 2005; Ahn et al., 2004). 
Maizes (2005) noted that cruciferous vegetables (such as: broccoli, cabbage, kale etc) contain 
phytochemicals which modulate the activity of cellular enzymes involved metabolism of 
oestrogen (Maizes, 2005). It was also hypothesized that cruciferous vegetables may alter 
steroid hormone metabolism, response of oestrogen receptor, as well as stabilize cellular 
proliferation therefore having positive influence on breast cancer risk (Maizes, 2005). 
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Although Cummings et al. (2009) found in a review that 5 out of 6 prospective studies 
exploring fruit and vegetable intake noted no statistically significant association with breast 
cancer (Cummings et al., 2009). Also a recent review conducted by Key (2011) showed that 
the association between vegetable intake is very small or non-existent (Key, 2011). 
Nonetheless the author noted that the benefit of increased vegetable and fruit consumption 
could still be identified especially for vegetables with high content of isoflavones that might 
have protective effect on breast cancer (Key, 2011). Other studies showed that in particular the 
ratio of fruit/vegetable to meat intake have influence on the incidence of breast cancer as 
omega-3 fatty acids found in fish inhibit the growth breast cancer tissue and fibre can bind the 
carcinogenic metabolites (Kapiszewska, 2006; Divisi et al., 2006; Fernandez et al., 2006; 
Aune et al., 2012; Demetriou et al., 2012). A Polish study by Kruk (2006) examined dietary as 
well as physical activity differences between women who had mastectomy and a control group 
(Kruk, 2006). Kruk found that women who consumed vegetables and fruits more often and 
were lightly or moderately physically active had significantly decreased risk of breast cancer 
(light activity OR=0.18, 95% CI=0.06–0.50, moderate activity: OR=0.20, 95% CI=0.08–0.50, 
Ptrend<0,001) (Kruk, 2006). However no such observation was made for women who were 
highly active physically (Kruk, 2006). Key (2011) highlighted that current nutritional advice 
relevant to cancer prevention should recommend an adequate fruit and vegetable intake but 
also should highlight the role of obesity and high alcohol intakes (Key, 2011).  
 
Alcohol and tobacco consumption 
Alcohol and tobacco intake have been hypothesised to be linked to breast cancer since the 
1980’s (Rosenberg et al., 1982) and later confirmed by other researchers. Seitz (2012) 
hypothesized that this link can be attributed to the ability of these substances to influence the 
cell cycle that may promote the carcinogenic effect (Seitz, 2012).  
 
Alcohol consumption 
Prior to 2006, when this study data was collected, studies have found alcohol consumption to 
have a moderate influence on breast cancer (Longnecker, 1994; McPherson et al., 2000; Key 
et al., 2001). Pöschl and Seitz (2004) showed that many epidemiological studies have found a 
clear association of chronic use of alcohol, even in moderate amounts, with an increased risk 
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for breast cancer. They reported that 84% of the reviewed case–control and 76% of cohort 
studies demonstrated that ethanol use is significantly related to the higher breast cancer risk 
than that of non users (Poschl and Seitz, 2004). They also added that 4% of all incidents of 
breast cancer in the US occurred primarily due to alcohol consumption (Poschl and Seitz, 
2004). In a later study Seitz et al. (2012) estimated in their meta-analysis that one alcoholic 
beverage per day (light alcohol intake) increases the breast cancer by approximately 4% and 
heavy alcohol consumption (>3 drinks per day) increases the risk by 40-50% equating to 5% 
of breast cancers in Northern Europe attributable to alcohol intake (Seitz et al., 2012). More 
recent studies have also confirmed that a causal relationship exists between higher intake of 
alcohol and breast cancer risk (Secretan et al., 2009; IARC, 2010) and Inumaru et al. (2011) 
reported that alcohol consumption is positively correlated with increased breast cancer risk in 
both pre- and postmenopausal women (Inumaru et al., 2011). Seitz et al. (2012) stipulated that 
it is due to alcohol increasing oestrogen levels being directly linked with breast cancer risk 
(Seitz et al., 2012).  
 
Alcohol consumption and its consequences are very important factors to take into 
consideration when talking about health in Poland. High levels of alcohol consumption 
amongst Poles stem from many years of political changes and social uncertainty as well as the 
fact that prior to the 1980’s the Polish socialist government used alcohol as a tool of socialist 
propaganda (Bielinska-Kwapisz and Mielecka-Kubien, 2011; Moskalewicz and Świątkiewicz, 
2000). Alcohol was an important element used to remedy economic problems as it was 
significantly contributing (9%-20%) to country’s revenue (Bielinska-Kwapisz and Mielecka-
Kubien, 2011; Moskalewicz and Świątkiewicz, 2000). Any information related to alcohol and 
its associated problems was often censored (Bielinska-Kwapisz and Mielecka-Kubien, 2011; 
Moskalewicz and Świątkiewicz, 2000). The amount of alcohol consumed in Poland has 
changed over time. In 1950’s it was 4.2 litres of pure alcohol per capita, peaking in 1980’s at 
11.2 litres and decreasing to 8.2 litres in 2005 (Bielinska-Kwapisz and Mielecka-Kubien, 
2011) with the latest (2009) estimate of alcohol consumption in Poland equalling to 13.60 
litres of pure alcohol per captia per year (WHO, 2012a). 
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Tobacco consumption 
WHO (2009) estimated that approximately 9 million Polish people smoke, accounting for 
about 29% of the adult population (WHO, 2009). A national survey showed that in 2007 34% 
of men and 23% of women declared to smoke daily (WHO, 2009). Later Zatoński et al. (2012) 
examined active smoking prevalence across 28 European countries and found that in Poland 
46% of men and 30.9% women aged 25-64 smoke translating to 7th worst place for Polish men 
and 6th for Polish women across the studied nations (Zatonski et al., 2012) and the trends 
remain stable throughout the years (Fronczak et al., 2012). Fronczak et al. (2012) observed 
that the environmental exposure to tobacco decreased over time and decreases with increasing 
age of the study subjects and has an inverse relationship with educational level (Fronczak et 
al., 2012).  
 
Many authors explored the relationship of tobacco exposure and the risk of breast cancer 
(Kuper et al., 2002; Morabia, 2002; Terry and Rohan, 2002; Mucha et al., 2006; Coyle, 2004; 
Johnson et al., 2011). Prior to 2006 several authors found some level of breast cancer risk 
increase to be associated with tobacco use. Morabia (2002) noted in a meta-analysis that risk 
increase among different levels of tobacco exposure (passive, active, past) resulted in breast 
cancer ORs ranging from 1.1 to 3.5 (Morabia, 2002). Kuper et al., (2002) indicated that RR for 
heavy smokers versus never smokers ranged from 0.9 to 1.2 and no evidence was found for 
the effect of heavy or long term smoking on the breast cancer risk (Kuper et al., 2002). 
However, Terry and Rohan (2002) reported that smoking for a long time (i.e., >20 years), 
smoking before a first full-term pregnancy, or being passively exposed to smoke increases the 
risk of breast cancer (Terry and Rohan, 2002). Mucha et al. (2006) estimated in a meta-
analysis that women who smoked heavily were 2.75 times (95% CI, 2.14-3.52) more likely to 
experience breast cancer than non smokers (Mucha et al., 2006). Similarly, Johnson et al. 
(2009) noted that early age of smoking initiation, higher pack-years and longer duration of 
smoking accounted for 15% to 40% increase in risk. Additionally women with N-
acetyltransferase 2 gene (NAT2) slow acetylation genotypes who were long-term smokers had 
their breast cancer risk increased by 35% to 50% (Johnson et al., 2011). 
 
62 
The evidence throughout the studies is inconsistent and some authors (Kuper et al., 2002; 
Morabia, 2002; Terry and Rohan, 2002) suggested that it may be reasonable to consider that 
the linkage of tobacco use to the carcinogenesis of breast may be different to organs such as 
the lungs, that are directly exposed to smoke, because breast tissue is exposed only to the 
tobacco metabolites, modified inside the body before reaching the mammary gland (Morabia, 
2002; Kuper et al., 2002). Kuper et al. suggested that even though smoking has anti-
oestrogenic effects and the smokers experience earlier menopause, which would have a 
protective effect, the toxic substances such as 7,12-dimethylbenz [a]anthracene, similar to 
those found in cigarettes have been found to have  a carcinogenic effect in animal studies and 
mutagens from smoke have been found in the breast of non lactating women (Kuper et al., 
2002).  
 
Physical exercise and body weight 
Some studies have pointed to the role of physical exercise in a significant reduction of breast 
cancer risk, ranging from 20% to 80% (Monninkhof et al., 2007; Kruk, 2007, Friedenreich and 
Cust, 2008). The majority of evidence published, prior to the introduction of the population 
based screening in Poland, supported the opinion that increased physical exercise may play an 
important role on reducing risk (30-82% risk reduction) of breast cancer development (Fintor, 
1999). In the late 1990’s Fintor (1999) hypothesized that this reduction may be direct and 
indirect as body fat plays a role in oestrogen production and oestradiol exposure over time 
seems to increase the risk of breast cancer. Additionally, the increased physical activity 
stimulates the immune system helping to fight cancerous cells with the greatest benefit of 
exercise seen amongst post-menopausal women (Fintor, 1999). Later studies confirmed this, 
specifying that the fact the relationship between body fat and breast cancer is linked to the 
ability of leptin to stimulate normal cell or tumour cell growth by enhancing production of in 
situ oestradiol and progression promotion of oestrogen-dependent breast cancer (Catalano et 
al., 2004; Ollberding et al., 2013). Other main candidate systems that link adiposity and cancer 
risk are insulin and the insulin-like growth factor-1 axis, endogenous reproductive hormones, 
and chronic inflammation (Patterson et al., 2013). In a review of the evidence published up to 
2010, Friedenreich (2010) reviewed observational epidemiologic studies as well as 
randomized exercise intervention trials in order to gain understanding of the link between 
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physical exercise and breast cancer risk and found that the average reduction in breast cancer 
risk was 25% between the most and the least active women. Friedenreich found that the 
strength of this association was most notable for recreational and household activities 
sustained over a lifetime of at least moderate intensity (Friedenreich, 2010). The exercise 
effect was more pronounced in women with normal body weight (BMI<25), without family 
history of breast cancer and those who experienced childbirth (Friedenreich, 2010). 
 
Later studies provided more conclusive evidence that moderate to heavy levels of physical 
activity have an inverse association with breast cancer development (for examples please refer 
to Anzuini et al., 2011; Friedenreich and Lynch, 2011). However, some of the studies 
specified that regular physical activity is a likely protective factor, but only in postmenopausal 
women, as there is lack of evidence for pre-menopausal women (Inumaru et al., 2011). 
 
In Poland the information on the physical activity is very limited (Wolfram et al., 2008). 
However the available evidence indicates that levels of physical activity in Poland are 
inadequate as, for example, Kaleta and Jegier (2005) found that only 2.3% of the population 
engaged in leisure-time physical activity, 23.3% engaged in physical activity at work and 
10.9% during housework (Kaleta and Jegier, 2005). Similarly, Drygas et al. (2008) found low 
activity levels amongst Polish people, as only about 17% occasionally practiced any form of 
exercise (Drygas et al., 2008). Later, in 2009, the European Commission's Directorate General 
for Education and Culture commissioned the Eurobarometer survey which was conducted in 
the 27 European Union Member States (European Commission, 2010). The researchers found 
that Poland was 6th amongst the countries (Bulgaria, Greece, Hungary, Romania, and Italy) 
with the lowest levels of participation in any form of sport (66% of Polish people reported not 
to do any sport) (European Commission, 2010). 
 
2.3.2.7. SOCIO-ECONOMIC FACTORS 
 
The transition of the Polish economy influenced women’s financial situation (Pascall and 
Kwak, 2009). As the job market was changing some of the job posts disappeared and more 
women than men were left without employment. Similarly, employers preferred to hire men 
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for executive roles due to the possibility of maternity leave and the requirement of long 
working hours which working mothers could not meet (Pascall and Kwak, 2009). In 2003, 
20.4% of Polish women were economically inactive (Central Statistical Office of Poland, 
2011) and on average they are paid 23% less than their male counterparts (Dębski et al., 
2010). The employment situation improved over time and in 2010, 10% of women were 
unemployed (Central Statistical Office of Poland, 2011). Unemployment and low level of 
completed education were found to be strong contributors to Polish women’s health problems 
including from respiratory, circulatory and neurotic disorders (Wroblewska, 2003).  
 
Socio-economic status has been well established as a predictor of breast cancer (Strumylaite et 
al., 2010). It was found that Polish women in poor financial situation are more likely to report 
their health state as less than good (Wroblewska, 2003). Women from lower socio-economic 
backgrounds may have nutritional deficiencies, be overweight or have higher abuse of toxic 
substances (WHO, 2005; Pampel et al., 2010). Breast cancer incidence is higher amongst 
women from groups with higher socio-economic status (Vainshtein, 2008; Borugian et al., 
2011) whilst mortality is more common in more disadvantaged ones (Vainshtein, 2008). 
Women with higher socio-economic status also get screened more often which may explain 
the higher incidence of breast cancer amongst those women. In addition, poorer women may 
have reduced access to the most advanced surgical and medical techniques (Segnan, 1997; 
Pruitt et al., 2009; Center for Substance Abuse Treatment, 2011). 
 
2.3.2.8. SUMMARY OF BREAST CANCER RISK FACTORS 
 
Numerous factors have been studied as predictors of breast cancer. It was noted that early 
menarche (younger than 12 years old), late menopause (after the age of 55 years old), 
increased concentrations of endogenous oestradiol (e.g., oral contraceptives, hormonal 
therapy), mutations in a number of genes (i.e. tumour suppressing genes such as: BRCA1, 
BRCA2), family history of breast cancer, obesity in postmenopausal women and alcohol use 
all play an important role in the increase of the risk of breast cancer (Inumaru et al., 2011; 
Rohan et al., 2013; Jevtic et al., 2010; Gonzalez, 2006; McPherson et al., 2000; Walker, 2009; 
Pharoah et al., 1997; Easton, 2002). Factors such as childbearing, early age at first childbirth, 
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higher number of childbirths, and breast feeding have been linked with decreased risk of 
breast cancer (Kelsey, 1993; Key et al., 2001; McPherson et al., 2012; McPherson et al., 2000; 
Clavel-Chapelon and Gerber, 2002; Walker, 2009; Lacey et al., 2013; Okobia and Bunker, 
2005; Collaborative Group on Hormonal Factors in Breast Cancer, 2012). A higher risk of 
breast cancer was also observed among women exposed to ionizing radiation and diagnostic 
X-rays. Lower breast cancer incidence in women on low fat diets has been hypothesised to be 
linked directly with lower weight and also with a higher consumption of fruit and vegetables, 
but the association with breast cancer has been inconsistent throughout the studies. However, 
the amount of evidence in favour of the higher vegetable and fruit consumption outweighs the 
number of studies with inconsistent results. The association of smoking and increased risk of 
breast cancer has been inconsistent prior to 2002, but later studies have shown that the risks 
were significantly higher among smokers. 
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Table 2 Summary of factors associated with increased and decreased risk of breast 
cancer in 2006 at the time of the data collection by strength of evidence identified from 
the literature 
Level of available evidence found in the published literature has been marked from the lowest 
‘♦ ‘ to the highest ‘♦♦♦♦’ according to the following criteria:  
♦  Unclear evidence or evidence coming from studies with small very specific 
populations 
♦♦  Mixed evidence with majority of publications indicating at least some level of 
association 
♦♦♦  Studies providing strong evidence indicating existence of association 
♦♦♦♦ Studies providing very strong evidence indicating at association 
 
Factors associated with increased risk of breast cancer: 
• Age ♦♦♦♦ 
• Early menarche ♦♦♦♦ 
• Late menopause ♦♦♦♦ 
• Nulliparity and late pregnancy ♦♦♦♦ 
• Family history and BRCA mutations ♦♦♦♦ 
• Use of exogenous hormones: HRT, oral contraception♦♦♦ 
• Use of tobacco ♦♦ 
• Use of alcohol ♦♦♦ 
• Diet high in fats ♦♦♦ 
• X-rays and ionising radiation ♦♦♦ 
• High socio-economic status ♦♦♦♦ 
Factors associated with decreased risk of breast cancer: 
• Diet rich in fruits and vegetables (despite the mixed evidence as high fruit and 
vegetable consumption was widely associated with high levels of antioxidants and 
general positive influence on health) ♦♦  
• Appropriate body weight ♦♦♦ 
• Increased physical activity ♦♦♦ 
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2.4. Cervical cancer epidemiology  
 
2.4.1. Incidence and mortality 
 
Cervical cancer originates in the cells of the cervix of the womb. It is often referred to as 
carcinoma in situ with only localized changes or an invasive cancer that started spreading to 
other organs (NHS Wales, WHO, 2006). In contrast to other types of cancer, cervical cancer 
can often be prevented (Alliance for Cervical Cancer Prevention (ACCP), 2004). Its slow 
progression gives an opportunity to treat precancerous changes if detected early (time to 
develop invasive cervical cancer has been estimated as approximately 10 years) (ACCP, 
2004).  
 
Cancer of the cervix uteri is estimated to be the second most common cancer in women around 
the world with the most recent estimates of world incidence in 2008 of 530,000. It accounts 
for 13% of all female cancers (GLOBOCAN, 2008a). The incidence of cervical cancer in 
Eastern Europe is approximately four times higher than in Western European countries 
(Friedman, 2011) and such East-West health disparities between Europe have been previously 
noted by many researchers (Krzyzanowski and Bobak, 1997; Mackenbach, 2006; Zatonski, 
2007; Zatonski and Bhala, 2012) and is also reflected in cervical cancer incidence and 
mortality rates (Bardin et al., 2008; Bobak and Marmot, 1996).  
 
In Poland cervical cancer is the third leading cause of death in women, after breast and lung 
cancers. In the year 2000 it accounted for approximately 5.4% of all female deaths and 
survival rates are amongst the worst in Europe (52.2%) (Jokiel and Bielska-Lasota, 2005). 
Whilst the years 1980-2000 brought a decrease in the incidence (from 25.2 to 20.1 per 100,000 
population), the mortality remained practically unchanged (from 10.9 to 10.0 per 100,000 
population) (Jokiel and Bielska-Lasota, 2005). Shortly after the implementation of the 
National Cancer Prevention Program and the introduction of a nationwide cervical cancer 
screening programme (2006) a noticeable increase in morbidity and mortality was observed. 
However, since 2008 some decline of absolute numbers of mortality and morbidity since 2009 
were reported (Bojar et al., 2012). The estimated crude incidence rate of cervical cancer was 
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lower than previously (19.1 per 100,000) but it was higher than worldwide (15.8 per 100,000) 
(table 3) (WHO, 2010). Some researchers hypothesized that if that trend continued, incidence 
would reach approximately 7-8 per 100,000 by 2025 (Didkowska et al., 2009).  
 
Table 3 Incidence of cervical cancer in Poland, Eastern Europe and the World (WHO, 
2010) 
Indicator Poland Eastern Europe World 
Crude incidence rate1 19.1 19.9 15.8 
Age-standardized incidence rate1 12.3 14.5 15.3 
Cumulative risk (%). Ages 0-74 years1 1.4 1.4 1.6 
Annual number of new cancer cases 3,770 31,013 529,828 
1 Rates per 100,000 women per year. Standardized rates have been estimated using the direct method and the 
World population as the reference. 
 
The crude mortality rate of cervical cancer remained unchanged in 2008 (10.4 per 100,000) 
which was again higher than that worldwide (8.2 per 100,000) (table 4) (WHO, 2010).  
 
Table 4 Mortality of cervical cancer in Poland, Eastern Europe and the World (WHO, 
2010)  
Indicator Poland Eastern Europe World 
Crude mortality rate1 10.4 10.2 8.2 
Age-standardized mortality rate1 6.2 6.3 7.8 
Cumulative risk (%). Ages 0-74 years1 0.7 0.7 0.9 
Annual number of deaths 2,059 15,817 275,128 
1 Rates per 100,000 women per year. Standardized rates have been estimated using the direct method and the 
World population as the reference. 
 
Additionally, a comparison of cervical cancer mortality rates between UK and Poland for three 
age groups was done (20-44, 45-69, and ≥70 years old).  Notable widening mortality gap was 
observed between the two countries in all age groups (Figures 6-8). Before the introduction of 
the national and centralised call-recall screening system (1988) in the UK, the mortality trends 
were unstable for 20-44 age group as in 1959 there were 4.9 cervical cancer deaths per 
100,000, dropping to 2.9 per 100,000 in 1977 and then increasing again to 4.2 per 100,000 in 
1988. After the call-recall system was introduced the mortality started decreasing again to 2.2 
per 100,000 in 2000 and then to 1.8 in 2010. In Poland similar trends can be observed in this 
age group but several years later. In 1992 the cervical cancer mortality peaked at 6.2 per 
100,000 but decreased to 4.3 per 100,000 in 2000 and then to 2.06 per 100,000 in 2010.  
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Figure 6 Comparison of cervix uteri cancer mortality trends 1958-2010 between Poland 
and the United Kingdom (standardized rates per 100,000 population) for women aged 
20-44 (data was sourced from Cancer Mortality Database,WHO, 2012) 
 
 
In other age groups a much slower mortality decrease in Poland than in the UK resulting in a 
widening gap between these countries. In the 45-69 age group (figure 5) mortality peaked at 
29.2 per 100,000 in 1972 and steadily decreased to 16.8 per 100,000 in 2010. Decrease can be 
also seen for the 70+ age group (figure 6) but there was larger variation in the rates reported 
from one year to another peaking at 35.1 per 100,000 in 1974 decreasing eventually to 21.6 
per 100,000 in 2010, respectively. In the UK the decrease in mortality over time in those two 
age groups was more steady and larger than that in Poland. In the 45-69 age group it was the 
highest in 1968 at 20.2 per 100,000 decreasing steadily to 4 per 100,000 in 2010 and in ≥70 
years old group it peaked at 32.7 per 100,000 in 1958 and decreased to 8.6 per 100,000 in 
2010.  
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Figure 7 Comparison of cervix uteri cancer mortality trends 1958-2010 between Poland 
and the United Kingdom (standardized rates per 100,000 population) for women aged 
45-69 (data was sourced from Cancer Mortality Database,WHO, 2012) 
 
 
Figure 8 Comparison of cervix uteri cancer mortality trends 1958-2010 between Poland 
and the United Kingdom (standardized rates per 100,000 population) for women aged 70 
or over (data was sourced from Cancer Mortality Database,WHO, 2012) 
 
Mortality due to cervical cancers could decrease as a consequence of decrease in incidence 
(Didkowska et al., 2009) achieved by introducing screening initiatives as suggested by 
Nowakowski et al. (2011). Nowakowski noted that in countries with nationwide screening the 
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number of pre-invasive cancers are higher and in situ lower as pre invasive lesions are 
detected much earlier, get treated and do not progress to the invasive state (Nowakowski and 
Kotarski, 2011). Similarly, as it was already noted in section 2.3.1 the low mortality rates 
noted for Poland prior to 1970s may be related to underreporting (Anderson et al., 1994; 
WHO, 2012c). 
 
2.4.2. Risk factors 
 
2.4.2.1. HUMAN PAPILLOMA VIRUS INFECTION 
 
It is recognized that the major risk factor for cervical cancer is infection with Human 
Papilloma Virus (HPV) which may damage the cells of the cervix leading to cervical cancer 
(Mocarska et al., 2012; NHS Choices, 2011; Bosch et al., 2002).  The name HPV stems from 
the fact that some types cause warts, or papillomas, which are of a benign nature. Many 
genotypes of HPV have been identified and strains were classified according to their potential 
to cause cervical lesions as “high-risk” or “low-risk”. Those categories refer to their 
association with cervical lesions. Pre-malignant or malignant lesions are usually linked to 
high-risk HPV and benign ones to low risk HPV (Munoz et al., 2003). Among the known 
variants, more than 40 are transferred from one person the other during sexual intercourse. 
Symptoms of infection can occur in the genital mucosa, as well as around the anus or mouth 
but most of them do not produce any symptoms and therefore may remain undetected 
(Mocarska et al., 2012). More than 118 different HPV types have been identified, and 12 are 
classified as carcinogens (Arron et al., 2011; de Sanjose et al., 2010). The HPV types most 
commonly associated with incidence of invasive cervical cancer are 16, 18, 31, 33 (de Sanjose 
et al., 2010; Smith et al., 2007) and 45 (Mocarska et al., 2012) with HPV 16 and HPV 18 
accounting for approximately 70-100% of all cervical cancers (Bosch et al., 1995; Clifford et 
al., 2003; Smith et al., 2007). In some patients other types (51, 52, 58, and 59) have also been 
found in addition to the earlier mentioned types (Mocarska et al., 2012). 
 
Transmission of HPV can be passed between heterosexual or same sex partners via genital 
contact during intercourse (vaginal or anal) but can also be transmitted during oral sex and 
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other genital-to-genital contact (CDC, 2012a). In rare cases, HPV can also be transmitted by a 
pregnant mother with genital HPV to her baby during delivery, which could potentially cause 
child to suffer the juvenile-onset of recurrent respiratory papillomatosis (CDC, 2012a; 
Rombaldi et al., 2009). 
 
Approximately 70-80% of women and men with an active sexual life at some point come into 
contact with the virus, and the global number of carriers is estimated at 310 million 
(Castellsague et al., 2009; Mocarska et al., 2012). The incidence of HPV infection is the 
highest among female 20-30 year olds and the highest attributable cervical cancer incidence 
occurs in the 5-6th decade of life (Castellsague et al., 2009; Mocarska et al., 2012). Over 99% 
of all cases of cervical cancer are linked to HPV but despite the HPV infection being 
necessary for cancer to form not every infected woman will develop it (Liu and Xu, 2012). 
Only limited studies were found to examine HPV distribution in the Polish female population. 
One of them by Bardin et al. (2008) showed that HPV prevalence in women living in Warsaw 
was 16.6% with the highest proportions reported in unmarried women (37.3%) and in the 25–
34 age group (24.2%) (Bardin et al., 2008). High-risk HPV types accounted for 11.3%, with 
type 16 being reported the most frequently (3.7%). High-risk HPV was found with almost all 
(except one) cervical cancers examined by the researchers and HPV16 accounted for 73% of 
those infections. Overall 79% of cervical cancers contained HPV16/18 (Bardin et al., 2008). 
Similar conclusions were reported in a study in another Polish region–Gdańsk that examined 
HPV prevalence in cervical cancer patients. The researchers found that HPV DNA was 
reported in 70.1% of cervical cancers without significant differences between different cancer 
stages (Liss et al., 2002). Another study explored HPV prevalence in CIN1 lesions and found 
that almost 54% were infected with HPV 16, 21.3% with HPV 33, 16.7% with HPV 18, 10.3% 
with HPV 31, 8% with HPV 45, and 1.6% with HPV 52 (Kedzia et al., 2010). High prevalence 
of HPV 16/18 in Poland could mean that a significant proportion of Polish women could be 
protected with HPV vaccinations (Bardin et al., 2008) (see section 2.5.2). 
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2.4.2.2. AGE AT SEXUAL INITIATION AND PARITY 
 
Risks for both cervical squamous cell carcinoma and adenocarcinoma have been linked to 
high numbers of sexual partners and young age at first intercourse (Cai et al., 2008; 
International Collaboration of Epidemiological Studies of Cervical Cancer et al., 2007). This 
can be linked directly to higher probability of exposure to HPV and therefore increased cancer 
risk during lifetime.  
 
High parity as well as young age (< 17 years) at first childbirth have been found to increase 
the risk of cervical cancer (Cai et al., 2008; International Collaboration of Epidemiological 
Studies of Cervical Cancer et al., 2007; Munoz et al., 2002) but it has also been noted that its 
influence might not to be of great significance in the industrialized populations where the 
parity tends to be low (Hellberg, 2012).  
 
In Poland, at the time that the data was collected for this study, 21% of 16 year old and 47% of 
18 year old Polish girls had initiated their sexual lives and almost 19% had their first 
intercourse at age 15 or earlier (UNDP and Ministerstwo Zdrowia, 2007). 13.1% of 16-18 year 
old girls had had three or more sexual partners in the past but majority had one (70%) (UNDP 
and Ministerstwo Zdrowia, 2007). Average age of women at first childbirth was 27.1 years old 
(UNDP and Ministerstwo Zdrowia, 2007) and the adolescent parity accounted for 
approximately 16% (International Conference on Population and Development, 2012). On 
average Polish woman aged 15–49 had 1.25 children (UNDP and Ministerstwo Zdrowia, 
2007) which is lower than an European average of 1.5 births per woman (Ezeh et al., 2012).  
 
2.4.2.3. VIRAL INFECTIONS AND IMMUNOSUPRESSION 
 
Many other environmental and endogenous risk factors, often associated with social or 
lifestyle factors, have been associated with cervical cancer in conjunction with presence of 
HPV. For example frequent viral infections with Chlamydia trachomatis or Neisseria 
gonorrhoeae or herpes (HSV2, herpes simplex virus) occurring in HPV infected women are 
more often linked to cervical cancers, as they cause cervical inflammations that involve 
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extensive tissue remodelling, disturbing the normal cervical tissue cycles (please refer to 
Paavonen, 2011; Sales and Katz, 2012). Also Human Immunodeficiency Virus (HIV) and 
immunodeficiency caused by other reasons (i.e. pharmacotherapy) have been found to 
increase risk of the cervical cancer in HPV positive women due to the fact that 
immunosuppression weakens body’s defences against cancer (Mocarska et al., 2012). 
 
2.4.2.4. USE OF EXOGENOUS HORMONES 
 
Multiple studies have also linked exogenous hormones such as use of OC with the increased 
risk of cervical cancer (Castellsague et al., 2006; McFarlane-Anderson et al., 2008; 
International Collaboration of Epidemiological Studies of Cervical Cancer et al., 2007). Smith 
et al. (2003) conducted analysis of 28 studies that included 12,531 women with cervical cancer 
and concluded that the risk of cervical cancer was increased with longer use of oral 
contraceptives (Smith et al., 2003). Later studies confirmed those conclusions by comparing 
women who have used OCs within the last decade to never-users, and found the users had a 
significantly increased risk of developing cervical cancer (Urban et al., 2012; Parkin, 2011). It 
is worth noting that the risk of developing cervical cancer is increased in patients taking OC 
for more than five years but after 10 years and discontinuation the risks are significantly 
reduced (Urban et al., 2012).  
 
2.4.2.5. OTHER LIFESTYLE FACTORS 
 
Tobacco use, especially in women positive for HPV, has been also reported as one of the 
factors associated with increased risk of squamous cell cervical cancers (Munoz et al., 2002, 
International Collaboration of Epidemiological Studies of Cervical Cancer (ICESCC) et al., 
2007; DeVita Jr et al., 2011b)  but not in the adenocarcinomas (ICESCC et al., 2007). The risk 
is especially high amongst current smokers (ICESCC et al., 2007). Gunnell et al. (2006) 
demonstrated that HPV infected smoking may pose a 27-fold risk increase (Gunnell et al., 
2006). Also in a recent meta-analysis conducted by Zeng et al. (2012) it was found that 
second-hand smoke can be an important risk factor for cervical cancer and that non-smoking 
women who were exposed to so called ”passive smoking” when compared to unexposed 
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women had a 73% higher risk of experiencing a cervical cancer (Zeng et al., 2012). It is 
thought that the substances formed during smoking impair resistance to oncogenic factors 
(similarly to immunosurppressed patients) and facilitate the HPV viral replication. 
Researchers hypothesised that the increase in numbers of young female smokers might be in 
part responsible for the increase of cervical cancer incidence (Kwasniewska et al., 2002; 
Moscicki et al., 2001; Plummer et al., 2003). This can be particularly important in Poland 
where approximately a third of the adult female population smokes (Zatonski et al., 2012; 
UNDP and Ministerstwo Zdrowia, 2007). 
 
2.4.2.6. SOCIO-ECONOMIC FACTORS 
 
Low socio-economic and educational statuses have been found to predict higher rates of 
cervical cancer. Women with lower socio-economic status are less likely to have access to and 
attend screening and therefore the precancerous changes might not get detected in time and 
result in a neoplasm (Mocarska et al., 2012). Similarly, those women are more likely to have 
nutritional deficiencies (i.e. folic acid), especially of foods rich in antioxidants having 
protective qualities on the immune system that might protect against cancer. This may be 
supported by the fact that over 80% of all cervical cancers occur in developing countries 
(WHO, 2005). Lower educational status has been also identified as the predictor of increased 
risk for cervical cancer due to the fact that women with lower finished education tend to 
initiate their sexual life as well as give birth at younger age than those with higher education 
(Parikh et al., 2002; Braaten et al., 2005;Franceschi et al., 2009). 
 
2.4.2.7. SUMMARY OF CERVICAL CANCER RISK FACTORS 
 
It is now confirmed that the biggest risk can be attributed to HPV infection which has been 
classified by the potential to cause cervical lesions as “high-risk” or “low-risk”. The majority 
(99%) of cervical cancer cases of all cases are HPV positive but it has been stipulated that 
there must exist other cervical cancer risk factors since not every HPV infected woman 
develops it (Liu and Xu, 2012). Those risks are linked to high numbers of sexual partners and 
young age at first intercourse, high parity, as well as young age (<17 years) at first childbirth. 
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Other factors may include immunosuppression (e.g., HIV infection, chemotherapy), frequent 
infections with: Chlamydia trachomatis, Neisseria gonorrhoeae or herpes (HSV2, herpes 
simplex virus), use of exogenous hormones such as oral contraception, use of tobacco and low 
socio-economic status. 
 
Table 5 Summary of factors associated with increased risk of cervical cancer in 2006, at 
the time of the data collection 
Level of available evidence found in the published literature has been marked from the lowest 
‘♦ ‘ to the highest ‘♦♦♦♦’ according to the following criteria:  
♦  Unclear evidence or evidence coming from studies with small very specific 
populations 
♦♦  Mixed evidence with majority of publications indicating at least some level of 
association 
♦♦♦  Studies providing strong evidence indicating existence of association 
♦♦♦♦ Studies providing very strong evidence indicating at association 
 
Factors associated with increased risk of cervical cancer: 
• Infection with HPV♦♦♦♦ 
• Immunosupression and repeat infections with Chlamydia trachomatis Neisseria 
gonorrhoeae or herpes♦♦♦ 
• Early age at sexual initiation, high number of sexual partners and multiparity ♦♦♦♦ 
• Use of exogenous hormones: oral contraception ♦♦♦ 
• Use of tobacco ♦♦♦♦ 
• Low socioeconomic status ♦♦♦ 
 
 
2.5. Cancer prevention and detection 
 
Effectiveness of healthcare systems can be measured by cancer survival (Coleman et al., 
2011). The regional and international differences in cancer survival show the level of 
avoidable mortality and help to guide or promote development of initiatives against cancer 
(Coleman et al., 2011). WHO (2011) promotes breast cancer control with national cancer 
control programmes as an integrated part of non-communicable disease prevention and 
control. Many types of medical screening programmes are used around the world. They 
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include screening for disease carriers, early stage disease, or screening for predisposition to 
diseases. The term ‘screening’ used in this thesis refers to the use of diagnostic tests such as 
mammography or cytology/Pap smears among healthy populations to identify individuals with 
the disease who might not have developed symptoms yet (WHO, 2011). Screening types 
include: organised population based often nationwide or opportunistic/spontaneous screening 
programmes (Hakama et al., 2008). Successful screening programmes should be accurately 
planned, population based, sustainable and targeted at the correct population (Yip et al., 2008). 
An ideal screening test should be highly sensitive in reducing false negative results and highly 
specific to decrease false positive results (Hakama et al., 2008) although achieving these two 
parameters at the same time might be difficult, as increasing one might cause a decrease in the 
other (Yip et al., 2008). Sensitivity and specificity have an influence on positive and negative 
predictive values–the proportion of patients testing positive with the condition or negative 
without the condition (Yip et al., 2008). It should also cover the whole population of patients 
meeting the eligibility of the screening living in the target area (Cancer Research UK, 2011; 
Cancer Research UK, 2009).  
 
Screening has many advantages and among them: better prognosis for some patients, less 
invasive treatment in early stages, reassurance for patients with negative results (Byrd et al., 
2007; Chamberlain, 1984; Todorova et al., 2006; WHO, 2011a). However, it may result in 
unfavourable outcomes such as: potential overtreatment of benign changes, cost to the health 
care system, false reassurance in the case of false positives, include embarrassment, 
interpretation ambivalences, creating a sense of “embodied risk”, psychological consequences 
of inconclusive results, blaming of non-attendees, false alarms, false reassurance, unnecessary 
biopsies, over-diagnosis, and over-treatment (Byrd et al., 2007; Chamberlain, 1984; Todorova 
et al., 2006; WHO, 2011a). Breast and cervical cancer screening are discussed in greater detail 
in the further sections (2.5.1-2.5.4). 
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2.5.1. Breast cancer prevention and detection 
 
Early detection of breast cancer is crucial to improve its outcomes and overall survival 
(Anderson et al., 2008). Even though various methods are being used for breast cancer 
screening including: BSE, clinical examinations by physician, ultrasound, mammography, 
magnetic resonance imaging (MRI), and DNA testing (Allen et al., 2010; Maria Skłodowska-
Curie Memorial Cancer Centre and Institute of Oncology, 2006; Ekiert et al., 2011) opinions 
vary as to which combinations of screening techniques are the most effective for identifying 
breast cancer (Chiu, 2002; Thornton and Pillarisetti, 2008). None of the screening 
examinations have a sensitivity of 100% and especially BSE has been questioned as a method 
of breast cancer detection (Allen et al., 2010). It has been highlighted that women need to be 
clearly informed about the inadequacy of BSE as part of screening (Chiu, 2002; Thornton and 
Pillarisetti, 2008). Nonetheless, BSE is still frequently perceived and recommended as a tool 
raising breast cancer awareness through empowering women to take responsibility for their 
own health (Thornton and Pillarisetti, 2008; Allen et al., 2010; WHO, 2011b). 
 
Mammography is the most common detection method used in organised mass breast cancer 
screening programmes and since the early years of screening there have been substantial 
improvements in screening methods (Blanks et al., 2002; Advisory Committee on Breast 
Cancer Screening, 2006). Mammographic screening sensitivity, in particular for small invasive 
cancers, was improved as a result of the increased use of two view mammography, higher film 
densities, and the increasing experience of radiologists (Blanks et al., 2002; Advisory 
Committee on Breast Cancer Screening, 2006). Mammographic screening is effective in 
decreasing breast cancer mortality by up to 30% in women over the 50 years old (Nystrom, 
1993; Shapiro, 1998; IARC, 2002; IARC, 2008; Gotzsche and Nielsen, 2011; Tria Tirona, 
2013) but its benefit versus potential harms has been extensively debated (Independent UK 
Panel on Breast Cancer Screening, 2012; Gotzsche and Nielsen, 2011). A Cochrane review by 
Gøtzsche and Nielsen (2011) reviewed randomised trials and concluded that due to differential 
cause of death misclassification breast cancer mortality was an unreliable outcome. 
Adequately randomised studies (N=3) failed to produce conclusive evidence of mortality 
reduction due to screening but the sub optimally randomised (N=4) produced significant 
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results of reduced mortality. Risk ratio for all of the trials was 0.81 (95% CI 0.74-0.87) and 
authors stated that it is likely to achieve breast cancer mortality reduction (15%) through 
screening. It was also noted that screening leads to over diagnosis in 30% and therefore it may 
result in over treatment (Gotzsche and Nielsen, 2011). Over diagnosis has been stipulated to 
be one of the most significant screening harms as it happens due to small cancers being 
detected early resulting in higher incidence being reported (Independent UK Panel on Breast 
Cancer Screening, 2012). If some of the smaller cancers are not found through the screening 
they might never progress substantially before the woman dying for another reason never 
knowing of the existence of her cancer. Various prospective randomized studies demonstrated 
the lack of a high benefit from screening women younger than 50 and several potentially 
harmful screening outcomes such as radiation exposure, over diagnosis, lead time, higher 
number of false positive results in younger women, and costs) (Jatoi and Miller, 2003; 
National Institute of Health (NIH) Consensus Statement, 1997; Primic-Zakelj, 1999; Nelson et 
al., 2009). Other studies also confirmed that 40 to 49 year old women have also more false-
positive results than other age groups (Nelson et al., 2009; Gotzsche and Nielsen, 2011). 
Similarly the latest literature review by Kerlikowske (2012) pointed towards the fact that even 
though after a period of 10 years of regular participation in screening women aged 40-49 years 
old benefit from a 15% decrease of breast cancer risk, the absolute benefit is small and the 
potential harms do not outweigh the benefits (Kerlikowske, 2012).  
 
Following these controversies an Independent UK Panel on Breast Cancer was assembled to 
conduct a meta-analysis using data from good quality international clinical trials and 
observational studies to summarise the available evidence on the benefits and harms of breast 
cancer screening. They estimated, that the RR of breast cancer mortality was 0·80 (95% CI 
0·73—0·89) for women invited to screening, versus controls, meaning that the RR of 
mortality reduction was 20% (Independent UK Panel on Breast Cancer Screening, 2012). The 
Panel highlighted that it is not possible to assess the over diagnosis in each individual and in 
reality only approximately 1% of women aged 50-52 years that get invited for screening 
would have experience of an over diagnosis in the next 20 years (Independent UK Panel on 
Breast Cancer Screening, 2012).  
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In addition to, or instead of mammography an MRI may be proposed to women at high risk of 
breast cancer (carrying BRCA 1/2 mutations or having as strong family history of breast 
cancer) but it was highlighted that woman’s age should be considered when offering MRI 
(NCCPC, 2006) (for more information on BRCA 1/2 and family history please refer back to 
section 2.3.2.2). It was proposed that Polish women aged 20-49 years old who have BRCA1/2 
mutation or TP53 mutation should be offered MRI annually (Maria Skłodowska-Curie 
Memorial Cancer Centre and Institute of Oncology, 2006; Nienartowicz, 2011). Polish Union 
of Oncology summarised guidance on breast cancer screening stating that in addition to 
mammography (or ultrasound for women with higher density breast tissue) every 2 years for 
ages 50-69 and clinical breast examination every year for women over 40 years old, BSE is 
also recommended to be performed every month by women of all ages (Jassem et al., 2011). 
 
The resources for routine screening mammography initiatives are often not available in low 
and middle income countries (such as Poland) and the disease is often diagnosed in its late 
stage (Tfayli et al., 2010; Yip et al., 2008). This was also the case for Poland prior to 2006 
despite sporadic presence of breast screening activities that were conducted mostly 
spontaneously among various populations and by different governmental or private 
organisations (i.e. first opportunistic local cervical screening initiative started in 1970s in 
Białystok) (Łoś, 2006). It is therefore difficult to quantify the coverage of such campaigns and 
the only attempt can be made through conducting surveys, such as the one used in this thesis.  
 
Currently, despite the ongoing screening programme the uptake numbers are still much below 
desirable levels (acceptable rate of screened women is >70% and desirable >75%) (Szewczyk, 
2011) as only 31%-39.8% of Polish women are taking up mammography (Madej et al., 2010; 
Central Statistical Office of Poland, 2012c). Therefore many lessons can be learnt from 
countries where the world’s first national breast screening programmes were set up many 
years ago (i.e. UK). Success of the screening programme can be assessed not only by 
achieving high coverage but also by studying the mortality decrease which has been seen for 
many countries with ongoing mass screening initiatives (Shapiro et al., 1998; GLOBOCAN, 
2008a; Advisory Committee on Breast Cancer Screening, 2006). Additionally the positive 
effect of screening can be also seen through an increase in incidence of early stage and in situ 
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breast cancers and a decrease in the incidence of late stage malignant neoplasms and therefore 
reduced mortality since women present with earlier, less aggressive tumours (McCann et al., 
1998; Hakama et al., 1997; Tabar et al., 1992; Kricker et al., 1999; Autier et al., 2010). 
Evidence shows that between 1989 and 2006 mortality was reduced by more than 20% in 15 
countries. For example England and Wales, Northern Ireland, and Scotland had the largest 
decreases in mortality (35%, 29%, and 30% respectively) in 1989 (Autier et al., 2010) and 
throughout the life of the UK programme (since 1988) over 100,000 cancers were found (100 
cancers per week) (NHS, 2013; NHS Breast Screening Programmes, 2008). Conversely, in 
Central and Eastern Europe such a decline was not present (i.e. Poland), with some countries 
experiencing even an increase of deaths due to this cancer (i.e. Romania) (Autier et al., 2010). 
 
Women who are entitled to free mammography in Poland are those who are 50-69 years old, 
who have not had a mammography done in the past 24 months or those who have been invited 
in writing after 12 months from the previous mammography (Narodowy Fundusz Zdrowia 
(NFZ), 2011b). Women can participate in this form of screening not only by invitation but 
they may choose to request a test from their physician who will assess their screening needs 
(Narodowy Fundusz Zdrowia (NFZ), 2011b).  
 
Table 6 Comparison of the main features of breast screening programmes in Poland and 
United Kingdom 
  Target screening population 
Screening 
location 
Screening 
procedures 
Screening 
personnel Uptake rates Note 
UK 
50-70– screened 
every 3 years; or 
by doctor’s 
indication 
Patient's local 
clinic, hospital 
or mobile 
screening unit 
Mammogram, 
clinical breast 
examination 
& BSE as a 
part of breast 
awareness 
programme 
Physician/ 
specialist 
breast 
nurse 
2010 - 77%† 
Programme is 
currently being 
extended to 
invite women in 
their late 40s and 
up to 73 years 
Poland 
50-69 – screened 
every 2 years; 
younger, older or 
women from a 
higher risk group 
by doctor’s 
indication 
Patient's local 
clinic, hospital 
or mobile 
screening unit 
Mammogram, 
clinical breast 
examination 
& BSE  
Physician 
2009 -31%‡ 
2009 -39.8%¥ 
National rollout 
since 2006 
†NHS/HSCIC, 2010a; ‡Madej et al., 2010; ¥(Central Statistical Office of Poland, 2012c) 
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2.5.2. Cervical cancer prevention and detection 
 
In most countries diagnosis of changes in the cervix is done with the use of traditional 
screening methods of molecular biology via cervical Papanicolaou test (Pap) (Everett et al., 
2011). During the test some of the cervix tissue is removed with a special brush and checked 
under a microscope (Gheit et al., 2007; Gershenson and Ramirez, 2008). However, concerns 
have been raised on the low sensitivity of the conventional Pap test as its estimates vary 
greatly between studies (30%-87%). Specificity was found to range from 86% to 100% 
(Nanda et al., 2000; Sasieni et al., 1996; Agency for Healthcare Research and Quality, 2011). 
More sensitive HPV detection methods, such as the HPV DNA testing have been proposed to 
increase efficacy of cervical cancer screening programmes (Hong et al., 2009), however 
Poland is still using the Pap test as a screening method (Spaczyński et al., 2009).  
 
Regular screening of all women at risk helps to detect those with an increased risk of 
developing an invasive cancer through an early treatment of pathological changes (NHS 
Cancer Screening Programmes, 2008). Cervical screening programmes including organised 
and opportunistic (i.e. screening of patients hospitalised for different reasons) types have been 
showed to decrease incidence and mortality from cervical cancer, and it has been previously 
observed that population based cancer screening initiatives tend to achieve higher attendance 
rates than those with opportunistic ones which might miss women at the highest risk of 
developing the disease (Anttila et al., 2009; Palencia et al., 2010; van der Aa et al., 2008). 
Numerous members of the European Union (e.g., Czech Republic, Estonia, others) either 
already have, or are in the process of introducing population-based cervical cancer screening 
programmes, but some of them need to improve the quality and coverage of screening (Anttila 
et al., 2009; van der Aa et al., 2008; OECD, 2012).  
 
Benefits of population based nationwide cervical cancer programmes can be further supported 
by the example of screening in the UK, which prior to national rollout of its population based 
screening in 1988 was largely ineffective (Quinn et al., 1999; NHS Cancer Screening 
Programmes, 2008). At least two thirds of women with invasive cervical cancer had never 
been screened because most of the cytological tests were performed on women presenting for 
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gynaecological, obstetric, or contraceptive reasons (Quinn et al., 1999; NHS Cancer Screening 
Programmes, 2008). The current success of screening has been achieved partially due to the 
use of a call and recall system which helped to keep track of any follow-ups and, in case the 
results of the smear appear normal and such approach could be also considered in other 
countries (Buehler and Parsons, 1997; Torres-Mejia et al., 2000) as well as high (>80%) 
average coverage reaching approximately 80 per cent (NHS Cancer Screening Programmes, 
2008). Additionally, the NHS screening system offered incentives in a form of payments to 
general practitioners and the first external quality assessment schemes for laboratories, 
resulting in great improvement of its performance (Quinn et al., 1999; NHS Cancer Screening 
Programmes, 2008). Currently, approximately 4,500 lives are saved each year (approximately 
64 million to date) and around 75% of cancer cases are prevented in women who attend 
regularly (Sasieni et al., 2003; NHS Cervical Screening Programme, 2012). Sasieni et al. 
(2003) estimated that single negative smear in the UK in the years 1990-2001 offered 
substantial protection against cervical cancer equalling to 41% for 20-39 age group, 69% for 
women aged 55-69 years old who attended screening every 3 years (table 7) (Sasieni et al., 
2003).  
 
Table 7 Percentage of Preventable Cancer - Protection offered by a single negative smear 
in UK between 1990-2001 (Sasieni et al., 2003) 
Screening interval group 20-39 years 40-54 years 55-69 years 
3-yearly screening 41% 69% 73% 
5-yearly screening 30% 63% 73% 
 
Women aged between 25 and 64 are provided with targeted cervical screening tests free of 
charge every three to five years depending on their age (CRUK, 2009; NHS Cancer Screening 
Programmes, 2008). Although the lower screening age limit is 25, following the death of the 
UK–Big Brother television celebrity Jade Goody, who died in 2009 from cervical cancer, a 
heated national debate on lowering the cervical screening age began (Metcalfe et al., 2011). 
However, there are frequent false positives, and low incidence rates of this cancer in women 
younger than 25 years old and therefore no extended screening is indicated for that age group 
(CRUK, 2009).  
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Similarly, Finland introduced an organised cervical screening programme (with a 5-year 
screening interval) in 1963 and extended it to the whole country by the 1970s. From the early 
70s coverage exceeded 80%, later reaching 90% (i.e. at least 1 smear made per female) and 
98% of women had been screened at least once in their lifetime (Van der Aa et al., 2008). The 
introduction of this programme resulted in a 50% reduction in cervical cancer mortality by the 
early 70s later reaching about 80% decrease in both mortality and age-adjusted mortality 
(Anttila and Nieminen, 2007). 
 
In Poland, the national cervical cancer screening programme was introduced in 2006 in 
response to an unfavourable epidemiologic situation, as approximately half of women 
diagnosed with cervical cancer would die from it (Spaczyński et al., 2010). Prior to the 
national rollout, cervical cancer screening was scarce, opportunistic, and restricted to only 
small mostly urban districts (Bardin et al., 2008).  
 
Following the Council of the European Union recommendations (Council of the European 
Union, 2003) the Polish Ministry of Health, with the National Health Fund of Poland and the 
Polish Gynaecological Society, developed a National Population Based Cervical Cancer 
Screening Programme targeting (by postal invitation) women aged 25 to 59 to be invited for 
screening (Bardin et al., 2008; Spaczyński et al., 2010). In the first few years of the 
programme (2007-2009) a slow increase in rates of screened women was observed. In 2007, 
the first year of the national rollout, 21.3% of eligible women were tested, in 2008 there were 
24.4% and in 2009 over 26.8% of women undertook the cervical cancer screening (Spaczyński 
et al., 2010). This means that the programme was still far behind countries with long history of 
population based screening (i.e. UK or Finland, please refer to table 8 below).  
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Table 8 Comparison of the main features of cervical cancer screening programmes in 
Poland, UK and Finland 
  Age of target population 
Screening 
location 
Screening 
procedures 
Screening 
personnel Uptake rates 
Poland 
25–59– screened every 
3 years (or more 
frequently);  
<25 or > 59 on request. 
Gynaecology 
clinic  
Liquid based 
cytology Gynaecologist 
2007–21.25% † 
2008–24.39% † 
2009–26.77% †  
2009–76.7% (uptake 
ever) € 
UK 25–49 – every 3 years; 50–64 – every 5 years. 
Patient's local 
general 
practice 
Liquid based 
cytology 
Nurse or 
physician 2008/9 –78.6%‡ 
Finland 30-60 - every 5-years 
Patient's local 
health care 
centres 
Liquid based 
cytology 
Trained nurses 
(midwives) 
2004–72%  
(90% including 
additional opportunistic 
screening) ¥   
†(Spaczyński et al., 2010); ‡(NHS, 2009);¥(Van der Aa et al., 2008); €(Central Statistical Office of Poland, 
2012c) 
 
Poland and other Eastern European countries introducing screening could draw from 
experiences of countries with much greater screening experience (Holland et al., 2006) by 
learning from the positive and negative experiences. For example, as mentioned previously it 
has been demonstrated that call-recall system improved the screening uptake in the UK.  
 
Currently, cervical cancer screening in Poland is always conducted in public or private 
gynaecology clinics and is accessible to women without a referral, cost free, from their general 
practitioner (Narodowy Fundusz Zdrowia (NFZ), 2011a) (see Appendix 1 for programme 
information leaflet). Women aged 25-59 who have not had a cytology conducted within 3 
years receive a postal screening invitation with a proposed appointment date or alternatively 
they can go to their gynaecologist directly and request for a test. Women from high risk 
groups (HIV, HPV, immunosuppressed etc.) that may be more prone to developing cervical 
lesions might be advised by their physician to attend cytology every 12 months (NFZ, 2011a) 
(for description of viral and immunosupression risk factors see section 2.4.2.3). Women who 
are outside the screening recommended age range can also undergo cost free cervical 
screening through a referral from their gynaecologist (NFZ, 2011a).  
 
In 2008, after the role of HPV in the formation of cervical cancer was demonstrated by Nobel 
Prize Laureate Harald zur Hausen, a prophylactic vaccine against several of the most 
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aggressive strains was developed (Mocarska et al., 2012). Currently, two HPV vaccines exist: 
Cervarix (produced by GlaxoSmithKline) and Gardasil (produced by Merck) (CDC, 2012b). 
These vaccines are made of HPV‐like particles that are non‐infectious and offer a new way of 
the cervical cancer prevention (CDC, 2012b; Mocarska et al., 2012). Both of these vaccines 
protect against two HPV types: 16 and 18 most commonly associated with cancers of cervix, 
vulva, vagina, penis, anus and oropharynx (Khalid et al., 2011). Gardasil additionally covers 
types 6 and 11 (CDC, 2012b). CDC (2012) highlighted that HPV vaccine is a strong 
preventative measure and it is safe and in protecting both women and men the most common 
HPV types (CDC, 2012b). Both vaccines are currently available in Poland (Gardasil is 
registered under name of Silgard) (Mocarska et al., 2012) but none of them is on the list of 
refunded medicinal products (Dziennik Urzędowy Ministra Zdrowia, 2012). 
 
While these vaccines give hope for reducing cervical cancer incidence there is a growing 
controversy around this new method because of the numerous reports of complications 
associated with those vaccines (Mocarska et al., 2012) such as pain, bruising, swelling at the 
injection site and fainting (Brankovic et al., 2013) and in some cases suspected serious 
disabilities or death (Tomljenovic et al., 2013). Irrespective of the creation of the vaccine, 
there is need for effective screening methods as the vaccine does not work for all HPV types 
and does not cover women prior to exposure to the virus (CDC, 2012a). Vaccine therefore will 
not eradicate the disease, but merely decrease its extent in the population (Garland, 2009) and 
the effective population based screening programmes are needed, especially in countries with 
high mortality from cervical cancer such as Poland and other countries in Eastern Europe 
(WHO, 2010).  
 
2.5.3. Inequalities in cancer and cancer screening 
 
Systematic morbidity and mortality inequalities exist in the population of every country, also 
including those with a high development index (e.g., UK, Netherlands, or Sweden) 
(Mackenbach, 2012; Mackenbach, 2006). The aim of cancer screening programmes is to 
decrease mortality rates by detecting cancers at an early stage by providing an early, less 
invasive treatment intervention (Mauad et al., 2009). However, unequal access to, and quality 
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of health care including cancer prophylaxis might result in health inequalities (Marmot et al., 
2012; Van der Meer and Mackenbach, 1998). The relationship between income inequality and 
health status has been well established (Chiu, 2003; Damiani et al., 2012). Socio-economic 
differences may result in unequal access to and uptake of breast and cervical cancer screening 
especially in countries without population-based cancer screening programmes (Palencia et al., 
2010). Additionally, lower levels of education have been typically associated with lower 
screening uptake (Sabates and Feinstein, 2004). It has been suggested that individuals’ social 
interactions, place of habitation, and psychosocial characteristics, all have an effect on a 
patient’s health outcomes (Martikainen et al., 2002; Chiu, 2003). Many of these inequalities, 
within and between countries, are caused by inequalities in the social conditions in which 
people live and work (Irwin et al., 2006). These determinants have an impact on patients’ 
wellbeing. Tackling the underlying causes of poor health and understanding the problem can 
contribute to improving health and health equity (Feachem, 2000). 
 
There is a growing body of theoretical and empirical work that explores the relationships 
between health inequalities and place of habitual residence (Mackenbach, 2012, Popay et al., 
2003). Often those health differences are discussed in the context of the populations living in 
different countries, regions or even as being part of different social classes. For example many 
researchers discussed significant mortality and morbidity health differences between 
Central/Eastern and Western Europe (Adeyi et al., 1997; Bobak and Marmot, 1996; Carlson, 
1998; Pardell et al., 2001; Zatonski and Bhala, 2012) often explaining them by the fact that 
Central/Eastern Europe was subject to substantial transition from communism to democracy 
(Adeyi et al., 1997; Wroblewska, 2003). Others noted health variations between regions of the 
same country, as for example breast cancer incidence varying between women from different 
socio-economic groups with higher rates among women with lower socio-economic status 
(Bray et al., 2004). This can be partially related to the fact that those from lower socio-
economic groups are more likely not to take up the screening (Bray et al., 2004). For example 
Doran et al. (2004) pointed towards the widely discussed term of ‘North South’, divide 
referring to health inequalities between Northern and Southern parts of Britain which they 
hypothesised was due to differences between social classes and the level of deprivation (Doran 
et al., 2004). Similarly, the Report of the Nuffield Council on Bioethics (2007) mentioned a 
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great variation in health risks, health-related behaviours, physical and mental health, and life 
expectancy between different social groups. The report stated that the lower health related 
indices have been linked to lower socio-economic status, female gender, being from racial or 
ethnic minority, living in places with lower degree of urbanisation (Nuffield Council on 
Bioethics, 2007). Also religious views have been found to influence heath outcomes and 
health beliefs as for example the level of alcohol or other addictive substances use can depend 
on persons’ religious views (Nuffield Council on Bioethics, 2007).  
 
It has been noted that inequalities in screening uptake of both programmes can be associated 
with being from an ethnic minority as these women may have different access to screening, 
lack of availability of screening advertisements in their language as well as potentially 
differing frequency of screening recommended by their physicians (Rodriguez et al., 2005; 
Scanlon et al., 2006; Thomas et al., 2005; Glick et al., 2012; Consedine et al., 2004; Tavafian, 
2012). For example a study conducted in the U.S.A. by Consedine et al. (2004) found that 
women from different ethnic backgrounds in migrant communities have notably different 
attitudes towards screening. They noted that in particular Eastern European women reported 
fewer mammograms than other ethnic groups (Consedine et al., 2004). However, ethnicity as a 
factor for health or health outcome inequalities would not play a significant role in ethnically 
homogenous societies such as Poland, or many of the other former Soviet bloc states (Vojtěch, 
2010). It has been estimated that only 3% of inhabitants of Poland constitute ethnic minorities 
(EURYDICE, 2012). Only Polish nationals having personal identification number were 
included in the data analysed in this thesis (please see 3.3 section).  
 
The type of screening programme (opportunistic vs. population based) has been previously 
found to be associated with differences in health outcomes. For example Palencia et al. (2010) 
found that most of the breast and cervical cancer inequalities in Europe are found in countries 
with opportunistic screening rather than population based initiatives (relative inequality 
indices (RII) for cervical cancer; and RII=3.11, 95% CI 1.78–5.42 for breast cancer) (Palencia 
et al., 2010). Over the past two decades, WHO created the Commission on Social 
Determinants of Health (2005-2008) and developed community based initiatives to provide 
guidance for government to improve patients’ health, health related education and the quality 
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of the services enhancing the status of women and their role in the health of families 
(Commission on Social Determinants of Health, 2008; Irwin et al., 2006; Marmot et al., 2012). 
In order for health screening to be effective and efficient a significant part (>70%) of the 
population has to participate in it (Mauad et al., 2009; Szewczyk, 2011). Reduction of 
morbidity and mortality through the uptake of screening programmes requires the constant 
engagement of professionals involved in the screening and reaching the populations at risk 
(including women that might live in remote rural locations) (Mauad et al., 2009). Fister and 
McKee (2005) noted that many citizens of transitional regions such as Poland still remain 
insufficiently involved in decisions about their health care (Fister and McKee, 2005). Abbott 
et al. (2006) hypothesised that health risk behaviours tend to be linked with an inclination of 
patients to rely on the state to care for their health instead of accepting responsibility for their 
own health decisions (Abbott et al., 2006). For example, European Commission (2012) found 
that Eastern European patients find themselves discouraged from involvement in their health 
care and lacking control over it if the physician does not spend (in their opinion) sufficient 
time on consultation (European Commission, 2012). They also look for more partnered 
interaction with their health provider and expressed the need to receive more comprehensive 
information. However, due to the superiority of physician’s experience and knowledge the 
Eastern European patients are more likely to give high control of their health to their physician 
and are less aware, than their counterparts from other member states, of the opportunities to 
take control of their own health (European Commission, 2012).  
 
Patient involvement in their own health care can be as important as good centralised screening 
systems (Fister and McKee, 2005) and in order to encourage patients to effectively participate 
in their care by participation in cancer screening many cultural, behavioural and socio-
economic factors have to be addressed (Bobak et al., 2000; Fister and McKee, 2005). 
Understanding the characteristics, needs, beliefs, and perceptions of people living in different 
communities and with various levels of income is one of the steps to create comprehensive 
health programmes and policies because perceptions often reflect the attitudes towards health 
and are an important element of social exclusion or inclusion (Bullock, 1999, Lott, 2002).  
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2.6. Determinants of breast and cervical screening  
 
Determinants of breast and cervical cancer screening uptake have been frequently discussed 
side by side as similar factors tend to be influence both of them (Jepson et al., 2000; Threlfall 
and Fazil, 2009; Gonzalez et al., 2012). Several studies have explored issues related to 
screening attendance and shown that breast and cervical screening attendance can be linked to 
factors such as: age, previous attendance, social status, health insurance coverage, ethnicity 
and religion (Singh and Badaya, 2012; Threlfall and Fazil, 2009). Also numerous beliefs, 
perceptions and attitudinal factors have been linked with variance in the uptake of screening.  
 
An earlier comprehensive literature review conducted by Jepson et al (2000) for the needs of 
the Health Technology Assessment (HTA) on the determinants of screening uptake grouped 
the determinants of breast and cervical screening uptake under common headers. These 
headers were adapted for the needs of this thesis to provide a guided overview of the most 
important determinants of breast and cervical cancer screening uptake. However, some of the 
determinants described below may have been allocated to several of these headers (for 
example recommendation and support of physician could be listed as both the facilitator and 
social influence).  
 
The determinants have been divided into the below groups: 
1) Socio-demographics (e.g., age, gender, education, income, ethnic origin, employment 
status, rural vs. urban setting). 
2) Knowledge, behaviours and other factors related to breast and cervical cancers (e.g., 
knowledge of disease and screening test, past screening behaviour and attendance for 
tests, perceived seriousness of disease or condition). 
3) Barriers and facilitating conditions (e.g. lack of transport, costs involved in attending 
screening, inconvenience i.e. difficulty in access, embarrassment, fear of finding test 
positive, fear of pain or discomfort of test procedure, recommendation by physician or 
other healthcare professional). 
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4) Social influences (knowing someone with the disease or condition, support of family, 
friends or significant others, support of physician or other healthcare provider, 
membership of a club, church or other organization, knowing someone who has been 
screened). 
5) Health status (family history of the disease or condition, experiencing symptoms of the 
disease or condition, number of previous visits to doctor, self-reported health status, 
able to perform activities of daily living). 
 
2.6.1. Socio-demographics 
 
Numerous studies have examined the relationship between socio-economic and demographic 
factors and the uptake of breast and cervical screening tests, as the characteristics of the 
screened population may influence the effectiveness and uptake of the screening programme 
(Lorant et al., 2002; Damiani et al., 2012; Damiani et al., 2011; Wells and Roetzheim, 2007; 
Garrido-Cumbrera et al., 2010; Palencia et al., 2010). Factors such as: older age (>50 for 
breast cancer), lower education, lower economic situation (incl. higher level of deprivation) 
being single or divorced, belonging to ethnic minority or living in a rural location, have been 
widely discussed as having a positive association with lower uptake of breast and cancer 
screening (Chiu, 2004; Sutton and Rutherford, 2005; Thomas et al., 2005). The most important 
determinants of breast and cervical cancer screening uptake are discussed in greater detail in 
the following sections. 
 
Age 
Differences between different age-groups in the uptake of cervical screening have been noted 
previously (Cancer Research UK, 2011). Young women in their 20s and 30s who decide not to 
attend cervical screening often report that this is due to unsuitable appointment times or 
difficulty fitting it around their busy lifestyles, whereas older women aged 50 and over tend to 
be embarrassed by the procedure (Cancer Research UK - Press release, 2011). Champion 
(1994) noted that breast screening compliance (1 and 5 year screening) was lower for women 
aged 50 or over than younger women (<50 years old) (Champion, 1994). Jepson et al. (2000) 
reported in their review that age was a significant predictor for Pap screening uptake in the 
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majority of the reviewed publications but the effects of the association in the reviewed studies 
were conflicting as the screening status and age of the study subjects varied (Jepson et al. 
2000). Also a Polish study conducted amongst 109 women attending cost free prophylactic 
mammography showed such positive correlation (Prażnowska et al., 2010). The breast 
screening attendance decreased after the age of 55 years old (target screening age in Poland is 
50-69) (Prażnowska et al., 2010).  
 
Marital status 
Marital status has been found to be associated with the uptake of both breast and cervical 
screening (Damiani et al., 2012; Sutton and Rutherford, 2005; Macedo et al., 2012; Martin-
Lopez et al., 2010; Jelastopulu et al., 2013; Soni, 2007). For example Soni (2007) found that 
married women (75.6%) were more likely than never married (62.8%) or no longer married 
(64.1%) to take up mammograms. Also married women (81.3%) were more likely than never 
married (72.8%) or no-longer married women (67.9%) to receive a breast exam. (Soni, 2007). 
Later Damiani et al. (2012) confirmed these findings. They reported that married were 1.83 
times more likely than single women to uptake regular breast cancer prevention 95% CI=1.56-
2.15). Being married in comparison to not being married was also significantly associated with 
higher uptake of Pap test (OR=2.41; 95% CI=2.23-2.60) (Damiani et al., 2012). Jelastopulu et 
al. (2013) found a very similar relationship between marital status and Pap test uptake. 
Married or partnered women were 2.4 times more likely to than single women to utilise 
cervical screening (95% CI 1.4-4.1). 
 
Education, employment and income 
Various studies across the world show that literacy and health literacy have been found to be 
linked with the uptake of screening (Day et al., 2010). A positive association of education and 
occupation with uptake of both breast and cervical screening has been confirmed by many 
researchers (Damiani et al., 2012; Duport et al., 2008; Hewitt et al., 2004). One of the studies 
conducted amongst Italian women revealed that higher levels of education and being in 
employment is related to higher likelihood to undergo a mammogram than being less educated 
or unemployed (OR=1.77; 95% CI=1.55-2.03, OR=1.63; 95% CI=1.40-1.91 respectively). 
When comparing women in the highest occupational class with those in the lowest it was 
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found that there was a significant difference between those groups (OR=1.81; 95% CI=1.63-
2.01). The researchers also found that screening invitees with lower education or lower 
occupational levels were more likely to attend organised screening programmes than the more 
advantaged women who also attended those services from their own initiative (Damiani et al., 
2012). Similar outcomes of lower uptake of cervical screening were observed amongst Polish 
women with basic education in comparison with the ones educated to a high school or higher 
level (20% versus 6% respectively) (Spaczyński et al., 2010). Thirty eight per cent (38%) of 
the women with highest education indicated that they attended screening only in private health 
clinics (Spaczyński et al., 2010). Over the years the literacy and education levels in Poland 
improved. In the mid 20th century over 50% of Polish people were literate (Unesco, 2006), by 
1994 reaching 99% and in 2010, 100% (World Bank, 2013). In 2002, 10.4% of women 
obtained a university degree versus 18.8% in 2011. This resulted in a decrease of numbers of 
women in each of the remaining educational groups (high school: 35.1% in 2002 vs. 33.7% in 
2011; technical: 16.9% in 2002 vs. 15.9% in 2011; complete primary: 31.4% in 2002 vs. 
25.0% in 2011; and incomplete primary or lack of formal education: 4.3 % in 2002 vs. 1.7% in 
2011) (Central Statistical Office of Poland, 2012b). Today education between ages 7 and 18 
years old is compulsory and guaranteed by the Constitution of the Republic of Poland to every 
citizen. Education delivered in public schools is cost free and with equally accessible to the 
citizens (EURYDICE, 2012).  
 
Researchers also showed that there is strong association between low income, level of 
deprivation and lower uptake of screening services (Blanks et al., 2002; Lofters et al., 2011; 
Champion, 1994). For example in Ontario (Canada) it has been shown that not being in the 35-
49 year age group and living in the neighbourhoods with the lowest income was one of the 
predictors of low cervical screening uptake (Lofters et al., 2011). Blanks et al. (2002) found 
that women who attended breast cancer screening in the UK were more likely to live in less 
deprived areas than those who did not attend it (Blanks et al., 2002). Due to the political and 
historical background it is difficult to assess the levels of deprivation in Poland. In 2009, there 
were 17.4% Polish women living in poverty (poverty line: <60% of median equalized income 
of households) and 15.3% in deep poverty (inability to afford four or more of nine essential 
needs) (Szarfenberg, 2010). The European Working Conditions Observatory (2010) noted that 
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the majority of the working poor (people who are below poverty line despite being employed) 
Poland are aged 40 years or more, and they live in multigenerational households (often two or 
three generations) (Towalski and Kuźmicz, 2010). It has been stated that working poor are 
visible in the labour market however they are not present in the social or fiscal policy 
institutions (Towalski and Kuźmicz, 2010). Towalski and Kuźmicz (2010) also described a 
study conducted in 2008 by the Centre for Public Opinion Research (CBOS) which indicated 
that on average, households that were classified as working poor were composed on average 
of 4.2 people; versus 3.2 in the working non-poor and 2.6 people in the non-working poor. The 
working poor were the most common amongst two generation (57.7%) and multi-generation 
households (16.8%), respectively (Centrum Badania Opinii Społecznej (CBOS), 2008; 
Towalski and Kuźmicz, 2010). The same study has also showed that the working poor have 
lower financial expectations when compared to all other groups including even those of the 
non-working poor (CBOS, 2008). Wide spread poverty amongst working Poles makes it 
challenging to consider employment status a proxy for economic situation. Therefore, the most 
important proxies for poverty or deprivation in Poland are the household characteristics and 
self-assessed needs and expectations (Towalski and Kuźmicz, 2010). Considering these facts 
the data on self-assessed economic status analysed in this thesis were treated as proxy for the 
level of economic status. 
 
Rural versus urban setting 
According to the most recent estimates (2011) 60.2% of Polish people live in the urban areas 
(61.8% in 2002) (Central Statistical Office of Poland, 2012b). Lower levels of both breast and 
cervical uptake can be observed especially amongst rural populations (Day et al., 2010; 
Spaczyński et al., 2010; Jokiel and Bielska-Lasota, 2005). Spaczyński at al. (2010) conducted 
a survey amongst a convenience sample of 1,625 Polish women (age: 25-59) who visited 
gynaecology clinics in Poland (for various reasons) and found that more women living in the 
rural areas (15.2%) than urban (8%) decide not to take up cervical screening (Spaczyński et 
al., 2010). Another study among Polish women that attended free prophylactic mammography 
showed that only 10% of the women in the studied sample lived in a rural region (Prażnowska 
et al., 2010). Even though the evidence for Poland is very limited it is likely that women from 
rural areas will have a limited access to the screening services.  
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2.6.2. Knowledge, behaviour, attitudes and beliefs 
 
Knowledge or awareness of breast and cervical cancers and their prophylaxis have been 
studied by many researchers and it has been noted that their lack may negatively influence the 
uptake of screening (Gronwald et al., 2006; Lyttle and Stadelman, 2006; Okobia et al., 2006; 
Paolino and Arrossi, 2011; Steven and Fitch, 2004). Other factors such as underlying attitudes, 
beliefs, perceptions and motivations towards health and disease, such as cancer, have been 
previously found to be related to the uptake of breast and cervical cancer screening 
programmes (Bowling, 1989; Sutton and Rutherford, 2005; Jepson et al., 2000) and could be 
at least partially explained by exploration of these factors on an individual level (Sutton and 
Rutherford, 2005). Women with positive attitudes showing intentions to take up breast 
screening were more likely to use those screening services (Jepson et al., 2000; Marcinkowska 
et al., 2006). Fylan (1998) and Waller et al. (2009) noted that women may think of cervical 
screening as unnecessary or not beneficial if they believe they are not at risk of developing 
cervical cancer (Waller et al., 2009; Fylan, 1998). Also embarrassment when attending 
cervical screening, as well being afraid of receiving referral for colpsocopy and other medical 
procedures can be considered barriers to screening uptake (Waller et al., 2009; Fylan, 1998). 
Another study amongst Swedish women confirmed Fylan’s findings as Eaker et al. (2001) 
found that non attendees did not think that cervical screening is beneficial (Eaker et al., 2001). 
A recent review of studies published between 2000 and 2008 confirmed that belief in the 
usefulness of screening was an important predictor of breast screening uptake (Vedel et al., 
2011). Also higher likelihood of breast screening attendance was found among women that 
undertook breast screening in the past than those who have never been screened (Lechner et 
al., 1997). This could be due to lack of such possibility or a conscious decision not to attend. 
But attending once does not mean that the woman will decide to repeat the screening (Lechner 
et al., 1997). Jepson et al. (2000) found a similar association in cervical screening (Jepson et 
al., 2000).  
 
A number of studies explored how knowledge of breast and/or cervical cancers and their 
prophylaxis was related to attendance (Wong et al., 2009; Okobia et al., 2006; Jokiel and 
Bielska-Lasota, 2005; Spaczyński et al., 2010). The studies looked not only at knowledge 
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amongst the general female population undergoing routine screening, or cancer patients but 
also amongst female healthcare professionals. For example a study conducted in Nigeria 
amongst community-dwelling women to assess their awareness, attitude and practice of breast 
cancer prophylaxis has shown that knowledge of the disease was very poor and only the 
minority practiced BSE or attended the clinics to have their breasts examined by a medical 
professional (Okobia et al., 2006). Similarly, another study among Malaysian women 
highlighted that many women believe that the purpose of the cervical smear test is detection of 
the existing cancers and that the lack of symptoms equalled to lack of need to undergo 
screening (Wong et al., 2009). Most of the women were not aware that the cancer could be 
prevented if changes were detected early (Wong et al., 2009).  
 
Other studies examined the level of knowledge about both breast and cervical screening. 
Lyttle and Stadelman (2006) reported in a study in West Virginia that awareness of breast 
cancer issues was much higher than those relating to cervical cancer (Lyttle and Stadelman, 
2006). The authors noted that many women based their knowledge on misconceptions that 
could have an unfavourable impact on the future uptake of cancer screening (Lyttle and 
Stadelman, 2006). Another study in Turkey examined knowledge of screening related topics 
amongst health professionals and found that health professionals may be insufficiently 
informed about screening and in particular about recommendations for cervical screening 
intervals and their dependence on the previous results. The study was conducted amongst a 
sample of nurses and found out that only 66.4% knew that if the repeated Pap smear tests were 
normal, screening could be done every 2–3 years (Yaren et al., 2008). Conversely, a study 
amongst health care professionals in the U.S.A. examining knowledge, perceptions and 
attitudes toward cervical screening found a good level of knowledge but noted that the 
educational resources for patients were insufficient (Tessaro et al., 1996). Paolino and Arrossi 
(2011) have shown that 49% of Argentinean women who had been screened and 73% of 
unscreened ones had inadequate levels of knowledge about Pap smears. Forty seven percent of 
screened and 30% of unscreened women had never heard about HPV. Having knowledge 
about cervical cancer screening was also positively linked to being screened in the previous 
three years (Paolino and Arrossi, 2011).  
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Limited Polish studies to date have examined the association between the levels of breast or 
cervical cancer screening uptake with knowledge, behaviours and attitudes towards either 
breast or cervical cancer or cancer screening (Jokiel and Bielska-Lasota, 2005; Spaczyński et 
al., 2010). One of the earlier studies conducted by Chojnacka-Szawłowska (1998) in the city 
of Gdańsk explored the psychological factors of knowledge of cancer symptoms in cancer 
patients in relation to that of the general population. The study was not specific to breast or 
cervical cancer but it included a number of patients (men and women) who were diagnosed 
with either of these cancers as well as healthy controls. Results have shown that approximately 
21% of cancer patients and 53.8% of respondents from the general population were unable to 
name any cancer symptoms. Forty one per cent of cancer patients were able to name at least 
one and 27.7% two cancer symptoms versus 32.3% of general population having knowledge 
of one symptom and 13.7% two symptoms. Chojnacka-Szawłowska (1998) noted that the 
female patients who had better knowledge of cancer symptoms were younger and the level of 
fear of cancer was not related to knowledge of the symptoms (Chojnacka-Szawłowska, 1998).  
 
In a later study, Jokiel and Bielska-Lasota (2005), aiming to measure women’s knowledge 
about Pap test and their screening practices, involved nationally representative samples at 5 
different time points between 1976 (N=1,035), 1986 (N=460), 1990 (N=455), 1998 (N=524), 
and 2002 (N=509). The results have shown at the last data collection point (2002) that 91% of 
women reported that they were aware of the importance of cervical screening and 88%, 75%, 
65%, and 31% in 1998, 1990, 1986 and 1976, respectively. The highest knowledge levels 
were noted amongst women aged 25-39 or 40-49 with the highest educational level and living 
in cities. Also the number of women visiting their gynaecologist increased from 33% in 1976 
to 46% in 2002 (p<0.001). The researchers also explored cancer registry data and found that 
the overall survival rate was 52.2% which one of the lowest amongst European countries. 
They also found that the relative excessive risk of death was related to progression in disease 
stages, delay in treatment and density of the population in the place of habitual residence 
(Jokiel and Bielska-Lasota, 2005).  
 
Zych et al. (2006) on the other hand attempted to gain understanding of women’s (from South-
East region of Poland, N=300) knowledge of breast cancer prevention and their familiarity 
98 
with its symptoms. They concluded that more than half of patients (51%) stated that they were 
aware of the need for BSE from the age of 20, 32% of women indicated that self-examination 
should be done beginning from the age of 30 and 6.9% pointed that the most appropriate 
period of women’s life falls during the menopause. Overall the results revealed that BSE and 
cancer symptoms were not well understood and women did not know when BSE should be 
done. Risk factors for breast cancer were known to most women but every second woman had 
trouble in naming at least four of them (Zych et al., 2006). 
 
Nowicki et al. (2008) examined knowledge and health screening behaviours amongst women 
who were employed in the healthcare sector, compared to those that were not. They found that 
there were no significant differences between the two groups in knowledge or screening 
behaviours related to cervical cancer. However, they surveyed a convenience sample of a 
relatively small size (N=207) women in both of the studied groups (Nowicki et al., 2008). 
 
Later Nita et al. (2010) conducted a survey amongst 109 visitors or mothers of children being 
hospitalised in the Orthopaedic and Traumatology Department of The Institute of Health of 
Mother Pole in Lodz and found that the women had inadequate levels of knowledge of both 
breast and cervical cancers. Authors of this hospital based study assessed that due to lack of 
knowledge of cancer and cancer prophylactic practices such as BSE (currently recommended 
in Poland) the knowledge amongst surveyed women was insufficient (Nita et al., 2010b).  
 
Two other Polish studies confirmed the previous findings of inadequate knowledge of breast 
and cervical cancer and its prophylaxis and highlighted the role of media in the increasing 
women’s knowledge of female cancers and cancer screening initiatives (Gronwald et al., 2006; 
Ulman-Włodarz et al. 2011). Gronwald et al. approached Polish women from the Pomeranian 
region who attended genetic BRCA1/BRCA2 testing after they read an advertising article in 
the women’s popular press. The researchers followed a sample (N=198) of BRCA1 (the most 
common BRCA mutation in Poland) carriers and non-carriers after one year and questioned 
them about their knowledge on breast cancer and its prevention. The majority (81%) of the 
carriers responded that they had been adequately informed during counselling about cancer 
prevention and 19% wanted to receive more information. At that stage (1 year after the first 
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screening) the satisfaction of undergoing the test was very high (98%). Gronwald et al. (2006) 
demonstrated also that carriers of BRCA1 followed the cancer prophylaxis more often than 
non-carriers (Gronwald et al., 2006). The researchers pointed out that Polish women at a high 
risk of breast cancer do not have the possibility to get genetically screened, due to high cost or 
lack of recognition by their health care providers (Gronwald et al., 2006). Therefore they 
remain unaware of their cancer predisposition. The second of the mentioned studies (Ulman-
Włodarz and Nowosielski, 2011) questioned 250 patients who attended gynaecology clinics in 
Krakow and found that the majority of women (68%) assessed that they had medium level of 
knowledge on cervical cancer. Similarly like the women from the study conducted by 
Gronwald et al (2006), it was found that that the primary sources of knowledge was the 
women’s press (59%), television (47%) and internet (38%) (Ulman-Włodarz and Nowosielski, 
2011). Only about a third of respondents gained their knowledge from their gynaecologist and 
as little as 3% attended following their personal screening invitation from the National Health 
Fund (Ulman-Włodarz and Nowosielski, 2011).  
 
2.6.3. Barriers and facilitating conditions 
 
Barriers or facilitators to screening have been extensively described in several literature 
reviews to date (Jepson, 2000; Consedine et al., 2004; Day et al., 2010). Perceived barriers to 
screening can include individual barriers or health system barriers. The most commonly 
explored barriers are: anticipated embarrassment, perception of pain related to screening or 
fear/anxiety related to the test results (Jepson et al., 2000) cultural barriers, fatalism, perceived 
effectiveness, lack of recommendation by a physician, male staff performing the screening, as 
well as lack of transport or costs involved in attending screening are significant predictors of 
lower screening uptake (Munn, 1993; Ahmad et al., 2001; Eisner et al., 2002; Sutton and 
Rutherford, 2005). The view that anxiety fear and embarrassment are correlated with lower 
uptake screening rates was confirmed by Ulman-Włodarz et al., (2011) in a study where Polish 
women indicated that the main reasons for non attendance were indeed: fear of pain (39%), 
lack of symptoms (18%), carelessness (15%) and embarrassment (12%) (Ulman-Włodarz and 
Nowosielski, 2011). Also factors such as apathy, lack of concern, low perceived need and the 
perception that without symptoms there is no need for screening, add to the important factors 
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that might mean the difference between the undertaken a screening test or not (Munn, 1993; 
Ahmad et al., 2001; Eisner et al., 2002; Sutton and Rutherford, 2005). 
 
Some discrepancies were also found in the literature with regards to psycho-emotional factors 
such as: anxiety, fear, or worry and whether they are actual barriers or facilitators of cancer 
screening. Consedine et al. (2004) reviewed literature on the fear of or anxiety related to 
having a positive test result for cancer and found that it is often linked to lower uptake but they 
also noted that these factors were found by other studies conducted in the past, possible 
motivators to take up the screening (Consedine et al., 2004). Vedel et al. (2011) found in their 
review that embarrassment, fear of embarrassment, discomfort or fear of the test are linked to 
the uptake of screening (Vedel et al., 2011). Similarly, a Polish study by Spaczynski et al. 
(2009) found that out of 1,625 surveyed Polish women who decided not to undertake the 
cervical screening the main reasons for non-attendance were: 24% lack of time, 23% aversion 
to have the test done by an unknown physician, and 15% dislike of the test (Spaczyński et al., 
2009). 
 
Since the early years of the first screening programmes researchers suspected that health 
system barriers such as insurance status or level or urbanisation would be an important 
predictor of cervical and breast screening uptake (Hayward et al., 1988, Smith and Haynes, 
1992). Later studies confirmed those assumptions. Jepson et al. (2000) found that in 7 out of 
12 reviewed studies rates of mammography were significantly higher amongst women who 
had health insurance coverage (Jepson et al., 2000). Other authors also found that lack of 
health insurance to cover the cancer screening tests (where no free screenings available) was a 
very strong predictor of non-attendance (Meissner et al., 2004; Rodriguez et al., 2005; Vedel 
et al., 2011). In Poland, insurance coverage is not of significance as since the last health care 
reform in 2003, the existing discrepancies in coverage have been resolved and currently every 
individual has the right to state funded health care (Golinowska and Kozierkiewicz, 2008).  
 
The facilitating conditions to screening may include factors that are on the opposite end of 
barriers including the most commonly identified patient's characteristics, knowledge related to 
cancer and its screening, belief in usefulness and safety of screening, presence of risk factors, 
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good health, health insurance covering the cost of the test, accessibility of the test and good 
health status (Meissner et al., 2007; Mondragon and Brandon, 2001; Sharp et al., 2005; Davey 
et al., 2005; Paolino and Arrossi, 2011). 
 
2.6.4. Social influences  
 
Social influences such as: knowing someone with the disease, having support of family, 
friends or significant others (e.g., physician), membership of a club, church or other 
organization, knowing someone who has been screened are an important factors that may 
influence the uptake of screening (Winkler et al., 2008; Champion, 1994; Marcinkowska et al., 
2006). For example Winkler et al. (2008) showed that women that undertook cervical 
screening were more likely to have friends encouraging each other to take up the Pap test. 
Screened women also knew more other women (friends, family, or acquaintances) that had 
been screened in the past 3 years (Winkler et al., 2008). Champion et al. (1994) noted that a 
suggestion to go for cancer screening made by a health care professional can be an important 
factor facilitating uptake, especially among older women (Champion, 1994). Marcinkowska et 
al. (2006) interviewed 57 Polish women with regards to the reasons for non-uptake of 
mammography and noted that some of the women expressed an opinion that their physician 
should play an important role in convening the health related messages and advise women on 
which tests they should undertake (Marcinkowska et al., 2006). Polish women also seem to 
follow the advice of their friends or neighbours or “what is being said” and emphasize the role 
of their physician in their health care (Marcinkowska et al., 2006) and another type of social 
factor that may influence screening uptake is media. It has been previously demonstrated that 
women take up the cost free preventive tests following messages transmitted in mass media 
(Lewandowska et al., 2012; Przestrzelska et al., 2006). For example more than 58% of Polish 
women, included in a study (N=100) by Lewandowska et al. (2012), obtained their knowledge 
from the mass media such as internet, television, and radio with only 18% receiving 
information from their health care professional, 16% from medical press and 8% from other 
sources (Lewandowska et al., 2012).  
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2.6.5. Health status  
 
Overall health status has been found to have an association with uptake of screening (Day et 
al., 2010; Sadler et al., 2007; Davey et al., 2005). People with poor health have been shown to 
be significantly less likely to use mammography than those with good health (Sadler et al., 
2007, Davey et al., 2005). Even though the body of evidence is not extensive, some studies 
pointed towards the examples of women with a physical or mental disability or chronic illness 
that may be experiencing challenges in accessing screening services and in particular 
mammography (Day et al., 2010). Day et al. (2010) have highlighted that despite the lack of 
strong evidence on the relationship of influence of screened population’s health it is important 
not to dismiss its importance when planning for screening programmes (Day et al., 2010). 
 
2.7. Theories used to predict health behaviours 
 
Health behaviours are complex and may be influenced by many factors and over the years 
many researchers tried to explain and predict behaviour by constructing theoretical 
frameworks to identify its determinants and predictors (Noar and Zimmerman, 2005). 
Understanding what influences health related behaviours may be particularly important for 
government funded population-based disease screening initiatives that often are very costly, 
labour intense and if not utilised to a desirable level by the target population may be 
ineffective, burdensome to the health care system and financially wasteful (Sankaranarayanan 
et al., 2001). 
 
However, people intending to perform a health-related behaviour do not always carry out this 
intention. Their intention usually accounts for no more than 20–30% of variance in behaviour 
(Armitage and Conner, 2001; Conner and Sparks, 2005; Sheeran, 2002). Various factors have 
been noted to play an important role in the uptake of screening with factors such as: 
characteristics of the cancer screened for, medical test characteristics, context of health care 
and individual patient characteristics (Figure 9) being among some of the most important ones 
(Weller et al., 2009).  
103 
Figure 9 Factors playing role in screening uptake strategies (adapted from Weller et al., 
2009)  
 
Researchers often used various theoretical models to identify, understand, explain and predict 
health related behaviours. Some of the most widely used behavioural theories included: Health 
Belief Model (HMB) (Rosenstock, 1974), Theory of Reasoned Action (Ajzen and Fishbein, 
1980, Fishbein and Ajzen, 1975), the Theory of Planned Behaviour (TPB) (Ajzen and 
Madden, 1986, Ajzen, 1991), Social Cognitive Theory (SCT) (Bandura, 1986), 
Transtheoretical Model (TTM) (Prochaska and DiClemente, 1983) the Health Action Process 
Approach model (HAPA) (Schwarzer, 1992) and other theories and behavioural constructs 
that attempt to explain or predict breast or cervical cancer screening behaviours.  
 
Noar and Zimmerman (2005) stated that many of the behavioural constructs and theories 
being used to explain or predict health behaviours overlap, or their components are 
conceptually rooted within each other (Noar and Zimmerman, 2005). It has also been 
previously noted that exploration of a single construct’s predictive value is greatly variable but 
also broad theories have been criticized for not being possible or difficult to test (Ogden, 
2003). The researchers also pointed out that many behavioural theories use different 
terminology but in fact are very similar or even the same (Conner and Norman, 1996; Noar 
and Zimmerman, 2005; Nigg et al., 2002; Sutton, 1998). A detailed overview of the most 
commonly used behavioural theories has been structured following a review by Noar and 
Zimmerman (2005) who made a comparison between the constructs of those theories (table 9). 
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Table 9 Similar or identical elements within five health behaviour theories (reproduced with permission from Noar and 
Zimmerman, 2005) 
Concept 
General tenet of the 
concept ‘Engaging in the 
behaviour is likely if…’ 
HBM TRA TPB SCT TTM 
Attitudinal beliefs 
Appraisal of the 
positive and negative 
aspects of the 
behaviour and 
expected outcome of 
the behaviour 
the positive aspects 
outweigh the negative 
aspects 
benefits, 
barriers/health 
motive 
behavioural 
beliefs and 
evaluation 
of those 
beliefs 
(attitudes) 
behavioural 
beliefs and 
evaluation 
of those 
beliefs 
(attitudes) 
outcome expectations / 
expectancies 
pros, cons (decisional 
balance) 
Self-efficacy beliefs/beliefs about control over the behaviour 
Belief in one's ability 
to perform the 
behaviour; 
confidence 
one believes in their 
ability to perform the 
behaviour 
self-efficacy – 
perceived 
behavioural 
control 
self-efficacy self-efficacy/temptation 
Normative and norm-related beliefs and activities 
Belief that others 
want you to engage 
in the behaviour (and 
one's motivation to 
comply); may 
include actual 
support of others 
one believes that people 
important to them want 
them to engage in the 
behaviour; person has 
others' support 
cues from media, 
friends (cues to 
action) 
normative 
beliefs and 
motivation 
to comply 
(subjective 
norms) 
normative 
beliefs and 
motivation 
to comply 
(subjective 
norms) 
social support helping relationships (process of change) 
Belief that others 
(e.g. peers) are 
engaging in the 
behaviour 
one believes that other 
people are engaging in the 
behaviour 
– – – 
social 
environment/norms; 
modelling 
social liberation 
(process of change) 
Responses to one's 
behaviour that 
increase or decrease 
the likelihood one 
one receives positive 
reinforcement from others 
or creates positive 
reinforcements for 
cues from media, 
friends (cues to 
action) 
–a –a reinforcement 
reinforcement 
management/stimulus 
control (processes of 
change) 
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Concept 
General tenet of the 
concept ‘Engaging in the 
behaviour is likely if…’ 
HBM TRA TPB SCT TTM 
will engage in the 
behaviour; may 
include reminders 
themselves 
Risk-related beliefs and emotional responses 
Belief that one is at 
risk if one does not 
engage in the 
behaviour, and that 
the consequences 
may be severe; may 
include actually 
experiencing 
negative emotions or 
symptoms and 
coping with them 
one feels at risk with 
regard to a negative 
outcome or disease 
perceived 
susceptibility/severity 
(perceived threat) 
– – 
emotional coping 
responses/expectancies 
about environmental 
cues 
dramatic relief 
(process of change) 
Intention/commitment/planning 
Intending or planning 
to perform the 
behaviour; setting 
goals or making a 
commitment to 
perform the 
behaviour 
one has formed strong 
behavioural intentions to 
engage in the behaviour; 
one has set realistic goals 
or made a firm 
commitment to engage in 
the behaviour 
– behavioural intentions 
behavioural 
intentions 
self-control/self-
regulation 
Contemplation / 
preparation (stages of 
change); self-
liberation (process of 
change) 
Variable names in parentheses indicate that the variable(s) above it are part of that larger category, according to the theory.a Both the TRA and TPB contain 
normative components that are conceptualized as beliefs in reinforcement (normative beliefs), rather than the actual reinforcement itself. It is not clear which 
conceptualization of these ideas is best for a theoretical framework 
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2.7.1. Health Belief Model (HBM) 
 
The HBM has been developed in late 1950s (Hayden, 2009; Abraham and Sheeran, 2005; 
Glanz et al., 2008) and since then it has been used widely in the past to determine the 
relationship between health beliefs and health behaviours as well as to inform interventions 
(Ersin and Bahar, 2011; Hall, 2012; Webb et al., 2010; Johnson et al., 2008; Hayden, 2009). 
The first use of HBM is attributed to Hochbaum (1958) who hypothesised that the 
perception of the likelihood and severity of negative health consequences combined with 
perceptions of prophylaxis would predict behaviour (Hochbaum, 1958; Hayden, 2009; 
Rosenstock, 1974). He showed that belief of susceptibility to tuberculosis accounted for 
82% of the participants that underwent the screening whereas only 21% of patients who 
believed in the beneficial effect of X-rays to detect and prevent TB undertook the X-ray 
(Hochbaum, 1958). Over time, the model has evolved and additional factors, such as self-
efficacy (Rosenstock et al., 1988) and the cost of preventative behaviours (Streecher et al., 
1997) were included. It was thought that the behaviour would partially reflect individual’s 
judgements of their own capability to take the actions needed to complete the task, meaning 
that the more barriers one would need to overcome, the less likely the desired action would 
be undertaken (Streecher et al., 1997). Later also other elements were added to the model. 
For example Austin et al. (2002) in their study examining factors associated with breast and 
cervical screening in Hispanic women used: perceived susceptibility, perceived severity, 
perceived benefits, perceived barriers, cues to action, and self‐efficacy. They described 
perceived susceptibility as individual’s opinion of the chances of suffering from a specific 
condition. Perceived severity was the individual’s opinion on the seriousness of getting 
condition and its repercussions. Perceived benefits are people’s opinions of the efficacy of 
the health action to reduce the risk or the impact of falling ill. Perceived barriers are material 
and psychological costs required to take the desired health action. Cues to action have been 
defined as an element that may prompt individual to action i.e. advertising, health 
professional’s advice etc (Austin et al., 2002). 
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Figure 10 Graphical representation of the HMB (Hayden, 2009) 
 
Abraham and Sheeran (2005) used a model that included: 1) threat evaluation that included 
perceived susceptibility to the health problem and perceived severity of the consequences of 
the illness; 2) behavioural evaluation including perceptions of the benefits of a 
recommended health behaviour and perceptions about the costs/barriers to the behaviour; 3) 
health motivation; and 4) cues to action including individual’s perceptions of symptoms, 
social influences and health education campaigns (Abraham and Sheeran, 2005). In brief, 
the HBM assumes that in order to plan a health intervention, the following are needed to be 
taken into consideration: perceived susceptibility and severity of the condition, perceived 
barriers and benefits to take an action; and cues to action (factors for activating the 
inclination to perform the anticipated behaviour) (Abraham and Sheeran, 2005; Hayden, 
2009; Glanz et al., 2008). 
 
Previous research has indicated that the predictive power of HBM is weak in the majority of 
health behaviour areas which is partially linked to absence of combinatorial principles (i.e. 
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how the model components interact with each other), poor construct definition, and 
weaknesses in the predictive validity of the HBM’s core psychological components 
(Armitage and Conner, 2000) as it does not account for: socio-economic status, cultural 
background, and previous experiences (Soliday and Hoeksel, 2000). However, regardless of 
the criticisms many researchers are still using the HBM components in conjunction with 
other additional components forming the base for new behavioural theories some of which 
have been created as long ago as in 1970’s (see for example: McMillan et al., 2008; Harvey 
and Lawson 2009). 
 
2.7.2. Theory of Reasoned Action (TRA) and Theory of Planned Behaviour 
(TPB) 
 
Fishbein and Ajzen in 1975 described and applied another model named the TRA to predict 
health behaviours. TRA takes into consideration intention as a predecessor of behaviour 
determined by attitudes (evaluation of taking the action) and subjective norms about the 
behaviour (Fishbein and Ajzen, 1975). Attitudes have been previously described as: 
probability, perceived severity and value of behavioural outcomes (Weinstein, 1993) and 
subjective norms as: the influence of others on the individual’s behaviour (social pressure) 
(Godin and Kok, 1996).  
 
This theory has been later criticised as having limitations. It was suggested that predicting 
intentions would be difficult or impossible and the score of the association would be 
substantially lowered if the individual perceived very limited control over their own 
behaviours or attitudes while at the same time perceiving high behavioural control (Godin 
and Kok, 1996). 
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Figure 11 Graphical representation of TPB (Ajzen, 1991) 
 
Following the criticisms of TRA, Ajzen (1991) reshaped the construct by adding perceived 
behavioural control (Figure 11). The model was named the Theory of Planned Behaviour 
(TPB) (Ajzen, 1991). It assumed that if behavioural intention is constant, highly controllable 
behaviours would have a higher likelihood to occur than less controllable ones (Armitage 
and Christian, 2003). The theory has been explored by many researchers in terms of 
predicting intentions and or behaviours but the results varied. It has been showed that TPB 
can account for moderate variance in intentions and behaviours but attitudes, subjective 
norms, and perceived behavioural control do not always allow the prediction of various 
health related behaviours (Taylor et al., 2006). 
 
Povey et al. (2000) used the TPB in a study of consumption of fruits and vegetables and a 
diet low in fats. It was found that attitudes were predictive of intention to eat a low-fat 
product but subjective norms were not. In the case of daily fruit and vegetable consumption 
both attitudes and subjective norms were positively predictive of intentions. Perceived 
behavioural control was negatively predictive of intention to increase fruit and vegetable 
consumption and decreased fat intake. The same study also showed that intentions were 
significantly associated with self-efficacy. Povey et al.’s (2000) conclusion was that 
perceived behavioural control is different from self-efficacy and it could be a better 
predictor of intentions in certain situations (Povey et al., 2000). Other researchers pointed 
towards embarrassment, pain and cancer worry as factors that could prevent women from 
attending the screening (Blomberg et al., 2008; Hay et al., 2005). Factors influencing 
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patients’ behaviours associated with screening have been noted to be influenced by attitudes, 
perception of barriers and benefits of screening, fear of cancer, the illness representations, 
and socio-demographics (Sutton and Rutherford, 2005; Orbell et al., 1996). Day et al. (2010) 
stated that women’s individual perceptions can lead to certain behaviours and those 
perceptions could be created by: adopting beliefs of people in the individual’s surroundings 
(i.e. peers and leaders), exposure to repetitive messages such as informative campaigns, and 
association of beliefs with strong positive or negative emotions and traumas (Day et al., 
2010). 
 
2.7.3. Social Cognitive Theory (SCT) 
 
The social learning or later renamed cognitive theory (SCT) is based on the assumption that 
behaviour is influenced by two factors: 1) incentives/reinforcements (value of specific health 
outcome) that are understood and possible to adopt by the individual and 2) expectancies, 
determined by the environment, such as consequences of own actions, competency to 
perform actions (self-efficacy) and their outcomes (Rosenstock et al., 1988). Situation-
outcome expectancies are linked to the perception that some consequences are beyond an 
individual’s control (Rosenstock et al., 1988). Expectancies of action outcomes link to the 
belief that there are specific actions necessary for a particular outcome.  
 
Figure 12 Graphical representation of SCT (Bandura, 1986) 
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The SCT theory has been found to be useful for behaviour change interventions as it takes 
into consideration cognitive, emotional and behaviour aspects (Branscum and Sharma, 2012; 
Fjeldsoe et al., 2012; Dilorio et al., 2000). The theory assumes that people with higher levels 
of self efficacy are more likely to perform new actions, put more effort into initiating and 
maintaining these behaviours (Bandura, 1997). The efficacy may be influenced by 
successful performance of a specific behaviour, strong experiences, received convincing 
verbal messages (i.e. from their physician), accomplishments, and physiological signs 
(Bandura, 1986; Bandura, 1997). Expectancies stem from a specific outcome of performed 
behaviour (Bandura, 1986). 
 
Băban and Crăciun (2007) stated that SCT overlaps with the previously described TRA and 
TPB on the concepts of perceived behavioural control and with HBM on the barriers (Băban 
and Crăciun, 2007). In agreement with this overlap assumption, a study by Allen et al. 
(2001) used elements of SCT and HBM to design intervention for mammography, breast 
clinical examination, and cytology (Allen et al., 2001). The authors noted that even though 
the uptake increase could be observed for all screening methods after controlling for cluster 
sampling and age strata only Pap test intervention was statistically significant (OR 1.28, 
95% CI=1.01, 1.62) (Allen et al., 2001). Another study also combined elements of HBM and 
SCT to develop an intervention program to improve cervical screening behaviours and found 
that the intervention group had significantly higher screening rates than non intervention 
group (70% vs. 11.1%) (Wang et al., 2010).  
 
In summary, SCT predicts that specific behaviours can be carried out if the individual 
perceives control over the action outcome, none or limited external barriers, and has 
confidence in own ability to perform an action (Rosenstock et al., 1988; Taylor et al., 2006). 
 
2.7.4. Transtheoretical Model (TTM) 
 
The Transtheoretical model (TTM) was first developed by Prochaska and DiClemente in 
1982 (Prochaska and DiClemente, 1983) as an approach to psychotherapy with the main 
concept being that successful behaviour change will occur after application of the 
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appropriate behavioural strategies at a correct stage and time of the desired change (Spencer 
et al., 2005). TTM was later adapted by Rakowski et al. (1992) to predict the readiness to 
participate in mammography (Rakowski et al., 1992) and by doing so he identified elements 
of the model used for breast cancer screening that would also apply to other cancer 
screening (Spencer et al., 2005). These adaptations pertain to the fact that cancer screening 
is a preventative measure and does not engage the individual in frequently thinking about the 
screening advantages and disadvantages, as is the case with behaviour change in the 
addictive behaviours (i.e. tobacco cessation, alcohol addictions) (Spencer et al., 2005). It has 
been noted that ethnic groups differ in their decisions of screening uptake and TTM has been 
found to have the potential to distinguish between groups of individuals with different 
characteristics (Pasick and Burke, 2008). Spencer et al. (2005) reviewed a large body of the 
literature describing use of TTM to study behaviour change leading towards uptake of breast 
and cervical cancer screening and they found through the TTM that barriers to screening and 
lack of perceived benefit of screening were the most important factors influencing lack of 
screening (Spencer et al., 2005).  
 
Figure 13 Graphical representation of TTM/ stages of change (Prochaska and Di 
Clemente, 1982) 
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2.7.5. Health Action Process Approach (HAPA) 
 
In addition, to the models discussed by Noar and Zimmerman there is another model that 
has been growing in popularity with relation to preventive behaviours (Garcia and Mann, 
2003; Luszczynska et al., 2011; Luszczynska and Schwarzer, 2003). The HAPA has been 
first described by Schwarzer (1992) and it connects three types of models: 1) the 
motivational (i.e. HMB or TRA/TPB), 2) behavioural enactment models (i.e. 
Implementation Intentions, Goal Theory etc) and 3) multi-stage models (i.e. TTM, HAPA) 
(Băban and Crăciun, 2007). Behavioural enactment models have not been discussed here as 
they have been found to have a very low predictive value (Băban and Crăciun, 2007). 
Initiation and maintenance of health behaviour processes in the HAPA model are based on 
the assumption that motivational and volitional (formation of decision to take action) phases 
must occur, where the volitional phase is divided into planning and maintenance (Băban and 
Crăciun, 2007; Luszczynska et al., 2011; Luszczynska and Schwarzer, 2003). The 
motivational phase leads to intention creation and includes such constructs as: growing risk 
awareness, outcome expectancies, and perceived task self-efficacy. Schwartz et al. (2003) 
highlighted that a minimum concern or threat levels have to occur before the thoughts of 
benefits of the action in question occur (Schwarzer et al., 2003). Self-efficacy to perform the 
action is the most influential factor of this phase and it acts as a mediator between two 
previously mentioned elements of the model: outcome expectancies and intentions (Băban 
and Crăciun, 2007).  
 
The second phase of the HAPA model is the action-volitional phase. It refers to the 
processes that occur after the formation of the intention (Băban and Crăciun, 2007). The 
processes of this stage are influenced by self-efficacy due to the fact that in order to perform 
an action one needs to have certain level of trust in own competence. Self–efficacy also 
determines the amount of effort and perseverance to perform the action (Băban and Crăciun, 
2007). 
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Figure 14 Graphical representation of Health Action Process Approach (Schwarzer, 
1992) 
 
HAPA has been used as the basis for planning interventions to modify risk behaviours like: 
use of alcohol (Murgraff and McDermott, 2003) or food hygiene (Chow and Mullan, 2010). 
It was also used in the context of promoting health behaviour enhancing interventions such 
as regular breast self-examination (Garcia and Mann, 2003; Luszczynska and Schwarzer, 
2003). In this respect, self-efficacy has been shown to be the best predictor of intention of 
performing breast self-examination and planning of the actual behaviour (Luszczynska and 
Schwarzer, 2003). However, it has been also noted that not all published evidence found the 
effect of planning on the relationship between intention and behaviour (Soureti et al., 2012). 
This suggested that planning of change may differ between people and it might depend on 
moderators such as for example: age, intention level, level of belief in self-efficacy (Soureti 
et al., 2012). 
 
2.7.6. Summary of the reviewed theories used in prediction of health behaviours 
 
HBM, TRA, TPB, SCT, TTM, and HAPA have been critically discussed by many 
researchers and governmental organisations to guide the most appropriate means of generic 
and specific interventions to support attitude and behaviour change at population and 
community levels (Day et al., 2010; Pasick and Burke, 2008; Taylor et al., 2006). TRA and 
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TBP were thought to have higher predictive power than HMB but TBP has lower ability to 
predict behaviours than TRA. Evidence on the effectiveness of TTM is varied, as in 
behavioural outcomes, as when TTM and SCT theory is applied in health promotion 
initiatives such as exercise or smoking cessation no difference was found with the other 
interventions (Taylor et al. 2006). However, many researchers noticed that the constructs of 
the behavioural models described above are either very similar or there is virtually no 
difference other than for nomenclature (Noar and Zimmerman, 2005; Ogden, 2003; Traube 
et al., 2011). Traube et al. (2011) noted that behavioural theories leave much of the variance 
in unexplained behaviour and their accuracy is often overestimated (Traube et al., 2011) 
According to Noar and Zimmerman (2005) there is a probability that the difference between 
attitudes, barriers, benefits, positive and expectances as well as pros and cons is very small 
and that there is no consensus in the literature on how the variables in those theories 
combine to predict behaviours (Noar and Zimmerman, 2005). Similarly, the HAPA model 
was criticised as some studies failed to show the effect of planning on the relationship of 
intention-behaviour suggesting that the mechanisms of factors mediating the change may be 
different between different people (Soureti et al., 2012).  
 
The answers to the questions of the survey analysed and discussed in this thesis relate to 
constructs that can be found in the majority of the discussed models (knowledge, 
behaviours, perceptions, and cues to action, attitudes and others) that have been widely used 
by researchers attempting to predict behaviours.  
 
2.8. Summary of the literature review 
 
Since the introduction of the nationwide cancer screening programmes in Poland the uptake 
of screening remained low as breast cancer screening reached 31%-39.8% (table 6) and 
cervical cancer screening reached 21.25%-26.77% (76.8%-uptake ever) (table 8). However, 
it has been hypothesized that the low initial uptake in the post-Soviet countries can be 
partially explained by the fact that those countries often already had relatively high uptake of 
cervical cancer screening during the Soviet era, as compulsory yearly medical checks 
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mandated by employers were a common practice (Palencia et al., 2010), although this could 
not be true in the case of mammographic screening since it was not available at that time.  
 
Screening programmes are of undoubted benefit as the scientific community has 
demonstrated over the years (Sabatino et al., 2012; Smith et al., 2009) the best way to detect 
early cancerous changes through the uptake of regular screening (NHS Cervical Screening 
Programme, 2012; NHS Cancer Screening Programmes, 2008). However, breast and 
cervical cancer screening has been associated with some unfavourable outcomes including 
embarrassment, interpretation ambivalences, creating a sense of “embodied risk”, 
psychological consequences of inconclusive results, blaming of non-attendees, false alarms, 
false reassurance, unnecessary biopsies, over-diagnosis, and over-treatment (Byrd et al., 
2007; Todorova et al., 2006; WHO, 2011a). In addition the test adequacy and sensitivity are 
not always accurate and in the case of inconclusive results women have to be recalled, which 
may cause undesirable emotional responses such as anxiety (Sasieni et al., 1996; WHO, 
2011a). As screening exposes healthy individuals to potentially harmful procedures (i.e. X-
rays, potential biopsies etc.) the appropriate information about the benefits of screening 
outweighing the risks needs to be provided along with the invitation to participate, so that 
the woman can make an informed decision whether to uptake the screening (Gøtzsche et al., 
2009).  
 
The review of the literature also demonstrated that when attempting to gain understanding of 
the factors that might contribute to women’s attendance to cancer screening it is necessary to 
take into consideration not only the characteristics of the cancer and cancer screening tests 
but also characteristics of the population, its socio-political and demographic background, 
women’s knowledge, attitudes, behaviours related to the screening of interest, and factors 
that may inhibit or facilitate the attendance. Such knowledge might contribute to successful 
planning or improving health initiatives including educational campaigns especially in 
countries like Poland which are either in early stages of the national roll-out of breast and 
cervical cancer screening initiatives and who have experienced similar and serious political 
changes (i.e. countries from the former Soviet bloc). Women invited for organised screening 
programmes should receive appropriate information on the benefits but also on harms 
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related to mammography and be encouraged to make an informed decision about whether to 
participate in it. Appropriate actions to raise awareness of breast cancer, its early symptoms 
and improving the uptake of cancer screening procedures in asymptomatic populations may 
help in cancer detection and early treatment (WHO, 2007). It is important to understand 
what drives Polish women’s decisions to uptake screening, in order to be able to address 
those factors and ascertain what can be done to improve uptake. However, a gap in the 
literature has been identified on the predictors of screening before the introduction of the 
nationwide screening programmes and the following chapter will aim to address that gap. 
The main constructs of the majority of behaviour change models (such as knowledge, 
attitudes, perceptions, behaviours, past history, cues to action, and others) as well as socio-
economic and socio-demographic variables have been used by researchers to predict and 
explain behaviours but most of the available evidence comes from societies with organised 
screening. Only a few of those studies looked at Eastern European populations and those 
that did rely mostly on opportunistic samples that are not representative of the whole 
population. 
 
The questions that arose from the literature review: 
1. What were the levels of Polish women’s knowledge on breast and cervical 
cancers and how did they differ amongst different socioeconomic groups? 
2. Was there an association between the levels of knowledge on cervical and breast 
cancers? 
3. Did levels of knowledge differ across different layers of the Polish society? 
4. Did level of knowledge of breast and cervical cancers differ between women who 
practiced prophylactic behaviours? 
5. Did cancer prophylactic behaviours differ across different layers of the Polish 
society? 
6. Was there a relationship between practicing breast and cervical prophylactic 
behaviours of Polish women at the introduction of nationwide screening? 
7. Which factors could be considered as predictors of breast and cervical cancer 
screening uptake at the time of data collection? 
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8. What factors were considered as barriers to breast and cervical screening by 
Polish women at the time of data collection? 
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CHAPTER 3 METHODOLOGY  
 
3.1. Introduction 
 
In order to inform the development of health initiatives it is necessary to understand what 
may influence the uptake of the screening. The aim of this study was to identify factors 
(knowledge, behaviours, and other factors relating to breast and cervical cancer screening) 
that may serve as potential predictors of the uptake of breast and cervical cancer prophylaxis 
in Poland on the brink of introduction of centralised and nationwide screening.  
 
Consideration was given whether to collect new data or use an already existing data set and 
conduct secondary analyses iv
 
. The required data needed to be able to fulfil the research 
objectives and to have the ability to distinguish between various socio-economic groups and 
demographic characteristics. Socio-economic and demographic characteristics would enable 
differentiation between women that performed prophylactic behaviours from those who did 
not.  
Generating new high quality data can be very expensive, difficult to organise and time 
consuming (Olsen, 2008, Law, 2005). Additionally, new repeat studies may create a 
potential for psychological, financial, or social harms (i.e., asking questions that participants 
may find uncomfortable comfortable) to participants or the researchers (Polonsky and 
Waller, 2011; British Psychological Society, 2010). The risks may include also harms to 
personal social status, data privacy, harms to personal beliefs, harms to relationships, and 
                                                 
 
iv Secondary analysis - reanalysis of data collected for non-research reasons or for a study with objectives other than the 
new analysis research (Vogt and Johnson, 2011) 
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disclosure of illegal behaviours. Even if the research carries no risks to the participants it can 
still cause disruptions (British Psychological Society, 2010). It is the responsibility of the 
researcher to try to minimise the potential risks and take ethical matters into consideration 
when planning a study (for further details see section 3.4.) (Polonsky and Waller, 2011; Law, 
2005). Use of secondary data gives an opportunity to reduce burden on the study subjects 
and improve beneﬁt/harm ratio especially in more vulnerable groups that may be particularly 
sensitive to repeat data collection (Law, 2005).  
 
Olsen (2008) in support of the use of secondary data noted that:  
“It is never possible to design a perfect study, ensure perfect compliance with the 
protocol, get error-free data, and analyse those data with appropriate statistical 
models. Because epidemiologists conduct their research in the real world, we 
often have to settle for less than ideal, and weigh the pros and cons of different 
design options. In this decision process we sometimes have to choose between 
using already existing data and generating new data. “ (p.481). 
 
The use of secondary data sources for research has increased over recent years mostly due to 
the increased availability of electronic healthcare records and administrative databases 
(Garmon Bibb, 2007; Harpe, 2009) for example Clinical Practice Research Datalink (CPRD) 
(formerly known as General Practice Research Database (GPRD) in the UK (e.g., Devine et 
al., 2010; Walker, 2011; Wood and Coulson, 2001), MarketScan® in the US (e.g., Janes et 
al., 2011; Mark and Chang, 2009) and others (e.g., Star et al., 2010; Wong and Murray, 
2005). Such databases are mostly used for pharmacoepidemiology and outcomes research 
(Harpe, 2009). Researchers wishing to explore factors that are known only to the studied 
population, such as emotional responses, beliefs, knowledge, perceptions or past 
experiences, need to rely on data that is collected by methods allowing them to gain such 
insights e.g. surveys, interviews, focus groups etc. (for example Ellaway et al., 2005; 
Cleland and Ali, 2006; Nishi et al., 2012; Roalfe et al., 2012). 
 
While secondary analysis of health survey data is a scientifically valid, practical and cost-
effective method to generate new evidence to support population health, there are several 
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limitations that have to be taken into consideration (Garmon Bibb, 2007). The main 
disadvantage of secondary data is that it might not be completely suitable for the research 
objective of the new study (Boslaugh, 2010; Garmon Bibb, 2007) and the researcher often 
needs to adapt the study to accommodate the data at hand (Boslaugh, 2010). Such an 
approach requires forming the research questions after seeing the data rather than designing 
a study to collect the tailored information (Boslaugh, 2010). Another challenge that the 
researcher may face is lack of the information around the data collection process, data 
cleaning and management (e.g., dealing with the missing values, data transformations etc) 
(Boslaugh, 2010). 
 
Garmon Bibb (2007) summarised the limitations of the secondary data use into three main 
groups which have been considered when this study was being designed: 1) difficulties of 
finding suitable data, 2) discrepancies of primary and secondary research objectives, and 3) 
data quality (Garmon Bibb, 2007). These three limitation groups are discussed below in 
more detail: 
 
1) Difficulties of finding suitable data 
Prior to joining the University of Salford as a Ph.D. student, between February and August 
of 2006, I worked at the Epidemiology and Cancer Prevention Division, at the Cancer 
Oncology Institute in Warsaw, Poland in Professor Witold Zatoński’s team as an intern-
junior researcher. Professor Zatoński knowing my further career steps engaged in 
communication with my supervisor at that time Professor Baker. On 11-13 September 2007, 
Professor Baker and I held a meeting with Professor Zatoński at the University of Salford 
during which he informed us about a recently conducted survey of which part would be 
relevant to my planned research project. He kindly agreed to share with me part (relevant to 
breast and cervical cancers) of the raw unpublished and nationally representative data 
collected as part of a large (Total N=8,000, women N=4,290) nationwide interviewer 
assisted survey conducted in Poland titled: Knowledge cancer and health prophylaxis in 
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Poland (2006)v
 
. The survey was designed by the Professor Zatoński’s team and the activities 
of data collection had been contracted out to Social Research Laboratory (Pracownia Badań 
Społecznych-PBS DGA) the largest Polish contract research company having experience in 
the field of social research (PBS DGA, 2013). The data used was deemed suitable to address 
the aims and objectives of this research project. The survey was carried out in the third 
quarter of 2006, at a time when Poland was introducing nationwide cervical and breast 
screening programmes for the first time in its history. Following the agreement of Professor 
Zatoński, his team member Dr Jolanta Lissowska sent me the data set and other documents 
describing the survey methodology.  
2) Discrepancies of primary and secondary research objectives 
The original survey examined topics related to knowledge and behaviours related to 
elements of healthy life styles included in the European Code against Cancer (e.g., dietary 
habits, tobacco and alcohol intake, general health and cancer prophylaxis etc). The main 
focus was put on widely understood factors of health prophylaxis with special emphasis on 
various types of cancers in the Polish population. However, as the aim of this thesis was to 
investigate the predictors of breast and cervical cancer prophylaxis uptake (e.g., knowledge, 
behaviours, and other factors) only responses to questions relating to breast and cervical 
cancers and their prophylaxis (as well as socio-demographic and socio-economic factors) 
were abstracted from the main dataset containing the responses of the representative sample 
of Polish women aged 18 and older (N=4,290) (Appendix 2).  
 
3) Data quality 
Careful consideration of the quality of the dataset used to perform secondary analyses is 
necessary (Garmon Bibb, 2007, Olsen, 2008). Even though, it is not possible to influence the 
data quality in the secondary data analysis, detailed information on the methods and main 
                                                 
 
v In order to provide clarity of the nomenclature throughout the thesis the tool of data collection that provided 
data for this thesis is referred to as “the survey”. Nonetheless, it is necessary to highlight that the study was 
based on structured face to face interviews. 
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study considerations should be available to the researcher (Garmon Bibb, 2007) which may 
serve as a tool to assess whether the study findings will be valid (Olsen, 2008).  
 
The appropriateness, sampling, collection methods and quality of the data planned for the 
use in this thesis were reviewed in order to ascertain suitability of the survey for the new 
analysis according to the objectives of this Ph.D. research project. Detailed description of 
the methods used and data limitations was obtained from Professor Zatoński (please see the 
Appendix 3 for the unpublished report from the realisation of the survey prepared by PBS-
DGA, and for a report by Dyzman-Sroka et al. (2008) published for one of the regions that 
participated in the survey please refer to the reference section). The study methods involved 
the use of a survey questionnaire that was administered face to face by the trained study 
investigators (i.e. community nurses). A structured approach with closed questions and a 
free text option allowed respondents to give answers other than the pre-defined answers. If 
specific questions were not relevant to the respondent they could be skipped. For further 
details on sampling and data collection please refer to sections 3.3.2-3.3.4.  
 
3.2. Study design 
 
The study was a cross-sectional, non-comparative survey that collected data of a quantitative 
nature. A wealth of sources describing the cross-sectional survey design and quantitative 
data qualities exist, all of which point toward the same advantages and disadvantages of 
these research methods (Brace et al., 2006; Chambliss and Schutt, 2010; Kruger, 2003; 
Rothman et al., 2008; Levin, 2006; Rindfleisch et al., 2008; Buehler, 2008; Mann, 2003; 
Bowling, 2002; Coggon et al., 2003; Assessment Capacities Project (ACAPS), 2012; IARC 
1999), which are discussed below.  
 
Quantitative research methods use variables that can be recorded numerically such as: 
nominal, ordinal, interval data or ratios (Brace et al., 2006). These numerical data descriptors 
(statistics) are usually based on a sample from the studied population and are used to explore 
data patterns (Chambliss and Schutt, 2010). Statistics may describe single variables or be 
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used to assess multi-item scales with the use of frequency distributions, measures of central 
tendency (e.g., mean, median, interquartile ranges etc) (Chambliss and Schutt, 2010; 
Banerjee and Chaudhury, 2010). They are also used to produce reliability tests, graphs (e.g., 
histograms, box plots) and other ways to describe the data (Chambliss and Schutt, 2010; 
Banerjee and Chaudhury, 2010). Statistics also help in describing associations between 
variables or to enhance the validity of the findings by serving as a control for other variables 
or to make inferences about the confidence of generalisation of the findings from the sample 
analysis to the population (Chambliss and Schutt, 2010; Banerjee and Chaudhury, 2010). 
Quantitative methods are most appropriate when there is a pre-existing knowledge on the 
topic of interest (as it was in case of this study) as the use of standardised data collection tool 
can allow testing a hypothesis (Bowling, 2002). Quantitative methods allow summaries of 
large datasets that can provide a more representative picture of the characteristic in question 
of the studied population (ACAPS, 2012; Kruger, 2003). They also facilitate studying the 
distribution of views in the population and comparisons of the variables and their categories 
making them an invaluable tool to evaluate of interventions (Kruger, 2003) (for examples of 
such evaluations see Lawson et al., 2010 and NHS National Services Scotland, 2011).  
 
However, quantitative designs have some challenges and disadvantages. This type of 
research methodology should be used only if data can be measured numerically and results 
quantified (Nykiel, 2007). Its outcomes are limited to the hypotheses preset prior to the 
study initiation that come from past research (Matveev, 2002; Muijs, 2004). Quantitative 
research also restricts the information on the context of the study without ability to control 
the research environment as the respondents answer predefined questions (Matveev, 2002). 
No in-depth description of the experience of the studied population and the study context is 
available (ACAPS, 2012; Matveev, 2002). The analyses require more elaborate statistics 
than in qualitative design and this may result in difficulties understanding the real meaning 
of the data from just looking at the numbers (Kruger, 2003). Despite these disadvantages the 
quantitative design allows for a more objective assessment and quantification of the studied 
phenomena (Muijs, 2004) such as for example knowledge and behaviours related to cervical 
and breast cancer screening uptake.  
125 
 
 
Table 10 Summary of the main strengths and weaknesses of the quantitative data 
(ACAPS, 2012) 
Strengths:  
• Quantifiable numeric estimates of studied characteristic 
• Potential for relatively uncomplicated data analysis  
• Verifiability  
• Comparability of data between and within different populations and at different 
points in time  
• No requirement of the analytical judgement except for consideration for the 
presentation of the results 
Weaknesses: 
• Potential gaps in information 
• Potentially laborious data collection  
• Potentially low participation amongst groups with studied characteristic 
 
Various tools of quantitative data collection exist (Muijs, 2004). However, when the 
outcome of interest is of a social nature (e.g., knowledge, behaviours or attitudes) and it 
cannot be observed directly from the population researchers may choose to use a survey as a 
tool to collect the desired data (Bowling, 2002; International Agency for Research on Cancer 
(IARC), 1999). Surveys are snapshots of a characteristic of interest of the studied population 
at a specific time point (IARC, 1999; Rothman et al., 2008). They are usually conducted at a 
single time point (cross-sectional) (Rindfleisch et al., 2008; Levin, 2006) and have the 
capability to allow studying multiple endpoints (Rindfleisch et al., 2008; Levin, 2006). 
Sometimes a cross-sectional survey can try to collect information on not only the current 
status of the studied characteristic but also the past by inclusion of questions directed at 
identifying past actions i.e. smoking behaviours (past and present) (see IARC, 1999 p 214, 
Example 10.3) as it was in the case of the survey analysed in this thesis that collected 
information on past screening behaviours. Surveys can be very useful research instruments 
in countries where health related data recording is not well developed or difficult to obtain 
(Buehler, 2008). For example, in Poland prior to the introduction of centralised breast and 
cervical screening, due to scarceness of screening initiatives and their ad hoc nature at the 
time it was difficult to assess the extent of and reasons for uptake (or lack of uptake) of the 
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screening. Nationally representative survey such as the one in this thesis can provide a better 
understanding of these factors. Additionally, surveys can be repeated at different times and 
allow for a relative longitudinality to explore changing trends of the studied factors 
(Rindfleisch et al., 2008) such as disease associated behaviours helping to understand the 
leading causes of the condition of interest (Buehler, 2008). If the survey analysed in this 
study is repeated it could help to assess whether the screening behaviours or level of cancer 
knowledge changed among Polish women. 
 
Cross-sectional survey studies are advantageous as they are cost and time efficient (Mann, 
2003) but they have been also criticised for being based on retrospective questioning, being 
subject to recall bias, prevalence-incidence bias (e.g., over representation of cases long-
lasting conditions and under representation of those short in duration) difficulty in 
establishing/interpreting causality (Levin, 2006; Bowling, 2002; Coggon et al., 2003; 
Rothman et al., 2008). Also low participation can be a potential problem for the researchers, 
whether due to respondents not wanting to answer to questions on a particular topic or due 
to the increasing number of survey research that causes intrusion in potential respondents’ 
lives (Galea and Tracy, 2007). It has been noted that participation tends to be higher 
amongst respondents who are particularly concerned with the research topic i.e. mobile 
phone use and cancer (Galea and Tracy, 2007). In case of the study described in this thesis 
participation rates were high due to sampling frame used and face to face mode of 
administration. For further information on the data collection tool (quantitative survey), 
sampling and mode of administration please refer to section 3.3.1. 
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Table 11 Summary of strengths and weaknesses of a cross-sectional survey design 
(Levin, 2006, Bowling, 2002, Coggon et al., 2003, Rothman et al., 2008, Galea and 
Tracy, 2007) 
 
Strengths:  
• Cross sectional studies are the best way to determine prevalence of the studied 
characteristic 
• Relative cost effectiveness 
• Time effectiveness 
• Potential to study multiple outcomes 
Weaknesses:  
• Subject to recall bias 
• Lack of possibility to ascertain causality  
• Potential of low participation 
 
 
3.3. Methods 
 
3.3.1. Data collection tool - questionnaire 
 
The aim of every survey questionnaire is to collect reliable, valid and unbiased data from a 
representative sample (McColl et al., 2001) with relative cost efficiency (Department of the 
Environment Transport and the Regions (DETR), 2000). Surveys collecting the data of 
interest can be designed as self-administered questionnaires as well as in a face to face or 
phone interviews (McColl et al., 2001). The use of questionnaires can allow the researcher to 
gather facts or opinions related to a selected topic and are seen as a good medium for 
measuring attitudes, motivation or values of respondents (Hartage and Cahill, 2008).  
 
The principal foci that should be used while designing the questionnaires include factors 
such as the wording of questions, position of questions, choice of formats of responses, 
modes of survey administration, formatting and the presentation of the questionnaire, 
possibilities of increasing response rates, and expert opinion about importance of particular 
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questions (Siniscalco and Auriat, 2005; McColl et al., 2001; Thayer-Hart et al., 2010) (please 
refer to sections 3.3.1.1-3.3.1.3).  
 
Data collection success can be affected by the patients characteristics like knowledge, 
personality, memory (Robson, 2002), literacy level, and other factors. Taking that into 
consideration the questionnaires ought to be designed with the use of uncomplicated 
questions (Polit and Hungler, 1991; Robson, 2002). However, in case of this study, levels of 
literacy were mitigated by a face to face data collection. 
 
3.3.1.1. FORMAT OF QUESTIONS 
 
All survey questionnaires should contain questions that are understandable to all respondents 
(Robson, 2002; Bowling, 2002). They can be based on open or closed questions or both. 
Closed questions ask the respondent to choose among possible answers and systematise 
responses and ease the preparation of the data for the analysis (Siniscalco and Auriat, 2005; 
Thayer-Hart et al., 2010). Incorporating closed questions for a single or multiple answer 
selection (Siniscalco and Auriat, 2005; McColl et al., 2001) permits the inclusion of more 
variables, as the format allows the respondents to answer more questions in the same time as 
in open ended questions (Siniscalco and Auriat, 2005). However, there is a possibility of 
missing the suitable options to select or incorrect answers being selected by mistake (McColl 
et al, 2001) which would introduce bias. Closed questions do not allow respondents to 
elaborate on the topic. It has been also noted previously that in some cases the respondent 
may be predisposed to systematically select the first/last option (Siniscalco and Auriat, 
2005). Closed questions can be easier to quantify and are less time consuming for both the 
respondent and the researcher but because of their structured character there is no room for 
answers other than those preselected by the researcher what can introduce researcher led 
biases (Russell, 2010; Siniscalco and Auriat, 2005).  
 
Open questions allow longer and more detailed answers with respondent’s own words but 
they can be time consuming for both respondent and the researcher and difficult to analyse as 
the interpretation may pose a challenge due to the potentially large variance of answers 
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(Russell, 2010; Siniscalco and Auriat, 2005). As the main survey consisted of a large study 
sample (N=8,000) that was drawn from all of the regions (urban and rural areas) in Poland 
and consisted of a large number of questions (on general health prophylaxis), open ended 
questions could extend the time required for face to face data collection. The coding 
interpretation of answers could be particularly difficult if answers were long and complex 
(Russell, 2010; Siniscalco and Auriat, 2005). However in the case of this study in addition to 
closed questions with pre-defined answers an additional option was given, i.e. ‘other’ to 
allow an alternative answer to be provided (see for example question 6, Appendix 2). The 
answers to free text option answers were noted by the interviewers (community nurses). This 
decreased potential problems with understanding and coding of the answers at a later stage.  
 
3.3.1.2. MODE OF ADMINISTRATION 
 
There are number of modes of questionnaire administration, including: postal questionnaire; 
telephone interviews; face to face interviews; and in recent years via the internet (DETR, 
2000, Robson, 2002). However, as the mode was used in this study was an interviewer 
assisted approach with a face to face data collection only this method is described below.  
 
Such face to face data collection approach allowed the interviewer to rectify any immediate 
misinterpretations or inconsistencies (Bowling, 2002; Doyle, 2005; Bowling, 2005). A semi-
structured approach (closed questions with open ended option) allowed the respondents to 
choose an answer that has not been listed in the pre-defined options (Bowling, 2002). Also, 
such face to face approach eliminated the requirement for minimum literacy levels of the 
respondents as the interviewers helped to clarify what is being asked (Bowling, 2005; Doyle, 
2005). 
 
However, face to face assisted surveys such as this one are not free of challenges. They are 
costly, time consuming, and they require the research staff to be able to meet with the 
respondents at an agreed time and location often depending on the respondent’s preference 
(Polit and Hungler, 1991; Roberts, 2007). The collection of the data can be influenced by the 
interviewer’s characteristics such as for example: personality, professional training and level 
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of interviewing experience resulting in potential biases that are impossible to identify once 
the data has been collected. For example respondents might modify their answers to put them 
in a more favourable light in the interviewer’s eyes (Opdenakker, 2006; Roberts, 2007). 
Additionally, when considering a face to face approach attention has to be paid to asking 
sensitive questions in the presence of third persons i.e. family members if the data is 
collected in respondent’s home (Lee, 1993). Sensitive topics may include questions that may 
cause distress, strong emotions (e.g., anger, sadness, embarrassment, anxiety) or harms (e.g., 
disclosure of information of personal nature) (Elmir et al., 2011; Jordan et al., 2007). 
Interviewing in the presence of other family members may cause the respondent to withhold 
sensitive information which they would be willing to share in confidence with the 
interviewer on one-off bases under assumption of unlikely scenario of crossing-paths with 
the interviewer ever again (Lee, 1993). As the study questions included questions 
predominantly on health related issues that can be considered sensitive the interviewers were 
trained to advice respondents to follow the best practices of attaining privacy during the 
interviewing process. Whenever possible the interviewers explained to the respondent and 
any other household members that the data should be collected in private as it relates only to 
the respondent’s views only. The interviewers suggested conducting the interview in another 
room or if not possible to sit with the respondent in a quieter part of the room (Bowling, 
2002). However, in practice this is not always possible to conduct the interviews in private as 
there may be distractions present or other persons may want to sit close to the interviewee. In 
such cases it is important that the interviewer shows patience and tactfully remind that the 
interview is intended for a particular respondent only (Bowling, 2002). Where it was not 
possible to ascertain interview privacy the information was noted by the interviewers and 
returned to PBS DGA for assessment.  
 
Despite the challenges the above described design allowed collecting a large quantity of 
complex information for a sample truly representative of all socio-economic and 
demographic layers of Polish society. All the respondents answered the questions in their 
own homes at a time convenient to them. The sections of the questionnaire utilised in this 
thesis can be found in the Appendix 2. 
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3.3.1.3. RELEVANT COMPONENTS OF THE SURVEY 
 
As mentioned previously only questions relevant to breast and cervical cancers, their 
prophylaxis and general socio-demographics were used in this study and are presented in the 
Appendix 2.  
The main topics covered by the relevant sections of the questionnaire (breast and cervical 
screening) included: 
 
• Knowledge of breast and cervical cancer related topics 
• Current behaviours related to the breast and cervical cancer screening: 
o Breast self-examinations 
o Mammography attendance  
o Gynaecological/PAP examinations 
• Past behaviours related to the breast and cervical cancer screening: 
o Breast self-examinations 
o Mammography attendance  
o Gynaecological/PAP examinations 
• Reasons for non-participation in screening and breast and cervical cancer medical 
examinations 
• Socio-economic and demographic details such as: age, education, social status etc. 
 
3.3.2. Sampling 
 
In order to source a study sample from the population of interest a sampling design needs to 
be decided upon (IARC, 1999). Samples selected on the bases of only the investigator’s 
judgement or established by convenience (e.g. volunteers, patients in a specific health care 
establishment etc.) cannot guarantee avoidance of selection bias. Such samples may not be 
representative of the studied population. Therefore, a random form of sampling was used in 
this study as it gave the same chance of being selected to each study participant and 
therefore decreased the potential for selection bias (Bowling, 2002; IARC, 1999). There are 
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many types of random sampling such as: simple random sampling (each subject has exactly 
the same chance of being selected), systematic sampling (each nth subject being selected 
from a non-cyclic random list of population), stratified random sampling (subjects selected 
from specific strata ensuring that each of strata is represented in the overall sample), and 
cluster random sampling (random sampling from pre-existing groups i.e. hospitals) 
(Boslaugh and Watters, 2008; Pagano and Gauvreau, 2000). Simple random sampling from 
a whole population has the lowest potential for selection bias as it truly samples from the 
whole population but for the same reasons may be very costly and difficult to achieve 
(Boslaugh and Watters, 2008; Pagano and Gauvreau, 2000) therefore another complex 
random sampling form (Boslaugh and Watters, 2008) was found to be better suited for this 
study. 
 
3.3.2.1. SAMPLING METHOD 
 
The sampling method used in this study was stratified cluster sampling proportional to size. 
In this form of sampling the population is drawn from the pre-existing subgroups (borough, 
street, village etc). This method is commonly used in the national surveys, especially in 
transition countries such as Poland, as the cost is very high (e.g., due to the costs associated 
with face to face design) (Boslaugh and Watters, 2008; Pagano and Gauvreau, 2000; 
Yansaneh, 2005) and the absence or low quality household listings results in the need for 
selection of geographical units first, followed by construction of household listings within 
the selected sampling units (Yansaneh, 2005). 
 
Such approach produces national estimates in a more cost effective way that includes several 
random selection levels (e.g., from cities to local municipalities to streets etc) (Boslaugh and 
Watters, 2008; Pagano and Gauvreau, 2000; Chromy and Abeyasekera, 2005). As the 
primary sampling units (e.g., cities) may contain different numbers of individuals in each 
sampling group (e.g. streets) techniques of sampling proportional to that sub-group size were 
used to provide samples truly representative of each of the sub-groups (Boslaugh and 
Watters, 2008; Pagano and Gauvreau, 2000). However, in this form of sampling some 
sampling precision might be lost due to the fact that the subjects tend to be similar within the 
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sampling units (e.g., inhabitants of villages sharing similar characteristics such as income 
level, education etc.) (Boslaugh and Watters, 2008; Yansaneh, 2005). 
 
3.3.2.2. SAMPLE SIZE 
 
Due to the need for a regional differentiation of the National Programme of Cancer 
Prevention, with potential regional differences in knowledge, access to healthcare the multi-
stage cluster random sampling proportional to size was applied.  
The study the sample consisted of 16 equinumerous regional sub-samples of 500 subjects 
selected from each voivodship (equivalent of a county). The total sample included equalled 
to 8,000 individuals of which 7,948 surveys were successfully conducted (Women 
accounted for 4,290 of the respondentsvi
 
). 
3.3.2.3. SAMPLING FRAME 
 
The following sampling scheme allowed for inclusion of a sample representative of the 
whole Polish population aged 18 or over.  
The subjects for the participation in the study were identified in the 16 voivodships (strata) 
from the following levels: 
1) Gmina (local municipality) 
2) Villages, streets  
3) Individuals (18+) 
1) First draw was conducted at municipal level  
The first level of sampling was simple and proportional. Territorial sampling units of the 
provinces were defined by the class of locations: 
• Rural municipalities and rural parts of the urban-rural municipalities 
                                                 
 
vi Please note that for the purpose of this thesis, the target population was constructed of women only. 
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• Urban municipalities (cities) and urban parts (cities/towns) in the urban-rural 
municipalities of up to 20,000 residents 
• Urban municipalities (cities) and urban parts (cities) in the urban-rural 
municipalities of 20,001 to 50,000 residents 
• Cities of 50,001 to 200,000 residents 
• Cities of 200,001 to 500,000 residents 
• Cities and urban agglomerations over 500,000 residents 
 
The sampling frame for this stage was the list of municipalities – primary sampling units 
(PSU). The draw took place independently in each stratum with probability proportional to 
the size of the population of people aged 18 years or more. 
 
Urban and rural municipalities were drawn basing on the ratio of the number of surveys in 
each stratum divided into clusters of addresses, which contained approximately 6-8 addresses 
in the core sample list and 10-25 in the reserve list.  
 
2) Villages in rural areas and rural parts of the urban-rural municipalities, streets in 
municipalities, and urban parts of urban-rural sampling units were the sampling units in the 
second sampling stage.  
 
The sampling of villages in the rural/rural-urban municipalities and streets in the 
urban/urban-rural areas was carried out by the Ministry of Internal Affairs and 
Administration from the set of randomly selected municipalities in first sampling stage. The 
sample selection was carried out through a simple random sampling scheme with probability 
of selection proportional to the size of the population aged 18 years or over residing in the 
streets/villages. 
 
3) The third level of sampling was done at the individual level (18+).  
Selection was done on the basis of a stratified sampling scheme with the probability of equal 
selection. Sampling of individuals was done by defining groups according to age and gender 
135 
 
 
(18-24, 25-39, 40-59 and 60 and over). The number of respondents was drawn from each age 
group. 
 
The identification of the potential participants was done through a draw of the PESELvii
 
 
numbers in the register maintained by the Ministry of Internal Affairs and Administration. 
The resister contains lists personal identification numbers (number given to each Polish 
national at birth). This method excluded people that: were removed from the register, were 
living abroad, had strictly confidential addresses, and those who did not agree to their data 
being used. The number of surveys was defined for each stratum before selection.  
For each of the 'gender-age' group desired survey numbers were derived from the number of 
surveys per locality type in each voivodship (as defined in 1st stage) and the fraction of the 
'gender-age' group in the population (in the locality type group). In this sampling stage, 
simple random sampling with the equal probability of selection was used by the Ministry of 
Internal Affairs and Administration to identify the individuals (addresses) from the lists of 
residents of villages/streets (identified the 2nd stage). 
 
After the core list reached its target numbers a reserve list was established. Potential 
participants from the reserve list would be approached to substitute individuals from the core 
list that were not able to participate in the study (i.e. refusal, other reasons). The selection of 
the potential participants from the reserve list was done following the same sampling scheme 
using the same strata of municipality, age and gender as the replaced individual. 
 
 
 
                                                 
 
vii  PESEL – Powszechny Elektroniczny System Ewidencji Ludności [Universal Electronic System for 
Registration of the Population] 
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3.3.3. Procedure 
 
The study was conducted by direct interview (face to face surveys assisted by trained 
interviewers – community nurses) in the third quarter of 2006. Further to training on the 
interviewing techniques the nurses made appointments (via telephone call) with the study 
participants. Each of the surveys was carried out in the respondents’ homes.  
 
In the first instance, the nurses attempted to reach the respondents from the core list of 
potential participants, and after exhausting that list they would then move to the names on 
the reserve list. 
 
3.3.4. Assurance of data collection quality 
 
In order to assure data quality an audit may be conducted that will help to uncover potential 
irregularities (Gliklich and Dreyer, 2010). It has been previously suggested that it can be 
conducted at random on 5%-20% of all data entries (Gliklich and Dreyer, 2010; Koch et al., 
2009). This is followed by the PBS DGA procedures, which audited by telephone 5% of all 
conducted surveys. Where PBS DGA was not able to contact the respondent by telephone an 
auditor was sent to the respondent’s address. A similar approach was taken if the interview 
did not take place or it was impossible to determine whether the nurse’s visit took place. The 
purpose of the audit was to examine whether any of the surveys were falsified. The audit 
included thorough checks of all the study documents and revealed that 69 of the surveys 
were falsified. The interviewers, who delivered those surveys, were removed from the study 
and the national network of interviewers. All 69 questionnaires have been removed from the 
database and replacement nurses were sent to the selected addresses. The reasons for non-
participation were recorded for all randomised subjects that were selected for participation 
but did not enter the final sample. They were classified as: refused to take part in the study, 
lived permanently abroad, were mentally ill, have died before the research took place or 
other reasons. 
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3.4. Ethical considerations 
 
Whilst planning a research project, the researcher should make sure that the study will be 
conducted ethically and take appropriate actions to minimise potential risks (Polonsky and 
Waller, 2011). In many countries ethical aspects of the study design and conduct are 
governed by ethics and/or governance committees with power to either grant or refute 
approval based on the research proposal submitted for their opinion (Hernandez et al., 2009). 
They may scrutinise the research plan to assure that the best methodology has been chosen 
that would justify the participation of the human subjects (Goodyear-Smith et al., 2002; 
Steinkamp et al., 2007). Many of the Western European countries with a long history of 
being democratic societies (such as for example: the United Kingdom, The Netherlands, or 
France) have well defined research ethics committees (Steinkamp et al., 2007). 
 
However, in Poland there is no effective system protecting rights of the research subjects in 
either the observational or interventional studies. Only, interventional studies being 
conducted by physicians need approval of bioethical committees. Also, there are no legal 
obligations for an approval of the independent research ethics committee for all 
observational and interventional studies conducted by investigators others than physicians 
and with the exception of clinical trials there is no need to monitor on-going studies 
(Czarkowski, 2012) which includes any surveys and re-analysis of previously collected data.  
 
Even though the observational design of the study did not require the researcher to apply for 
ethical permission to the Polish authorities, the student gained governance and ethics 
approval from the Governance and Ethics Committee of the University of Salford (approval 
number: RGEC07/070) and several risk minimisation measures have been taken to protect 
data of the individuals in the analysed data set (please see the sections 3.4.1-3.4.2). 
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3.4.1. Data confidentiality 
 
Despite the fact that the research using secondary data does not collect new data directly 
from the subjects it needs to take into consideration various ethical aspects (Polonsky and 
Waller, 2011). The main ethical issues that are relevant to the use of secondary data are 
mostly those that pertain to privacy and conﬁdentiality of the study subjects (for example 
risks of identification of the participants, unauthorised access to the personal data etc) 
(Olsen, 2008; Polonsky and Waller, 2011; Law, 2005). The risk for loss of confidentiality in 
the secondary research may be decreased through the anonymisation of the participants’ 
records (removal of any data that would allow identification of study subjects) (Law, 2005; 
El Emam and Dankar, 2008; National Research Council (US) Panel on Collecting Storing 
Accessing and Protecting Biological Specimens and Biodata in Social Surveys, 2010). This 
needs to be done by the researcher that originally collected the data before sharing it any 
further (Law, 2005). Additionally, the development of the new technologies may pose a 
threat for the interception on the data by unauthorised parties (e.g., unauthorised access to the 
researcher’s computer or other location) (Law, 2005). Anonymisation and restricted access to 
data were used in this study. All of the identifiers (names, dates of birth, PESEL numbers, 
and addresses) were removed before the researcher obtained the data so that no party 
(including the researcher) could attempt re-identification. The data were accessible only to 
the researcher and her supervisors and stored on double password protected computer (BIOS 
and Windows passwords). The computer was also protected from viruses and other potential 
security breaches with up-to-date version of AVG Anti-virus and internet security tools by 
AVG Technologies USA, Inc., CA, US. 
 
 
3.4.2. Consent 
 
Written informed consent was obtained by the interviewers from all study participants prior 
to the completion of the surveys. A copy of the consent form can be found in the Appendix 
4. 
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3.4.1. Receipt of the data 
 
After Professor Zatoński’s approval, the data relevant to breast and cervical cancers, their 
prophylaxis and socio-demographic characteristics was sent on the 27th May 2007 to the 
Ph.D. student by Dr Jolanta Lissowska, the Scientific Coordinator of the survey, working in 
Epidemiology and Cancer Prevention Division at the Maria Skłodowska-Curie Memorial 
Cancer Centre and Institute of Oncology. 
 
3.5. Data management 
 
The data from the whole surveyviii
Brace et al., 2006
 was coded and entered with the use of the Statistical 
Package for Social Sciences (SPSS) v15 by PBS DGA. SPSS is considered to be the 
“industry standard” aiding the statistical analysis of data that has been widely used 
especially in psychology and the social sciences ( ). The main strengths of 
SPSS include ease of labelling and output editing (Pevalin and Robson, 2009). However, it 
may be slow in handling large and complex data sets and demanding with regards to the 
punctuation in comparison to Stata (Pevalin and Robson, 2009). This slow performance of 
SPSS was observed by the researcher during the data handling stage and therefore the 
dataset was converted into StataSE v11 data file format which showed an improved response 
time and lower use of the computer memory. Additionally, as the data analysed in this thesis 
in was collected with the use of stratified cluster sampling there was need to account for 
sampling design in all analyses and Stata provides a range of commands that can be used for 
this purpose (Kreuter and Valliant, 2007). Stata can be considered a user-driven program 
that enables its users to download program’s extensions allowing for analyses that originally 
were not part of the package (Pevalin and Robson, 2009). All analyses were done using this 
package (for details on data analysis please see section 3.6). 
                                                 
 
viii It is important to highlight again that only female subjects were kept for the data cleaning, quality checks 
and analyses. 
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3.5.1. Data quality and data cleaning 
 
Prior to the start of the analyses the data needed to be checked for errors, outliers and 
missing values (Pallant, 2007; Bowling, 2002). In the first instance, the data was visually 
inspected to assess whether the recorded data looked plausible (Pallant, 2007; Bowling, 
2002). Further checks for errors were done using descriptive statistics (summary data tables) 
and graphs (histograms, scatter plots etc) (Pallant, 2007). As the data set contained both 
categorical and continuous variables different approaches were used for each of them. 
Frequencies, minimum and maximum values, and valid and missing cases were tabulated 
and inspected for the categorical variables and minimum, maximum and mean values for the 
continuous variables (Pallant, 2007). For example if for the categorical variable (Have you 
ever undergone cytology?) the possible range of answers was 1-3 (e.g., yes, no, or I don’t 
know), with missing values coded as 9, the value 4 would indicate an obvious error. 
Similarly, if a minimum value of a continuous variable such as age was recorded as 6 years 
old, it would suggest an error, since the age inclusion criterion was 18 years old or over. 
Additionally, some of other values indicative of erroneous recording were possible to 
identify. For example if an answer to question about mammography attendance was set to 
‘no’ but the next question about the age of first mammography had inserted answer ’58 
years old’, the first variable could be corrected to ‘yes’. In case of other errors that were 
uncovered but were impossible to rectify the value was set to missing.  
 
The format of missingness recording was also checked and brought to a unified format. In 
several variables, missing values were coded as: “9”, “-9”, “99”, or “98”. To avoid 
confusion and to enable the ease the data interpretation all missing values were recoded in 
Stata to: “.”. 
 
3.5.2. Construction of the additional variables 
 
Based on the available data, and the literature, several additional variables were constructed 
through aggregation or scoring of the existing data to enable easier or more meaningful 
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analyses (Pallant, 2007). For example transformation of the interval variables into groups 
may allow more powerful analyses such as Analysis of Variance or regression analyses. 
Collapsing categories may be useful in data analysis if the original variable records large 
number of groups (e.g. very granular information on the level of education) and there are 
very few observations in each of the groups (Pallant, 2007; Boslaugh and Watters, 2008; 
Kirkwood and Sterne, 2003) which was the case for several variables analysed in this study 
(e.g., household size, income source). 
 
Age 
In order to enable comparison of the age groups with respect to key outcome variables the 
interval age variable was used to develop the new ordinal variables.  
The additional age variables included: 
• 18-24, ≥25 
• 18-49, ≥50 
• 18-24, 25-29, 30-39, 40-49, 50-59, 60-69, ≥70 (the first two age groups 18-24 and 
25-29 have been split unequally to allow greater detail in analyses exploring 
knowledge and prophylactic behaviours in screening target and non-target population 
(i.e. cytology in women <25 and detailed age groups for women ≥25) 
 
Education 
This survey questionnaire allowed respondents to select one of several very detailed options 
describing their highest level of education achieved. However, after exploration of the 
numbers of observations in each of the categories a new education variable was created to 
allow for larger numbers in each of the groups and therefore more meaningful analyses 
(Kirkwood and Sterne, 2003) (table 12). In the new variable, the respondents that did not 
give an answer to this question were treated as missing values and therefore removed. 
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Table 12 New education variable created through collapsing of categories 
Old variable New variable 
• Lack of formal education, incomplete primary school 
• Completed primary school 
• Incomplete high school or technical school 
• Completed high school, technical school, vocational 
qualifications 
• Bachelor’s degree or incomplete master’s degree 
• Completed master’s degree 
• Higher education than masters or doctoral degree 
• Refused to answer 
• Primary or lower  
• Technical [or incomplete high school] 
• Medium [i.e. high school level] 
• Higher [completed university degree 
or higher] 
 
Income source / employment 
Similarly, as in case of the education, the questionnaire allowed respondents to give a very 
specific answer to the question about main source of income source/employment in past 12 
months (table 13). Several of the categories have been collapsed to help in the meaningful 
analyses with larger numbers in each of the components of the variable. In the new variable, 
all respondents that did not give an answer to this question were treated as missing values 
and therefore removed. It is important to highlight again that after the review of the available 
literature, the income source was not considered a good proxy of deprivation in Poland due 
to the historical context of employment explained in the section 2.6.1.  
 
 
Table 13 New Source of income variable created through collapsing of categories 
Old variable New variable  
• Employed in the public sector 
• Employed in the private sector 
• Self-employed in sector other than farming 
• Self-employed in farming (own farm)  
• Self-employed in farming (not in an own farm)  
• Retired 
• Disability, social benefits  
• Family benefits 
• Unemployment benefit 
• Benefits from social service 
• Income sources other than from employment (pre-retirement 
benefit, alimony, studentship, property)  
• Support of a person from outside of the household 
• Employed  
• Self-employed 
• Retired 
• Disability benefits  
• Benefits (family, social etc) 
• Unemployment benefits  
• Dependence of a person from 
outside the household 
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Number of people in the household 
The number of people per household has been previously assessed as a good proxy for level 
of deprivation in Poland (CBOS, 2008; Towalski and Kuźmicz, 2010). The questionnaire 
allowed respondents to enter the number of people living in their households and the 
answers ranged from 1 to 12 persons living under one roof. Numbers of respondents who 
reported large number of residents per household was relatively small in comparison to 
those who reported up to 4 people therefore answers that indicated households with 5 or 
more people were recoded into one common category. The newly created variable included: 
1 person, 2 people, 3 people, 4 people, and 5 people or more. 
 
 
Behavioural items 
Two variables relating to breast and cervical cancer prophylactic behaviours were treated as 
outcome variables and have been dichotomised to allow for regression analyses 
 
Table 14 Variables relating to breast and cervical cancer prophylaxis transformed into 
dichotomous format 
Question Possible responses  New variable 
Are you examining your breasts 
by your-self (at home)? 
• Yes  
• Yes, but rarely 
• No never 
• Yes [included ‘Yes’ and ‘Yes, 
but rarely’] 
• No 
Have you ever had a 
mammography? 
• Yes  
• No 
• I don’t know, it is difficult to 
say 
• Yes 
• No 
Have you ever had cytology? • Yes  
• No 
• I don’t know, it is difficult to 
say 
• Yes 
• No 
 
3.5.3. Formation of the scoring scales 
 
Responses to single questions may be affected by many factors such as question wording, 
interviewer and other biases (Bowling, 2002). Creation of a scale might be a useful approach 
to combine a number of variables to measure a wider concept (Pevalin and Robson, 2009). 
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Creation of scores for a specific concept may include batteries (series of single items relating 
to the same concept) and/or scales (series of items about a similar concept that can be scored 
(Bowling, 2002).  
 
Bowling (2002) noted: 
“...the same form of response scale should not be used too frequently throughout the 
questionnaire, as this can again lead to a response set (a tendency to answer all the 
questions in a specific direction regardless of their content). The wording and format 
of response categories should be varied to avoid this...” (p. 250). 
 
Following this, scoring scales were created of the items in the questionnaire that measured 
the same concept (i.e., knowledge related to breast and cervical cancers). In addition, the 
scored items were also weighted to reflect the level of the measured concept (Bowling, 
2002). For example, the more correct screening knowledge the higher the score (i.e. 
knowledge of the effect of smoking cessation on risk of cervical cancer: large protective 
effect=2, somewhat protective=1), and inversely the less correct knowledge the lower the 
score (i.e. lack of knowledge of protective effect of smoking cessation on risk of cervical 
cancer=0). The level of the weights was sourced from the published literature reviewed in 
the previous chapter (for details please refer back to sections 2.3.2 and 2.4.2).  
 
The reliability coefficient (Cronbach’s Alpha) was used to assess the reliability and internal 
consistency of the items in the newly created scales. The coefficient estimates the reliability 
of a scale based on correlation among the items of the scale. The coefficient score can range 
from 0.00 and 1.00 but there is no agreement over the minimum acceptable level for the 
scale to be considered reliable. It has been noted that some researchers consider 0.70 and 
above to be a good indicator of the reliability whilst others consider 0.50 and over to be 
sufficient to assume internal consistency (Bowling, 2002; Bland and Altman, 1997; 
Nunnaly, 1978). The scales used in this study demonstrated good or moderate reliability: for 
the overall knowledge (α=0.72), breast cancer knowledge (α=0.58), cervical cancer 
knowledge (α=0.58). 
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As the breast and cervical cancer knowledge scores included varying number of items 
(breast cancer-13 items and cervical cancer-6 items) the range of maximum possible scores 
differed greatly for both scales (breast cancer: 0-26 items and cervical cancer: 0-12). 
Therefore the total knowledge total score ranged from 0 to 38. The relatively wide variation 
in the scales’ scores was later decreased by dividing each of the newly created scoring scale 
by the number of questions that formed the scale (Pallant, 2007) creating a new possible 
range of scores from 0 to 2. This was done to present results as means with their standard 
deviations allowing for easier comparability of the scores’ during the analyses. This 
approach is frequently used by researchers analysing multi-item health and social science 
surveys to allow the use of inferential statistics (for example this is frequently used to 
analyse SF-12, SF-36 surveys (Gandek et al., 1998; Jenkinson et al., 1999; Butterworth and 
Crosier, 2004). However, the levels of the items in the surveys need to be the same meaning 
that respondents with the same mean score have the same weight of the tested construct 
(Hadžibajramovic et al., 2013). . In case of the data analysed in this thesisstudy all subjects 
sharing the same mean of cancer knowledge (measured construct) would have exactly the 
same magnitude of score (Hadžibajramovic et al., 2013). 
 
All scores were divided into thirds and recoded to create new categorical variables with 
three levels: low score (from 0 to 0.6666666=from 0% to 33.3% of the total score values), 
medium score (between 0.6666667 and 1.333332-from 33.4 to 66.6% of the total score 
values) and high score (1.333333 to 2=from 66.7% to 100% of the total score values). This 
was done to allow more detailed interpretation and more meaningful use in multivariate 
logistic regression analyses. The non-scored items were analysed in a descriptive way. In 
order to allow easier interpretation of the results the score assigned to each of the items is 
presented together in the results section (section 4.2) and the scoring only in appendix 5. 
 
3.6. Data analysis 
 
All descriptive and inferential statistics were carried out by the researcher using Stata v11 
(StataCorp LP, TX, USA).  
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Descriptive statistics (means, standard deviations, ranges, minimum and maximum values, 
percentages and frequencies) were used for analysis of the demographic data as well as 
knowledge, behaviours and other factors related to breast and cervical cancers and their 
prophylaxis. Cronbach’s alpha statistic was calculated as a measure of the internal reliability 
for the knowledge scales. The scores were later used in the analyses either as means or as a 
categorical variable with values of low, medium or high (for score ranges please refer back 
to section 3.5.3.6). 
 
In order to account for variability in the population and to decrease potential for bias due to 
complex sampling, sampling design characteristics (16 strata and 63 PSUs) and final 
probability weights (that included non-response and likelihood of inclusion in the survey) 
(Lee and Forthofer, 2006; Kreuter and Valliant, 2007; Yansaneh, 2005) were incorporated in 
all analyses. Analyses were done with the use of –SVY– prefix commands (for details on 
Stata programming techniques applied in this study please see: StataCorp LP., 2007). All 
results have been calculated on estimation samples allowing for a closer representation of 
the real population from which the sample has been drawn and (Lee and Forthofer, 2006). 
Corresponding design effects have been reported with the analyses (mean generalised design 
effects for Chi square analyses). Stratified cluster sampling usually produces design effect 
coefficient larger than 1 representing the level of the precision that is lost due to higher 
likelihood of homogeneity between subjects in this type of sampling versus simple random 
sampling (Boslaugh and Watters, 2008; Yansaneh, 2005; Lee and Forthofer, 2006; Hahs-
Vaughn, 2005).  
 
In cases of analyses of means of continuous variables across dichotomous variables (i.e. 
differences of mean knowledge scores for practice versus non-practice of cancer 
prophylactic behaviours), despite the fact that some outcome variables were approximately 
normally distributed (i.e. knowledge scores), independent t-test could not be performed as it 
does not account for sampling design (UCLA: Statistical Consulting Group). Instead, a 
design adjusted Wald test with F statistic (test command after sub-group mean estimation) 
was obtained (UCLA: Statistical Consulting Group, Bruin, 2006). The F statistic (ratio of 
two standardised chi-squared random variables) is given with m (numerator; tied to the 
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dimensions of the table) and n (denominator; reflecting survey design equalling to number 
of PSUs minus number of strata) degrees of freedom (Archer et al., 2007; Lee and Forthofer, 
2006; StataCorp LP., 2007; Burns et al., 2003). Pearson Chi-square tests (with Rao-Scott 
correction) with survey design correction were performed and reported with design based F-
statistic to assess differences between categorical variables (Archer et al., 2007). 
 
Linear regression was used as an equivalent to one-way ANOVA to examine continuous 
variables and explore differences between specific groups of categorical variables (Lee and 
Forthofer, 2006). Multifactorial evaluation was performed using binary logistic regression 
techniques to produce odds ratios (OR) and 95% confidence intervals (95% CI). Logistic 
regression was used for the likelihood of taking up mammography and cytology. Factors 
included in the logistic models were age, education, income/employment status, self-
reported material conditions, marital status, previous tumour diagnosis and type of tumour, 
having a family member or a friend diagnosed with cancer, breast and cervical cancer 
knowledge (high, medium, low) and for mammography model also BSE. They were 
assessed for the inclusion basing on OR, 95% CI and p-values and were included in the 
multivariate model basing of backward elimination. All predictors where considered 
statistically significant if p-value was less than 0.05 (p<0.05). The results from the analyses 
are presented in the next chapter.  
  
148 
 
 
CHAPTER 4 RESULTS 
 
This chapter provides a descriptive summary of the study sample and reports results of the 
data analysis aiming to address the following research questions: 
 
1. What were the levels of Polish women’s knowledge on breast and cervical cancers 
and how did they differ amongst different socioeconomic groups? 
2. Was there an association between the levels of knowledge on cervical and breast 
cancers? 
3. Did levels of knowledge differ across different layers of the Polish society? 
4. Did levels of knowledge of breast and cervical cancers differ between women who 
practiced prophylactic behaviours? 
5. Did cancer prophylactic behaviours differ across different layers of the Polish 
society? 
6. Was there a relationship between practicing breast and cervical prophylactic 
behaviours of Polish women at the introduction of nationwide screening? 
7. Which factors could be considered as predictors of breast and cervical cancer 
screening uptake at the time of data collection? 
8. What factors were considered as barriers to breast and cervical screening by Polish 
women at the time of data collection? 
Answers to the above questions will be provided in the following sections. 
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4.1. Socio-demographic and socio-economic variables 
 
The study included seven socio-demographic/economic variables which were divided into 
two groups: socio-demographic and socio-economic characteristics. Such grouping allowed 
distinguishing between the descriptive demographic variables and those that could be used 
to in an attempt describe the economic layers (material conditions) of the studied population. 
 
Socio-demographic variables included:  
• Respondents’ age  
• Marital status 
• City size 
 
Socio-economic variables included:  
• Education 
• Household size (number of people living in the household)  
• Source of income (in last 12 months) 
• Material conditions (self-assessed) 
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Socio-demographic variables 
Table 15 Socio-demographic characteristics of the study population (age, marital status 
and city size) 
Socio-demographic characteristic N (%) 
All respondents 4,290 (100) 
Age 
18-24 636 (12.8) 
25-29 297 (7.36) 
30-39 870 (21.8) 
40-49 650 (16.5) 
50-59 780 (19.3) 
60-69 418 (9.09) 
70+ 639 (13.3) 
Marital status 
Married/ in relationship 2,114 (53) 
Widowed 884 (16.2) 
Separated/divorced 288 (11.6) 
Single  998 (19.2) 
City size 
City above 100,000 1,201 (27.9) 
City 50,000-100,000 368 (8.97) 
City <50,000 1,048 (24.8) 
Village 1,673 (38.4) 
 
The age distribution amongst participants of the study was positively skewed with the 
majority of participants being in the younger age group. The mean age of the sample was 
46.1 years with standard deviation (SD) of 18.3 years and age range from 18 to 93 years.  
 
The majority, 21.8% (N=870) of women were aged between 30 and 39. The next group in 
terms of size 19.3% (N=780) were women 50-59 years old. Women between 40 and 49 
years old accounted for 16.5% (N=650), between 18 to 24 years old for 12.8% (N=636), 
between 60 to 69 years old for 9.1% (N=418), 25 to 29 years old for 7.4% (N=297) and over 
70 years old for 13.3% (N=639). The highest proportion of the respondents, 53% (N=2,114) 
were either married or in an informal relationship, 19.2% (N=998) were single, 16.2% 
(N=884) were widows and 11.6% (N=288) were divorced or separated. Thirty eight per cent 
(N=1,673) of women lived in villages; followed by a group of 27.9% (N=1,201) living in 
large cities with more than 100,000 residents, 24.8% (N=1,048) lived in cities below 50,000 
people and 9% (N=368) in cities between 50 and 100,000 residents. 
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Socio-economic variables 
In order to ease the interpretation of the data, education, household size and source of 
income were presented after being recoded into new variables (for details please refer back 
to section 3.5.2). 
 
Table 16 Socio-economic characteristics of the study population (age, marital status 
and city size) 
Socio-economic characteristic N% 
All respondents 4,290 (100) 
Education  
Primary or lower 958 (21.7) 
Technical 973 (22.7) 
Medium level i.e. high school 1,669 (39.3) 
Higher 678 (16.3) 
Household size  
1 person 982 (20.9) 
2 people 996 (24.4) 
3 people 867 (20.9) 
4 people 822 (19.9) 
≥5 people 611 (13.9) 
Source of income 
Employed 1,549 (39.9) 
Self-employed 336 (8.7) 
Retired 1,122 (25.9) 
Disability benefits 257 (6.4) 
Other benefits (family, social etc) 485 (11.5) 
Unemployment benefits 76 (1.8) 
Dependent on a person from outside 
household 
257 (5.8) 
Material conditions 
We live poorly 237 (5.46) 
We live modestly 1,250 (29.1) 
We live on average level 2,135 (50.5) 
We live well 592 (13.8) 
We live very well 56 (1.14) 
 
The majority, 39.3% (N=1,669) were educated to medium i.e. high school level, 22.7% 
(N=973) had technical education, 21.7% (N=958) reported primary or lower education and 
higher was reported by 16.3% (N=678). The proportion of various household sizes was 
almost evenly spread between respondents who reported living in households with 1-4 
inhabitants, as 24.4% (N=996) lived in 2 person households, 20.9% (N=867) in 3, 20.9% 
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(N=982) in 1, and 19.9%- (N=822) in 4. There were 13.9% (N=611) of respondents who 
declared living in households composed of 5 people or more.  
 
The majority of women (39.9%, N=1,549) were employed or retired (25.9%, N=1,122). The 
rest of women declared self-employment (8.7%, N=336), disability benefits (6.4%, N=257), 
other benefits (11.5%, N=485), unemployment benefits (1.8%, N=76) and dependence on a 
person from outside household (5.8%, N=257). When asked about material conditions half 
of women (50.5%, N=2,135) said that they lived on an average economical level which was 
followed by those who lived modestly, 29.1% (N=1,250) said that lived modestly, 13.8% 
(N=592) lived well, 5.4% (N=237) lived in poverty, and only 1.1% (N=56) described their 
economical situation as very good (“We live very well”).  
 
4.2. Scored and unscored elements of theoretical constructs: 
knowledge, behaviours and cues to action 
 
The study sample relating to breast and cervical cancers and their prophylaxis has been 
analysed by groups of questions on either of the cancers. Cancer related knowledge, 
behaviours, cues to action, respondents’ demographic and socio-economic characteristics are 
described in this section. Where appropriate a weighted scoring (sourced from the literature 
review - sections 2.3.2 and 2.4.2) has been applied to knowledge items to create a scale that 
would help to quantify the knowledge levels. Questions that were not possible to include in 
overall scoring were explored in a descriptive fashion (for details on the scoring 
methodology please refer back to section 3.5.3).  
 
In order to allow easy interpretation of results, specific scoring applied to each element of 
the scale was presented immediately in the tables reporting specific proportions and 
frequencies of answers to each question. Scores per each item in the scale could take values 
of 0 (lack of knowledge), 1 (presence of some degree of the correct knowledge), or 2 
(presence of the correct knowledge). The answers considered as correct knowledge have 
been marked with the use of bold underlined font and font of answers with a score value of 
0 was left unchanged (font style as that of the main text). The results are reported as 
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frequencies and proportions for each of the scored element and the score values are 
presented as notes below each table (for scoring applied to the questions without the 
corresponding frequencies and proportions please refer to Appendix 5).  
 
4.2.1. Knowledge of topics related to breast and cervical cancers 
 
The following sections 4.2.1.1 and 4.2.1.2 describe each of the knowledge items. However 
no final knowledge scoring is discussed until section 4.3 where it is discussed with other 
study variables. 
 
4.2.1.1. KNOWLEDGE OF TOPICS RELATED TO BREAST CANCER 
 
Table 17 Scored questions on the awareness of the need for BSE and mammography 
allowing early cancer detection 
Question   N (%) 
 Have you ever heard about the need for regular breast-self-examination? 
 
Yes 3,970 (93%)† 
 
No 275 (6%) 
 
I don't know, it’s difficult to say 45 (1%) 
 
Total 4,290 (100%) 
 Have you heard that mammography can allow early detection of cancer? 
 
Yes 3,943 (92.3%)† 
 
No 166 (3.4%) 
 
I don't know, it’s difficult to say 181 (4.3%) 
 Total 4,290 (100%) 
†Score: 2; other responses were scored 0 
 
The majority (93%, N=3,970) of women reported of having heard about the need of BSE 
whilst only 6 % (N=275) were not aware of such need and 1% was unsure. 92.3%, N=3,943) 
of the surveyed women said that they have heard that mammographic test can allow early 
detection of cancer, 3.4% (N=166) had not had such knowledge and 4.3% (181) were not 
sure.  
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Table 18 Do you believe that change of certain habits and behaviours can have 
protective effect on cancer? Please specify which of the following behaviours may 
influence the development of breast cancer 
Breast cancer  
N (%) A B C D E F 
Regular 
mammography 
below 50 y.o. 
2,697 (63.5) 1,065 (24.6) 146 (3.2) 105 (2.6)† 17 (0.4)‡ 260 (5.6) 
Regular 
mammography 
above 50 y.o. 
2,750 (64.9)† 1,024 (23.5)‡ 138 (3.05) 104 (2.5) 12 (0.3) 262 (5.8) 
Hormonal 
contraception 239 (5.5) 415 (9.6) 669 (15.4) 507 (12.1)‡ 677 (15.8)† 1,783 (41.7) 
HRT after 
menopause 285 (6.9) 525 (11.5) 583 (13.6) 472 (11.4)‡ 479 (11.4)† 1,946 (45.2) 
Increase of 
vegetable and 
fruit intake 
1,142 (26.8) 1,379 (31.9)† 670 (15.6)‡ 645 (14.8) 5 (0.2) 449 (10.7) 
Limitation of 
fatty foods 
intake 
1,109 (26.5)† 1,386 (31.8)‡ 693 (16.2) 599 (13.5) 46 (1.1) 457 (10.9) 
Limitation of 
alcohol use 1,185 (28)† 1,393 (31.7)‡ 693 (16.2) 559 (12.8) 22 (0.7) 438 (10.6) 
Smoking 
cessation 2,104 (49.2) 1,364 (31.4)‡ 286 (6.6)† 258 (6.1) 30 (0.8) 248 (5.9) 
Increase of 
physical exercise 1,199 (28.5)† 1,449 (33.9)‡ 630 (14.4) 538 (12.3) 4 (0.1) 470 (10.8) 
Regular BSE 2,848 (67.1)† 1,067 (24.4)‡ 102 (2.4) 74 (1.6) 199 (4.6) 0 (0) 
Frequent X-rays 
(various body 
parts) 
580 (13.4) 617 (14.2) 443 (10.2) 370 (8.7) 1,493 (35.5)† 787 (18) 
†Score: 2; ‡score: 1; other responses were scored 0 
Key: 
To a large extent it can protect against cancer 
It can have protective influence against cancer 
It can have a somewhat protective influence against cancer 
It does not influence cancer development 
Contrarily, it can lead to cancer development 
I don’t know, it is difficult to say 
A 
B 
C 
D 
E 
F 
 
The scoring of the majority of the items in the following tables was based on evidence from 
the literature review. The evidence on smoking and fruit and vegetable consumption with 
regards to the risk of breast cancer had a certain degree of variation in the published studies. 
Nonetheless the studies published closer to the data collection time (2000-2006), reported 
smoking to increase breast cancer risk and vegetable and fruit consumption to decrease it. 
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The table above (table 18) reports on respondents views on the effect of certain habits on the 
risk of breast cancer. The majority (63.5%, N=2,697) of women thought that mammography 
below age of 50 was greatly protective of breast cancer. Almost identical answers were 
given to the question on the protective effect of mammography above age of 50 years old. 
However, at the time of data collection (2006) regular mammography was not recommended 
below age of 50 as a routine screening as it does not provide good imaging of breast with 
denser tissue and in addition it emits low doses of radiation which in itself is considered a 
cancer risk factor. Very few women (0.4%, N=17) were aware of its harmful effect. 2.6% 
(N=105) of women selected the answer that it does not influence cancer development. This 
was considered as somewhat correct answer (score: 1) as in the literature published up to 
2006 there was mixed evidence between harmful or no effect on cancer development. 64.9% 
(N=2,750) women indicated large extent of protective effect of mammography above 50 
years of age and 23.5% (N=1,024) responded that mammography had protective effect. 
Questions relating to hormonal contraception and HRT use had a large variation of answers, 
with 15.8% (N=677) and 11.4% (N=479) indicating harmfulness of these therapies, 
respectively. Most of the respondents (41.7% for contraception and 45.2% for HRT) were 
unsure what was also the correct answer as at the time of the data collection there was some 
discussion on harmfulness versus no effect of both therapies. Vegetable and fruit intake was 
reported by 15.6% (N=670) women indicated some positive influence on the protective 
effect and 31.9% (N=1,386) reported protective effect. Limitation of alcohol use was 
considered by 28% (N=1,185) of respondents to have a large protective effect against breast 
cancer and 31.7% (N=1,386) thought that it had a protective effect. Smoking cessation has 
been noted by 6.6% (N=286) as having only some effect on risk reduction. An increase in 
physical exercise was correctly assessed by the majority of respondents as greatly protective 
(28.5%, N=1,199) and protective (33.9%, N=1,449). Regular practice of BSE was a question 
that was mostly answered correctly (67.1%, N=2,848 - greatly protective effect and 24.4%, 
N=1,067 protective effect). X-rays have been correctly considered as harmful by 35.5% 
(N=1,493) women. 
 
Not all questions could be scored and included in the scales and therefore they were 
analysed in a descriptive fashion. 
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Table 19 Where have you heard for the first time that mammography allows early 
detection of cancer 
Source of knowledge N (%) 
Family, friends 474 (11.5) 
Doctor 1,127 (28) 
Radio, television 1,495 (38.9) 
Women's press 481 (12.6) 
Other press 49 (1.2) 
School (college, courses, occupation, etc.) 141 (3.7) 
Other sources 47 (1.4) 
I don't remember 105 (2.7) 
Total 3,919 (100) 
No scoring applied 
 
The biggest proportion (38.9%, N=1,495) of the respondents got to know about the benefits 
of mammographic screening from radio or television, 28% (N=1,127) from their doctor, 
12.6% (N=481) from women’s press, and 11.5% (N=474) heard about it from family or 
friends. 
 
4.2.1.2. KNOWLEDGE OF TOPICS RELATED TO CERVICAL CANCER 
 
Table 20 Have you heard that cytology may allow early cancer detection? 
  N (%) 
Yes 3,871 (90.7)† 
No 217 (4.5) 
I don't know, it's difficult to say 202 (4.7) 
Total 4,290 (100) 
†Score: 2; other responses were scored 0 
 
Majority of women (90.7%, N=3,871) had indicated correctly that the regular cytology may 
allow early detection of cancer, 4.5% (N=217) had no such knowledge and 4.7% (N=202) 
were unsure. 
 
The next table (table 21) presents respondents’ views on the effect of various behaviours that 
may influence the development of breast cancer. In some cases more than one answer was 
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possible to select and the evidence weights were applied to reflect what was known in the 
literature at the time of data collection (for detail on the published evidence please refer back 
to section 2.4.2) 
 
Table 21 Do you believe that change of certain habits and behaviours can have 
protective effect on cancer? Please specify which of the following behaviours may 
influence the development of cervical cancer? 
Cervical 
cancer  
N (%) 
A B C D E F 
Regular 
cytology 3,272 (76.9)† 618 (14.1) 64 (1.4) 60 (1.3) 7 (0.2) 269 (6.1) 
Hormonal 
contraception 363 (8.2) 514 (11.9) 615 (14.2) 419 (10.9)‡ 640 (14.5)† 1,739 (40.6) 
Early sexual 
initiation 115 (2.7) 113 (2.5) 703 (16.3) 999 (23) 1,107 (25.8)† 1,253 (29.7) 
Large number 
of sexual 
partners 
141 (3.1) 125 (2.8) 491 (11.2) 703 (16.1) 1,742 (41.2)† 1,088 (25.6) 
Smoking 
cessation 1,791 (41.4)† 1,125 (26.6)‡ 390 (8.9) 443 (10.5) 50 (1.4) 491 (11.2) 
†Score: 2; ‡score: 1; other responses were scored 0 
 
Key: 
To a large extent it can protect against cancer 
It can have protective influence against cancer 
It can have a somewhat protective influence against cancer 
It does not influence cancer development 
Contrarily, it can lead to cancer development 
I don’t know, it is difficult to say 
A 
B 
C 
D 
E 
F 
 
Regular cytology is one of the most effective methods of cancer prevention strategies and 
76.9% (N=3,272) answered this correctly. The weight of published evidence in 2006 
identified that hormonal contraception may increase cervical cancer risk (see section 
2.4.2.7). 10.9% (N=640) pointed towards the correct answer but 40.6% (N=1,739) did not 
know the correct answer to this question. Strong evidence supporting the association of early 
sexual initiation, high number of sexual partners and smoking with increased risk of cervical 
cancer was identified in the literature prior to 2006. Respondents’ opinions were divided on 
the influence of early sexual initiation on cancer risk. 25.8% (N=1,107) indicated the correct 
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answer associating it with higher risk whilst 29.7% (N=1,253) did not know. 25.6% 
(N=1,088) did not know that a large number of sexual partners was associated with an 
increased risk of cervical cancer and 41.2% (N=1,742) answered correctly. Smoking 
cessation was correctly associated with decreased risk by most of the respondents (41.4%, 
large extent of protective effect and 26.6%, protective effect). 
 
Table 22 Where have you heard for the first time that cytology allows early cancer 
detection? 
  N (%) 
Family, friends 467 (11.9) 
Doctor 1,584 (41.1) 
Radio, television 1,007 (25.9) 
Women's press 474 (12.6) 
Other press 49 (1.5) 
School (college, courses, occupation, etc.) 134 (3.4) 
Other sources 35 (1.1) 
I don't remember 100 (2.6) 
Total 3,850 (100) 
No scoring applied 
 
41.1% (N=1,584) of women indicated that the doctor was the first source of knowledge 
about the cytology allowing early cancer detection, 25.9% (N=1,007) said that they got to 
know about it from radio or television, 12.6% (N=474) from women’s press and 11.9% 
(N=467) from friends or family.  
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4.2.2. Behaviours related to breast and cervical cancer 
 
4.2.2.1. BEHAVIOURS RELATED TO BREAST CANCER 
 
Initially, it was intended to create a scale for the behaviour items for breast cancer; however, 
after the closer examination of the items to be included this was decided against. As 
mammography was not part of the normal routine health care it would be impossible to 
make an assessment of whether the women made a conscious choice to take up the 
screening. For example, they might not have had a chance to take up cost free 
mammography offered as part of an ad hoc prophylactic initiative as it might not have been 
offered in their city. 
 
Table 23 Questions on performance of BSE and mammography 
Question   N (%) 
Are you examining your breasts by yourself (at home)? 
 Yes, regularly 1,223 (32.3) 
 Yes, rarely 1,662 (42.2) 
 Never 1,072 (25.5) 
  Total 3,957 (100) 
Have you ever had a mammography? 
 Yes 1,320 (32.1) 
 No 2,922 (66.8) 
 I don't know, it is difficult to say 48 (1.1) 
 Total 4,290 (100) 
Have you ever undertaken a mammography organised as a part of cost free prophylactic 
action/initiative (i.e., organised by popular press, church etc.)? 
 Yes 529 (40.4) 
 No 784 (59.6) 
 Total 1,313 (100) 
How often do you undergo mammography? (Question answered by women who declared having had 
mammogram in the past)? 
 Once a year 247 (18.5) 
 Every 2-3 years 349 (26.8) 
 Every 4-5 years 96 (7.4) 
 Less frequently than once every 5 years 63 (5.2) 
 Rarely-only when I have a chance 124 (9.6) 
 Until now I had only one mammography 423 (31.5) 
 I don't know, it's difficult to say 12 (1) 
  Total 1,314 (100) 
No scoring applied 
160 
 
 
The following table (table 23) presents questions relevant for breast cancer prophylaxis 
(BSE and mammography). Regular BSE was reported by 32.3% (N=1,223) of respondents, 
42.2% (N=1,662) did it rarely, and 25.5% (N=1,072) reported never having done it. 32% 
(N=1,320) of the women reported having had a mammogram at least once in the past and 
1.1% (N=48) were not sure. 40.4% (N=529) of the women who attended mammography 
previously, attended a free prophylactic test that was organised as part of a cost free 
prophylactic action (e.g., organised by a church or other organisation). Of the women who 
reported having had a mammogram in the past in the previous question (32.1%, N=1,320), 
31.5% had only one, 26.8% (N=349) reporting undergoing it every 2-3 years, 18.5% 
(N=247) did it once a year, 7.4% (N=96) every 4-5 years, 9.6% (N=124) had it rarely-only 
when they had chance, and 5.2% (N=63) had it less frequently than once every 5 years. 
 
4.2.2.2. BEHAVIOURS RELATED TO CERVICAL CANCER 
 
Despite the fact that every woman in Poland had cost and referral free access to 
gynaecologist at the time of data collection (NFZ, 2011a) it was decided not to form a 
scoring scale and behavioural elements separately. The decision not to proceed with 
formation of the scale was motivated by lack of clear and widely available guidance for 
women on the importance and the recommended frequency of screening. 
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Table 24 Questions on uptake of prophylactic behaviours related to cervical cancer 
Question N (%) 
In what situations do you go to a gynaecologist? 
 
Whenever I have to (worrying symptoms, pregnancy) 2,273 (52,2) 
 
I am going for routine tests regularly and when there is need 1,770 (43.3) 
 
I have never been to a gynaecologist 224 (4.5) 
 
Total 4,267 (100) 
Have you ever undergone cytology?  
 
Yes 3,184 (78.8) 
 
No 835 (18.5) 
 
I don't know. it’s difficult to say 119 (2.7) 
 
Total 4,138 (100) 
How often do you undergo cytology? (Question answered by women who declared having had cytology 
at least once)  
 
Once a year 932 (30.4) 
 
Every 2-3 years 748 (23.2) 
 
Every 4-5 years 250 (7.7)‡ 
 
Less than once every 5 years 269 (8.2) 
 
Rarely – only when there is occasion 544 (17.9) 
 
Until now I had only one such test 351 (10.7) 
 
I don't know, it’s difficult to say 76 (2) 
  Total 3,170 (100) 
No scoring applied 
 
Answers to the above question revealed that 43.3% (N=1,770) practices the correct health 
behaviours with relation to their gynaecological checks, 52.2% (N=2,273) visits 
gynaecologist only when they have to and 4.5% (N=224) has never visited such doctor. 
Almost seventy nine percent (78.8%, N=3,184) of women had cytology at least once in their 
lives, 18.5% (N=835) never had the test, and 2.7% was unsure of answer (N=119). There 
were several correct answers to the question on the frequency of cytology that included 
attending cytology once a year (30.4%, N=932) or, every 2-3 years (23.2%, N=748), which 
are now a part of a recommended screening interval (i.e. every 2-3 years if the results of the 
previous screen were negative). Other answers included every 4-5 years (7.7%, N=250), 
rarely – only when there is occasion 17.9% (N=544), until now I had only one such test 
(10.7%, N=351), and I don't know, it’s difficult to say (2%, N= 76). 
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4.2.3. Cues to action and barriers related to breast and cervical cancer  
 
Two items were identified as potential cues to action to be included in a scoring scale. 
However, after the scale reliability was tested with Cronbach’s alpha (α=0.35) showing a 
low reliability and the fact that family history of cancer or having a friend with cancer can 
be either a facilitator or a barrier to screening (Lamyian et al., 2007;; Kissal and Beser, 
2011; Borugian et al., 2009) it was decided against the creation of the scoring scale. 
 
Table 25 Questions considered as cues to action on cancer diagnosis amongst family or 
friends 
Question   N (%) 
Have any of your family members ever been diagnosed with a cancer? 
 
Yes 2,089 (48.1) 
 
No 2,073 (49.1) 
 
I don't know 121 (2.8) 
 Total 4,283 (100) 
Have any of your friends ever been diagnosed with a cancer? 
 
Yes 2,142 (50.9) 
 
No 1,707 (39.9) 
 
I do not know 407 (9.3) 
  Total 4,256 (99.2) 
No scoring applied 
 
Almost half (48.1%, N=2,089) of all women have responded that at least one of their family 
members was diagnosed with cancer. Considering that only 7 answers were recorded as 
missing and the sample is nationally representative an assumption can be made that around 
half of the Polish women have a family member who experienced cancer. Similarly, half 
(50.9%, N=2,142) of the sample had a friend who was diagnosed with cancer. 
The questions above were later tested for inclusion in the regression models as model 
covariates. 
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4.2.3.1. CUES TO ACTION AND BARRIERS RELATED TO BREAST CANCER 
 
Table 26 Questions on the reasons for uptake and lack of uptake of breast cancer 
prophylaxis 
Question   N (%) 
What was the main reason for your last mammography? 
 
I noticed worrying symptoms 129 (9.8) 
 
I belong to high risk group (cancer in the family) 83 (6.3) 
 
I used a openly available prophylactic programme 441 (34.2) 
 
I care about my health and I undergo prophylaxis (own initiative) 221 (16.8) 
 
My doctor referred me to confirm or refute diagnosis 144 (10.7) 
 
My doctor referred me for prophylactic test 260 (19.5) 
 
Other 28 (2.2) 
 
I don't know, it's difficult to say 7 (0.5) 
 
Total 1,313 (100) 
Due to what reason you have never undergone mammography? Please indicate one main reason 
 
There is nothing wrong with me-I feel healthy 1,128 (37.9) 
 
My doctor has never referred me for it 797 (28.7) 
 
I don't have time 72 (3) 
 
The test is too expensive 48 (1.4) 
 
There was no such action in my neighbourhood 100 (4) 
 
I am too young 599 (20.2) 
 
I have never heard about such test 29 (0.7) 
 
Other reason 80 (3.1) 
 
I don’t know, it's difficult to say 33 (1.1) 
 
Total 2,886 (100) 
Why you have never undertaken mammography offered as part of the cost free prophylactic 
action/initiative? 
 
I have not heard of such actions 212 (27.8) 
 
I did not feel the need for such test 174 (22.4) 
 
when such initiative was organised I did not have time 77 (9.8) 
 
I go for mammography from my own initiative 147 (19.5) 
 
There were no free spaces 33 (4) 
 
Other reason 128 (16.5) 
  Total 771 (100) 
No scoring applied 
 
The first question in the table above was answered only by women who have attended 
mammography before (N=1,320). 34.2% (N=441) of them attended an openly available 
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screening programme, 19.5% (N=260) were referred by their doctor for mammography as a 
prophylactic test, 16.8% (N=221) declared that they take care about my health and therefore 
they undergo prophylaxis (own initiative), 10.7% (N=144) were referred by their doctor to 
confirm or refute diagnosis, 9.8% (N=129) noticed worrying symptoms, 6.3% (N=83) 
reported that they belonged to a high risk group (cancer in the family), 2.2% (N=28) 
indicated other reasons, and 0.5% (N=7) were not sure. 
 
When asked about the reasons for not taking up mammography the majority (37.9%, 
N=1,128) indicated that there was nothing wrong with them and felt healthy and therefore 
they did not attend the screening. Second and third most commonly given answers were lack 
of doctor’s referral for such test and being too young (28.7%, N=797 and 20.2%, N=599 
respectively). Other answers ranged between 0.7% and 4%. 
 
Additionally, women were asked if they attended mammography as part of cost free 
prophylactic initiative and 59.6% (N=784). Women who did not attend cost free 
prophylactic actions indicated the main reasons for not doing so. The biggest proportion of 
those women 27.8% (N=212) have not heard of such actions, 22.4% (N=174) did not feel 
the need for such test, 19.5% (N= 147), underwent mammography elsewhere (their own 
initiative), 9.8% (N=77) did not have time when such actions were organised, 4% (N=33) 
said that there were no free spaces available, and 16.5% (N=128) indicated other reasons. 
Other reasons included: different age group, housebound, too expensive, mammography 
after surgery (including mastectomy), breast pain, due to medication, friends advice, 
employers requirement and others. 
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4.2.3.2. CUES TO ACTION AND BARRIERS RELATED TO CERVICAL CANCER 
 
Table 27 Questions on the reasons for uptake and lack of uptake of cervical cancer 
prophylaxis 
Question   N (%) 
What was the main reason for your first cytology? 
 
Planned pregnancy 300 (9.9) 
 
Worrying symptoms (own initiative) 413 (12.8) 
 
I am in a high risk group (cervix cancer in the family) 43 (1.5) 
 
Prophylactic test (own initiative) 1,181 (37.4) 
 
I benefited from a free prophylactic programme 102 (3.3) 
 
Doctor’s referral to confirm or refute the diagnosis 305 (9.2) 
 
Doctor’s referral for a prophylactic test  727 (22.6) 
 
Other 29 (0.9) 
 
I don't know, it’s difficult to say 81 (2.4) 
 
Total 3,181 (100) 
Due to what reason you have never undergone cytology? 
 
There is nothing wrong with me - I feel healthy 366 (44.9) 
 
My doctor never referred me for it 334 (39.2) 
 
I don’t have time 16 (2.3) 
 
It's too expensive 5 (0.6) 
 
There are no such tests in my neighbourhood 9 (1) 
 
I'm too young 34 (3.7) 
 
I've never heard of such a study 35 (3.9) 
 
Other 9 (1) 
 
I don't know, it's difficult to say 22 (3.4) 
 
Total 830 (100) 
Due to what reason you have never been to gynaecologist? 
 
There is nothing wrong with me - I feel healthy 137 (61.7) 
 
I'm too young 35 (15.8) 
 
I do not have time 4 (1.8) 
 
Too expensive 1 (0.5) 
 
I am scared/ I don't like 26 (11.7) 
 
Other reason 11 (5) 
 
I don't know, difficult to say 8 (3.6) 
  Total 222 (100) 
No scoring applied 
 
Women were asked about main reason for their first cytology test. The most commonly 
given answers included: 37.4% (N=1,181) prophylactic test (own initiative), 22.6% (N=727) 
doctor’s referral for a prophylactic test, 12.8% (N=413) worrying symptoms, 9.9% (N=300) 
planned pregnancy, 9.2% (N=305) doctor’s referral to confirm or refute the diagnosis, and 
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0.9% (N=29) indicated that their last cytology was done due to other reasons than the pre-
defined answers. 
 
Women that have never undertaken cytology were asked for the reasons for not doing so. 
The most commonly repeated answers were: 44.9% (N=366) There is nothing wrong with 
me - I feel healthy and 39.2% (N=334) my doctor never referred me for it. Other answers 
included: I don’t have time (2.3%, N=16), It's too expensive (0.6%, N=5), There are no such 
tests in my neighbourhood (1%, N=9), I'm too young (3.7%, N=34), I've never heard of such 
a study (3.9%, N=35), Other (1%, N=9) and I don't know, it's difficult to say (3.4%, N=22). 
 
In addition to questions about no cytology uptake, women were also asked also about the 
reasons for never visiting a gynaecologist (in Poland accessible without referral). Only 222 
women responded to this question and majority (61.7%, N=137) indicated that they felt that 
there was nothing wrong with them. 15.8% (N=35) stated that they were too young for that, 
11.7% (N=26) were scared/didn’t like visiting gynaecologist. Other responses ranged from 
0.5% to 5%. 
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4.2.4. Screening and health history 
 
Table 28 Questions relating to age at first mammography and the number of times 
mammographies undertaken as part of cost free prophylactic initiative 
Question   N (%) 
How old were you when you had your first mammography? 
 <20 y.o  19 (1.5) 
 20-24 y.o 37 (2.9) 
 25-29 y.o 48 (3.6) 
 30-34 y.o 62 (5.6) 
 35-39 y.o 112 (9.4) 
 40-44 y.o 179 (14) 
 45-49 y.o 200 (14.5) 
 50-54 y.o 249 (18.8) 
 55-59 y.o 136 (9.9) 
 ≥60 151 (10.5) 
 I don't remember 127 (9.1) 
  Total 1,320 (100) 
How many times have you undertaken a mammography organised as a part of cost free prophylactic 
action/initiative (i.e., organised by popular press, church etc.)? 
 Once 345 (64.3) 
 2 times 100 (20.6) 
 3 to 5 times 70 (12.8) 
 More than 5 times 10 (2.3)   Total 525 (100) 
No scoring applied 
 
The age at the first mammography was widely spread by all age groups. This might be 
partially due to the fact that free mammographic events/actions organised by for example 
churches often do not apply age limit. The biggest group of respondents (64.3%, N=345) 
declared that they attended a mammography organised as a part of cost free prophylactic 
action/initiative once, 20.6% (N=100) attended twice, 12.8% (N=70) 3 to 5 times, and 2.3% 
(N=10) more than 5 times. 
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Table 29 Questions relating to age at first cytology and the reason for the first (ever) 
visit to gynaecologist 
Question   N (%) 
How old were you when you had your first cytology? 
 
<20 y.o  430 (13.9) 
 
20-24 y.o 943 (30.7) 
 
25-29 y.o 407 (13.2) 
 
30-34 y.o 222 (7.5) 
 
35-39 y.o 100 (3.1) 
 
40-44 y.o 118 (3.7) 
 
45-49 y.o 75 (2.5) 
 
50-54 y.o 91 (2.7) 
 
55-59 y.o 30 (0.8) 
 
≥60 42 (1.2) 
 
I don't remember 649 (20.6) 
  Total 3,107 (100) 
What was the reason for your first (ever) visit at the gynaecologist? 
 
Prescription for contraception 120 (2.9) 
 
Worrying symptoms, treatment 779 (19.6) 
 
Prophylactic tests, no symptoms 1,189 (29.3) 
 
Pregnancy 1,702 (42) 
 
Other 26 (0.7) 
 
I do not remember 223 (5.4) 
  Total 4,039 (100) 
No scoring applied 
 
The majority of the surveyed women had their first cytology done when they were: 20-24 
years old (30.7, N=943), <20 years old (13.9%, N=430), 25-29 years old (13.2%, N=407), 
30-34 years old (7.5%, n=222). The proportions of age of first cytology in each of the 
remaining groups decreased with age (from 3.7% to 0.8%). 20.6% (N=649) did not 
remember what age they were at the first cytological test.  
 
The final question relating to cervical cancer screening was on the reason for the first (ever) 
visit to the gynaecologist. The vast majority (42%, N=1,702) indicated that their first visit 
was related to their pregnancy, 29.3% (N=1,189) went for prophylactic tests without any 
symptoms, 19.6% (N=779) had worrying symptoms or required treatment, 22.9% (N=120) 
required a prescription for contraception, 5.4% (N=223) did not remember, and 0.7% 
(N=26) indicated other reasons.  
169 
 
 
Table 30 Have you ever been diagnosed with cancer (yes). Please specify the cancer’s 
location (body part)? 
Type of cancer N (%) 
No cancer 4,098 (95.7) 
Breast cancer 62 (1.3) 
Cervical cancer 25 (0.6) 
Other cancer 105 (2.4) 
Total 4,290 (100) 
 
The respondents were asked whether they have ever been diagnosed with cancer before and 
192 (4.3%) of them gave a positive response. Table above presents how many of those 
cancers were in breast (1.3%, N=62) or cervical (0.6%, N=25). Other cancers included (in 
the order of frequency): colon, lung, stomach, skin, endometrium, other uterus, ovary, 
mouth, liver, other cancer of digestive system, cancer of bone or cartilage, urinary system, 
brain or other cancer of central nervous system, thyroid, not specified malignant cancers, 
malignant cancers of blood, lymph, or other not specified carcinoma. 
 
4.3. Answers to the research questions  
 
4.3.1. What were the levels of Polish women’s knowledge on breast and cervical 
cancers and how did they differ amongst different socioeconomic groups?  
 
The knowledge score is the sum of the breast and cervical cancer scores and the following 
table summarises all three knowledge scores. Means have been presented with their standard 
deviations and standard errors as well as minimum and maximum values and 95% 
confidence intervals (table 31). 
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Table 31 Mean knowledge scores for the estimation sample (mean, S.D., S.E., 95% CI) 
N=4,290 Total knowledge score 
Breast cancer 
knowledge score 
Cervical cancer 
knowledge score 
Mean 1.00 0.98 1.03 
S.D. (S.E.) 0.27 (0.008) 0.25 (0.007) 0.46 (0.015) 
95% CI 0.98,1.02 0.96,0.99 0.99,1.06 
Min 0.11 0.08 0 
Max 1.68 1.62 2 
D.eff. 2.13 1.81 2.22 
 
The mean total cancer knowledge score was 1.00 (S.D. 0.27), mean breast cancer knowledge 
score 0.98 (S.D. 0.25), and mean cervical cancer knowledge score 1.03 (S.D. 0.46). As 
mentioned in the section 3.5.3 the knowledge scores were recoded into categorical variables 
that included three levels: low - from 0 to 0.6666666, medium - from 0.6666667 to 
1.333332, and high - from 1.333333 to 2. The details of the knowledge scores distribution is 
presented in the next table (table 31). 
 
Table 32 Comparison of knowledge scores as categorical variables with three levels: 
low, medium, and high  
Knowledge score (N=4,290)  % (N) S.E. 95% CI D.eff. 
Total knowledge score*  
 
Low 10.26 (439) 1.03 8.37 12.52 2.22 
 
Medium 80.64 (3,462) 1 78.55 82.57 1.65 
 
High 9.11 (389) 0.68 7.82 10.58 1.56 
Breast cancer knowledge score  
 
Low 10.24 (449) 0.92 8.53 12.24 1.99 
 
Medium 84.66 (3,625) 0.84 82.88 86.28 1.54 
  High 5.1 (216) 0.45 4.28 6.08 1.33 
Cervical cancer knowledge score  
 
Low 28.24 (1,238) 1.36 25.59 31.04 1.97 
 
Medium 38.23 (1,639) 1.14 35.96 40.55 1.54 
  High 33.53 (1,413) 1.31 30.94 36.23 1.82 
*Frequencies of total knowledge score categories are result of the additive effect of score elements within each 
observation 
 
Majority (80.6%) of women had medium level total cancer knowledge, 10.3% had low and 
9.1% had high. The differences can be noted by splitting the knowledge on breast and 
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cervical cancer as women had generally worse knowledge on cervical cancer as 28.2% had 
low knowledge in comparison to 10.2%. However, due to more even cervical knowledge 
score distribution more women had high level of knowledge (33.5%) than breast cancer 
knowledge (5.1%). 
 
4.3.2. Was there an association between the levels of knowledge on cervical and 
breast cancers? 
 
Pearson’s correlation for women’s knowledge on breast and cervical cancers and their 
prophylaxis showed that there was statistically significant medium strength positive 
correlation (Rho=0.506, p<0.001) (Weinberg and Abramowitz, 2008; Pallant, 2007). That 
means that if cervical cancer knowledge increased so did breast cancer knowledge.  
 
4.3.3. Did levels of knowledge differ across different layers of the Polish society? 
 
In this section an assessment of differences in knowledge score amongst women in different 
layers of the society (i.e. socio-demographics, socio-economics) is provided. As the breast 
and cervical cancer knowledge scores are correlated the following tests use the total 
knowledge score. 
 
To assess the differences in knowledge scores across different socio-demographic and socio-
economic groups, univariate simple linear regression analyses with an adjusted Wald test 
(with Rao-Scott correction) (Lee and Forthofer, 2006) were performed for the groups of the 
studied variables and marked for significance in each of the following tables in this section. 
The regression analysis was chosen over ANOVA due to specifics of Stata commands that 
account for survey design however both of these techniques are equivalent in estimating the 
linear relationships between the variables in question (Lee and Forthofer, 2006). The null 
hypothesis assumed no differences in knowledge scores (total and per each cancer type) for 
women in each of the categories of the socio-demographic and economic variables. Mean 
knowledge scores were reported instead of the regression coefficients for more meaningful 
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interpretation of the differences in knowledge between various socio-demographic and 
socio-economic groups. 
 
Table 33 Univariate linear regression analyses of knowledge scores for various socio-
demographic variables adjusted for design effects (mean, S.D., S.E., 95% CI) 
   Total knowledge score for both cancers 
  
  N Mean S.D. (S.E.) 95% CI D.eff p-value 
Age groups (N=4,290) 
 
18-24 636 1.00** 0.27 (0.01) 0.97, 1.02 0.87 
<0.001*** 
F(6,42)=11.88 
25-29 297 1.01 0.23 (0.02) 0.98, 1.05 1.13 
30-39 870 1.03‡ 0.22 (0.01) 1.01, 1.04 - 
40-49 650 1.04 0.24 (0.01) 1.02, 1.07 0.99 
50-59 780 1.04 0.27 (0.01) 1.01, 1.06 1.10 
60-69 418 1.03 0.29 (0.02) 1.00, 1.07 1.14 
70+ 639 0.86*** 0.36 (0.03) 0.80, 0.91 1.74 
Marital status (N=4,284) 
 
Married/in relationship 2,114 1.02‡ 0.25 (0.01) 1.00, 1.04 - 
0.001** 
F(3,45)=6.40 
Widow 884 0.94*** 0.35 (0.02) 0.90, 0.99 1.32 
Separated 288 1.04 0.20 (0.02) 1.00, 1.08 1.5 
Single (never married) 998 1 0.29 (0.01) 0.97, 1.02 1.08 
City size (N=4,290) 
 
City >100k 1,201 1.04‡ 0.25 (0.01) 1.01, 1.07 - 
0.031** 
F(3,45)=3.24 
City 50-100k 368 1.01 0.23 (0.02) 0.97, 1.05 1.77 
City <50k 1,048 1.02 0.25 (0.01) 1.00, 1.05 1.78 
Village 1,673 0.97** 0.31 (0.02) 0.94, 1.00 2.04 
*p<0.05 level; **p<0.01, ***p< 0.001 level; ‡Reference category 
 
Significant differences were noted for all three socio-demographics. For age the reference 
category was set for 40-49 age group due to the largest size (N=870). After inspection of the 
above table and additional assessment of scatter plot a somewhat curvilinear relationship 
was noted between age and knowledge with lower knowledge in the eldest age group and to 
lesser extent in the youngest. Only two age categories 18-24 and 70 and over had 
significantly lower mean knowledge score with p<0.01 and p<0.001, respectively.  
Only widowed women and the ones that lived in villages had significantly lower level of 
knowledge in comparison with the reference groups (p<0.001 and p<0.01, respectively).  
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Table 34 Univariate linear regression analyses of knowledge scores for various socio-
economic variables adjusted for design effects (mean, S.D., S.E., 95% CI) 
     Total knowledge score for both cancers     
    N Mean S.D. (S.E.) 95% CI D.eff p-value 
Education (N=4,278) 
 
Primary 958 0.89‡ 0.35 (0.02) 0.85,0.93 - 
<0.001*** 
F(3,45)=20.50 
Technical 973 1.03*** 0.24 (0.01) 1.00,1.05 1.6 
Medium 1,669 1.04*** 0.25 (0.01) 1.02,1.05 1.51 
Higher 678 1.06*** 0.22 (0.01) 1.03,1.08 1.57 
Material conditions (N=4,270) 
 
We live poorly 237 0.89*** 0.35 (0.03) 0.83,0.96 1.34 
<0.001*** 
F(4,44)=6.25 
We live modestly 1,250 0.98** 0.30 (0.02) 0.94,1.01 1.32 
We live on average level 2,135 1.03‡ 0.25 (0.01) 1.01,1.04 - 
We live well 592 1.03 0.23 (0.01) 1.01,1.05 1.06 
We live very well 56 1.05 0.26 (0.03) 0.98,1.12 1.02 
Source of income  (N=4,261)      
 Employed 1,549 1.04‡ 0.23 (0.01) 1.02, 1.06 - 
0.003** 
F(6, 42) =4.03 
 Self-employed 336 1.00** 0.24 (0.01) 0.97, 1.02 1.04 
 Retired 1,122 0.97*** 0.33 (0.02) 0.93, 1.00 1.77 
 Disability benefits 257 0.99 0.31 (0.03) 0.94, 1.05 1.36 
 Other benefits (family, social) 485 0.99** 0.27 (0.02) 0.95, 1.02 1.27 
 Unemployment  76 1.01 0.26 (0.03) 0.94, 1.07 1.02 
 
Dependent on a person from 
outside household 257 0.99* 0.28 (0.02) 0.95, 1.04 1.28 
Household size (N=4,278)  
 
1 person  982 0.96‡ 0.32 (0.02) 0.93,1.00 - 
0.004** 
F(4,44) =4.46 
2 people 996 1.00* 0.28 (0.02) 0.97,1.03 1.17 
3 people 867 1.03*** 0.25 (0.01) 1.01,1.05 1.34 
4 people 822 1.03* 0.25 (0.01) 1.01,1.04 1.21 
5 or more 611 1.01 0.26 (0.02) 0.97,1.04 1.43 
*p<0.05 level; **p<0.01, ***p<0.001 level; ‡Reference category 
 
Analyses of the knowledge scores by socio-economic variables (table 34) showed that there 
were significant differences for all three variables (p<0.001 for education and material 
conditions and p<0.01 for the household size). All educational levels had significantly 
higher cancer knowledge from the reference category-primary education (all p<0.001). 
Similarly, the knowledge also increased with the increasing material conditions (p<0.001 for 
we leave poorly category, p<0.01 for we live modestly category) but there was no 
statistically significant difference in knowledge between the reference and the last two 
categories. Significantly lower knowledge score was found amongst self-employed 
(p<0.01), retired (p<0.001), and on other benefits (family, social) (p<0.05) when compared 
to the employed women. The knowledge also differed statistically (p<0.01) for reference 
category (1 person) increasing with the household size with exception of the last category of 
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5 people or more (however it was just outside of the 0.05 level with a p value of 0.056). 
Category of 2 people per household was different to the reference category at 0.05 level 
(p<0.05) and 3 and 4 people per household categories at 0.001 level. Additionally, to 
supplement the information on the differences of the knowledge scores two variables on the 
previous cancer diagnosis were explored (table 35).  
 
Table 35 Univariate linear regression analyses of previous cancer diagnosis and 
tumour type adjusted for design effects (mean, S.D., S.E., 95% CI) 
  Total knowledge score for both cancers   
  N Mean S.D. (S.E.) 95% CI D.eff p-value 
Past cancer diagnosis (N=4,243)   
 
Yes 192 1.06** 0.28 (0.02) 1.02, 1.11 1.03 0.006** 
F(1,47)=8.48 No 4,051 1.00‡ 0.27 (0.01) 0.99, 1.02 - 
Type of cancer (N=4,290)   
 
No cancer 4,098 1.00‡ 0.27 (0.01) 0.98, 1.02 - 
0.023* 
F(3,45)=3.52 
Breast 62 1.10** 0.24 (0.03) 1.03, 1.16 1.03 
Cervical 25 1.05 0.26 (0.07) 0.91, 1.18 1.26 
Other 105 1.05 0.29 (0.03) 1.00, 1.10 0.93 
*p<0.05 level; **p<0.01; ‡Reference category 
 
Knowledge scores for women who reported to have been diagnosed with any type of cancer 
were significantly higher to those that did not report such diagnosis (p<0.01). The 
knowledge was also higher for women who were diagnosed with breast cancer (p<0.01) but 
the result showed borderline (p=0.051) for cervical cancer diagnosis. 
 
4.3.4. Did levels of knowledge of breast and cervical cancers differ between 
women who practiced prophylactic behaviours? 
 
The tests for differences in knowledge scores were performed using design adjusted Wald 
test and presented with corresponding F statistic. The analyses were performed depending 
on the age of women: BSE was assessed for all ages, mammography for women aged 50 an 
older, cytology for women aged 25 and older (table 36).  
 
 
175 
 
 
Table 36 Wald test adjusted for design effects of the differences of the mean total 
cancer knowledge scores by practice of BSE, mammography uptake and cytology 
uptake 
Mean total cancer knowledge score S.E. 95% CI D.eff. p-value 
BSE (all ages)       
 No 0.96 0.01 0.94, 0.99 1.62 <0.001 F(1,47)=49.05  Yes 1.05 0.01 1.04, 1.07 1.6 
Mammography among women aged ≥50      
 No 0.98 0.01 0.96, 1.00 1.84 <0.001 F(1,47) =66.11   Yes 1.07 0.01 1.06, 1.09 1.23 
Cytology among women aged ≥25     
 No 0.88 0.03 0.83, 0.93 1.81 <0.001 F(1,47)=43.78   Yes 1.05 0.01 1.03, 1.06 1.66 
 
The total cancer knowledge scores were showed to be significantly higher (p<0.001) for 
women who practiced any of the above described cancer prophylactic behaviours.  
Additionally, the total knowledge scores have been separated into breast and cervical cancer 
scores. The two types of cancer scores were examined for respective prophylactic 
behaviours (breast cancer knowledge for BSE and mammography and cervical cancer 
knowledge for cytology) (table 37). 
 
Table 37 Wald test adjusted for design effects of the differences of the mean breast 
cancer knowledge score by practice of BSE or mammography uptake†, and mean 
cervical cancer knowledge score by cytology uptake‡ adjusted for design effects. 
Mean cancer knowledge scores S.E. 95% CI D.eff. p-value 
BSE (all ages)†     
 No 0.95 0.01 0.93, 0.98 1.55 <0.001 
 Yes 1.03 0.01 1.01, 1.04 1.35 F(1,47)=32.02 
Mammography among women aged ≥50† 
 No 0.88 0.02 0.84, 0.91 1.71 <0.001 
 Yes 1.04 0.01 1.02, 1.06 1.23 F(1,47)=63.48 
Cytology among women aged ≥25‡ 
 No 0.83 0.04 0.75, 0.90 1.67 <0.001 
  Yes 1.1 0.01 1.07, 1.13 1.78 F(1,47)=58.98 
†mean breast cancer knowledge score; ‡mean cervical cancer knowledge score 
Similarly as in case of the total cancer knowledge scores both breast and cervical cancer 
knowledge were shown to be significantly higher (p<0.001) for women who practiced 
respective prophylactic behaviours. Therefore further logistic regression analyses use the 
total cancer knowledge scores as covariates. 
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4.3.5. Did cancer prophylactic behaviours differ across different layers of the 
Polish society? 
 
In order to examine the differences of breast and cervical cancer behaviours across different 
layers of Polish society Pearson Chi-square tests were performed. The following tables 
present differences in BSE practice, mammography uptake (ever) and cytology uptake (ever) 
for women from different socio-demographic and socio-economic groups as well as those 
who had previous cancer diagnosis and those who did not. 
 
4.3.5.1. BSE BY SOCIO-DEMOGRAPHIC VARIABLES 
 
Table 38 Pearson Chi square analysis of socio-demographic variables and practice of 
BSE adjusted for design effects 
    BSE practice   
  
No  Yes 
  
% (N) 95% CI % (N) 95% CI m.d.eff† p-value 
Age (N=3,957) 
 
 18-24 36.97 (232) 31.75,42.51 63.03 (365) 57.49,68.25 
1.58 
<0.001** 
F(5.04, 236.68) 
=19.72 
 25-29 27.5 (81) 22.33,33.34 72.5 (205) 66.66,77.67 
 30-39 19.12 (156) 16.39,22.18 80.88 (674) 77.82,83.61 
 40-49 18.45 (126) 15.27,22.11 81.55 (489) 77.89,84.73 
 50-59 20.21 (148) 16.75,24.17 79.79 (596) 75.83,83.25 
 60-69 25.57 (105) 19.63,32.57 74.43 (281) 67.43,80.37 
 70+ 44.1 (224) 36.91,51.56 55.9 (275) 48.44,63.09 
  Total 25.53 (1,072) 23.20,28.00 74.47 (2,885) 72.00,76.80 
Marital status (N=3,951)  
 
Married/ in 
relationship 21.7 (454) 19.33,24.28 78.3 (1,535) 75.72,80.67 
1.78 
<0.001** 
F(2.44, 114.47) 
=10.18 
 Widow 32.16 (249) 26.89,37.92 67.84 (511) 62.08,73.11 
 
Separated/ 
divorced 23.31 (63) 17.70,30.05 76.69 (216) 69.95,82.30 
 Single 32.42 (305) 28.19,36.96 67.58 (618) 63.04,71.81 
  Total 25.53 (1,071) 23.20,28.01 74.47 (2,880) 71.99,76.80 
City size (N=3,957) 
 city >100K 22.45  (270) 18.94,26.40 77.55 (878) 73.60,81.06 
2.46 
0.011* 
F(2.74, 129.01) 
=3.99 
 city 50-100K 25.44 (95) 20.24,31.45 74.56 (262) 68.55,79.76 
 city <50K 22.55 (221) 19.70,25.68 77.45 (758) 74.32,80.30 
 Village 30.03 (486) 25.59,34.89 69.97 (987) 65.11,74.41 
  Total 25.53 (1,072) 23.20,28.00 74.47 (2,885) 72.00,76.80 
*p<0.05, **p<0.001†mean generalised design effects 
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Significant differences were found for all socio-demographic variables in women who 
practiced BSE (p<0.001 for age and marital status and p<0.05 for the size of the city) (table 
37). For example the highest proportions of women who practiced BSE were in age groups 
30-39 (80.9%, N=674), 40-49 (81.6%, N=489), and 50-59 (79.8%, N=596); whilst the 
lowest for women over 70 years old (55.9%, N=275). More women who were married/in 
relationship and separated/divorced declared practice BSE than other groups (78.3%, 
N=1,535 and 76.69%, N=216, respectively). Also more women in the cities admitted to 
practicing BSE (cities >100K: 77.6%, N=878, cities <50K: 77.5%, N=758, and cities 50-
100K: 74.6%, N=262) than those living in the villages (70%, N=987).  
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4.3.5.2. BSE BY SOCIO-ECONOMIC VARIABLES 
 
Table 39 Pearson Chi square analysis adjusted for design effects of socio-economic 
variables and practice of BSE 
  BSE practice    
 
No Yes   % (N) 95% CI % (N) 95% CI m.d.eff† P-value 
Education (N=3,946)     Primary 39.73 (324) 35.04, 44.62 60.27 (445) 55.38, 64.96 
1.27 
<0.001** 
 
F(2.94, 138.02) 
=40.02 
Technical 28.27 (273) 25.06, 31.73 71.73 (631) 68.27, 74.94 
Medium level 21.76 (361) 19.29, 24.44 78.24 (1,244) 75.56, 80.71 
Higher 15.24 (112) 12.29, 18.74 84.76 (556) 81.26, 87.71 
Total 25.53 (1,070) 23.20, 28.01 74.47 (2,876) 71.99, 76.80 
Household size (N=3,946)      
1 person 28.77 (260) 23.79, 34.32 71.23 (606) 65.68, 76.21 
1.36 
0.004* 
F(3.58, 168.48) 
=4.22 
2 people 27.71 (249) 24.01, 31.74 72.29 (663) 68.26, 75.99 
3 people 21.11 (192) 18.05, 24.53 78.89 (629) 75.47, 81.95 
4 people 22.22 (200) 18.96, 25.86 77.78 (583) 74.14, 81.04 
5 or more 28.76 (168) 24.53, 33.41 71.24 (396) 66.59, 75.47 
Total 25.52 (1069) 23.20, 28.00 74.48 (2877) 72.00, 76.80 
Source of income (N=3,761)      Employed 19.08 (295) 16.89,21.49 80.92 (1,202) 78.51,83.11 
1.49 
<0.001** 
F(4.46, 209.64) 
=6.5 
Self-employed 26.80 (94) 20.51,34.19 73.20 (220) 65.81,79.49 
Retired 30.79 (312) 25.93,36.12 69.21 (657) 63.88,74.07 
Disability benefits 26.49 (59) 20.18,33.92 73.51 (158) 66.08,79.82 
Other benefits 
(family, social) 29.34 (130) 24.89,34.23 70.66 (317) 65.77,75.11 
Unemployment  29.89 (21) 19.74,42.50 70.11 (53) 57.50,80.26 
Dependent on a 
person from 
outside household 
29.04 (85) 22.89,36.08 70.96 (158) 63.92,77.11 
Total 25.02 (996) 22.76,27.44 74.98 (2,756) 72.56,77.24 
Material conditions (N=3,942)         we live poorly 43.45 (80) 32.78, 54.76 56.55 (110) 45.24, 67.22 
1.64 
<0.001** 
F(3.15, 147.86) 
=12.82 
we live modestly 30.68 (359) 26.50, 35.21 69.32 (757) 64.79, 73.50 
we live on 
average level 22.67 (494) 20.40, 25.11 77.33 (1519) 74.89, 79.60 
we live well 20.39 (125) 17.30, 23.87 79.61 (443) 76.13, 82.70 
we live very well 17.92 (10) 10.14, 29.69 82.08 (45) 70.31, 89.86 
Total 25.53 (1,068) 23.20, 28.00 74.47 (2874) 72.00,76.80 
*p<0.01;** p<0.001; †mean generalised design effects 
 
Table 39 shows that BSE practice differed for all socio-economic variables (p<0.001 for 
education and material conditions and p<0.01 for household size) (table 39). With respect to 
level of education the highest proportion of women who practiced BSE were among those 
with higher education (84.8%, N=556) and the lowest among those who achieved primary 
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education (60.3%, N=445). Women from households with three and four people per 
household had significantly higher levels of BSE (78.9%, N=629 and 77.8%, N=583). More 
employed women (80.9% N=1,202) ever had mammography than any other group (57.5% to 
73.5 %). Women’s perception of their material conditions was shown to be linked with BSE. 
Proportions of BSE were larger among women with better material status (from 56.5%, 
N=110 for women who declared to live poorly to 82.1%, N=45 of those that stated to live 
very well). 
 
4.3.5.3. BSE BY PREVIOUS CANCER DIAGNOSIS 
 
Table 40 Pearson Chi square analysis adjusted for design effects of BSE practice by 
previous cancer diagnosis and cancer type 
    BSE practice   
  No  Yes   
  % (N) 95% CI % (N) 95% CI m.d.eff† p-value 
Previous cancer (N=3,915)    
 No 25.5 (1,020) 23.10, 28.06 74.5 (2,716) 71.94, 76.90 
1.11 0.675 F(1,47)=0.18  Yes 23.95 (38) 17.67, 31.60 76.05 (141) 68.40, 82.33 
 Total 25.44 (1,058) 23.10, 27.92 74.56 (2,857) 72.08, 76.90 
Type of cancer (N=3,957)       
 No cancer 25.6 (1,034) 23.21, 28.15 74.4 (2,744) 71.85, 76.79 
1.24 
0.083 
F(2.88,135.46) 
=2.3 
 Breast cancer 9.39 (6) 3.43, 23.24] 90.61 (53) 76.76, 96.57 
 Cervical cancer 31.79 (7) 13.67, 57.83 68.21 (17) 42.17, 86.33 
 Other 30.35 (25) 21.21, 41.37 69.65 (71) 58.63, 78.79 
  Total 25.53 (1,072) 23.20, 28.00 74.47 (2,885) 72.00,76.80 
†mean generalised design effects 
 
The above table (table 40) presents numbers of respondents that have been diagnosed with 
cancer (any type) in the past. The results show that there were no statistically significant 
associations between the groups.  
 
4.3.5.4. MAMMOGRAPHY UPTAKE BY SOCIO-DEMOGRAPHIC VARIABLES IN WOMEN AGED 50 
AND OVER 
 
The following table (table 41) reports on differences for mammography uptake (ever) for 
women aged 50 or more. This age limitation was applied to coincide with the currently 
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recommended screening age. However, 9.5% (N=403) of all women have had 
mammography before the age of 50 including 43 women who were below age of 30 years 
old. 
 
Table 41 Pearson Chi square analysis adjusted for design effects of mammography 
(ever) uptake by socio-demographic variables 
    Mammography ever   
  
No Yes   
% (N) 95% CI % (N) 95% CI m.d.eff† p-value 
Age (N=1,808)      
 50-59 33.95 (260) 28.79, 39.52 66.05 (514) 60.48, 71.21 
1.23 
<0.001 
F(1.99,93.42) 
=85.18 
 60-69 41.33 (177) 33.39, 49.74 58.67 (236) 50.26, 66.61 
 70+ 71.94 (454) 65.13, 77.87 28.06 (167) 22.13, 34.87 
  Total 47.48 (891) 41.37, 53.68 52.52 (917) 46.32, 58.63 
Marital status (N=1,806)      
 
Married/in 
relationship 42.56 (291) 35.40, 50.04 57.44 (391) 49.96, 64.60 
1.5 
<0.001 
F(2.50,117.28) 
=10.89 
 Widow 58.4 (471) 51.15, 65.30 41.6 (328) 34.70, 48.85 
 
Separated/ 
divorced 35.69 (46) 26.01, 46.69 64.31 (81) 53.31, 73.99 
 Single 43.05 (81) 35.07, 51.41 56.95 (117) 48.59, 64.93 
  Total 47.43 (889) 41.30, 53.63 52.57 (917) 46.37, 58.70 
Size of the city (N=1,808)      
 city >100K 29.88 (168) 25.39, 34.79 70.12 (356) 65.21, 74.61 
3.4 
<0.001 
F(2.65,124.61) 
=23.59 
 
city 50-
100K 40.81 (66) 31.20, 51.17 59.19 (87) 48.83, 68.80 
 city <50K 44.25 (203) 35.60, 53.27 55.75 (233) 46.73, 64.40 
 Village 64.77 (454) 59.31, 69.87 35.23 (241) 30.13, 40.69 
  Total 47.48 (891) 41.37, 53.68 52.52 (917) 46.32, 58.63 
†mean generalised design effects 
 
Mammography uptake differed for all socio-demographic variables (p<0.001). The highest 
proportions of women who ever had mammography were in 50-59 age group (66.1%, 
N=514) and the lowest amongst women over 70 years old (28.1%, N=167). Also, women 
who were separated/divorced (64.3%, N=81) or married/in relationship (57.4%, N=391) had 
higher mammography uptake than those who were single or widowed (57%, N=117 and 
41.6%, N=328, respectively). However, as it was noted already in section 4.3.2 the widowed 
women also tend to be older. Also more women in the cities admitted to having ever had 
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mammography and the uptake was the highest in the cities >100K (70.1%, N=356), and 
decreased linearly with decreasing city size to the lowest in villages (35.2%, N=241). 
 
4.3.5.5. MAMMOGRAPHY UPTAKE BY SOCIO-ECONOMIC VARIABLES IN WOMEN AGED 50 AND 
OVER 
 
Table 42 Pearson Chi square analysis adjusted for design effects of mammography 
uptake (ever) by socio-economic variables 
    Mammography ever     
  No  Yes   
    % (N) 95% CI % (N) 95% CI m.d.eff† p-value 
Education (N=1,805)      
 Primary 66.39 (486) 60.77,71.59 33.61 (232) 28.41,39.23 
1.45 
<0.001** 
F(2.93, 137.93) 
= 57.46 
 Technical 46.2 (165) 40.16,52.35 53.8 (170) 47.65,59.84 
 Medium  34.94 (202) 29.56,40.74 65.06 (360) 59.26,70.44 
 Higher 20.52 (37) 14.87,27.62 79.48 (153) 72.38,85.13 
  Total 47.5 (890) 41.39,53.70 52.5 (915) 46.30,58.61 
Household size (N=1,806)     
 1 person 50.56 (424) 43.56,57.54 49.44 (378) 42.46,56.44 
1.24 
0.017* 
F(3.76, 176.74) 
= 3.18 
 2 people 43.81 (270) 36.31,51.60 56.19 (351) 48.40,63.69 
 3 people 46.49 (97) 38.20,54.98 53.51 (106) 45.02,61.80 
 4 people 38.32 (38) 26.63,51.53 61.68 (44) 48.47,73.37 
 5 or more 59 (61) 48.54,68.70 41 (37) 31.30,51.46 
  Total 47.41 (890) 41.24,53.67 52.59 (916) 46.33,58.76 
Source of income  (N=1,783)      
 Employed 29.6 (65) 22.05,38.45 70.4 (151) 61.55,77.95 
1.49 
<0.001** 
F(5.03, 236.33) 
=4.42 
 Self-employed 50 (31) 36.88,63.13 50 (32) 36.87,63.12 
 Retired 50.91 (583) 43.89,57.90 49.09 (510) 42.10,56.11 
 
Disability 
benefits 46.06 (86) 37.34,55.02 53.94 (103) 44.98,62.66 
 
Other benefits 
(family, social) 54.9 (101) 43.34,65.94 45.1 (83) 34.06,56.66 
 Unemployment  44.94 (4) 15.41,78.53 55.06 (8) 21.47,84.59 
 
Dependent on a 
person from 
outside household 
42.62 (10) 23.12,64.71 57.38 (16) 35.29,76.88 
 Total 47.71 (880) 41.59,53.90 52.29 (903) 46.10,58.41 
Material conditions (N=1,798)          
 we live poorly 57.76 (98) 47.10,67.74 42.24 (62) 32.26,52.90 
1.33 
<0.001** 
F(3.48, 163.40) 
=6.38 
 we live modestly 52.74 (395) 45.24,60.11 47.26 (333) 39.89,54.76 
 
we live on 
average level 43.43 (337) 37.32,49.76 56.57 (410) 50.24,62.68 
 we live well 32.3 (50) 22.33,44.20 67.7 (97) 55.80,77.67 
 we live very well 34.48 (5) 13.96,63.07 65.52 (11) 36.93,86.04 
  Total 47.47 (885) 41.37,53.64 52.53 (913) 46.36,58.63 
*p<0.05 level;**p<0.001 level; †mean generalised design effects 
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Mammography uptake (ever) was significantly associated with all socio-economic variables 
(p<0.001 for education, income source and material conditions, and p=0.017 for household 
size) (table 42). The proportions of women who have ever had mammography were higher 
amongst higher educational levels. For example there were 33.6% (N=232) of women that 
completed primary education stated that they had at least one mammography in their lives 
and 79.5% (N=153) among those who achieved higher education. Mammography 
attendance was approximately the most prevalent amongst women who lived in homes 
composed of four people of whom larger proportion declared to ever had this test (61.7%, 
N=44). Source of income demonstrated that more employed women (70.4%, N=151) ever 
had mammography than any other source of income group (45.1% to 57.4%). Similarly as in 
case of BSE there was bigger proportion of women with higher self-assessed material 
conditions who had mammography (we live well: 67.7%, N=97; we live very well: 65.5%, 
N=11) than the ones that declared worse material situation (we live on an average level: 
56.6%, N=410, we live modestly: 47.3%, N=333, and we live poorly: 42.2%, N= 62). 
 
4.3.5.6. MAMMOGRAPHY UPTAKE BY PREVIOUS CANCER DIAGNOSIS 
 
Table 43 Pearson Chi square analysis adjusted for design effects of mammography 
uptake (ever) by cancer diagnosis and type 
    Mammography ever  
  No Yes   
    % (N) 95% CI % (N) 95% CI m.d.eff† p-value 
Previous cancer (N=1,785)      
 No 49.16 (846) 43.00,55.34 50.84 (807) 44.66,57.00 
1.44 
<0.001 
F(1, 47) 
=27.89  
Yes 21.7 (32) 13.66,32.67 78.3 (100) 67.33,86.34 
 Total 47.19 (878) 41.04,53.42 52.81 (907) 46.58,58.96 
Type of cancer (N=1,808)          
 No cancer 49.45 (859) 43.33,55.58 50.55 (817) 44.42,56.67 
1.28 
<0.001 
F(2.05, 96.52) 
=24.11 
 Breast cancer 1.05 (1) 0.15,6.93 98.95 (44) 93.07,99.85 
 Cervical cancer 10.7 (2) 3.90,26.14 89.3 (10) 73.86,96.10 
 Other 35.4 (29) 22.63,50.65 64.6 (46) 49.35,77.37 
  Total 47.48 (891) 41.37,53.68 52.52 (917) 46.32,58.63 
†mean generalised design effects 
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Table 43 shows that uptake of mammography was significantly more common (78.3%, 
N=100) in women who had been diagnosed with cancer (of any body part) than those who 
have never had such diagnosis (50.8%, N=807). Unsurprisingly the exploration of the cancer 
type and mammography uptake revealed that almost 99% (N=44) of women who were 
diagnosed with breast cancer have had mammography. Similarly, more women who have 
been diagnosed with cervical cancer declared also to ever having had mammography 
(89.3%, N=10). Also other cancer diagnoses were reported in women that took up 
mammography (64.6%, N=46) but there was no difference in proportions between women 
who have never been diagnosed with cancer. 
 
4.3.5.7. CYTOLOGY UPTAKE BY SOCIO-DEMOGRAPHIC VARIABLES FOR WOMEN AGED 25 AND 
OVER 
 
Table 44 Pearson Chi square analysis adjusted for design effects of cytology uptake 
(ever) by socio-demographic variables 
    Cytology ever   
  
No Yes    
% (N) 95% CI % (N) 95% CI m.d.eff† p-value 
Age (N=3,472)       
 25-29 16.41 (45) 11.44,22.96 83.59 (243) 77.04,88.56 
2.22 
<0.001 
F(4.57, 214.64) 
=35.09 
 30-39 7.6 (72) 5.65,10.14 92.4 (788) 89.86,94.35 
 40-49 12.65 (84) 9.63,16.43 87.35 (550) 83.57,90.37 
 50-59 11.84 (83) 9.15,15.18 88.16 (670) 84.82,90.85 
 60-69 19.6 (75) 13.54,27.50 80.4 (315) 72.50,86.46 
 70+ 39.66 (225) 32.59,47.20 60.34 (322) 52.80,67.41 
  Total 15.88 (584) 13.34,18.80 84.12 (2,888) 81.20,86.66 
Marital status (N=3,467)     
 
Married/in 
relationship 12.34 (221) 9.83,15.39 87.66 (1,697) 84.61,90.17 
2.05 
<0.001 
F(2.75, 129.28) 
=22.55 
 Widow 28.33 (229) 22.78,34.61 71.67 (568) 65.39,77.22 
 
Separated/ 
divorced 8.21 (25) 4.92,13.38 91.79 (254) 86.62,95.08 
 Single 23.99 (108) 18.33,30.74 76.01 (365) 69.26,81.67 
  Total 15.87 (583) 13.32,18.79 84.13 (2,884) 81.21,86.68 
Size of the city (N=3,472)     
 city >100K 6.53 (81) 4.52,9.37 93.47 (916) 90.63,95.48 
3.71 
<0.001 
F(2.75, 129.42) 
=13.88 
 city 50-100K 18.01 (49) 13.42,23.75 81.99 (260) 76.25,86.58 
 city <50K 16.21 (140) 12.33,21.03 83.79 (708) 78.97,87.67 
 Village 22.22 (314) 18.62,26.29 77.78 (1,004) 73.71,81.38 
 Total 15.88 (584) 13.34,18.80 84.12 (2,888) 81.20,86.66 
†mean generalised design effects 
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Similarly, as for mammography attendance, the above table (table 44) presents the 
differences in proportions of the cytology uptake (ever) have been presented for women 
aged 25 or over due to the recommended screening age. However, there were 6.7% (296) 
women who ever undertook it that were between 18 and 24 years old at the time of the 
survey. 
 
Statistically significant differences for having ever had cytology were found across all of the 
socio-demographic variables (p<0.001). The highest proportions of women who ever had 
cytology were in 30-39 age group (92.4% N=788) and the lowest in women over 70 years 
old (60.34%, N=322). Separated/divorced and married/in relationship were amongst the 
largest groups that had at least one cytology in their lives (91.8%, N=254 and 87.7%, 
N=1,697, respectively). 93.5% (N=916) of women in the cities above 100K inhabitants had 
attended cytology in comparison to 77.8% (N=1,004) living in the villages. 
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4.3.5.8. CYTOLOGY UPTAKE BY SOCIO-ECONOMIC VARIABLES FOR WOMEN AGED 25 AND OVER 
 
Table 45 Pearson Chi square analysis adjusted for design effects of cytology uptake 
(ever) by socio-economic variables 
   Cytology ever   
 
 
No Yes   
% (N) 95% CI % (N) 95% CI m.d.eff† p-value 
Education (N=3,466) 
 
Primary 32.96 (278) 28.15,38.14 67.04 (526) 61.86, 71.85 
2.02 
<0.001 
F(2.55, 120.05) 
=70.17 
 
Technical 14.92 (125) 12.35,17.92 85.08 (663) 82.08, 87.65 
 
Medium level 11.49 (143) 9.33,14.07 88.51 (1,095) 85.93, 90.67 
 
Higher 5.66 (38) 4.00,7.95 94.34 (598) 92.05, 96.00 
  Total 15.9 (584) 13.36,18.82 84.1 (2,882) 81.18, 86.64 
Household size (N=3,465) 
 
1 person 23.92 (215) 18.98,29.67 76.08 (657) 70.33, 81.02 
1.52 
<0.001 
F(3.55, 166.91) 
=14.30 
 
2 people 18.63 (162) 14.13,24.16 81.37 (692) 75.84, 85.87 
 
3 people 12.87 (85) 9.97,16.44 87.13 (586) 83.56, 90.03 
 
4 people 7.84 (53) 5.60,10.88 92.16 (571) 89.12, 94.40 
 
5 or more 13.63 (69) 9.97,18.36 86.37 (375) 81.64, 90.03 
  Total 15.92 (584) 13.37,18.84 84.08 (2,881) 81.16, 86.63 
Source of income (N=3,373) 
 
Employed 9.37 (128) 7.55,11.57 90.63 (1,196) 88.43, 92.45 
1.54 
<0.001 
F(4.86, 228.56) 
=15.00 
 
Self-employed 12.73 (41) 9.18,17.38 87.27 (259) 82.62, 90.82 
 
Retired 24.83 (261 19.45,31.12 75.17 (754) 68.88, 80.55 
 
Disability 
benefits 20.51 (46) 14.76,27.78 79.49 (177) 72.22, 85.24 
 
Other benefits 
(family, social) 20.22 (70) 15.26,26.29 79.78 (270) 73.71, 84.74 
 
Unemployment 
benefits 16.68 (11) 8.61,29.86 83.32 (53) 70.14, 91.39 
 
Dependent on a 
person from 
outside 
household 
9.82 (12) 5.64,16.56 90.18 (95) 83.44, 94.36 
 
Total 15.94 (569) 13.38,18.88 84.06 (2,804) 81.12, 86.62 
Material conditions (N=3,457) 
 
we live poorly 25.77 (52) 17.67,35.97 74.23 (151) 64.03, 82.33 
1.27 
<0.001 
F(3.28, 154.04) 
=14.20 
 
we live 
modestly 21.37 (237) 17.67,25.61 78.63 (820) 74.39, 82.33 
 
we live on 
average level 13.64 (242) 11.25,16.45 86.36 (1,457) 83.55, 88.75 
 
we live well 8 (45) 5.23,12.06 92 (408) 87.94, 94.77 
 
we live very 
well 8.6 (5) 3.84,18.13 91.4 (40) 81.87, 96.16 
  Total 15.89 (581) 13.34,18.81 84.11 (2,876) 81.19, 86.66 
†mean generalised design effects 
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Similarly, having ever had cytology (table 45) differed across all socio-economic variables 
(p<0.001). As it was in case of other previously described prophylactic behaviours (BSE, 
mammography) proportions of cytology attendance were noted to be greater with increasing 
education level. Women with higher education were the largest group, (94.3%, N=598), 
followed by medium level (88.5%, N=1,095), technical (85.1%, N=663) and primary (67%, 
N=526). Cytology was the most prevalent in women living in households of 4 people 
(92.2%, N=571) and the least in single person households (76.1%, N=657). Employed, 
dependent on a person from outside the household and self-employed women were the 
largest groups that stated to ever having had cytology (90.6%, N=1,196, 90.2%, N=95, and 
87.3%, N=259, respectively). Similarly as in case of the two previously discussed breast 
cancer prophylactic behaviours cytology was the more commonly reported for women with 
better self-assessed material conditions (we live very well: 91.4%, N=40; we live well: 92, 
N=408, we live on an average level: 86.4%, N=1,457; we live modestly: 78.6%, N=820, and 
we live poorly: 74.2%, N=151). 
 
4.3.5.9. CYTOLOGY UPTAKE BY PREVIOUS CANCER DIAGNOSIS 
 
Table 46 Pearson Chi square analysis adjusted for design effects of cytology uptake 
(ever) by cancer diagnosis 
    Cytology ever   
  
No Yes 
  
  
% (N) 95% CI % (N) 95% CI m.d.eff† p-value 
Previous cancer (N=3,434) 
 No 16.31 (565) 13.74,19.25 83.69 (2,685) 80.75,86.26 
0.63 
0.011* 
F(1, 47)  
=7.08  
Yes 8.71 (15) 4.98,14.81 91.29 (169) 85.19,95.02 
 Total 15.93 (580) 13.37,18.86 84.07 (2,854) 81.14,86.63 
Type of cancer (N=3,472) 
 No cancer 16.25 (569) 13.69,19.19 83.75 (2719) 80.81,86.31 
0.68 
0.06 
F(2.86, 
134.31)  
=2.57 
 Breast cancer 5.38 (4) 1.72,15.61 94.62 (54) 84.39,98.28 
 Cervical cancer 4.48 (1) 0.57,27.76 95.52 (23) 72.24,99.43 
 Other 11.5 (10) 5.72,21.77 88.5 (92) 78.23,94.28   Total 15.88 (584) 13.34,18.80 84.12 (2,888) 81.20,86.66 
*p<0.05; †mean generalised design effects 
 
Only previous cancer diagnosis was significantly associated with cytology. 91.3% (N=169) 
of women who have been diagnosed with any type of cancer attended cytology at least once 
in their lives versus 83.7% (N=2,685) women who never had such diagnosis. 
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4.3.6. Was there a relationship between practicing breast and cervical 
prophylactic behaviours of Polish women at the introduction of nationwide 
screening? 
 
A Pearson chi-square (with Rao-Scott correction) was also used to address the next study 
question about the relationship between practicing breast and cervical cancer prophylactic 
behaviours. In particular it was tested whether women who practice BSE also take up 
mammography or cytology and whether the ones who take up mammography also take up 
cytology. The tests were conducted for specific age groups that are screening target groups 
for breast and cervical screening: cytology for ages 25 and over and mammography for ages 
50 and over and presented with corresponding design based F statistic. 
 
Results from the analysis (details in the tables 47, 48, and 49) revealed that there were 
significant associations (p<0.001) for all groups: BSE practice in women who also took up 
cytology; BSE in women who also took up mammography; and also women who took up 
mammography were also more likely to undergo cytology p<0.001.  
 
Table 47 Pearson Chi square analysis adjusted for design effects of BSE practice and 
mammography uptake (ever) amongst women aged 50 or over 
  Mammography ever   
    No Yes   
  N=1,617 % (N) S.E. 95% CI % (N) S.E. 95% CI m.d.eff† p-value 
BSE             
  
 No 62.04 (309) 4.5 52.67,70.60 37.96 (164) 4.5 29.40,47.33 
5.22 <0.001 F(1,47)= 54.74  Yes 35.82 (416) 2.22 31.48,40.40 64.18 (728) 2.22 59.60,68.52 
  Total 43.17 (725) 2.88 37.49,49.03 56.83 (892) 2.88 50.97,62.51 
†mean generalised design effects  
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Table 48 Pearson Chi square analysis adjusted for design effects of BSE and cytology 
uptake (ever) amongst women aged 25 or over 
  Cytology ever   
    No Yes    
N=3,233 % (N) S.E. 95% CI % (N) S.E. 95% CI m.d.eff† p-value 
BSE 
        
 No 24.02 (195) 2.31 19.68,28.97 75.98 (580) 2.31 71.03,80.32 
3.16 
<0.001 
F(1,47)= 
47.43  
Yes 10.59 (274) 1.07 8.63,12.94 89.41 (2,184) 1.07 87.06,91.37 
  Total 13.68 (469) 1.13 11.57,16.11 86.32 (2,764) 1.13 83.89,88.43 
†mean generalised design effects 
 
Table 49 Pearson Chi square analysis adjusted for design effects of mammography 
uptake (ever) and cytology uptake (ever) amongst women aged 50 or over 
  Mammography ever   
    No Yes 
  
N=1,678  % (N) S.E. 95% CI % (N) S.E. 95% CI m.d.eff† p-value 
Cytology ever 
       
 No 82.49 (316) 2.64 76.53,87.19 17.51 (63) 2.64 12.81,23.47 
4.2 
<0.001 
F(1,47)= 
147.84  
Yes 34.57 (468) 2.59 29.56,39.95 65.43 (831) 2.59 60.05,70.44 
 Total 44.95 (784) 2.98 39.06,50.98 55.05 (894) 2.98 49.02,60.94 
†mean generalised design effects 
 
Just over sixty four percent (64.2%, N=728) of women who practiced BSE undertook 
mammography at least once in their life. Whilst among the women who reported never 
practicing BSE 62% (N=309) said that they have never taken up mammography. However, 
only 4% (99 out of 2,884) who responded to a question for the reason for non-attendance to 
mammography (table 26) gave reason of lack of availability of such test.  
 
Results of the analyses revealed that only 10.6% (274) of women who practice BSE never 
undertook cytology in their life (table 47) but 75.6% (N=580) of women that do not practice 
BSE had at least one cytology test in the past (table 48). Sixty five percent (65.4%, N=831) 
of women age 50 or over, who had at least one previous cytology also had taken up 
mammography at least once in their life but 82.5% (N=316) who have never had cytology 
also reported of never having mammography (table 49). 
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4.3.8. Which factors could be considered as predictors of breast and cervical 
cancer screening uptake at the time of data collection? 
 
Two logistic regression (LR) was used to analyse the predictors of screening behaviours. 
Firstly, univariate analyses were conducted to assess the candidate predictors for the 
multivariate models (model 1: mammography uptake (ever) for women aged 50 or over and 
model 2: cytology uptake (ever) for women aged 25 or over). Independent variables 
included: socio-demographics and socio-economics, knowing someone (family or friend 
who experienced cancer), and cancer knowledge level (low, medium, or high). Initially type 
of cancer diagnosed was explored for inclusion in the models but it was removed due to the 
co linearity with mammography. BSE was also tested as an independent variable to be added 
to the mammography model. 
 
Each of the independent variables considered for inclusion in either of the models has been 
assessed for goodness for model fit basing on the p-values, 95% confidence intervals, odds 
ratios and post estimation regression tests. Variables that were deemed not suitable were not 
included in the final model. 
 
4.3.8.1. BREAST CANCER PROPHYLAXIS 
 
Univariate logistic regression was performed for all candidate predictors of mammography 
uptake. The results have been split into several tables presenting predictors in groups (e.g., 
socio-demographics, socio-economics) that have been formed in the descriptive analyses. 
This was done merely to allow easier information flow and no particular order or grouping 
of the variables has a specific meaning in presentation of the univariate logistic regression 
analyses. Detailed description of odds ratios related to the uptake of mammography is 
presented in the section reporting on multivariate logistic analyses as the univariate 
assessment was used in the process of finding the best multivariate model fit that controls 
for the final set of covariates.  
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Table 50 Univariate logistic regression of mammography uptake (ever) across different 
socio-demographic predictors adjusted for design effects (OR, S.E., 95% CI, p-value, 
F-statistic) 
Predictor (N total) N Adj OR S.E. p-value 95% CI D.eff. p-value 
Age (N=917)        
 50-59 514 Ref - - - - - <0.001*** 
F(2,46)=82.69  60-69 236 0.73 0.1 0.031* 0.55 0.97 1.12 
 70+ 167 0.2 0.03 <0.001*** 0.16 0.26 1.06 
Marital status (N=917)             
 
Married/ in 
relationship 391 Ref - - - - - <0.001*** 
F(3,45)=12.53  Widow 328 0.53 0.07 <0.001*** 0.41 0.68 1.12 
 Separated/divorced 81 1.34 0.32 0.229 0.83 2.15 1.49   Single  117 0.98 0.18 0.914 0.68 1.42 1.07 
City size (N=915)        
 city >100K 356 Ref - - - - - <0.001*** 
F(3,45)=31.74  
city 50-100K 87 0.62 0.15 0.059 0.37 1.02 1.3 
 city <50K 233 0.54 0.12 0.009** 0.34 0.85 1.67   Village 241 0.23 0.04 <0.001*** 0.17 0.31 1.2 
*p<0.05;**p<0.01;*** p<0.001; Ref: reference category, Adj OR Adjusted Odds Ratio   
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Table 51 Univariate logistic regression of mammography uptake (ever) across different 
socio-economic predictors adjusted for design effects (OR, S.E., 95% CI, p-value, F-
statistic) 
Predictor (N total) N Adj OR S.E. p-value 95% CI D.eff p-value 
Education (N=915)       
 Primary 232 Ref - - - - -  
 Technical 170 2.3 0.34 <0.001*** 1.72 3.09 1.06 <0.001*** 
F(3,45)=51.32  
Medium level 360 3.68 0.47 <0.001*** 2.84 4.77 1.10 
 Higher 153 7.65 1.59 <0.001*** 5.04 11.61 1.05 
Material conditions (N=913)           
 we live poorly 62 Ref - - - - -  
 
we live 
modestly 333 1.23 0.22 0.26 0.86 1.75 0.99 
0.002** 
F(4,44)=5.13 
 
we live on 
average level 410 1.78 0.33 0.003** 1.23 2.57 1.02 
 we live well 97 2.87 0.7 <0.001*** 1.75 4.69 1.01 
  we live very well 11 2.6 1.54 0.114 0.79 8.56 1.01 
Source of income (N=903)           
 Employed 151 Ref - - - -   
 Self-employed 32 0.42 0.13 0.007** 0.23 0.78 1.10 
0.002** 
F(6,42)=4.40 
 Retired 510 0.41 0.08 <0.001*** 0.27 0.6 1.25 
 
Disability 
benefits 103 0.49 0.11 0.002** 0.32 0.76 1.06 
 
Other benefits 
(family, social 
etc) 
83 0.35 0.09 <0.001 0.21 0.57 1.22 
 
Unemployment 
benefits 8 0.52 0.38 0.373 0.12 2.27 1.13 
  
Dependent on a 
person from 
outside 
household 
16 0.57 0.25 0.197 0.24 1.36 1.15 
Household size (n=916)             
 1 person 378 Ref - - - -   
 2 people 351 1.31 0.15 0.024* 1.04 1.66 1.09 
0.023** 
F(4,44)=3.16 
 3 people 106 1.18 0.2 0.343 0.84 1.66 1.08 
 4 people 44 1.65 0.44 0.07* 0.96 2.83 1.19 
  5 or more 37 0.71 0.16 0.129 0.46 1.11 1.00 
*p<0.05;**p<0.01; ***p<0.001; Ref: reference category, Adj OR Adjusted Odds Ratio 
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Table 52 Univariate logistic regression of mammography uptake (ever) by cancer and 
type diagnosis, having a friend/family member with cancer diagnosis and overall 
cancer knowledge level adjusted for design effects (OR, S.E., 95% CI, p-value, F-
statistic) 
Predictor  
(N total) N Adj OR S.E. p-value 95% CI D.eff. p-value 
Previous cancer (any type) (N=907)          
 No 807 Ref - - - - - <0.001 
F(1,47)=25.04   Yes 100 3.49 0.87 <0.001*** 2.11 5.77 1.14 
Cancer type (N=917)a       
 
No 
cancer 817 Ref - - - - - 
<0.001*** 
F(3,45)=18.06 
 
Breast 
cancer 44 92.52 88.8 <0.001*** 13.42 637.92 0.63 
 
Cervical 
cancer 10 8.16 4.39 <0.001*** 2.76 24.11 0.62 
  Other 46 1.79 0.51 0.047* 1.01 3.16 1.14 
Cancer diagnosis in the family (N=917)      
 No 442 Ref - - - - - 0.001**   Yes 475 1.18 0.06 0.001** 1.07 1.3 1.02 F(1,47)=12.19 
Friend with cancer diagnosis (N=917)          
 No 353 Ref - - - - - <0.001*** 
F(1,47)=35.43   Yes 564 1.83 0.19 <0.001*** 1.49 2.25 1.07 
Knowledge level (N=917)            
 Low 47 Ref - - - - - <0.001*** 
F(2,46)=56.82  
Medium 742 5.06 0.97 <0.001*** 3.44 7.45 1.17 
  High 128 10.73 2.41 <0.001*** 6.83 16.87 1.00 
BSE (N=892)       
 No 164 Ref - - - - - <0.001*** F(1,47)=52.74   Yes 728 2.93 0.43 <0.001*** 2.17 3.94 1.29 
*p<0.05;**p<0.01; ***p<0.001; avariable dropped from the final model due to co linearity; Adj OR Adjusted 
Odds Ratio 
 
All univariate logistic analyses showed highly significant results either at 0.05 or 0.001 
levels. However, not all of the above presented results were significant after controlling for 
the covariates entered in the final multivariate model. 
 
Following univariate logistic regression analyses of mammography predictors, for women 
aged 50 or over, all of the previously assessed independent variables were entered into the 
initial model for better assessment of the effect of the variables on each other. Backward 
elimination was used to identify only the significant predictors which, consequently, were 
included in the model (table 53). 
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Table 53 Multivariate logistic regression of mammography uptake (ever) across 
different socio-demographic and socio-economic predictors adjusted for design effects 
(OR, S.E., p-value, 95% CI) 
Predictor  
(N total) N Adj OR S.E. p-value 95% CI D.eff. p-value 
Age (N=917)       
 50-59 514 Ref - - - -  <0.001*** 
F(2,46)=24.73  60-69 236 0.75 0.13 0.108 0.53 1.07 1.24 
  70+ 167 0.3 0.06 <0.001*** 0.20 0.43 1.3 
City size (N=917)       
 
City 
>100K 356 Ref - -  - -  
<0.001*** 
F(3,45)=7.05  
City 50-
100K 87 0.58 0.16 0.049* 0.34 1.0 1.27 
 City <50K 233 0.53 0.13 0.011* 0.33 0.86 1.56 
  Village 241 0.35 0.08 <0.001*** 0.23 0.56 1.41 
Education (N=915)       
 Primary 232 Ref - - - -  
<0.001*** 
F(3,45)=7.59 
 Technical 170 0.86 0.16 0.424 0.59 1.25 1.1 
 Medium  360 1.31 0.27 0.189 0.87 1.98 1.38 
  Higher 153 2.32 0.5 <0.001*** 1.52 3.56 0.92 
Knowledge level (N=917)          
 Low 47 Ref - - - -  <0.001*** 
F(2,46)=18.20  Medium 742 2.34 0.4 <0.001*** 1.67 3.22 0.87 
  High 128 4.15 1.03 <0.001*** 2.51 6.85 0.98 
BSE (N=892)        
 No 164 Ref - - - -  <0.001*** 
F(1,47)=22.40   Yes 728 1.98 0.29 <0.001*** 1.48 2.65 1.15 
*p<0.05;**p<0.01; ***p<0.001; Wald goodness-of-fit test p=0.984; Ref: reference category, Adj OR Adjusted 
Odds Ratio 
 
The variables that have tested insignificant in the multivariate analyses included: source of 
income (p=0.830), household size (p=0.159), material conditions (p=0.693), marital status 
(p=0.858), friend with cancer diagnosis (p=0.153) and cancer diagnosis in the family 
(p=0.229). Even though when previous cancer diagnosis was entered into the multivariate 
model it was highly statistically significant and the likelihood of mammography was 3 times 
as high (OR=3.03, 95% CI, 1.91-4.80, p<0.001) it was not included in the final model. The 
reason for non-inclusion was that the majority of breast cancer diagnoses would have been 
done through mammography and therefore previous cancer diagnosis was highly linearly 
correlated with the outcome. The final model for mammography included six explanatory 
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covariates: age, city size, education, knowledge, previous cancer diagnosis and BSE (table 
54). 
 
Older age was a significant predictor of lower mammography uptake for the oldest age 
group (70 and older) as in comparison with the reference category (50-59) of those women 
were 70% less likely to undergo this test at least once in their lives (OR=0.30, 95% CI, 0.20-
0.43, p<0.001). Women living in cities with less than 50,000 inhabitants or villages were 
significantly less likely to attend mammography in comparison with the reference category 
which was set for cities above 100,000 inhabitants (Cities 50-100K: OR 0.58, 95% CI, 0.34-
1.0, p<0.05; cities less than 50K: OR=0.53, 95% CI, 0.33-0.86, p<0.05; villages: OR=0.35, 
95% CI, 0.23-0.56, p<0.001). Women with higher education (completed university degree) 
were 2.3 times more likely to take up mammography when compared to the reference 
category - no formal education (OR=2.32, 95% CI, 1.52-3.56, p<0.001). Other education 
categories: technical and high school level were not significant (p=0.424 and 0.189, 
respectively). Total cancer and cancer prophylaxis knowledge had linear relationship with 
mammography attendance as the higher the knowledge the higher likelihood of breast 
screening. Women with scores in medium range were 2.34 times more likely and women 
with high scores were 4.2 times more likely to take up mammography than those with low 
cancer knowledge (OR=2.34, 95% CI, 1.67-3.22, p<0.001 and OR=4.15, 95% CI, 2.51-6.85, 
p<0.001, respectively). Last of the predictors in this model was the practice of BSE and 
unsurprisingly women who reported performing BSE (rarely or regularly) were over 2 times 
more likely to also undergo mammography (OR=1.98, 95% CI, 1.48-2.65, p<0.001). 
The model was tested with the use of Wald goodness-of-fit test which was insignificant at 
0.05 level (p=0.984) under the null hypothesis that there are no differences between fitted 
and expected values and therefore the fit of the model was assessed as good. Further model 
details are presented in the table below. 
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4.3.8.2. CERVICAL CANCER PROPHYLAXIS 
 
Identical approach was used for the assessment of the predictors related with cervical 
screening (cytology uptake) as for mammography (section 4.3.7.1). Both univariate and 
multivariate logistic regressions were done for women older than 25 years old. As it was 
done in case of analyses of mammography uptake the detailed description of odds ratios is 
presented in the section on multivariate logistic analyses. 
 
Table 54 Univariate logistic regression of cytology uptake (ever) across different socio-
demographic predictors adjusted for design effects (OR, S.E., 95% CI, p-value, F-
statistic) 
Predictor (N=total) N Adj OR S.E. p-value 95% CI D.eff. p-value 
Age (N=2,596)     25-29 243 Ref - - - - -  30-39 788 2.39 0.61 0.001** 1.42 4.01 1.28 
<0.001*** 
F(5,43)=31.35 
40-49 550 1.36 0.32 0.2 0.85 2.17 1.2 
50-59 670 1.46 0.31 0.077 0.96 2.23 1.09 
60-69 315 0.81 0.23 0.457 0.45 1.44 1.4 
70+ 322 0.3 0.07 <0.001*** 0.19 0.48 1.28 
Marital status (N=2,884)          
Married/ in 
relationship 1,697 Ref - - - - - 
<0.001*** 
F(3,45)=25.28 Widow 568 0.36 0.05 <0.001*** 0.27 0.47 1.19 
Separated/divorced 254 1.57 0.46 0.127 0.87 2.84 1.61 
Single  365 0.45 0.08 <0.001*** 0.31 0.65 1.34 
City size (N=2,888)          city >100K 916 Ref - - - - - 
<0.001*** 
F(3,45)=12.33 
city 50-100K 260 0.32 0.09 <0.001*** 0.18 0.55 1.40 
city <50K 708 0.36 0.1 <0.001*** 0.21 0.62 1.69 
Village 1,004 0.24 0.06 <0.001*** 0.15 0.39 1.57 
*p<0.05;**p<0.01; ***p<0.001; Ref: reference category, Adj OR Adjusted Odds Ratio 
 
 
  
196 
 
 
Table 55 Univariate logistic regression of cytology uptake (ever) across different socio-
economic predictors adjusted for design effects (OR, S.E., 95% CI, p-value, F-statistic) 
Predictor (N=total) N Adj OR S.E. p-value 95% CI D.eff. p-value 
Education (N=2,882)        
 Primary 526 Ref - - - - - <0.001*** 
F(3,45)=39.28  
Technical 663 2.8 0.34 <0.001*** 2.2 3.57 0.95 
 Medium  1,095 3.79 0.55 <0.001*** 2.83 5.06 1.23 
 Higher 598 8.19 1.81 <0.001*** 5.26 12.77 1.18 Material conditions 
(N=2,876)              
 we live poorly 151 Ref - - - - - 
<0.001*** 
F(4,44)=8.98 
 
we live 
modestly 820 1.28 0.27 0.246 0.84 1.94 1.16 
 
we live on 
average level  1,457 2.2 0.51 0.001** 1.38 3.5 1.30 
 we live well 408 3.99 1.26 <0.001*** 2.12 7.53 1.32 
  we live very well 40 3.69 1.72 0.007** 1.44 9.44 0.79 
Source of income (N=2,804)              
 Employed 1,196 Ref - - - - - 
<0.001*** 
F(6,42)=10.40 
 Self-employed 259 0.71 0.14 0.078 0.48 1.04 1.00 
 Retired 754 0.31 0.05 <0.001*** 0.23 0.43 1.35 
 
Disability 
benefits 177 0.4 0.09 <0.001*** 0.26 0.62 1.14 
 
Other benefits 
(family, 
social ) 
270 0.41 0.08 <0.001*** 0.27 0.61 1.23 
 
Unemployment 
benefits 53 0.52 0.19 0.078 0.25 1.08 1.01 
  
Dependent on 
a person from 
outside 
household 
95 0.95 0.29 0.864 0.52 1.75 0.94 
Household size (N=2,881)        
 1 person 657 Ref - - - - - 
<0.001*** 
F(4,44)= 17.41 
 2 people 692 1.37 0.21 0.044* 1.01 1.87 1.26 
 3 people 586 2.13 0.32 <0.001*** 1.58 2.87 1.06 
 4 people 571 3.7 0.65 <0.001*** 2.6 5.26 1.05   5 or more 375 1.99 0.46 0.004** 1.26 3.16 1.41 
*p<0.05;**p<0.01; ***p<0.001; Ref: reference category; Adj OR Adjusted Odds Ratio 
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Table 56 Univariate logistic regression of cytology uptake (ever) by cancer and type 
diagnosis, having a friend/family member with cancer diagnosis and overall cancer 
knowledge level adjusted for design effects (OR, S.E., 95% CI, p-value, F-statistic) 
Predictor (N=total) N Adj OR S.E. p-value 95% CI D.eff. p-value 
Previous cancer (N=2,685)        
 No 2,685 Ref - - - - - 0.012* F(1,47)=6.80 
 Yes 169 2.04 0.56 0.012* 1.18 3.54 1.00 Cancer type (N=2,888)a              
 No cancer 2,719 Ref - - - - - 
0.036* 
F(3,45)=3.09 
 Breast cancer 54 3.41 2.06 0.047* 1.01 11.48 0.97 
 Cervical cancer 23 4.14 4.19 0.168 0.54 31.79 1.02 
  Other 92 1.49 0.54 0.269 0.73 3.07 1.12 
Cancer diagnosis in the family (N=1,307)        
 No 645 Ref - - - - - <0.001*** 
F(1,47)= 21.72   Yes 662 1.28 0.07 <0.001*** 1.15 1.42 1.11 
Friend with cancer diagnosis (N=1,307)       
 No 559 Ref - - - - - <0.001*** 
F(1,47)=33.67 
 Yes 748 1.79 0.18 <0.001*** 1.46 2.19 1.07 
Knowledge level (N=1,307)            
 Low 89 Ref - - - - - <0.001*** 
F(2,46)=54.14  
Medium 1,055 4.89 0.79 <0.001*** 3.54 6.75 1.27 
  High 163 8.66 2.3 <0.001*** 5.08 14.77 1.15 
*p<0.05;**p<0.01; ***p<0.001; Ref: reference category; Adj OR Adjusted Odds Ratio; avariable dropped 
from the multivariate model due to co linearity 
 
Following the univariate assessment, each of the variables was assessed for interaction and 
significance and after adjusting for other covariates there were only two variables that 
became insignificant in the multivariate analyses included: source of income (p=0.612) and 
material conditions (p=0.658). Similarly as in case of mammography women with previous 
cancer diagnosis (of any body part) were more likely to uptake cytology (OR=2.02, 95% CI, 
1.01-4.02, p=0.046) but due to likely co linearity previous cancer diagnosis was not included 
in the multivariate model. The final model included eight variables: age, city size, marital 
status, education, household size, knowledge, cancer in the family and having a friend 
diagnosed with cancer (table 57). 
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Table 57 Multivariate logistic regression of cytology uptake (ever) across different 
socio-demographic and socio-economic predictors adjusted for design effects (OR, S.E., 
p-value, 95% CI) 
Predictor (N=total) N Adj OR S.E. p-value 95% CI D.eff. p-value 
Age (N=2,218)              
 25-29 243 Ref - - - - - 
<0.001*** 
F(5,43) =812 
 30-39 788 2.34 0.66 0.004** 1.34 4.13 1.30 
 40-49 550 1.37 0.34 0.216 0.83 2.25 1.18 
 50-59 670 1.99 0.49 0.007** 1.22 3.26 1.13 
 60-69 315 1.18 0.37 0.601 0.63 2.21 1.22   70+ 322 0.65 0.19 0.148 0.36 1.17 1.17 
Marital status (N=2,884)           
 
 
Married/in 
relationship 1,697 Ref - - - - - <0.001*** 
F(3,45)=9.57  Widow 568 0.72 0.16 0.152 0.46 1.13 1.22 
 Separated/divorced 254 1.34 0.4 0.324 0.74 2.43 1.46   Single  365 0.33 0.07 <0.001*** 0.21 0.51 1.17 
City size (1,884)      
  City >100K 916 Ref - - - - - <0.001*** 
F(3,45) =7.48  
City 50-100K 260 0.3 0.08 <0.001*** 0.17 0.52 1.32 
 City <50K 708 0.37 0.1 0.001** 0.21 0.65 1.67 
 Village 1,004  0.31 0.08 <0.001*** 0.18 0.52 1.56 Education (N=1,787)           
  Primary 526 Ref - - - - - <0.001*** 
F(3,45)=13.57  
Technical 663 1.24 0.17 0.129 0.94 1.64 0.91 
 Medium 1,095  1.74 0.3 0.002** 1.23 2.46 1.16   Higher 598 3.54 0.72 <0.001*** 2.35 5.32 0.93 
Household size (N=2,881)      
  1 person 657 Ref - - - - - 
0.014* 
F(4,44)= 3.28 
 2 people 692 0.92 0.2 0.694 0.60 1.41 1.20 
 3 people 586 1.01 0.24 0.980 0.63 1.61 1.11 
 4 people 571 1.67 0.41 0.042* 1.02 2.73 1.00 
 5 or more 375 1.43 0.38 0.191 0.83 2.44 1.11 
Family with cancer (N=2,888)            
 No 1,394 Ref - - - - - 0.023* F(1,47)= 5.56   Yes 1,494 1.16 0.075 0.023* 1.02 1.33 1.16 
Friend with cancer (N=2,888)       
 No 1,272 Ref - - - - - 0.033* F(1,47)= 4.83  Yes 1,616 1.30 0.15 0.03* 1.02 1.65 1.08 Knowledge level (N=2,888)              
 Low 163 Ref - - - - - <0.001*** 
F(2,46)=25.51  Medium 2,423 3.16 0.55 <0.001*** 2.23 4.49 1.20   High 302 4.91 1.40 <0.001*** 2.77 8.72 1.14 
*p<0.05;**p<0.01; ***p<0.001; Ref: reference category; Adj OR Adjusted Odds Ratio; Wald goodness-of-fit 
test p=0.457 
 
Only two of the age categories were significantly different to the reference category (25-29). 
Women aged between 30-39 years old were 2.3 times (OR=2.34, 95% CI, 1.34-4.13, 
p<0.01), and women aged 50-59 were 2 times more likely (OR=1.99, 95% CI, 1.22-3.26, 
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p<0.05) to have had cytology at least once in their lives. Other age categories were not 
significant. Marital status was also a significant predictor but only for single women that 
were less likely to have cytology in comparison with the reference category (married/in 
relationship) (OR=0.33, 95% CI, 0.21-0.51). Women living in any location with less than 
100,000 inhabitants were much less likely (OR ranged from 0.30-0.37, with p-values 
ranging from <0.001 to 0.001). 
 
Education was linearly associated with cytology attendance. The higher the educational level 
the higher OR of cytology. Women with medium education were 1.7 (OR 1.74, 95 CI, 1.23-
2.46, p<0.01) and with higher 3.5 (OR 3.54, 95 CI, 2.35-5.32, p<0.001) times more likely to 
ever having had cytology. Cervical screening among women with technical education did 
not differ from that of women with primary (p=0.129). Household size was insignificant for 
the majority of the levels of this covariate with the exception of women who lived in 
households of four people. They were 1.7 times more likely to undergo cervical cancer 
screening than women living in single households. However, the p value was close to the 
0.05 cut off point as it equalled to 0.042 and the lower bound of the confidence interval was 
1.02 and therefore narrowly missing the (OR=1.67, 95% CI, 1.02-2.73, p=0.042). Even 
though the statistical significance was relatively low for this covariate, it was decided to 
keep it in the model as post estimation Wald test still showed significance (p=0.014). 
 
Similarly, the next two variables showed marginal significance and 95% CIs narrowly 
missing value 1. However as in case of the household size the significance was close to 0.05 
cut off level of significance. Having family member with previous cancer diagnosis was 
associated with 1.16 times increase and knowing someone with cancer diagnosis was 
associated with 1.29 times increase of cytology uptake (OR=1.16, 95% CI, 1.02-1.32, 
p<0.05; OR=1.29, 95% CI, 1.01-1.65, p<0.05). 
 
Categorical total knowledge score was the last covariate in the model. It had a highly 
significant linear relationship. Women who had medium knowledge score were 3.3 times 
more likely to attend cytology and women with high scores were 4.9 times as likely to have 
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this test when compared to women with low cancer knowledge (OR=3.16, 95% CI, 2.23-
4.49, p<0.001; OR=4.91, 95% CI, 2.77-8.72, p<0.001). 
 
The model was tested with the use of Wald goodness-of-fit test insignificant at 0.05 level 
(p=0.457) under the null hypothesis that there are no differences between fitted and expected 
values and therefore the fit of the model was assessed as good. Further model details are 
presented in the table on the next page. 
 
4.3.7. What factors were considered as barriers to breast and cervical screening 
by Polish women at the time of data collection? 
 
The details on the frequencies and proportions of answers on barriers to breast and cervical 
screening uptake have been tabulated in section 4.2.3. This section attempts to summarise 
and compare that information for both screening types. 
 
Figure 15 Comparisons of lack of uptake of mammography (N=2,922) and cytology 
(N=835) 
 
Comparison of the reasons for lack of uptake of mammography and cytology was done for 
women who declared in previous questions that they did not attend mammography or 
cytology. The figure below shows that majority of women indicated that the main reason for 
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no attendance to either breast or cervical screening was feeling that they felt healthy (37.9%, 
N=1,128 for cytology and 44.9%, N=366 for mammography), the next popular answer was 
lack of referral by doctor (28.7%, N=797 for cytology and 39.2%, N=334 for 
mammography). 20.2% (N=599) of women stated that they were too young to undergo 
mammography (594 women who selected this option were younger than 50 years old) and 
3.7% (N=34) stated that they were too young to undergo cytology (31 of these women were 
younger than 25 years old). The remaining answers ranged between 0.6% and 4%. 
 
Tables 26 and 27 in section 4.2.3 show that main reason for non attendance to either type of 
screening (mammography or cytology) is the feeling of lack of need of the test as they felt 
healthy and did not see anything being wrong with their health (37.9% vs. 44.9%), This was 
closely followed by lack of physician’s referral (28.7%-29.2%). Despite lack of organised 
screening only a small proportion of women who declared lack of attendance to screening 
said that either mammography (4%) or cytology (1%) were not available in their 
neighbourhood. Also only a small proportion of non-attendees have never heard about these 
tests (mammography: 0.7%, cytology: 3.9%). Having time or thinking that these tests are 
expensive accounted for only 0.6%-3% of responses. 
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CHAPTER 5 DISCUSSION  
 
5.1. Introduction 
 
The study was aimed at determining factors influencing uptake of breast and cervical cancer 
screening. Women’s knowledge on breast and cervical cancers, socio-demographic and 
socio-economic factors were identified, characterised and tested as predictors of breast and 
cervical screening uptake. Even though the data analysed in this study was collected in 2006 
the study is still timely. Despite the fact that the national screening population-based 
initiatives have been implemented for several years the uptake of both types of screening did 
not increase substantially. In addition, no similar nationally representative studies 
identifying predictors of screening uptake in Polish society exist to date. Identification of 
factors influencing breast and cervical screening uptake explains not only the situation in 
Poland in 2006 but can also help in understanding the current low uptake rates. The study 
can serve to inform the policy and health promotion campaigns aiming to improve or 
ascertain the desirable uptake levels. It also adds to the body of evidence needed to plan 
initiatives in countries in similar geo-political situations that are yet to establish population 
based screening programmes (i.e. Romania, Bulgaria).  
 
The majority of the elements discussed in this thesis relate to the constructs that are often 
included in the main theoretical frameworks aiming to predict or influence screening 
behaviour (please refer back to section 2.7). As the study used secondary data containing 
questions to which the answers were often related to several constructs at the same time, it 
was not possible to discuss each of the construct elements separately. Additionally, many of 
those constructs have been found to be equivalent across the theories (Noar and Zimmerman, 
2005; Ogden, 2003) and therefore the discussion of the results of this study is presented in 
three main groups: 
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• Knowledge of breast and cervical cancers (included: knowledge and perceived 
benefits of screening and performing other health related behaviours, perceived 
susceptibility) 
• Breast and cervical cancer screening behaviours and their predictors (included: past 
prophylactic behaviours) 
• Barriers to breast and cervical cancer screening (included: barriers i.e. reasons for 
lack of uptake and cues to action i.e.: environmental influences) 
 
Study strengths, limitations and challenges are discussed and recommendations provided 
towards the end of this chapter.  
 
5.2. Summary of findings and discussion 
 
5.2.1. Knowledge on breast and cervical cancer and their prophylaxis 
 
A number of studies explored the role of knowledge in breast and/or cervical cancer 
screening (Gronwald et al., 2006; Lyttle and Stadelman, 2006; Okobia et al., 2006; Paolino 
and Arrossi, 2011; Steven and Fitch, 2004; Wong et al., 2009; Jokiel and Bielska-Lasota, 
2005; Spaczyński et al., 2010; Parsa et al., 2006). However, they frequently assess single 
elements of knowledge or use scoring defined using study specific metrics. Also they report 
on different societies with varying levels of education, access to healthcare, and health care 
related knowledge. Therefore comparison of their results with the situation in Poland is 
difficult.  
 
More meaningful interpretation of knowledge in the current study was possible through the 
use of weighted scores applied to the knowledge items. Comparison of the mean breast and 
cervical cancer knowledge scores revealed that knowledge of breast cancer was lower than 
of cervical cancer score (mean: 0.98, S.D. 0.25 and mean: 1.03, S.D. 0.46, respectively). 
Next, the knowledge scores were recoded into three levels: low, medium, and high (for 
scoring methodology please see section 3.5.3). The majority of women (80.6%) had medium 
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level of total cancer knowledge, 10.3% had low and 9.1% had high. However, after splitting 
breast and cervical cancer knowledge notable differences were revealed. Breast cancer 
knowledge that was classified as medium level was the most prevalent (84.7%). Low 
knowledge values accounted for 10.2% and high values for 5.1%. Approximately 95% of 
women (10.2% with low score+84.7% with medium score) did not reach a breast cancer 
knowledge score above 66.6% (score values below 1.333332) of the total score possible 
(maximum score value of 2). The majority (93%) of women were aware of the need for 
breast self-examination (BSE) and 92.3% that mammography may allow early cancer 
detection. 
 
Cervical cancer knowledge score was relatively evenly distributed (low: 28.2%, medium: 
38.2%, and high: 33.5%). As the knowledge scores were evenly divided into thirds (please 
see section 3.5.3), this means that approximately 65% of women (28.2% with low 
score+38.2% with medium score) did not reach a breast cancer knowledge score above 
66.6% (score values below 1.333332) of the total score possible (maximum score value of 2) 
and 33.5% had scores within the highest 33.3% of maximum possible knowledge score. This 
result was different from another Polish study by Ulman-Włodarz and Nowosielski (2011) 
who noted that the majority of women (68%) had medium level of cervical cancer 
knowledge (Ulman-Włodarz and Nowosielski, 2011). However their study was based on 
women’s self-assessed knowledge and a small convenience sample (N=250) and therefore it 
was not representative of Polish women in general population.  
 
In the current study the majority (90.7%) of women knew that cytology may allow early 
detection of cervical cancer which is in line with a previous Polish study (2002) on cervical 
cancer knowledge that 91% of women reported that they were aware of the importance of 
cervical screening (Jokiel and Bielska-Lasota, 2005) but not with some of the other studies 
of communities in other countries. For example Wong et al. (2009) found that Malaysian 
women did not know that prevention of cervical cancer was possible if changes were 
detected early (Wong et al., 2009). The fact that more women had high cervical cancer 
knowledge than breast cancer knowledge (33.5% vs. 5.1%) seems to be consistent with the 
assumption that even prior to introduction of a population based screening, women would 
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have higher cervical cancer knowledge than on breast cancer as opportunistic cervical 
screening was present in some areas of Poland even as early as in the 1970’s (city of 
Białystok) (Łoś, 2006; Bardin et al., 2008). 
 
The current study also demonstrated a moderate correlation between both types of 
knowledge (Rho=0.506, p<0.001). This meant that with increasing breast cancer knowledge 
cervical cancer knowledge increased as well. No published evidence was found to report on 
the strength of this correlation. This suggests that it may be beneficial to provide women 
with information on both types of cancers and their prophylaxis at the same time. This 
approach has already been implemented to some extent as screening information leaflets on 
both types of screening are being provided to Polish women (please see appendix 2). 
 
Significant differences in knowledge were noted for all socio-demographic and socio-
economic variables (age, marital status, city size, education, material status, household size, 
and source of income). The youngest (18-24 years old) and the oldest (≥70 years old) 
women had significantly lower knowledge in comparison to other age groups. Similarly 
widowed women, those living in villages, and having lower education had significantly 
lower levels of knowledge. This was consistent with earlier findings (Jokiel and Bielska-
Lasota, 2005; Okobia et al., 2006). Women with average or better material conditions also 
had a better understanding of the studied cancers and their prophylaxis. Interestingly, 
increasing household size was also associated with higher knowledge with the exception of 
the households composed of 5 people or more. Women with previous cancer diagnosis had 
better knowledge which was especially notable amongst those that had experienced breast 
cancer but not for those who were diagnosed with cervical cancer. The study demonstrated 
that majority of women learnt about mammography from radio or television (38.9%, 
N=1,495), their doctor (28%, N=1,127), women’s press (12.6%, N=481), or family and 
friends (11.5%, N=474). On the other hand physicians were the main source of first 
knowledge about cytology (41.1%, N=1,584), followed by, radio or television (25.9%, 
N=1,007), women’s press 12.6% (N=474) and from friends or family (11.9%, N=467). 
Ulman-Włodarz and Nowosielski, (2011) found that the majority of women in their study 
gained their knowledge from women’s press (59%), television (47%) and internet (38%), 
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gynaecologist (30%) and midwife (38%) (Ulman-Włodarz and Nowosielski, 2011). 
Najdyhor et al (2013) also confirmed in their study that the majority of women gained their 
knowledge from press (47%) and television (46%) (Najdyhor et al., 2013). 
 
5.2.2. Breast and cervical cancer screening behaviours and their predictors 
 
Breast and cervical prophylactic behaviours were explored with the use of Chi square tests 
and univariate and multivariate logistic regression models. It was done to provide a more 
detailed understanding of the proportions related to each of the studied prophylactic 
behaviours as well as to allow for assessment of the likelihood of performing them. Breast 
and cervical screening predictors were tested in two separate models that were based on 
logistic regression analyses that included dichotomous outcome variables (mammography 
ever-yes/no and cytology ever yes/no).  
 
Following the univariate analyses of each of the variables multivariate analyses were 
conducted using backward elimination. Only variables that have tested significant after 
adjusting for other covariates and sampling design were included. The final mammography 
model included: age, size of the city, education, knowledge and BSE and the cytology 
model included: age, size of the city, marital status, education, household size, 
knowledge, cancer in the family and having a friend diagnosed with cancer. Even 
though not all variables explored in the section 4.3.5 were included in the final models they 
are discussed below together to provide an overview of the study results. 
 
According to the recent report by the Central Statistical Office of Poland in 2009 the overall 
mammography uptake (ever) and cytology uptake (ever), whether part of national screening 
programme or not, have not reached above 39.8% and 76.7%, respectively (Central 
Statistical Office of Poland, 2012c). This closely follows the results reported in this thesis as 
32.1% of all women reported ever having had mammography and 78.8% ever having had 
cytology. Only 32.3% of women in this study admitted to regularly practice BSE and only 
52.5% of women aged 50 or over (32.1% for all age groups) ever undertook mammography. 
This is in line with other Polish studies which showed that 31%-39.8% of Polish women 
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ever had mammography (Central Statistical Office of Poland, 2012c, Madej et al., 2010). 
Also the current study found that vast majority (78.8%) of women had cytology at least once 
in their lives which also reflected data (76.7%) reported by Central Statistical Office of 
Poland (76.7%) (Central Statistical Office of Poland, 2012c). Mammography analyses were 
limited to women aged 50 and older in accordance with the widely recommended target 
screening age. However, there was a substantial proportion of women who had been 
screened at age younger than 50 years old (9.5%, N=403). Forty three (43) women were 
younger than 30 years old at their first mammography, age that is not recommended for 
mammography due to X-ray radiation exposure resulting in an unfavourable benefit/harm 
ratio in young women (<50 years old) (Preston et al., 2002) and especially for those with 
BRCA1/2 mutations (Gronwald et al., 2008). This mammography uptake at a young age 
could be a result of previously discussed prophylactic ad hoc actions that often did not have 
age limits. Similarly cytology uptake was analysed for women at an above screening target 
age group and therefore only women aged 25 or over at the time of data collection were 
included in these analyses. However, as it was in case of mammography there were 6.7% 
(N=296) younger than 25 years old at their first cytology. This can be related to the fact that 
in Poland every woman has access to a gynaecologist free of charge or referral and therefore 
a number of respondents might have been screened if their physician proposed such a test.  
 
Age is a well known predictor of screening and it has been frequently pointed out as having 
a negative relationship with breast and/or cervical cancer screening attendance (Labeit et al., 
2013; Jepson et al., 2000). However, the published studies describe different age screening 
targets and include subject with varying characteristics and therefore the results of such 
studies may be conflicting (Kim et al., 2008; Jepson et al., 2000).  
 
In the current study mammography (ever) was the most prevalent in 50-59 age group 
(66.1%, N=514) and the least amongst in women over 70 years old (28.1%, N=167). 
Cytology was the most common in 30-39 year olds (92.4% N=788) and the least in women 
over 70 years old (60.3%, N=322). Multivariate logistic models found that older age (≥70) 
was a significant predictor of lower mammography uptake (OR=0.30, 95% CI, 0.20-0.43, 
p<0.001) in comparison to 50-59 years old age group. Women aged 30-39 years old were 
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2.3 times (OR=2.34, 95% CI, 1.34-4.13) and 50-59 years old 2 times more likely (OR=1.99, 
95% CI, 1.22-3.26) to attend cytology in comparison to 25-29 year olds. Surprisingly, two 
other studies showed that breast screening attendance was lower for women over 50 years 
old (Champion, 1994) and 55 years old (Prażnowska et al., 2010) when compared to their 
younger counterparts. Champion noted that at the time of data collection the recommended 
screening age for women was from 35 and 40 years old at the first mammogram, then from 
40 to 49 years old every 2 years and after the age of 50 it was recommended to be conducted 
annually. Prażnowska et al., (2010) on the other hand conducted their study on women who 
took part in cost free ad hoc initiative in 2007 and therefore no target screening age was 
defined. Cancer Research UK noted that lack of cytology uptake in younger women (in their 
second and third decade of life) can be mostly linked to inconvenient appointment times, 
whereas in older women (above age of 50 years old) to embarrassment (Cancer Research 
UK - Press release, 2011).  
 
Women who were separated/divorced (64.3%, N=81) or married/in relationship (57.4%, 
N=391) had higher mammography uptake than those who were single or widowed (57%, 
N=117 and 41.6%, N=328, respectively). Marital status was found to be a significant 
predictor only for single women performing cytology who were less likely to do so in 
comparison to those in relationships (OR=0.33, 95% CI, 0.21-0.51, p<0.001). These findings 
are in line with other studies (Damiani et al., 2012; Sutton and Rutherford, 2005; Macedo et 
al., 2012; Martin-Lopez et al., 2010; Jelastopulu et al., 2013) which found that women in 
relationships are more likely (most frequently reported likelihood of 2.4 times) to attend 
screening than their unmarried counterparts.  
 
Also both mammography and cytology were more commonly taken up in the cities and their 
uptake decreased linearly with the decreasing population density. For example 
mammography was reported by (70.1%, N=356) and cytology by 93.5% (N=916) in cities 
larger than 100,000 people and by 35.2% (N=241) and 77.8% (N=1,004) those living in the 
villages. Multivariate logistic models revealed that the likelihood of mammography and 
cytology attendance increased significantly with the size of the city the women lived in. 
Women living in cities smaller than 100,000 inhabitants were significantly less likely to 
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attend mammography than those living in the largest number of inhabitants (villages 
OR=0.35, 95% CI 0.23-056, p<0.001; cities <50,000 OR=0.53, 95% CI, 0.33-0.86, p<0.05; 
cities 50,000-100,000, 95% CI 0.34-1.0 p<0.05). Women living in cities 50,000-100,000 
(OR=0.30, 95% CI 0.17-0.52, p<0.001), villages (OR=0.31, 95% CI 0.18-052, p<0.001), 
and cities <50,000 inhabitants (OR=0.37, 95% CI 0.21-0.65, p<0.01) had significantly lower 
likelihood of taking up cytology than the reference category that has been set to a city larger 
than 100,000 inhabitants. Two other Polish studies also indicated that women living in urban 
areas took up both types of screening more frequently than women from rural settings 
(Spaczyński et al., 2010; Prażnowska et al., 2010). According to study by Prażnowska et al. 
(2010) 90% of free prophylactic mammography attendees lived in urban region (Prażnowska 
et al., 2010). Spaczyński at al. (2010) noted that higher proportion of women in rural areas 
did not take up cytology (15.2% vs.8%) (Spaczyński et al., 2010).  
 
As previously discussed in section 2.6.2, education, occupation, and material conditions can 
play important role in uptake of breast and cervical screening (Damiani et al., 2012; Duport 
et al., 2008; Hewitt et al., 2004; Day et al., 2010). Having higher levels of education, being 
employed and being in a better material situation has been linked with higher uptake, 
especially that higher educated, wealthier women may attend screening through private care 
(Damiani et al., 2012; Spaczyński et al., 2010; Blanks et al., 2002; Lofters et al., 2011; 
Champion, 1994). The current study confirms that these findings are also true for Polish 
women. The results demonstrated additionally that more women with higher levels of 
achieved education practiced the studied prophylactic behaviours (BSE: higher education, 
84.8%, N=556 vs. primary 60.3%, N=445; mammography: higher education, 79.5%, N=153 
vs. primary education, 33.6%, N=232; and cytology: higher education, 94.3%, N=598 vs. 
primary, 67%, N=526). The logistic models confirmed that higher education was linearly 
associated with higher likelihood of taking up either of the screening tests (highest vs. 
lowest education: mammography OR=2.32, cytology OR=3.54, p<0.001).  
 
Even though employed women constituted the group that the most often reported for both 
mammography (80.9% N=1,202) and cytology (90.6%, N=1,196) employment variable 
tested insignificant for both screening methods. Schumacher et al. (2008) made a similar 
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observation and concluded that employment was not associated with uptake of either breast 
or cervical screening (Schumacher et al., 2008). Conversely Damiani (2012) found that 
women being in employment had higher likelihood to undergo a mammogram than 
unemployed ones (OR=1.63; 95% CI 1.40-1.91) (Damiani et al., 2012). Similarly, 
Jelastopulu et al. (3013) found this relationship to be true for cytology uptake as 
unemployed women had much lower likelihood of getting screened than the employed ones 
(OR=0.5, 95% CI 0.3-0.7) (Jelastopulu et al., 2013). 
 
Higher uptake rates were found for women who declared better material conditions. 
Mammography uptake increased from 42.2% (N=62) amongst women living poorly to 
65.5% (N=11) among those living very well. The same patterns were visible for cytology as 
74.2% (N=151) of the poorest group declared ever having a smear versus women who stated 
to live well: 92% (N=408) or very well 91.4% (N=40). Other researchers found that better 
material conditions are positively associated with practicing breast and cervical cancer 
screening behaviours (Blanks et al., 2002; Lofters et al., 2011; Champion, 1994). For 
example Blanks et al. (2002) found that in the UK breast cancer screening attendance was 
higher in women from less deprived areas (Blanks et al., 2002). Lofters et al. (2011) 
demonstrated this also for cervical screening uptake in Canada (Lofters et al., 2011). The 
current study follows these findings with regards to larger proportions of women with better 
material conditions undergoing mammography and cytology. However, after testing in the 
respective multivariate logistic regression analyses self-assessed material status was found to 
be insignificant and therefore was not included in the final models. Additionally household 
size (number of people per household) was assessed and both mammography and cytology 
uptake was the most prevalent amongst women living in households composed of four 
people (61.7%, N=44 and 92.2%, N=571, respectively). However after adjusting for other 
variables in the regression models it was statistically significant only for cytology and only 
one household size category. Women living in the households composed of four people in 
comparison to single person households were 1.7 times more likely to have ever had 
cytology (OR=1.67, 95% CI 1.02-2.73, p<0.05). No other studies exploring the household 
size as a proxy for material conditions and breast or cervical screening were found for 
comparison with the current findings.  
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Women knowing someone with a cancer or having a family member with previous cancer 
diagnosis were also more likely to take up cytology (OR=1.30, 95% CI, 1.02-1.65, p<0.05, 
and OR=1.16, 95% CI, 1.02-0.65, p<0.001, respectively) but not mammography. On the 
other hand two studies in Asian communities found that women with family history of 
breast or cervical cancer were more likely to attend both breast and cervical cancer 
screening. Lee-Lin (2007) found that women were five times more likely to have had a 
recent mammogram if they had family member with breast cancer (OR=5.31, CI=1.09-
25.84) (Lee-Lin et al., 2007). Matsubara et al. (2013) found that not only women with 
family history of breast cancer were more likely to have mammography but also those 
whose sister was diagnosed with uterine cancer had higher likelihood to take up not only 
cytology (OR=1.89; 95% CI 1.39-2.58), but also mammography (OR=1.54; 95% CI 1.13-
2.09). 
 
Mammography was also more commonly reported (78.3%, N=100) by women who had 
been diagnosed with cancer (of any body part) than those who have never had such 
diagnosis (50.8%, N=807). Unsurprisingly, further exploration of the cancer type revealed 
that almost 99% (N=44) of women who were diagnosed with breast cancer have had 
mammography as the diagnosis would be either done or confirmed with mammographic 
tests. Interestingly also, more women who have been diagnosed with cervical cancer 
declared mammography more often (89.3%, N=10). Other cancer diagnoses were also more 
often reported by women that took up mammography (64.6%, N=46) but there was no 
difference in proportions between women who have never been diagnosed with cancer. 
91.3% (N=169) of women who reported cytology also admitted having had been diagnosed 
with cancer in the past in comparison to women who never had such diagnosis (83.7%, 
N=2,685). This result could be influenced by the fact that many of the women who were 
diagnosed with cervical cancer would have cytology done as a diagnostic/confirmatory test.  
 
Day et al. (2010) reviewed studies exploring health literacy and cancer knowledge and 
concluded that there is a strong association with the uptake of cytology however evidence 
relating to mammography was mixed (Day et al., 2010). The current study shows that cancer 
prophylaxis knowledge is strongly related with both types of screening. Women with scores 
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in medium range were 2.3 times more likely to have had mammography in comparison to 
3.2 likelihood for cytology (mammography: OR=2.3, 95% CI, 1.67-3.22 and cytology: 
OR=3.16, 95% CI, 2.23-4.49, p<0.001). Women with high scores were 4.2 times more likely 
to take up mammography and 4.9 times more likely to take up cytology than those with low 
knowledge (mammography: OR=4.15, 95% CI, 2.51-6.85, p<0.001 and cytology: OR=4.91, 
95% CI, 2.77-8.72, p<0.001, respectively).  
 
Last of the predictors tested in mammography model was the practice of BSE. However 
before including it as a covariate in the logistic regression model it was explored across 
different socio-demographic and socio-economic variables. Due to lack of organised and 
population based mammographic screening programme at the time of the data collection it 
could serve as proxy to women’s breast screening behaviours. The analyses revealed that 
64.2% (N=728) of women who declared BSE also undertook mammography at least once in 
their life and similarly 62% (N=309) of women who have never had mammography also 
declared never practicing BSE. However, it is important to highlight that some of the 
women in the current study who were asked about ever having mammography would not 
have had an opportunity to undergo such a test as it was not available nationally at that time. 
It was found that the highest proportions of BSE were noted for the following age groups: 
30-39 (80.9%, N=674), 40-49 (81.6%, N=489), and 50-59 (79.8%, N=596); whilst it was the 
lowest in women over 70 years old (55.9%, N=275). 78.3% (N=1,535) of married women 
practiced BSE in comparison with 67.6% (N=618) among single ones. Also more women 
living in the cities declared BSE (77.6% (N=878) of women in the cities >100,000, 77.5% 
(N=758) in <50,000 cities, and 74.6% (N=262) in cities with 50-100,000 inhabitants). Also 
employed women constituted a group that the most often practiced BSE (80.9%, N=1,202). 
BSE practice ranged from 56.5%, N=110 for women who declared to live poorly to 82.1%, 
N=45 of those that stated to live very well. The largest group of women who declared BSE 
lived in households composed of three (78.9%, N=629) or four people (77.8%, N=583). No 
statistically significant associations were found for BSE practice and previous cancer 
diagnosis or cancer type. 
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After exploration of BSE and mammography uptake in the univariate logistic regression, 
BSE was entered into the multivariate model and was found to be statistically significant 
predictor of mammography. Women who reported performing BSE were 2 times more 
likely to also undergo mammography (OR=1.98, 95% CI, 1.48-2.65, p<0.001). Very few 
other studies were found exploring this relationship but their findings are supportive of the 
results of the current study. For example Dunn et al. (2010) found that BSE practice (ever) 
was associated with mammography uptake (Malay women: adjusted OR=7.343, CI=2.686-
20.079; Chinese women adjusted OR=3.466, CI=1.330-9.031) (Dunn et al., 2010). Jelinski 
et al. (2005) found that in age-adjusted analyses women who performed BSE were 
significantly more likely to have mammography (OR=1.31; 95% CI=1.05, 1.64) but when 
the researchers adjusted for other variables this significance was lost (OR=1.01; 95% 
CI=0.75, 1.35; respectively) (Jelinski et al., 2005).  
 
Additional analyses looked at the relationship between BSE, mammography and cytology 
practice. Interestingly, only 10.6% (N=274) of women who practiced BSE never undertook 
cytology. However 75.6% (N=580) of respondents that do not practice BSE had at least one 
cytology test in the past. Majority of women aged 50 or over (65.4%, N=831), who reported 
ever having cytology also had taken up mammography but 82.5% (N=316) who have never 
had cytology also reported never having mammography. No other studies exploring 
association between BSE and cytology or mammography and cytology were found. Results 
of this study show that there is a clear association between practicing one of the above 
described prophylactic behaviours with another one, irrespectively of whether it is breast or 
cervical cancer related procedure.  
 
5.2.3. Barriers to breast and cervical cancer screening 
 
The main reasons for non attendance to either type of screening included: the feeling of lack 
of need of the test -feeling healthy (mammography: 37.9%, N=1,128 and cytology: 44.9%, 
N=366 respectively), followed by lack of referral by doctor (28.7%, N=797 for cytology and 
39.2%, N=334 for mammography). A fifth of women (20.2%, N=599) stated that they were 
too young to undergo mammography (594 selected this answer correctly as they were 
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younger than 50 years old) and 3.7% (N=34) stated that for cytology (31 were younger than 
25 years old). Not having time or thinking that these tests are expensive accounted only 
0.6%-3 % of responses. In another Polish study Iwanowicz-Palus et al. (2010) noted that in 
the main reasons for lack of cytology uptake was lack of time (33.3%), lack of symptoms 
(27.3%), cost of the test (21.2%), lack of referral (9.1%), unconvincing invitation (6.1%), 
and fear of diagnosis (Iwanowicz-Palus et al., 2010). However these results were based on 
answers given by 33 women. Ulman-Włodarz and Nowosielski (2011) on the other hand 
found that main reasons for lack of cytology uptake included fear of pain (39%), lack of 
symptoms (18%), carelessness (15%), embarrassment (12%), lack of referral (11%) and fear 
of the diagnosis (5%) (Ulman-Włodarz and Nowosielski, 2011). In addition to the above 
discussed questions above women were asked about the reasons for never visiting 
gynaecologist. However, only 222 women responded to this question and the majority 
(61.7%, N=137) indicated that they did not need it as they felt that there was nothing wrong 
with them. 15.8% (N=35) stated that they were too young for that, 11.7% (N=26) were 
scared/didn’t like visiting gynaecologist.  
 
Even though prior to 2006 there was no nationwide breast screening various institutions in 
different cities occasionally organised ad hoc screening and only small proportions of 
respondents declared the reason for non-attendance as lack of availability of mammography 
(4%) or cytology (1%). Women were additionally asked why they did not take part in ad hoc 
and cost free prophylactic actions. The most common reason was lack of knowledge of such 
actions (27.8%), followed by feeling of not needing such test (22.4%), women who already 
attend mammography elsewhere from their own initiative (19.5%), 9.8% did not have time 
when such actions were organised, 4% said that there were no free spaces available, and 
16.5% (N=128) indicated other reasons for lack of uptake of such actions. Some of the other 
reasons included: different age group, housebound, too expensive, mammography after 
surgery (including mastectomy), breast pain, friend’s advice, attending mammography 
elsewhere on employer’s requirement. Najdyhor et al. (2013) showed that at the time of data 
collection for their study (2011) women were aware of some major breast screening actions 
organised by non-governmental organisations (e.g., Amazonki: 86%, Kampania AVON 
Różowa Wstążeczka: 71%) (Najdyhor et al., 2013). 
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5.3. Strengths, challenges, and limitations 
 
The study has many strengths. The data was obtained from an original survey study that 
collected information on the knowledge and behaviours pertaining to cancer (all types) and 
its widely understood prophylaxis. It was conducted on a large sample (N=4,290), 
representative of the Polish female population. Its representativeness has been ascertained 
through a rigorous data collection process following stratified cluster sampling that included 
individuals from all regions of Poland (for description of sampling please refer back to 
section 3.3.2). The data was collected by trained interviewers and subsequently audited. All 
collected data relevant to breast and cervical cancers was extracted and analysed with the 
aim to identify the predictors of population based screening for these cancers. No Polish or 
Eastern European studies exploring breast and cervical prophylactic behaviours and their 
predictors in the same set of individuals, especially communities without nationwide and 
population based screening were found. The published evidence to date is mostly based on 
small, purposive or convenience samples often looking at knowledge or behaviour for only 
one type cancer (Jokiel and Bielska-Lasota, 2005, Spaczyński et al., 2010, Gronwald et al., 
2006, Zych et al., 2006, Najdyhor et al., 2013, Nowicki et al., 2008, Nita et al., 2010a). The 
study also uses a novel approach to assessing knowledge on breast and cervical cancers and 
their prophylactic by creation and application of scoring scales based on a thorough review 
of published evidence that was available at the time of data collection (sections 2.3-2.6) and 
that the respondents could have been exposed to via various channels (please see tables 18 
and 21).  
 
Whilst using secondary data is scientifically valid, time, and cost efficient it is not free from 
several challenges and limitations. These challenges are inherent to using information that 
has been collected for a different purpose than to answer question at hand (Garmon Bibb, 
2007). Even though the researcher had formed the main research question at the beginning 
of this project, only after the receipt of the data set it was possible to assess fully its 
appropriateness for this thesis. As the data was collected for another project the researcher 
had no control over the design of the questionnaire, or the data collection process (Boslaugh, 
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2010). The researcher recognises a possibility of biases that might have occurred not only at 
the design but also at the data collection (i.e. interviewer bias) and data input stages. 
Nonetheless, some data checks were still possible as even though there were some 
transformed variables, collapsed into more meaningful categories, the original variables 
were also provided to the researcher. Additionally, the questions of the survey followed a 
logical order and therefore in the case of questionable value in many cases the researcher 
could assess whether the value was correct. If the correctness of the values could not be 
ascertained they were set to missing (please refer back to section 3.5.1). Despite the inability 
to influence the original design and its processes, thanks to the wealth of information 
obtained through the receipt of the detailed documentation describing rigorous sampling, 
data collection and data quality check methods, the researcher and her supervisors were 
reassured of its appropriateness for this thesis. 
 
Additionally, cross-sectional face to face administered surveys aiming to explore self-
reported health related factors such as cancer and cancer prophylaxis can suffer from many 
limitations and challenges. They are costly and time consuming as the interviewers need to 
travel to the respondents’ location (Polit and Hungler, 1991; Roberts, 2007). Since the 
survey analysed in this study is based on retrospective questioning and it collected 
information on respondents’ knowledge and factors pertaining to cancer and its prophylaxis 
it can be subject to a recall bias (Levin, 2006; Bowling, 2002; Coggon et al., 2003; Rothman 
et al., 2008). For example respondents may not recall or remember incorrectly their 
screening attendance circumstances (e.g., number of previous screening tests). The validity 
of data could be also influenced the interviewers’ characteristics (e.g., professional training 
or interviewing experience) (Opdenakker, 2006; Roberts, 2007). Even though all 
interviewers were well trained in interviewing techniques it is possible that their personality 
or professional health care training (community nurses) could result in respondents 
modifying their answers to match what they thought the interviewer considered to be the 
correct health behaviour (Opdenakker, 2006; Roberts, 2007) (e.g., regular screening uptake 
despite rare or lack of uptake). Additionally topics explored by the survey included topics 
that may be considered sensitive (e.g., cancer diagnosis, presence or absence of regular 
screening uptake, reasons for lack of screening uptake) it is possible that the respondents 
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changed or withheld information, especially in cases where it was not possible to ascertain 
complete privacy of responses (i.e. third persons, family members present at the location of 
the data collection). 
 
Literacy and health literacy (for definition please refer to glossary) also can play significant 
role in studies exploring predictors of early disease detection such as cancer screening (Day 
et al., 2010; Nutbeam, 2010; Smith and McCaffery, 2010). People with lower literacy are 
likely to be less well informed of health issues and therefore resulting in low health literacy 
(Miller et al., 2007). Poor health literacy can be complex in case of cancer prevention, as it 
may be linked with limited understanding of risks and benefits of screening, cancer 
symptoms, and treatment resulting in later stage at cancer diagnosis what may later cancer 
stage at diagnosis, (Davis et al., 2002). As the overall health literacy level could not be 
assessed in this study due to unavailability of such data cancer related knowledge due to its 
correlation to health literacy (Gazmararian et al., 2003; Kim et al., 2001) was used to partly 
explain women’s understanding of the breast and cervical cancers. This provided a guide to 
explore whether their knowledge was sufficient to enable women to take informed decisions 
about screening uptake and whether more work needed to be done to increase their 
knowledge.  
 
Several additional considerations needed to be taken into account. Health related surveys 
conducted on a national scale often use multiple complex sampling designs what poses 
several analytical challenges (such as the loss of precision due to sampling and therefore the 
need to select an analytical program that would allow to account for this). In this study there 
was need to account for the intricacies of complex sampling and many of the statistical tests 
that are commonly used for analysis of samples collected with the use of simple random 
sampling or even convenience sampling (e.g., t-tests, ANOVA) could not be used here as 
they would produce erroneous estimates (Lee and Forthofer, 2006, Kreuter and Valliant, 
2007, Yansaneh, 2005, Hahs-Vaughn, 2005). Also only a few statistical computer 
programmes were found to be equipped to handle such analyses (Lee and Forthofer, 2006). 
Stata was found to provide relatively good accessibility of commands for various types of 
analyses required for this study (Kreuter and Valliant, 2007). -SVY- Stata commands with 
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their respective suffixes and pre specified values of the sampling design were suitable to 
carry out the analyses (Lee and Forthofer, 2006). Majority of the commands used for 
analyses were included as part of the main software package offered by StataCorp 
(StataCorp LP., 2007). However two of them (test and svylogitgof) were written by Stata 
users and validated by other researchers (Lee and Forthofer, 2006, Bruin, 2006, Archer et 
al., 2007, UCLA: Statistical Consulting Group). Use of the -SVY- commands also required 
reporting of the results to be adapted. Where applicable F statistic with corresponding design 
based degrees of freedom adjusted for sampling design was reported (please refer back to 
the section 3.6. for details on the types of statistical tests used in this thesis). Due to specifics 
of stratified cluster sampling some precision loss was expected however the reported design 
effects showed that the loss of precision was relatively minimal (most of the design effects 
values were around the value 1). 
 
5.4. Conclusions and recommendations 
 
Identification of the factors that are the most influential on the uptake of breast and cervical 
screening is an important public health issue. The current study proposes cancer knowledge, 
city size, and overall education as the strongest predictors for both breast and cervical cancer 
screening. For mammography also age and BSE and for cytology marital status, household 
size, having family member with cancer, and knowing someone with cancer have been 
demonstrated as predictors of screening uptake. 
 
As it is not possible to influence age, education (completed schooling level), marital status, 
household size or whether women have a family member or a friend with cancer, it is 
recommended that the organisations planning screening services pay special attention to the 
provision of the information campaigns highlighting the importance and acceptability of 
breast and cervical screening. It is also suggested that attention is paid to the distribution of 
this information in places with lower population density (for example in primary care 
centres) as the information on the benefits of screening may not be as available as in large 
cities.  
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In addition, a follow up research is suggested on the predictors identified in this study. 
Especially it is recommended to assess whether the uptake of screening (whether as part of 
the national screening programme or in private practices) has improved. The study should be 
conducted also on a representative sample of Polish women but focus on breast and cervical 
cancer related prophylaxis topics only (as opposed to the main survey from which only a 
subset of data was analysed in this thesis). This will help expand on other factors (than 
identified in this thesis) that may explain screening behaviours amongst Polish women and 
help to plan prophylactic campaigns aimed at increase of screening uptake. The future study 
should incorporate elements of theoretical constructs that have been the most commonly 
used in previous cancer screening research. This thesis shows that not only personal 
characteristics but also cancer knowledge as part of overall health literacy play important 
role in predicting the screening. Many of the constructs from the theories reviewed in this 
study (HBM, TRA, TPB, SCT, TTM, and HAPA) can be associated with the elements 
discussed by Weller et al. (2009) as influencing screening uptake (Figure 9). However, the 
data was of secondary nature and therefore it was not possible to test other constructs of the 
discussed theories such as: behaviours, attitudes, perceived benefit or threat, cues to action, 
perceived susceptibility, intentions, subjective norms and many others as significant 
constructs in predicting screening behaviours (please refer back to section 2.7). As the 
majority of theoretical frameworks are based on constructs using different nomenclature but 
in fact being equivalent, it is suggested to focus on the elements that have been summarised 
as comparable across all of the theories (please see section 2.7.6) (Ogden, 2003, Noar and 
Zimmerman, 2005). Even though it has been stipulated that the theoretical constructs have a 
limited power to explain and predict behaviours (Ogden, 2003, Noar and Zimmerman, 2005) 
and very limited evidence still exists on how these theoretical constructs relate to Poland and 
countries with complex geo-political past, it is suggested that in Poland and or other 
transitional countries of Central and Eastern Europe not only the building blocks of these 
theories are studied but also the context of the healthcare system (i.e. healthcare reforms) 
and the women’s trust in it. It is also suggested that a wider and more qualitative study, 
inclusive of the majority of the constructs that were discussed in this thesis is conducted. 
Particularly the constructs such as knowledge, cues to action and behaviours which were to 
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an extent covered by this study, but also perceived threats and benefits, susceptibility, 
personal norms and intentions should be explored. It will help to understand in more detail 
which constructs are the most influential in the Polish society and possibly allow more 
precise prediction of screening behaviours what can help in designing more effective 
screening policies and screening promotion campaigns. The study could include qualitative 
interviews with not only women themselves but also their health service providers such as 
doctors and nurses providing screening. Such approach could provide better understanding 
of the factors that in reality are driving and influencing the provision of the service and its 
uptake.  
 
There are many techniques that can be used to improve uptake of screening and one of the 
more recent approaches has been particularly successful. The use of social marketing has 
been previously shown to improve the cancer related health literacy and increase uptake of 
cervical screening. For example researchers in New Zealand (Bethune and Lewis, 2009) 
described new creative strategies of social marketing used to reach women from ethnic 
minorities based on HBM and TTM. Part of this social marketing campaign used short 
humorous TV, radio and outdoor advertising. The programme also included work aiming to 
improve service delivery and access to services especially for hard to reach groups of 
women. This initiative became a platform for engagement of all stakeholders. Similar results 
in respect of the use social marketing techniques in screening campaigns were found in 
London in 2002. This campaign included mass-media messages (billboards, posters, 
television transmissions with a celebrity component, bus advertisements and many others) as 
well as various forms of personal contact with the service providers (written personal 
invitations with information on the importance of cervical screening, provision of toll free 
infoline) (Millett et al., 2005). The study showed that the coverage increased in target and 
non-target groups of women.  
 
Social marketing campaigns as the ones described above may be particularly helpful in 
societies such as Poland where the screening uptake is still low and women’s decision to 
take up screening may be different and more complex than in Western societies. Such 
engagement of multiple stakeholders may prove to be very effective tool in reaching desired 
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screening targets across all groups of the society and improving cancer knowledge through 
comprehensive educational initiatives (with the use of media and information available from 
healthcare providers), thus enabling women to take decision to undergo cancer screening. 
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Appendix 1 Information leaflet on the availability of breast and 
cervical cancer screening in Poland 
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Appendix 2 Questionnaire used to collect data in the study 
conducted in Poland in 2006 
 
 
KNOWLEDGE ABOUT CANCER AND CANCER PREVENTION 
Interviewer’s name 
and surname 
Interviewer’s 
number 
Respondent’s 
identification 
number 
Questionnaire 
number 
...................................... |__|__|__|__|__| |__|__|__|__|__| |__|__| 
Respondents gender 
City of the 
questionnaire 
completion 
Date of the data 
collection  
(mm dd) 
Time of the 
data collection  
1. female 
2. male ............................ |__|__|  |__|__| |__|__|:|__|__| 
 
Dear Sir or Madam, 
 
PBS DGA (formerly - Social Research Group) is carrying out a study on behalf of the 
Centre of Oncology in Warsaw with the aim to explore: 
1) knowledge  
2) attitudes of Polish people to elements of healthy lifestyle included in the European Code 
Against Cancer. 
 
This is a scientific study carried within “the National Programme of Fight Against 
Cancer” of the Ministry of Health. 
 
We kindly request for your participation in this study. 
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PROPHYLACTIC TESTS 
1. Have you ever heard about the need for regular breast self-examination (at home)? 
(G8) 
 
1. Yes  
2. No – go to 3 
3. I don’t know, it is difficult to say – go to 3 
2. Are you examining your breasts by your-self (at home)?  
 
1. Yes, regularly 
2. Yes, but rarely 
3. No, never 
3. Have you ever had a mammography?  
 
1. Yes  
2. No – go to 9 
3. I don’t know, it is difficult to say– go to 10 
4. How old were you when you had your first mammography?  
 
|___|___|   years 
 
98. I don’t remember 
5. How often do you undergo mammography?  
 
1. Once per year 
2. Every 2-3 years 
3. Every 4-5 years  
4. Less than once per 5 years 
5. Rarely (occasionally) – only when I have an occasion 
6. Until now I had only one mammography 
7. I don’t know, it is difficult to say 
6. What was the main reason for your last mammography?  
Interviewer: Read all answers to the respondent. Only one answer is possible to select 
 
1. I noticed worrying symptoms 
2. I belong to a high risk group (breast cancer in the family) 
3. I used a openly available prophylactic programme 
4. I care about my health and therefore undergo prophylactic tests 
5. My doctor referred me to confirm or refute diagnosis 
6. My doctor referred me for a prophylactic test 
7. Other, specify ............................................................................................................ 
8. I don’t know, it is difficult to say 
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7. Have you ever undertaken a mammography organised as a part of cost free 
prophylactic action/initiative (i.e.: organized by popular press, church etc.) 
 
1. Yes   Interviewer: ask how many times:  |__|__|__| times then go to 10 
2. No  
 
8. Why you have never undertaken mammography offered as part of the cost free 
prophylactic action/initiative?  
 
1. I have never heard about such action 
2. I did not feel the need to undertake such test 
3. I did not have time when the free prophylactic action was available 
4. I undergo mammography regularly 
5. There were no places left 
6. Other, specify ..................................... 
9. Due to what reason you have never undergone mammography? Please indicate one 
main reason  
 
1. There is nothing wrong with me – I feel healthy 
2. My doctor never referred me for it 
3. I do not have time  
4. This test is too expensive 
5. There is no possibility to undertake this test in my neighbourhood 
6. I am too young 
7. I have never heard of such test 
8. Other reason, specify .......................................................... 
9. I don’t know, it is difficult to say  
10. In what situations do you go to a gynaecologist? 
Interviewer: Only one answer is possible 
 
1. Only when I have to (worrying symptoms, pregnancy) – go to 12 
2. I go regularly to undertake prophylactic tests and when I need to (i.e. pregnancy, illness) 
– go to 12 
3. I have never visited a gynaecologist – ask the question 11 
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CAUTION: Question asked only to the women who have never visited a gynaecologist  
 
11. Due to what reason you have never visited a gynaecologist? Please indicate one main 
reason  
Interviewer: Do not read the answers – Try to mark or write down the answer that is given 
spontaneously. 
 
1. There is nothing wrong with me, I feel healthy 
2. I am too young (I am still inactive sexually) 
3. I do not have time  
4. This test is too expensive 
5. I am scared/I don’t like it 
6. Other reason, specify ........................................................................................................ 
7. [do not reveal] I don’t know, it is difficult to say 
12. What was the reason for your first (ever) visit at the gynaecologist?  
Interviewer: Only one answer is possible  
 
1. Prescription related to contraception 
2. Worrying symptoms, treatment 
3. Prophylactic test, without any symptoms 
4. Pregnancy 
5. Other, specify ........................................................................................... 
6. I don’t remember 
13. Have you ever had your breasts examined by a gynaecologist?  
 
1. Yes 
2. No 
3. I don’t know, it is difficult to say 
14. Have you ever undergone cytology?  
 
1. Yes   
2. No – go to 18 
3. I don’t know it is difficult to say- 
15. How old were you at your first (ever) cytology?  
 
|___|___| years 
98. I don’t remember 
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16. How often do you undergo cytology?  
 
1. Once per year 
2. Every 2-3 years 
3. Every 4-5 years  
4. Less than once per 5 years 
5. Rarely (occasionally) – only when I have an occasion 
6. Until now I had only one such examination 
7. I don’t know, it is difficult to say 
17. What was the main reason for your last cytology?  
 
1. Planned pregnancy 
2. I had worrying symptoms (by my own initiative)  
3. I belong to high risk group (cervical cancer in the family) 
4. I undertook it as prophylactic examination (by my own initiative) 
5. I undertook it as part of prophylactic initiative 
6. My doctor referred me to confirm or refute diagnosis 
7. My doctor referred me for it as a prophylactic test 
8. Other, specify ................................................................................. 
9. I don’t know, it is difficult to say 
18. Due to what reason you have never undergone cytology?  
 
1. There is nothing wrong with me – I feel healthy 
2. My doctor never referred me for it 
3. I do not have time  
4. This test is too expensive 
5. There is no possibility to undertake this test in my neighbourhood 
6. I am too young 
7. I have never heard of such test 
8. Other reason, specify .......................................................... 
9. I don’t know, it is difficult to say 
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KNOWLEDGE ABOUT CANCERS 
 
Interviewer: Reveal the answer sheet 
 
Do you believe that change of certain habits and behaviours can have protective effect on cancer? 
Please specify which of the following behaviours may influence the development of breast cancer 
Breast cancer (I1A) 
To a large 
extent it 
can protect 
against 
cancer 
It can have 
protective 
influence 
against 
cancer 
It can have a 
somewhat 
protective 
influence 
against 
cancer 
It does not 
influence 
cancer 
development  
Contrarily, 
it can lead to 
cancer 
development 
I don’t 
know, it 
is 
difficult 
to say 
1. Regular mammography 
below the age of 50  1 2 3 4 5 9 
2. Regular mammography 
above the age of 50 1 2 3 4 5 
9 
3. Use of hormonal 
contraception 1 2 3 4 5 
9 
4. Use of hormonal 
replacement therapy 1 2 3 4 5 
9 
5. Increase of intake of 
fruits and vegetables 1 2 3 4 5 
9 
6. Decrease of fat intake 1 2 3 4 5 
9 
7. Limitation or avoidance 
of alcohol 1 2 3 4 5 
9 
8. Smoking cessation 1 2 3 4 5 
9 
9. Increase of physical 
activity  1 2 3 4 5 
9 
10. Regular breast self-
examination  1  2  3  4  5 
 9 
11. Frequent X-rays (various 
body parts) 1 2 3 4 5 
9 
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Cervical cancer (I1B) 
To a large 
extent it can 
protect 
against 
cancer 
It can have 
protective 
influence 
against 
cancer 
It can have 
a somewhat 
protective 
influence 
against 
cancer 
It does not 
influence 
cancer 
developmen
t  
Contrarily, 
it can lead 
to cancer 
developmen
t 
I don’t 
know, it 
is 
difficult 
to say 
1. Regular cytology 1 2 3 4 5 9 
2. Use of hormonal 
contraception 1 2 3 4 5 9 
3. Young age of sexual 
initiation 1 2 3 4 5 9 
4. High number of sexual 
partners 1 2 3 4 5 9 
5. Smoking cessation 1 2 3 4 5 9 
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SOURCES OF KNOWLEDGE ABOUT CANCER PROPHYLAXIS 
19. Have you ever heard that...? 
 
Interviewer: Reveal answer sheet 
 YES NO I don’t 
know, it is 
difficult to 
say 
If so, where have you heard about it for the 
first time? 
1.Regular 
mammography allows 
early detection of 
breast cancer 1 2 9 
1. From family or friends 
2. From a doctor 
3. From the radio or TV 
4. From the women’s press 
5. From other press 
6. From school (university, courses, work etc.) 
7. From other sources, 
specify...................................... 
8. I don’t remember 
2.Regular cytology 
allows early detection 
of cervical cancer 
1 2 9 
1. From family or friends 
2. From a doctor 
3. From the radio or TV 
4. From the women’s press 
5. From other press 
6. From school (university, courses, work etc.) 
7. From other sources, 
specify...................................... 
8. I don’t remember 
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SOCIO-DEMOGRAPHIC DATA 
20. Date of birth (L1) 
    |___|___| - |___|___| - |___|___|___|___| 
           day  month   year 
21. What is your education?  
1. Lack of formal education, incomplete primary school 
2. Completed primary school 
3. Incomplete high school or technical school 
4. Completed high school, technical school, vocational qualifications 
5. Bachelor’s degree or incomplete master’s degree 
6. Completed master’s degree 
7. Higher education than masters or doctoral degree 
8. [Do not reveal] Refused to answer 
22. What is your marital status?  
1. Married , in an informal relationship 
2. Widow 
3. Separated, divorces 
4. Single (never married) 
23. Have you ever been diagnosed with cancer?  
 
1. Yes     
2. No – go to 24 
3. I don’t know, it is difficult to say– go to 25 
24. Please specify the cancer’s location (body part)  
…………………………………………………………………………….................................... 
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25. Please specify the main source of your income in the last 12 months.  
Interviewer: Only one answer possible 
 
1. Employed in the public sector 
2. Employed in the private sector 
3. Self-employed in sector other than farming 
4. Self-employed in farming (own farm)  
5. Self-employed in farming (not in an own farm)  
6. Retired 
7. Disability, social benefits  
8. Family benefits 
9. Unemployment benefit 
10. Benefits from social service 
11. Income sources other than from employment (pre-retirement benefit, career benefit, 
alimony, studentship, income from a property)  
12. Support of a person from outside of the household 
26. How many people (including you) live in your household?  
 
|___|___| people 
27. According to you what are the material conditions of your household?  
 
1. We live poorly – we cannot pay for our basic needs  
2. We live modestly – we have to be careful about our expenses 
3. We live moderately – we can afford daily expenses but we need to save for larger 
purchases  
4. We live well – we can afford many things without major need for saving  
5. We live very well – we can afford a certain level of luxury 
28. Has ever anyone from your family been diagnosed with cancer?  
 
1. Yes 
2. No 
3. I don’t know 
29. Has ever anyone from your friends been diagnosed with cancer?  
 
1. Yes 
2. No 
3. I don’t know 
30. Voivodship, where the questionnaire is administered  
 
1. Dolnośląskie 
2. Kujawsko-pomorskie 
3. Lubelskie 
4. Lubuskie 
5. Łódzkie 
6. Małopolskie 
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7. Mazowieckie 
8. Opolskie 
9. Podkarpackie 
10. Podlaskie 
11. Pomorskie 
12. Śląskie 
13. Świętokrzyskie 
14. Warmińsko-mazurskie 
15. Wielkopolskie 
16. Zachodniopomorskie 
31. Size of the city  
 
1. Village  
2. Small town (less than 50.000 habitants) 
3. Medium size town (50-100.000 habitants) 
4. Large city (above 100.000 habitants) 
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Appendix 3 Report from the conduct of the survey (prepared by 
PBS-DGA) 
 
 
 
WIEDZA O NOWOTWORACH I 
PROFILAKTYCE 
BADANIE POPULACYJNE 
ZAŁOŻENIA I REALIZACJA 
 
 
 
 
 
WARSZAWA / SOPOT 2006-2007 
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Schemat doboru respondentów do badania. 
W badaniu zastosowano schemat losowania warstwowego, trzystopniowego. 
Jednostkami losowania I stopnia były gminy. Jednostkami losowania II stopnia były 
wsie w gminach wiejskich i częściach wiejskich gmin miejsko-wiejskich i ulice w 
gminach miejskich oraz częściach miejskich gmin miejsko-wiejskich Jednostkami 
losowania III stopnia były osoby. 
 
Losowanie próby I stopnia: 
Pierwszy etap losowania był losowaniem warstwowym i proporcjonalnym. W tym 
celu utworzono w każdym z województw warstwy terytorialne zdefiniowane przez 
klasę miejscowości: 
- gminy wiejskie i części wiejskie w gminach miejsko-wiejskich 
- gminy miejskie (miasta) oraz części miejskie (miasta) w gminach miejsko-wiejskich 
do 20000 mieszkańców 
- gminy miejskie (miasta) oraz części miejskie (miasta) w gminach miejsko-wiejskich 
od 20001 do 50000 mieszkańców 
- miasta od 50001 do 200000 mieszkańców 
- miasta od 200001 do 500000 mieszkańców 
- miasta oraz aglomeracje miejskie ponad 500000 mieszkańców. 
Dla każdej z warstw określona została liczba wywiadów do zrealizowania. Ponieważ 
dobór jest proporcjonalny, liczba wywiadów w warstwie jest pochodną wielkości 
próby oraz frakcji warstwy w populacji osób w wieku 18 lat i więcej. 
Wynikająca z proporcji liczba wywiadów w warstwie dzielona była na wiązki 
adresowe. Wiązka składała się średnio z około  6-8 adresów podstawowych i 10-25 
adresów rezerwowych. Dla tak zdefiniowanych wiązek wylosowano gminy. 
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Operatem losowania na tym etapie doboru próby był spis gmin w warstwie. 
Losowanie odbywało się niezależnie w każdej warstwie z prawdopodobieństwem 
proporcjonalnym do wielkości populacji osób w wieku 18 lat i więcej. 
 
Losowanie próby II stopnia: 
Losowanie wsi w gminach wiejskich/miejsko-wiejskich oraz losowanie ulic w 
gminach miejskich/miejsko-wiejskich było wykonane przez MSWiA ze zbioru gmin 
wylosowanych w etapie I. Dobór zrealizowany był wg schematu prostego z 
prawdopodobieństwem proporcjonalnym do liczby osób w wieku 18 i więcej na 
ulicy/wsi. 
 
Losowanie próby III stopnia: 
Dobór zrealizowany był wg schematu warstwowego z jednakowym 
prawdopodobieństwem wyboru.  
W każdej z warstw typu miejscowości (w każdym z województw) zdefiniowana 
została warstwa ‘płciowo-wiekowa’ będąca skrzyżowaniem płci i grupy wieku: 18-
24, 25-39, 40-59 oraz 60 i więcej lat. 
Dla każdej z warstw ‘płciowo-wiekowej’ obliczona została liczba wywiadów do 
zrealizowania – jest ona pochodną liczby wywiadów w typie miejscowości w 
województwie (określone w etapie 1 losowania) i frakcji warstwy ‘płciowo-wiekowej’ 
w populacji (w warstwie typ miejscowości). 
Losowanie osób (adresów) w etapie III losowania było wykonane przez MSWiA ze 
zbioru PESEL, mieszkających we wsiach/ulicach wylosowanych w etapie II, przy 
użyciu losowania prostego z jednakowym prawdopodobieństwem doboru. 
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Dobór respondentów ‘zastępczych’ (rezerwa) 
W przypadku niezrealizowania wywiadu z osobą z ‘próby podstawowej’, wywiad 
został przeprowadzony z respondentem z ‘listy rezerwowej’, który dobierany był wg 
identycznego schematu jak lista ‘podstawowa’. Jeśli respondent z ‘próby 
podstawowej’ nie wyraził zgody na udział w badaniu, nie mógł być on zastąpiony 
innym respondentem. Założono, że brak wywiadu w warstwie określonej przez typ 
miejscowości, płeć oraz wiek, w ‘próbie podstawowej’, będzie uzupełniany przez 
wywiad z respondentem z tej samej warstwy określonej przez typ miejscowości, 
płeć i wiek.  
Realizacja prac terenowych 
Badanie przeprowadzono metodą wywiadu bezpośredniego w III kwartale 2006. Po 
odpowiednim przeszkoleniu pielęgniarki środowiskowe umawiały się na wizyty z 
potencjalnymi respondentami. Po uzyskaniu pisemnej zgody pielęgniarki 
przeprowadzały ankiety oraz mierzyły wzrost i ważyły respondentów.  
Potencjalni respondenci, z którymi nie udało się zrealizować wywiadów (z różnych 
przyczyn, np odmowa, nieobecność itp. ) byli umieszczani na specjalnych listach, 
na których opisywano szczegółowo powody niezrealizowania wywiadu.  
W pierwszej kolejności pielęgniarki miały za zadanie dotrzeć do osób z tzw. próby 
podstawowej, a po wyczerpaniu tej listy, do nazwisk „rezerwowych”. 
Zgodnie z procedurami PBS DGA 5% zrealizowanych wywiadów poddano kontroli 
telefonicznej. W sytuacji, gdy nie udało się skontaktować telefonicznie z 
respondentem, pod wskazany adres wysyłano kontrolera. Podobnie postępowano, 
gdy w czasie wywiadu telefonicznego nie udało się ustalić, czy wizyta pielęgniarki 
się odbyła. Jeśli w wyniku kontrolo okazywało się, że wywiady zostały sfałszowane, 
wówczas sprawdzano wszystkie ankiety zrealizowane przez daną pielęgniarkę.  
W wyniku kontroli okazało się, że 69 ankiet zostało sfałszowanych. Wszczęto 
procedury usunięcia pielęgniarek z ogólnopolskiej sieci ankieterskiej. Sfałszowane 
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ankiety usunięto z bazy danych, a pod wylosowane adresy wysłano nowe 
pielęgniarki.  
 
Sposób realizacji próby i efektywność (przy liczeniu efektywności usunięto 
potencjalnych respondentów, którzy nie powinni trafić do próby, tzw. not eligible, 
czyli osoby, o których uzyskano informację, że mieszkają na stałe poza granicami 
Polski, chorych psychicznie oraz osoby, które zmarły przed rozpoczęciem badania, 
a które figurowały w listach adresowych z PESELa) są przedstawione w poniższych 
tabelach. 
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REALIZACJA PROBY - POPULACJA OGÓLNOPOLSKA 
Tabela 1 Realizacja próby  –  populacja ogólnopolska w podziale na typ próby i status wywiadu 
 Typ próby - podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 3775 47.67 4216 34.01 7991 39.33 
Odmowa 1291 16.30 2471 19.93 3762 18.52 
Dłuższa nieobecność 1874 23.66 3909 31.53 5783 28.46 
Nie przebywa pod 
wskazanym adresem 
396 5.00 661 5.33 1057 5.20 
Inne 143 1.81 280 2.26 423 2.08 
Nie wchodzi do badania* 440 5.56 861 6.94 1301 6.40 
Total 7919 100.00 12398 100.00 20317 100.00 
* zgon, choroba psychiczna, stały pobyt poza granicami Polski 
 
Tabela 2 Realizacja próby  –  populacja ogólnopolska w podziale na status  wywiadu i typ próby 
 Typ próby - podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 3775 47.24 4216 52.76 7991 100.00 
Odmowa 1291 34.32 2471 65.68 3762 100.00 
Dłuższa nieobecność 1874 32.41 3909 67.59 5783 100.00 
Nie przebywa pod 
wskazanym adresem 
396 37.46 661 62.54 1057 100.00 
Inne 143 33.81 280 66.19 423 100.00 
Nie wchodzi do badania* 440 33.82 861 66.18 1301 100.00 
Total 7919 38.98 12398 61.02 20317 100.00 
* zgon, choroba psychiczna, stały pobyt poza granicami Polski 
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Tabela 3 Realizacja próby  –  populacja ogólnopolska w podziale na płeć i status wywiadu 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 4290 41.99 3701 36.64 7991 39.33 
Odmowa 1930 18.89 1832 18.14 3762 18.52 
Dłuższa nieobecność 2743 26.85 3040 30.10 5783 28.46 
Nie przebywa pod 
wskazanym adresem 
489 4.79 568 5.62 1057 5.20 
Inne 154 1.51 269 2.66 423 2.08 
Nie wchodzi do badania* 611 5.98 690 6.83 1301 6.40 
Total 10217 100.00 10100 100.00 20317 100.00 
* zgon, choroba psychiczna, stały pobyt poza granicami Polski 
 
 
Tabela 4 Realizacja próby  –  populacja ogólnopolska w podziale na status wywiadu i płeć 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 4290 53.69 3701 46.31 7991 100.00 
Odmowa 1930 51.30 1832 48.70 3762 100.00 
Dłuższa nieobecność 2743 47.43 3040 52.57 5783 100.00 
Nie przebywa pod 
wskazanym adresem 
489 46.26 568 53.74 1057 100.00 
Inne 154 36.41 269 63.59 423 100.00 
Nie wchodzi do badania* 611 46.96 690 53.04 1301 100.00 
Total 10217 50.29 10100 49.71 20317 100.00 
* zgon, choroba psychiczna, stały pobyt poza granicami Polski 
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Tabela 5 Realizacja próby  –  populacja ogólnopolska w podziale na grupy wieku i status wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 1289 36.85 4933 37.69 1769 47.41 7991 39.33 
Odmowa 540 15.44 2457 18.77 765 20.50 3762 18.52 
Dłuższa nieobecność 1128 32.25 3834 29.29 821 22.00 5783 28.46 
Nie przebywa pod 
wskazanym adresem 
221 6.32 702 5.36 134 3.59 1057 5.20 
Inne 92 2.63 255 1.95 76 2.04 423 2.08 
Nie wchodzi do 
badania* 
228 6.52 907 6.93 166 4.45 1301 6.40 
Total 3498 100.00 13088 100.00 3731 100.00 20317 100.00 
* zgon, choroba psychiczna, stały pobyt poza granicami Polski 
 
Tabela 6 Realizacja próby  –  populacja ogólnopolska w podziale na status wywiadu i grupy wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 1289 16.13 4933 61.73 1769 22.14 7991 100.00 
Odmowa 540 14.35 2457 65.31 765 20.33 3762 100.00 
Dłuższa nieobecność 1128 19.51 3834 66.30 821 14.20 5783 100.00 
Nie przebywa pod 
wskazanym adresem 
221 20.91 702 66.41 134 12.68 1057 100.00 
Inne 92 21.75 255 60.28 76 17.97 423 100.00 
Nie wchodzi do 
badania* 
228 17.52 907 69.72 166 12.76 1301 100.00 
Total 3498 17.22 13088 64.42 3731 18.36 20317 100.00 
* zgon, choroba psychiczna, stały pobyt poza granicami Polski 
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EFEKTYWNOSC - POPULACJA OGÓLNOPOLSKA 
 
Tabela 7 Efektywność  –  populacja ogólnopolska w podziale na typ próby i status wywiadu 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 3775 50.47 4216 36.54 7991 42.02 
Odmowa 1291 17.26 2471 21.42 3762 19.78 
Dłuższa nieobecność 1874 25.06 3909 33.88 5783 30.41 
Nie przebywa pod 
wskazanym adresem 
396 5.29 661 5.73 1057 5.56 
Inne 143 1.91 280 2.43 423 2.22 
Total 7479 100.00 11537 100.00 19016 100.00 
 
Tabela 8 Efektywność  –  populacja ogólnopolska w podziale na status wywiadu i typ próby 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 3775 47.24 4216 52.76 7991 100.00 
Odmowa 1291 34.32 2471 65.68 3762 100.00 
Dłuższa nieobecność 1874 32.41 3909 67.59 5783 100.00 
Nie przebywa pod 
wskazanym adresem 
396 37.46 661 62.54 1057 100.00 
Inne 143 33.81 280 66.19 423 100.00 
Total 7479 39.33 11537 60.67 19016 100.00 
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Tabela 9 Efektywność –  populacja ogólnopolska w podziale na płeć i status wywiadu 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 4290 44.66 3701 39.33 7991 42.02 
Odmowa 1930 20.09 1832 19.47 3762 19.78 
Dłuższa nieobecność 2743 28.56 3040 32.31 5783 30.41 
Nie przebywa pod 
wskazanym adresem 
489 5.09 568 6.04 1057 5.56 
Inne 154 1.60 269 2.86 423 2.22 
Total 9606 100.00 9410 100.00 19016 100.00 
 
Tabela 10 Efektywność –  populacja ogólnopolska w podziale na  status wywiadu i płeć 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 4290 53.69 3701 46.31 7991 100.00 
Odmowa 1930 51.30 1832 48.70 3762 100.00 
Dłuższa nieobecność 2743 47.43 3040 52.57 5783 100.00 
Nie przebywa pod 
wskazanym adresem 
489 46.26 568 53.74 1057 100.00 
Inne 154 36.41 269 63.59 423 100.00 
Total 9606 50.52 9410 49.48 19016 100.00 
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Tabela 11 Efektywność –  populacja ogólnopolska w podziale na grupy wieku i status wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 1289 39.42 4933 40.50 1769 49.62 7991 42.02 
Odmowa 540 16.51 2457 20.17 765 21.46 3762 19.78 
Dłuższa nieobecność 1128 34.50 3834 31.48 821 23.03 5783 30.41 
Nie przebywa pod 
wskazanym adresem 
221 6.76 702 5.76 134 3.76 1057 5.56 
Inne 92 2.81 255 2.09 76 2.13 423 2.22 
Total 3270 100.00 12181 100.00 3565 100.00 19016 100.00 
 
 
 
Tabela 12 Efektywność  –  populacja ogólnopolska w podziale na status wywiadu i grupy wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 1289 16.13 4933 61.73 1769 22.14 7991 100.00 
Odmowa 540 14.35 2457 65.31 765 20.33 3762 100.00 
Dłuższa nieobecność 1128 19.51 3834 66.30 821 14.20 5783 100.00 
Nie przebywa pod 
wskazanym adresem 
221 20.91 702 66.41 134 12.68 1057 100.00 
Inne 92 21.75 255 60.28 76 17.97 423 100.00 
Total 3270 17.20 12181 64.06 3565 18.75 19016 100.00 
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EFEKTYWNOŚĆ - POPULACJA OGÓLNOPOLSKA – PŁEĆ 
 
Tabela 13 Efektywność  –  populacja ogólnopolska, kobiety,  w podziale na typ próby i status 
wywiadu 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 2124 53.94 2166 38.21 4290 44.60 
Odmowa 707 17.95 1223 21.58 1930 20.09 
Dłuższa nieobecność 878 22.30 1865 32.90 2743 28.56 
Nie przebywa pod 
wskazanym adresem 
184 4.67 305 5.38 489 5.09 
Inne 45 1.14 109 1.92 154 1.60 
Total 3938 100.00 5668 100.00 9606 100.00 
 
 
Tabela 14 Efektywność  –  populacja ogólnopolska, mężczyźni,  w podziale na typ próby i status 
wywiadu 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 1651 46.63 2050 34.93 3701 39.33 
Odmowa 584 16.49 1248 21.26 1832 19.47 
Dłuższa nieobecność 996 28.13 2044 34.83 3040 32.31 
Nie przebywa pod 
wskazanym adresem 
212 5.99 356 6.07 568 6.04 
Inne 98 2.77 171 2.91 269 2.86 
Total 3541 100.00 5869 100.00 9410 100.00 
 
 
285 
 
 
Tabela 15 Efektywność  –  populacja ogólnopolska, kobiety,  w podziale na status wywiadu i typ 
próby 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 2124 49.51 2166 50.49 4290 100.00 
Odmowa 707 36.63 1223 63.37 1930 100.00 
Dłuższa nieobecność 878 32.01 1865 67.99 2743 100.00 
Nie przebywa pod 
wskazanym adresem 
184 37.63 305 62.37 489 100.00 
Inne 45 29.22 109 70.78 154 100.00 
Total 3938 41.00 5668 59.00 9606 100.00 
 
Tabela 16 Efektywność  –  populacja ogólnopolska, mężczyźni,  w podziale na  status wywiadu i typ 
próby 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 1651 44.61 2050 55.39 3701 100.00 
Odmowa 584 31.88 1248 68.12 1832 100.00 
Dłuższa nieobecność 996 32.76 2044 67.24 3040 100.00 
Nie przebywa pod 
wskazanym adresem 
212 37.32 356 62.68 568 100.00 
Inne 98 36.43 171 63.57 269 100.00 
Total 3541 37.63 5869 62.37 9410 100.00 
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Tabela 17 Efektywność  –  populacja ogólnopolska, kobiety,  w podziale na grupy wieku i status 
wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 636 40.43 2597 44.21 1057 48.96 4290 44.66 
Odmowa 256 16.27 1196 20.36 478 22.14 1930 20.09 
Dłuższa nieobecność 542 34.46 1708 29.08 493 22.83 2743 28.56 
Nie przebywa pod 
wskazanym adresem 
109 6.93 292 4.97 88 4.08 489 5.09 
Inne 30 1.91 81 1.38 43 1.99 154 1.60 
Total 1573 100.00 5874 100.00 2159 100.00 9606 100.00 
 
 
Tabela 18 Efektywność  –  populacja ogólnopolska, mężczyźni,  w podziale na grupy wieku i status 
wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 653 38.48 2336 37.04 712 50.64 3701 39.33 
Odmowa 284 16.74 1261 19.99 287 20.41 1832 19.47 
Dłuższa nieobecność 586 34.53 2126 33.71 328 23.33 3040 32.31 
Nie przebywa pod 
wskazanym adresem 
112 6.60 410 6.50 46 3.27 568 6.04 
Inne 62 3.65 174 2.76 33 2.35 269 2.86 
Total 1697 100.00 6307 100.00 1406 100.00 9410 100.00 
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Tabela 19 Efektywność  –  populacja ogólnopolska, kobiety,  w podziale na status wywiadu i grupy 
wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 636 14.83 2597 60.54 1057 24.64 4290 100.00 
Odmowa 256 13.26 1196 61.97 478 24.77 1930 100.00 
Dłuższa nieobecność 542 19.76 1708 62.27 493 17.97 2743 100.00 
Nie przebywa pod 
wskazanym adresem 
109 22.29 292 59.71 88 18.00 489 100.00 
Inne 30 19.48 81 52.60 43 27.92 154 100.00 
Total 1573 16.38 5874 61.15 2159 22.48 9606 100.00 
 
 
Tabela 20 Efektywność  –  populacja ogólnopolska, mężczyźni,  w podziale na status wywiadu i grupy wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 653 17.64 2336 63.12 712 19.24 3701 100.00 
Odmowa 284 15.50 1261 68.83 287 15.67 1832 100.00 
Dłuższa nieobecność 586 19.28 2126 69.93 328 10.79 3040 100.00 
Nie przebywa pod 
wskazanym adresem 
112 19.72 410 72.18 46 8.10 568 100.00 
Inne 62 23.05 174 64.68 33 12.27 269 100.00 
Total 1697 18.03 6307 67.02 1406 14.94 9410 100.00 
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EFEKTYWNOŚĆ -  WOJEWÓDZTWO DOLNOŚLĄSKIE 
 
Tabela 21 Efektywność  –  województwo dolnośląskie w podziale na typ próby i status wywiadu 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 228 52.05 270 35.62 498 41.64 
Odmowa 71 16.21 135 17.81 206 17.22 
Dłuższa nieobecność 94 21.46 215 28.36 309 25.84 
Nie przebywa pod 
wskazanym adresem 
28 6.39 85 11.21 113 9.45 
Inne 17 3.88 53 6.99 70 5.85 
Total 438 100.00 758 100.00 1196 100.00 
 
Tabela 22 Efektywność  –  województwo dolnośląskie w podziale na status wywiadu i typ próby 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 228 45.78 270 54.22 498 100.00 
Odmowa 71 34.47 135 65.53 206 100.00 
Dłuższa nieobecność 94 30.42 215 69.58 309 100.00 
Nie przebywa pod 
wskazanym adresem 
28 24.78 85 75.22 113 100.00 
Inne 17 24.29 53 75.71 70 100.00 
Total 438 36.62 758 63.38 1196 100.00 
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Tabela 23 Efektywność –  województwo dolnośląskie w podziale na płeć i status wywiadu 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 261 43.94 237 39.37 498 41.64 
Odmowa 96 16.16 110 18.27 206 17.22 
Dłuższa nieobecność 151 25.42 158 26.25 309 25.84 
Nie przebywa pod 
wskazanym adresem 
57 9.60 56 9.30 113 9.45 
Inne 29 4.88 41 6.81 70 5.85 
Total 594 100.00 602 100.00 1196 100.00 
 
Tabela 24 Efektywność –  województwo dolnośląskie w podziale na  status wywiadu i płeć 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 261 52.41 237 47.59 498 100.00 
Odmowa 96 46.60 110 53.40 206 100.00 
Dłuższa nieobecność 151 48.87 158 51.13 309 100.00 
Nie przebywa pod 
wskazanym adresem 
57 50.44 56 49.56 113 100.00 
Inne 29 41.43 41 58.57 70 100.00 
Total 594 49.67 602 50.33 1196 100.00 
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Tabela 25 Efektywność –  województwo dolnośląskie w podziale na grupy wieku i status wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 87 41.04 302 39.89 109 48.02 498 41.64 
Odmowa 30 14.15 141 18.63 35 15.42 206 17.22 
Dłuższa nieobecność 58 27.36 189 24.97 62 27.31 309 25.84 
Nie przebywa pod 
wskazanym adresem 
25 11.79 73 9.64 15 6.61 113 9.45 
Inne 12 5.66 52 6.87 6 2.64 70 5.85 
Total 212 100.00 757 100.00 227 100.00 1196 100.00 
 
 
 
Tabela 26 Efektywność  –  województwo dolnośląskie w podziale na status wywiadu i grupy wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 87 17.47 302 60.64 109 21.89 498 100.00 
Odmowa 30 14.56 141 68.45 35 16.99 206 100.00 
Dłuższa nieobecność 58 18.77 189 61.17 62 20.06 309 100.00 
Nie przebywa pod 
wskazanym adresem 
25 22.12 73 64.60 15 13.27 113 100.00 
Inne 12 17.14 52 74.29 6 8.57 70 100.00 
Total 212 17.73 757 63.29 227 18.98 1196 100.00 
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EFEKTYWNOŚĆ -  WOJEWÓDZTWO KUJAWSKO-POMORSKIE 
Tabela 27 Efektywność  –  województwo kujawsko-pomorskie w podziale na typ próby i status 
wywiadu 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 245 51.15 251 33.03 496 40.03 
Odmowa 91 19.00 131 17.24 222 17.92 
Dłuższa nieobecność 114 23.80 351 46.18 465 37.53 
Nie przebywa pod 
wskazanym adresem 
27 5.64 25 3.29 52 4.20 
Inne 2 0.42 2 0.26 4 0.32 
Total 479 100.00 760 100.00 1239 100.00 
 
Tabela 28 Efektywność – województwo kujawsko-pomorskie w podziale na status wywiadu i typ 
próby 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 245 49.40 251 50.60 496 100.00 
Odmowa 91 40.99 131 59.01 222 100.00 
Dłuższa nieobecność 114 24.52 351 75.48 465 100.00 
Nie przebywa pod 
wskazanym adresem 
27 51.92 25 48.08 52 100.00 
Inne 2 50.00 2 50.00 4 100.00 
Total 479 38.66 760 61.34 1239 100.00 
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Tabela 29 Efektywność –  województwo kujawsko-pomorskie w podziale na płeć i status wywiadu 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 264 40.74 232 39.26 496 40.03 
Odmowa 124 19.14 98 16.58 222 17.92 
Dłuższa nieobecność 238 36.73 227 38.41 465 37.53 
Nie przebywa pod 
wskazanym adresem 
22 3.40 30 5.08 52 4.20 
Inne 0 0.00 4 0.68 4 0.32 
Total 648 100.00 591 100.00 1239 100.00 
 
Tabela 30 Efektywność –  województwo kujawsko-pomorskie w podziale na  status wywiadu i płeć 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 264 53.23 232 46.77 496 100.00 
Odmowa 124 55.86 98 44.14 222 100.00 
Dłuższa nieobecność 238 51.18 227 48.82 465 100.00 
Nie przebywa pod 
wskazanym adresem 
22 42.31 30 57.69 52 100.00 
Inne 0 0.00 4 100.00 4 100.00 
Total 648 52.30 591 47.70 1239 100.00 
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Tabela 31 Efektywność –  województwo kujawsko-pomorskie w podziale na grupy wieku i status 
wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 87 39.73 317 39.77 92 41.26 496 40.03 
Odmowa 36 16.44 138 17.31 48 21.52 222 17.92 
Dłuższa nieobecność 82 37.44 306 38.39 77 34.53 465 37.53 
Nie przebywa pod 
wskazanym adresem 
14 6.39 32 4.02 6 2.69 52 4.20 
Inne 0 0.00 4 0.50 0 0.00 4 0.32 
Total 219 100.00 797 100.00 223 100.00 1239 100.00 
 
 
 
Tabela 32 Efektywność  –  województwo kijawsko-pomorskie w podziale na status wywiadu i grupy 
wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 87 17.54 317 63.91 92 18.55 496 100.00 
Odmowa 36 16.22 138 62.16 48 21.62 222 100.00 
Dłuższa nieobecność 82 17.63 306 65.81 77 16.56 465 100.00 
Nie przebywa pod 
wskazanym adresem 
14 26.92 32 61.54 6 11.54 52 100.00 
Inne 0 0.00 4 100.00 0 0.00 4 100.00 
Total 219 17.68 797 64.33 223 18.00 1239 100.00 
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EFEKTYWNOŚĆ -  WOJEWÓDZTWO ŁÓDZKIE 
Tabela 33 Efektywność – województwo łódzkie, w podziale na typ próby i status wywiadu 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 243 50.10 269 40.03 512 44.25 
Odmowa 107 22.06 173 25.74 280 24.20 
Dłuższa nieobecność 115 23.71 178 26.49 293 25.32 
Nie przebywa pod 
wskazanym adresem 
15 3.09 42 6.25 57 4.93 
Inne 5 1.03 10 1.49 15 1.30 
Total 485 100.00 672 100.00 1157 100.00 
 
Tabela 34 Efektywność – województwo łódzkie w podziale na status wywiadu i typ próby 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 243 47.46 269 52.54 512 100.00 
Odmowa 107 38.21 173 61.79 280 100.00 
Dłuższa nieobecność 115 39.25 178 60.75 293 100.00 
Nie przebywa pod 
wskazanym adresem 
15 26.32 42 73.68 57 100.00 
Inne 5 33.33 10 66.67 15 100.00 
Total 485 41.92 672 58.08 1157 100.00 
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Tabela 35 Efektywność –  województwo łódzkie w podziale na płeć i status wywiadu 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 273 44.03 239 44.51 512 44.25 
Odmowa 155 25.00 125 23.28 280 24.20 
Dłuższa nieobecność 160 25.81 133 24.77 293 25.32 
Nie przebywa pod 
wskazanym adresem 
28 4.52 29 5.40 57 4.93 
Inne 4 0.65 11 2.05 15 1.30 
Total 620 100.00 537 100.00 1157 100.00 
 
Tabela 36 Efektywność –  województwo łódzkie w podziale na  status wywiadu i płeć 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 273 53.32 239 46.68 512 100.00 
Odmowa 155 55.36 125 44.64 280 100.00 
Dłuższa nieobecność 160 54.61 133 45.39 293 100.00 
Nie przebywa pod 
wskazanym adresem 
28 49.12 29 50.88 57 100.00 
Inne 4 26.67 11 73.33 15 100.00 
Total 620 53.59 537 46.41 1157 100.00 
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Tabela 37 Efektywność –  województwo łódzkie w podziale na grupy wieku i status wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 73 46.79 316 42.59 123 47.49 512 44.25 
Odmowa 33 21.15 166 22.37 81 31.27 280 24.20 
Dłuższa nieobecność 41 26.28 210 28.30 42 16.22 293 25.32 
Nie przebywa pod 
wskazanym adresem 
6 3.85 42 5.66 9 3.47 57 4.93 
Inne 3 1.92 8 1.08 4 1.54 15 1.30 
Total 156 100.00 742 100.00 259 100.00 1157 100.00 
 
 
 
Tabela 38 Efektywność  –   województwo łódzkie w podziale na status wywiadu i grupy wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 73 14.26 316 61.72 123 24.02 512 100.00 
Odmowa 33 11.79 166 59.29 81 28.93 280 100.00 
Dłuższa nieobecność 41 13.99 210 71.67 42 14.33 293 100.00 
Nie przebywa pod 
wskazanym adresem 
6 10.53 42 73.68 9 15.79 57 100.00 
Inne 3 20.00 8 53.33 4 26.67 15 100.00 
Total 156 13.48 742 64.13 259 22.39 1157 100.00 
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EFEKTYWNOŚĆ -  WOJEWÓDZTWO LUBELSKIE 
Tabela 39 Efektywność – województwo lubelskie, w podziale na typ próby i status wywiadu 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 257 52.56 245 35.66 502 42.69 
Odmowa 60 12.27 158 23.00 218 18.54 
Dłuższa nieobecność 163 33.33 274 39.88 437 37.16 
Nie przebywa pod 
wskazanym adresem 
7 1.43 10 1.46 17 1.45 
Inne 2 0.41 0 0.00 2 0.17 
Total 489 100.00 687 100.00 1176 100.00 
 
Tabela 40 Efektywność – województwo lubelskie w podziale na status wywiadu i typ próby 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 257 51.20 245 48.80 502 100.00 
Odmowa 60 27.52 158 72.48 218 100.00 
Dłuższa nieobecność 163 37.30 274 62.70 437 100.00 
Nie przebywa pod 
wskazanym adresem 
7 41.18 10 58.82 17 100.00 
Inne 2 100.00 0 0.00 2 100.00 
Total 489 41.58 687 58.42 1176 100.00 
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Tabela 41 Efektywność –  województwo lubelskie w podziale na płeć i status wywiadu 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 273 45.88 229 39.41 502 42.69 
Odmowa 104 17.48 114 19.62 218 18.54 
Dłuższa nieobecność 208 34.96 229 39.41 437 37.16 
Nie przebywa pod 
wskazanym adresem 
9 1.51 8 1.38 17 1.45 
Inne 1 0.17 1 0.17 2 0.17 
Total 595 100.00 581 100.00 1176 100.00 
 
Tabela 42 Efektywność –  województwo lubelskie w podziale na  status wywiadu i płeć 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 273 54.38 229 45.62 502 100.00 
Odmowa 104 47.71 114 52.29 218 100.00 
Dłuższa nieobecność 208 47.60 229 52.40 437 100.00 
Nie przebywa pod 
wskazanym adresem 
9 52.94 8 47.06 17 100.00 
Inne 1 50.00 1 50.00 2 100.00 
Total 595 50.60 581 49.40 1176 100.00 
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Tabela 43 Efektywność – województwo lubelskie w podziale na grupy wieku i status wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 85 38.81 303 41.39 114 50.67 502 42.69 
Odmowa 16 7.31 141 19.26 61 27.11 218 18.54 
Dłuższa nieobecność 116 52.97 273 37.30 48 21.33 437 37.16 
Nie przebywa pod 
wskazanym adresem 
1 0.46 14 1.91 2 0.89 17 1.45 
Inne 1 0.46 1 0.14 0 0.00 2 0.17 
Total 219 100.00 732 100.00 225 100.00 1176 100.00 
 
 
 
Tabela 44 Efektywność  –   województwo lubelskie w podziale na status wywiadu i grupy wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 85 16.93 303 60.36 114 22.71 502 100.00 
Odmowa 16 7.34 141 64.68 61 27.98 218 100.00 
Dłuższa nieobecność 116 26.54 273 62.47 48 10.98 437 100.00 
Nie przebywa pod 
wskazanym adresem 
1 5.88 14 82.35 2 11.76 17 100.00 
Inne 1 50.00 1 50.00 0 0.00 2 100.00 
Total 219 18.62 732 62.24 225 19.13 1176 100.00 
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EFEKTYWNOŚĆ -  WOJEWÓDZTWO LUBUSKIE 
Tabela 45 Efektywność – województwo lubuskie, w podziale na typ próby i status wywiadu 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 249 52.64 241 31.30 490 39.42 
Odmowa 91 19.24 195 25.32 286 23.01 
Dłuższa nieobecność 104 21.99 294 38.18 398 32.02 
Nie przebywa pod 
wskazanym adresem 
26 5.50 26 3.38 52 4.18 
Inne 3 0.63 14 1.82 17 1.37 
Total 473 100.00 770 100.00 1243 100.00 
 
Tabela 46 Efektywność – województwo lubuskie w podziale na status wywiadu i typ próby 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 249 50.82 241 49.18 490 100.00 
Odmowa 91 31.82 195 68.18 286 100.00 
Dłuższa nieobecność 104 26.13 294 73.87 398 100.00 
Nie przebywa pod 
wskazanym adresem 
26 50.00 26 50.00 52 100.00 
Inne 3 17.65 14 82.35 17 100.00 
Total 473 38.05 770 61.95 1243 100.00 
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Tabela 47 Efektywność –  województwo lubuskie w podziale na płeć i status wywiadu 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 257 40.79 233 38.01 490 39.42 
Odmowa 153 24.29 133 21.70 286 23.01 
Dłuższa nieobecność 187 29.68 211 34.42 398 32.02 
Nie przebywa pod 
wskazanym adresem 
26 4.13 26 4.24 52 4.18 
Inne 7 1.11 10 1.63 17 1.37 
Total 630 100.00 613 100.00 1243 100.00 
 
Tabela 48 Efektywność –  województwo lubuskie w podziale na  status wywiadu i płeć 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 257 52.45 233 47.55 490 100.00 
Odmowa 153 53.50 133 46.50 286 100.00 
Dłuższa nieobecność 187 46.98 211 53.02 398 100.00 
Nie przebywa pod 
wskazanym adresem 
26 50.00 26 50.00 52 100.00 
Inne 7 41.18 10 58.85 17 100.00 
Total 630 50.68 613 49.32 1243 100.00 
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Tabela 49 Efektywność – województwo lubuskie w podziale na grupy wieku i status wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 80 35.56 313 38.40 97 47.78 490 39.42 
Odmowa 52 23.11 189 23.19 45 22.17 286 23.01 
Dłuższa nieobecność 74 32.89 268 32.88 56 27.59 398 32.02 
Nie przebywa pod 
wskazanym adresem 
18 8.00 31 3.80 3 1.48 52 4.18 
Inne 1 0.44 14 1.72 2 0.99 17 1.37 
Total 225 100.00 815 100.00 203 100.00 1243 100.00 
 
 
 
Tabela 50 Efektywność – województwo lubuskie w podziale na status wywiadu i grupy wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 80 16.33 313 63.88 97 19.80 490 100.00 
Odmowa 52 18.18 189 66.08 45 15.73 286 100.00 
Dłuższa nieobecność 74 18.59 268 67.34 56 14.07 398 100.00 
Nie przebywa pod 
wskazanym adresem 
18 34.62 31 59.62 3 5.77 52 100.00 
Inne 1 5.88 14 82.35 2 11.76 17 100.00 
Total 225 18.10 815 65.57 203 16.33 1243 100.00 
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EFEKTYWNOŚĆ -  WOJEWÓDZTWO MAŁOPOLSKIE 
Tabela 51 Efektywność – województwo małopolskie, w podziale na typ próby i status wywiadu 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 225 48.18 274 36.93 499 41.27 
Odmowa 62 13.28 140 18.87 202 16.71 
Dłuższa nieobecność 122 26.12 227 30.59 349 28.87 
Nie przebywa pod 
wskazanym adresem 
36 7.71 73 9.84 109 9.02 
Inne 22 4.71 28 3.77 50 4.14 
Total 467 100.00 742 100.00 1209 100.00 
 
Tabela 52 Efektywność – województwo małopolskie w podziale na status wywiadu i typ próby 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 225 45.09 274 54.91 499 100.00 
Odmowa 62 30.69 140 69.31 202 100.00 
Dłuższa nieobecność 122 34.96 227 65.04 349 100.00 
Nie przebywa pod 
wskazanym adresem 
36 33.03 73 66.97 109 100.00 
Inne 22 44.00 28 56.00 50 100.00 
Total 467 38.63 742 61.37 1209 100.00 
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Tabela 53 Efektywność –  województwo małopolskie w podziale na płeć i status wywiadu 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 263 43.76 236 38.82 499 41.27 
Odmowa 118 19.63 84 13.82 202 16.71 
Dłuższa nieobecność 152 25.29 197 32.40 349 28.87 
Nie przebywa pod 
wskazanym adresem 
48 7.99 61 10.03 109 9.02 
Inne 20 3.33 30 4.93 50 4.14 
Total 601 100.00 608 100.00 1209 100.00 
 
Tabela 54 Efektywność –  województwo małopolskie w podziale na  status wywiadu i płeć 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 263 52.71 236 47.29 499 100.00 
Odmowa 118 58.42 84 41.58 202 100.00 
Dłuższa nieobecność 152 43.55 197 56.45 349 100.00 
Nie przebywa pod 
wskazanym adresem 
48 44.04 61 55.96 109 100.00 
Inne 20 40.00 30 60.00 50 100.00 
Total 601 49.71 608 50.29 1209 100.00 
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Tabela 55 Efektywność – województwo małopolskie w podziale na grupy wieku i status wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 81 40.10 300 38.86 118 50.21 499 41.27 
Odmowa 25 12.38 137 17.75 40 17.02 202 16.71 
Dłuższa nieobecność 69 34.16 234 30.31 46 19.57 349 28.87 
Nie przebywa pod 
wskazanym adresem 
16 7.92 79 10.23 14 5.96 109 9.02 
Inne 11 5.45 22 2.85 17 7.23 50 4.14 
Total 202 100.00 772 100.00 235 100.00 1209 100.00 
 
 
 
Tabela 56 Efektywność – województwo małopolskie w podziale na status wywiadu i grupy wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 81 16.23 300 60.12 118 23.65 499 100.00 
Odmowa 25 12.38 137 67.82 40 19.80 202 100.00 
Dłuższa nieobecność 69 19.77 234 67.05 46 13.18 349 100.00 
Nie przebywa pod 
wskazanym adresem 
16 14.68 79 72.48 14 12.84 109 100.00 
Inne 11 22.00 22 44.00 17 34.00 50 100.00 
Total 202 16.71 772 63.85 235 19.44 1209 100.00 
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EFEKTYWNOŚĆ -  WOJEWÓDZTWO MAZOWIECKIE 
Tabela 57 Efektywność – województwo mazowieckie, w podziale na typ próby i status wywiadu 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 207 48.36 263 35.88 470 40.48 
Odmowa 65 15.19 134 18.28 199 17.14 
Dłuższa nieobecność 102 23.83 215 29.33 317 27.30 
Nie przebywa pod 
wskazanym adresem 
35 8.18 82 11.19 117 10.08 
Inne 19 4.44 39 5.32 58 5.00 
Total 428 100.00 733 100.00 1161 100.00 
 
Tabela 58 Efektywność – województwo mazowieckie w podziale na status wywiadu i typ próby 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 207 44.04 263 55.96 470 100.00 
Odmowa 65 32.66 134 67.34 199 100.00 
Dłuższa nieobecność 102 32.18 215 67.85 317 100.00 
Nie przebywa pod 
wskazanym adresem 
35 29.91 82 70.09 117 100.00 
Inne 19 32.76 39 67.24 58 100.00 
Total 428 36.86 733 63.14 1161 100.00 
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Tabela 59 Efektywność –  województwo mazowieckie w podziale na płeć i status wywiadu 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 277 46.17 193 34.40 470 40.48 
Odmowa 80 13.33 119 21.21 199 17.14 
Dłuższa nieobecność 162 27.00 155 27.63 317 27.30 
Nie przebywa pod 
wskazanym adresem 
53 8.83 64 11.41 117 10.08 
Inne 28 4.67 30 5.35 58 5.00 
Total 600 100.00 561 100.00 1161 100.00 
 
Tabela 60 Efektywność –  województwo mazowieckie w podziale na  status wywiadu i płeć 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 277 58.94 193 41.06 470 100.00 
Odmowa 80 40.20 119 59.80 199 100.00 
Dłuższa nieobecność 162 51.10 155 48.90 317 100.00 
Nie przebywa pod 
wskazanym adresem 
53 45.30 64 54.70 117 100.00 
Inne 28 48.28 30 51.72 58 100.00 
Total 600 51.68 561 48.32 1161 100.00 
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Tabela 61 Efektywność – województwo mazowieckie w podziale na grupy wieku i status wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 69 35.03 278 38.88 123 49.40 470 40.48 
Odmowa 33 16.75 130 18.18 36 14.46 199 17.14 
Dłuższa nieobecność 59 29.95 205 28.67 53 21.29 317 27.30 
Nie przebywa pod 
wskazanym adresem 
22 11.17 70 9.79 25 10.04 117 10.08 
Inne 14 7.11 32 4.48 12 4.82 58 5.00 
Total 197 100.00 715 100.00 249 100.00 1161 100.00 
 
 
 
Tabela 62 Efektywność – województwo mazowieckie w podziale na status wywiadu i grupy wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 69 14.68 278 59.15 123 26.17 470 100.00 
Odmowa 33 16.58 130 65.33 36 18.09 199 100.00 
Dłuższa nieobecność 59 18.61 205 64.67 53 16.72 317 100.00 
Nie przebywa pod 
wskazanym adresem 
22 18.80 70 59.83 25 21.37 117 100.00 
Inne 14 24.14 32 55.17 12 20.69 58 100.00 
Total 197 16.97 715 61.58 249 21.45 1161 100.00 
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EFEKTYWNOŚĆ -  WOJEWÓDZTWO OPOLSKIE 
Tabela 63 Efektywność – województwo opolskie, w podziale na typ próby i status wywiadu 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 265 55.91 230 35.66 495 44.24 
Odmowa 93 19.62 172 26.67 265 23.68 
Dłuższa nieobecność 82 17.30 186 28.84 268 23.95 
Nie przebywa pod 
wskazanym adresem 
27 5.70 36 5.58 63 5.63 
Inne 7 1.48 21 3.26 28 2.50 
Total 474 100.00 645 100.00 1119 100.00 
 
Tabela 64 Efektywność – województwo opolskie w podziale na status wywiadu i typ próby 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 265 53.54 230 46.46 495 100.00 
Odmowa 93 35.09 172 64.91 265 100.00 
Dłuższa nieobecność 82 30.60 186 69.40 268 100.00 
Nie przebywa pod 
wskazanym adresem 
27 42.86 36 57.14 63 100.00 
Inne 7 25.00 21 75.00 28 100.00 
Total 474 42.36 645 57.64 1119 100.00 
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Tabela 65 Efektywność – województwo opolskie w podziale na płeć i status wywiadu 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 266 48.45 229 40.18 495 44.24 
Odmowa 137 24.95 128 22.46 265 23.68 
Dłuższa nieobecność 108 19.67 160 28.07 268 23.95 
Nie przebywa pod 
wskazanym adresem 
29 5.28 34 5.96 63 5.63 
Inne 9 1.64 19 3.33 28 2.50 
Total 549 100.00 570 100.00 1119 100.00 
 
Tabela 66 Efektywność –  województwo opolskie w podziale na  status wywiadu i płeć 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 266 53.74 229 46.26 495 100.00 
Odmowa 137 51.70 128 48.30 265 100.00 
Dłuższa nieobecność 108 40.30 160 59.70 268 100.00 
Nie przebywa pod 
wskazanym adresem 
29 46.03 34 53.97 63 100.00 
Inne 9 32.14 19 67.86 28 100.00 
Total 549 49.06 570 50.94 1119 100.00 
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Tabela 67 Efektywność – województwo opolskie w podziale na grupy wieku i status wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 70 36.27 311 43.44 114 54.29 495 44.24 
Odmowa 45 23.32 169 23.60 51 24.29 265 23.68 
Dłuższa nieobecność 57 29.53 175 24.44 36 17.14 268 23.95 
Nie przebywa pod 
wskazanym adresem 
15 7.77 44 6.15 4 1.90 63 5.63 
Inne 6 3.11 17 2.37 5 2.38 28 2.50 
Total 193 100.00 716 100.00 210 100.00 1119 100.00 
 
 
 
Tabela 68 Efektywność – województwo opolskie w podziale na status wywiadu i grupy wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 70 14.14 311 62.83 114 23.03 495 100.00 
Odmowa 45 16.98 169 63.77 51 19.25 265 100.00 
Dłuższa nieobecność 57 21.27 175 65.30 36 13.43 268 100.00 
Nie przebywa pod 
wskazanym adresem 
15 23.81 44 69.84 4 6.35 63 100.00 
Inne 6 21.43 17 60.71 5 17.86 28 100.00 
Total 193 17.25 716 63.99 210 18.77 1119 100.00 
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EFEKTYWNOŚĆ -  WOJEWÓDZTWO PODKARPACKIE 
Tabela 69 Efektywność – województwo podkarpackie, w podziale na typ próby i status wywiadu 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 236 52.21 266 42.83 502 46.78 
Odmowa 67 14.82 80 12.88 147 13.70 
Dłuższa nieobecność 117 25.88 253 40.47 370 34.48 
Nie przebywa pod 
wskazanym adresem 
22 4.87 15 2.42 37 3.45 
Inne 10 2.21 7 1.13 17 1.58 
Total 452 100.00 621 100.00 1073 100.00 
 
Tabela 70 Efektywność – województwo podkarpackie w podziale na status wywiadu i typ próby 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 236 47.01 266 52.99 502 100.00 
Odmowa 67 45.58 80 54.42 147 100.00 
Dłuższa nieobecność 117 31.62 253 68.38 370 100.00 
Nie przebywa pod 
wskazanym adresem 
22 59.46 15 40.54 37 100.00 
Inne 10 58.82 7 41.18 17 100.00 
Total 452 42.12 621 57.88 1073 100.00 
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Tabela 71 Efektywność – województwo podkarpackie w podziale na płeć i status wywiadu 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 267 50.28 235 43.36 502 46.78 
Odmowa 77 14.50 70 12.92 147 13.70 
Dłuższa nieobecność 165 31.07 205 37.82 370 34.48 
Nie przebywa pod 
wskazanym adresem 
16 3.01 21 3.87 37 3.45 
Inne 6 1.13 11 2.03 17 1.58 
Total 531 100.00 542 100.00 1073 100.00 
 
Tabela 72 Efektywność –  województwo podkarpackie w podziale na  status wywiadu i płeć 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 267 53.19 235 46.81 502 100.00 
Odmowa 77 52.38 70 47.62 147 100.00 
Dłuższa nieobecność 165 44.59 205 55.41 370 100.00 
Nie przebywa pod 
wskazanym adresem 
16 43.24 21 56.76 37 100.00 
Inne 6 35.29 11 64.71 17 100.00 
Total 531 49.49 542 50.51 1073 100.00 
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Tabela 73 Efektywność – województwo podkarpackie w podziale na grupy wieku i status wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 78 40.00 319 46.64 105 54.12 502 46.78 
Odmowa 20 10.26 97 14.18 30 15.46 147 13.70 
Dłuższa nieobecność 88 45.13 232 33.92 50 25.77 370 34.48 
Nie przebywa pod 
wskazanym adresem 
5 2.56 28 4.09 4 2.06 37 3.45 
Inne 4 2.05 8 1.17 5 2.58 17 1.58 
Total 195 100.00 684 100.00 194 100.00 1073 100.00 
 
 
 
Tabela 74 Efektywność – województwo podkarpackie w podziale na status wywiadu i grupy wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 78 15.54 319 63.55 105 20.92 502 100.00 
Odmowa 20 13.61 97 65.99 30 20.41 147 100.00 
Dłuższa nieobecność 88 23.78 232 62.70 50 13.51 370 100.00 
Nie przebywa pod 
wskazanym adresem 
5 13.51 28 75.68 4 10.81 37 100.00 
Inne 4 23.53 8 47.06 5 29.41 17 100.00 
Total 195 18.17 684 63.75 194 18.08 1073 100.00 
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EFEKTYWNOŚĆ -  WOJEWÓDZTWO PODLASKIE 
Tabela 75 Efektywność – województwo podlaskie, w podziale na typ próby i status wywiadu 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 225 47.17 289 34.45 514 39.06 
Odmowa 93 19.50 234 27.89 327 24.85 
Dłuższa nieobecność 123 26.21 254 30.27 379 28.80 
Nie przebywa pod 
wskazanym adresem 
28 5.87 50 5.96 78 5.93 
Inne 6 1.26 12 1.43 18 1.37 
Total 477 100.00 839 100.00 1316 100.00 
 
Tabela 76 Efektywność – województwo podlaskie w podziale na status wywiadu i typ próby 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 225 43.77 289 56.23 514 100.00 
Odmowa 93 28.44 234 71.56 327 100.00 
Dłuższa nieobecność 123 32.98 254 67.02 379 100.00 
Nie przebywa pod 
wskazanym adresem 
28 35.90 50 64.10 78 100.00 
Inne 6 33.33 12 66.67 18 100.00 
Total 477 36.25 839 63.75 1316 100.00 
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Tabela 77 Efektywność – województwo podlaskie w podziale na płeć i status wywiadu 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 284 43.36 230 34.80 514 39.06 
Odmowa 153 23.36 174 26.32 327 24.85 
Dłuższa nieobecność 174 26.56 205 31.01 379 28.80 
Nie przebywa pod 
wskazanym adresem 
41 6.26 37 5.60 78 5.93 
Inne 3 0.46 15 2.27 18 1.37 
Total 655 100.00 661 100.00 1316 100.00 
 
Tabela 78 Efektywność –  województwo podlaskie w podziale na  status wywiadu i płeć 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 284 55.25 230 44.75 514 100.00 
Odmowa 153 46.79 174 53.21 327 100.00 
Dłuższa nieobecność 174 45.91 205 54.09 379 100.00 
Nie przebywa pod 
wskazanym adresem 
41 52.56 37 47.44 78 100.00 
Inne 3 16.67 15 83.33 18 100.00 
Total 655 46.77 661 50.23 1316 100.00 
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Tabela 79 Efektywność – województwo podlaskie w podziale na grupy wieku i status wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 79 33.19 303 36.68 132 52.38 514 39.06 
Odmowa 61 25.63 208 25.18 58 23.02 327 24.85 
Dłuższa nieobecność 75 31.51 251 30.39 53 21.03 379 28.80 
Nie przebywa pod 
wskazanym adresem 
22 9.24 48 5.81 8 3.17 78 5.93 
Inne 1 0.42 16 1.94 1 0.40 18 1.37 
Total 238 100.00 826 100.00 252 100.00 1316 100.00 
 
 
 
Tabela 80 Efektywność – województwo podlaskie w podziale na status wywiadu i grupy wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 79 15.37 303 58.95 132 25.68 514 100.00 
Odmowa 61 18.65 208 63.61 58 17.74 327 100.00 
Dłuższa nieobecność 75 19.79 251 66.23 53 13.98 379 100.00 
Nie przebywa pod 
wskazanym adresem 
22 28.21 48 61.54 8 10.26 78 100.00 
Inne 1 5.56 16 88.96 1 5.56 18 100.00 
Total 238 18.09 826 62.77 252 19.15 1316 100.00 
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EFEKTYWNOŚĆ -  WOJEWÓDZTWO POMORSKIE 
Tabela 81 Efektywność – województwo pomorskie, w podziale na typ próby i status wywiadu 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 242 50.95 258 32.01 500 39.03 
Odmowa 90 18.95 218 27.05 308 24.04 
Dłuższa nieobecność 101 21.26 242 30.02 343 26.78 
Nie przebywa pod 
wskazanym adresem 
28 5.89 64 7.94 92 7.18 
Inne 16 2.95 24 2.98 38 2.97 
Total 475 100.00 806 100.00 1281 100.00 
 
Tabela 82 Efektywność – województwo pomorskie w podziale na status wywiadu i typ próby 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 242 48.40 258 51.60 500 100.00 
Odmowa 90 29.22 218 70.78 308 100.00 
Dłuższa nieobecność 101 29.45 242 70.55 343 100.00 
Nie przebywa pod 
wskazanym adresem 
28 30.43 64 69.57 92 100.00 
Inne 16 36.84 24 63.16 38 100.00 
Total 475 37.08 806 62.92 1281 100.00 
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Tabela 83 Efektywność – województwo pomorskie w podziale na płeć i status wywiadu 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 275 42.05 225 35.89 500 39.03 
Odmowa 153 23.39 155 24.72 308 24.04 
Dłuższa nieobecność 165 25.23 178 28.39 343 26.78 
Nie przebywa pod 
wskazanym adresem 
45 6.88 47 7.50 92 7.18 
Inne 16 2.45 22 3.51 38 2.97 
Total 654 100.00  100.00 1281 100.00 
 
Tabela 84 Efektywność –  województwo pomorskie w podziale na  status wywiadu i płeć 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 275 55.00 225 45.00 500 100.00 
Odmowa 153 49.68 155 50.32 308 100.00 
Dłuższa nieobecność 165 48.10 178 51.90 343 100.00 
Nie przebywa pod 
wskazanym adresem 
45 48.91 47 51.09 92 100.00 
Inne 16 42.11 22 57.89 38 100.00 
Total 654 51.05 627 48.95 1281 100.00 
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Tabela 85 Efektywność – województwo pomorskie w podziale na grupy wieku i status wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 93 43.87 305 36.70 102 42.86 500 39.03 
Odmowa 39 18.40 197 23.71 72 30.25 308 24.04 
Dłuższa nieobecność 51 24.06 248 29.84 44 18.49 343 26.78 
Nie przebywa pod 
wskazanym adresem 
21 9.91 59 7.10 12 5.04 92 7.18 
Inne 9 3.77 22 2.65 8 3.36 38 2.97 
Total 212 100.00 831 100.00 238 100.00 1281 100.00 
 
 
Tabela 86 Efektywność – województwo pomorskie w podziale na status wywiadu i grupy wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 93 18.60 305 61.00 102 20.40 500 100.00 
Odmowa 39 12.66 197 63.96 72 23.38 308 100.00 
Dłuższa nieobecność 51 14.87 248 72.30 44 12.83 343 100.00 
Nie przebywa pod 
wskazanym adresem 
21 22.83 59 64.13 12 13.04 92 100.00 
Inne 9 21.05 22 57.89 8 21.05 38 100.00 
Total 212 16.55 831 64.87 238 18.58 1281 100.00 
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EFEKTYWNOŚĆ -  WOJEWÓDZTWO ŚLĄSKIE 
Tabela 87 Efektywność – województwo śląskie, w podziale na typ próby i status wywiadu 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 500 44.85 291 33.14 500 37.20 
Odmowa 275 18.45 189 21.53 275 20.46 
Dłuższa nieobecność 521 32.83 368 41.91 521 38.76 
Nie przebywa pod 
wskazanym adresem 
48 3.86 30 3.42 48 3.57 
Inne 0 0.00 0 0.00 0 0.00 
Total 1344 100.00 878 100.00 1344 100.00 
 
Tabela 88 Efektywność – województwo śląskie w podziale na status wywiadu i typ próby 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 500 41.80 291 58.20 500 100.00 
Odmowa 275 31.27 189 68.73 275 100.00 
Dłuższa nieobecność 521 29.37 368 70.63 521 100.00 
Nie przebywa pod 
wskazanym adresem 
48 37.50 30 62.50 48 100.00 
Inne 0 0.00 0 0.00 0 100.00 
Total 1344 34.67 878 65.33 1344 100.00 
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Tabela 89 Efektywność – województwo śląskie w podziale na płeć i status wywiadu 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 265 39.79 235 34.66 500 37.20 
Odmowa 149 22.37 126 18.58 275 20.46 
Dłuższa nieobecność 229 34.38 292 43.07 521 38.76 
Nie przebywa pod 
wskazanym adresem 
23 3.45 25 3.69 48 3.57 
Inne 0 0.00 0 0.00 0 0.00 
Total 666 100.00 678 100.00 1344 100.00 
 
Tabela 90 Efektywność –  województwo śląskie w podziale na  status wywiadu i płeć 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 265 53.00 235 47.00 500 100.00 
Odmowa 149 54.18 126 45.82 275 100.00 
Dłuższa nieobecność 229 43.95 292 56.05 521 100.00 
Nie przebywa pod 
wskazanym adresem 
23 47.92 25 52.08 48 100.00 
Inne 0 0.00 0 0.00 0 100.00 
Total 666 49.55 678 50.45 1344 100.00 
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Tabela 91 Efektywność – województwo śląskie w podziale na grupy wieku i status wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 78 37.14 313 35.89 109 41.60 500 37.20 
Odmowa 29 13.81 184 21.10 62 23.66 275 20.46 
Dłuższa nieobecność 96 45.71 342 39.22 83 31.68 521 38.76 
Nie przebywa pod 
wskazanym adresem 
7 3.33 33 3.78 8 3.05 48 3.57 
Inne 0 0.00 0 0.00 0 0.00 0 0.00 
Total 210 100.00 872 100.00 262 100.00 1344 100.00 
 
 
Tabela 92 Efektywność – województwo śląskie w podziale na status wywiadu i grupy wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 78 15.60 313 62.60 109 21.80 500 100.00 
Odmowa 29 10.55 184 66.91 62 22.55 275 100.00 
Dłuższa nieobecność 96 18.43 342 65.64 83 15.93 521 100.00 
Nie przebywa pod 
wskazanym adresem 
7 14.58 33 68.75 8 16.67 48 100.00 
Inne 0 0.00 0 0.00 0 0.00 0 100.00 
Total 210 15.63 872 64.88 262 19.49 1344 100.00 
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EFEKTYWNOŚĆ -  WOJEWÓDZTWO ŚWIĘTOKRZYSKIE 
Tabela 93 Efektywność – województwo świętokrzyskie, w podziale na typ próby i status wywiadu 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 223 47.85 277 54.21 500 51.18 
Odmowa 64 13.73 45 8.81 109 11.16 
Dłuższa nieobecność 140 30.04 148 28.96 288 29.48 
Nie przebywa pod 
wskazanym adresem 
28 6.01 21 4.11 49 5.02 
Inne 11 2.36 20 3.91 31 3.17 
Total 466 100.00 511 100.00 977 100.00 
 
Tabela 94 Efektywność – województwo świętokrzyskie w podziale na status wywiadu i typ próby 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 223 44.60 277 55.40 500 100.00 
Odmowa 64 58.72 45 41.28 109 100.00 
Dłuższa nieobecność 140 48.61 148 51.39 288 100.00 
Nie przebywa pod 
wskazanym adresem 
28 57.14 21 42.86 49 100.00 
Inne 11 35.48 20 64.52 31 100.00 
Total 466 47.70 511 52.30 977 100.00 
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Tabela 95 Efektywność – województwo świętokrzyskie w podziale na płeć i status wywiadu 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 257 53.21 243 49.19 500 51.18 
Odmowa 62 12.84 47 9.51 109 11.16 
Dłuższa nieobecność 136 28.16 152 30.77 288 29.48 
Nie przebywa pod 
wskazanym adresem 
15 3.11 34 6.88 49 5.02 
Inne 13 2.69 18 3.64 31 3.17 
Total 483 100.00 494 100.00 977 100.00 
 
Tabela 96 Efektywność –  województwo świętokrzyskie w podziale na  status wywiadu i płeć 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 257 51.40 243 48.60 500 100.00 
Odmowa 62 56.88 47 43.12 109 100.00 
Dłuższa nieobecność 136 47.22 152 52.78 288 100.00 
Nie przebywa pod 
wskazanym adresem 
15 30.61 34 69.39 49 100.00 
Inne 13 41.94 18 58.06 31 100.00 
Total 483 49.44 494 50.56 977 100.00 
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Tabela 97 Efektywność – województwo świętokrzyskie w podziale na grupy wieku i status wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 75 45.45 304 49.43 121 61.42 500 51.18 
Odmowa 10 6.06 78 12.68 21 10.66 109 11.16 
Dłuższa nieobecność 59 35.76 186 30.24 43 21.83 288 29.48 
Nie przebywa pod 
wskazanym adresem 
13 7.88 28 4.55 8 4.06 49 5.02 
Inne 8 4.85 19 3.09 4 2.03 31 3.17 
Total 165 100.00 615 100.00 197 100.00 977 100.00 
 
 
Tabela 98 Efektywność – województwo świętokrzyskie w podziale na status wywiadu i grupy wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 75 15.00 304 60.80 121 24.20 500 100.00 
Odmowa 10 9.17 78 71.56 21 19.27 109 100.00 
Dłuższa nieobecność 59 20.49 186 64.58 43 14.93 288 100.00 
Nie przebywa pod 
wskazanym adresem 
13 26.53 28 57.14 8 16.33 49 100.00 
Inne 8 25.81 19 61.29 4 12.90 31 100.00 
Total 165 16.89 615 62.95 197 20.16 977 100.00 
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EFEKTYWNOŚĆ -  WOJEWÓDZTWO WARMIŃSKO- MAZURSKIE 
Tabela 99 Efektywność – województwo warmińsko-mazurskie, w podziale na typ próby i status 
wywiadu 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 233 50.65 270 40.91 503 44.91 
Odmowa 73 15.87 75 11.36 148 13.21 
Dłuższa nieobecność 112 24.35 248 37.58 360 32.14 
Nie przebywa pod 
wskazanym adresem 
24 5.22 35 5.30 59 5.27 
Inne 18 3.91 32 4.85 50 4.46 
Total 460 100.00 660 100.00 1120 100.00 
 
Tabela 100 Efektywność – województwo warmińsko-mazurskie w podziale na status wywiadu i typ 
próby 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 233 46.32 270 53.68 503 100.00 
Odmowa 73 49.32 75 50.68 148 100.00 
Dłuższa nieobecność 112 31.11 248 68.89 360 100.00 
Nie przebywa pod 
wskazanym adresem 
24 40.68 35 59.32 59 100.00 
Inne 18 36.00 32 64.00 50 100.00 
Total 460 41.07 660 58.93 1120 100.00 
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Tabela 101 Efektywność – województwo warmińsko-mazurskie w podziale na płeć i status wywiadu 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 280 48.11 223 41.45 503 44.91 
Odmowa 83 14.26 65 12.08 148 13.21 
Dłuższa nieobecność 177 30.41 183 34.01 360 32.14 
Nie przebywa pod 
wskazanym adresem 
30 5.15 29 5.39 59 5.27 
Inne 12 2.06 38 7.06 50 4.46 
Total 582 100.00 538 100.00 1120 100.00 
 
Tabela 102 Efektywność –  województwo warmińsko-mazurskie w podziale na  status wywiadu i płeć 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 280 55.67 223 44.33 503 100.00 
Odmowa 83 56.08 65 43.92 148 100.00 
Dłuższa nieobecność 177 49.17 183 50.83 360 100.00 
Nie przebywa pod 
wskazanym adresem 
30 50.85 29 49.15 59 100.00 
Inne 12 24.00 38 76.00 50 100.00 
Total 582 51.96 538 48.04 1120 100.00 
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Tabela 103 Efektywność – województwo warmińsko-mazurskie w podziale na grupy wieku i status 
wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 91 43.75 308 42.19 104 57.14 503 44.91 
Odmowa 21 10.10 104 14.25 23 12.64 148 13.21 
Dłuższa nieobecność 66 31.73 253 34.66 41 22.53 360 32.14 
Nie przebywa pod 
wskazanym adresem 
17 8.17 37 5.07 5 2.75 59 5.27 
Inne 13 6.25 28 3.84 9 4.95 50 4.46 
Total 208 100.00 730 100.00 182 100.00 1120 100.00 
 
 
Tabela 104 Efektywność – województwo warmińsko-mazurskie w podziale na status wywiadu i 
grupy wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 91 18.09 308 61.23 104 20.68 503 100.00 
Odmowa 21 14.19 104 70.27 23 15.54 148 100.00 
Dłuższa nieobecność 66 18.33 253 70.28 41 11.39 360 100.00 
Nie przebywa pod 
wskazanym adresem 
17 28.81 37 62.71 5 8.47 59 100.00 
Inne 13 26.00 28 56.00 9 18.00 50 100.00 
Total 208 18.57 730 65.18 182 16.25 1120 100.00 
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EFEKTYWNOŚĆ -  WOJEWÓDZTWO WIELKOPOLSKIE 
Tabela 105 Efektywność – województwo wielkopolskie, w podziale na typ próby i status wywiadu 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 247 53.00 261 36.66 508 43.12 
Odmowa 79 16.95 173 24.30 252 21.39 
Dłuższa nieobecność 106 22.75 219 30.76 325 27.59 
Nie przebywa pod 
wskazanym adresem 
27 5.79 41 5.76 68 5.77 
Inne 7 1.50 18 2.53 25 2.12 
Total 466 100.00 712 100.00 1178 100.00 
 
Tabela 106 Efektywność – województwo wielkopolskie w podziale na status wywiadu i typ próby 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 247 48.62 261 51.38 508 100.00 
Odmowa 79 31.35 173 68.65 252 100.00 
Dłuższa nieobecność 106 32.62 219 67.38 325 100.00 
Nie przebywa pod 
wskazanym adresem 
27 39.71 41 60.29 68 100.00 
Inne 7 28.00 18 72.00 25 100.00 
Total 466 39.56 712 60.44 1178 100.00 
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Tabela 107 Efektywność – województwo wielkopolskie w podziale na płeć i status wywiadu 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 265 45.38 243 40.91 508 43.12 
Odmowa 123 21.06 129 21.72 252 21.39 
Dłuższa nieobecność 158 27.05 167 28.11 325 27.59 
Nie przebywa pod 
wskazanym adresem 
32 5.48 36 6.06 68 5.77 
Inne 6 1.03 19 3.20 25 2.12 
Total 584 100.00 594 100.00 1178 100.00 
 
Tabela 108 Efektywność –  województwo wielkopolskie w podziale na  status wywiadu i płeć 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 265 52.17 243 47.83 508 100.00 
Odmowa 123 48.81 129 51.19 252 100.00 
Dłuższa nieobecność 158 48.62 167 51.38 325 100.00 
Nie przebywa pod 
wskazanym adresem 
32 47.06 36 52.94 68 100.00 
Inne 6 24.00 19 76.00 25 100.00 
Total 584 49.58 594 50.42 1178 100.00 
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Tabela 109 Efektywność – województwo wielkopolskie w podziale na grupy wieku i status wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 79 39.70 322 41.55 107 50.45 508 43.12 
Odmowa 36 18.09 172 22.19 44 21.57 252 21.39 
Dłuższa nieobecność 64 32.16 219 28.26 42 20.59 325 27.59 
Nie przebywa pod 
wskazanym adresem 
10 5.06 50 6.45 8 3.92 68 5.77 
Inne 10 5.03 12 1.55 3 1.47 25 2.12 
Total 199 100.00 775 100.00 204 100.00 1178 100.00 
 
 
Tabela 110 Efektywność – województwo wielkopolskie w podziale na status wywiadu i grupy wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 79 15.55 322 63.39 107 21.06 508 100.00 
Odmowa 36 14.29 172 68.25 44 17.46 252 100.00 
Dłuższa nieobecność 64 19.69 219 67.38 42 12.92 325 100.00 
Nie przebywa pod 
wskazanym adresem 
10 14.71 50 73.53 8 11.76 68 100.00 
Inne 10 40.00 12 48.00 3 12.00 25 100.00 
Total 199 16.89 775 64.79 204 17.32 1178 100.00 
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EFEKTYWNOŚĆ -  WOJEWÓDZTWO ZACHODNIOPOMORSKIE 
Tabela 111 Efektywność – województwo zachodniopomorskie, w podziale na typ próby i status 
wywiadu 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 241 49.79 261 35.13 502 40.91 
Odmowa 99 20.45 219 29.48 318 25.92 
Dłuższa nieobecność 124 25.62 237 31.90 361 29.42 
Nie przebywa pod 
wskazanym adresem 
20 4.13 26 3.50 46 3.75 
Inne 0 0.00 0 0.00 0 0.00 
Total 484 100.00 743 100.00 1227 100.00 
 
Tabela 112 Efektywność – województwo zachodniopomorskie w podziale na status wywiadu i typ 
próby 
 Typ próby – podstawa Typ próby – rezerwa Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 241 48.01 261 51.99 502 100.00 
Odmowa 99 31.13 219 68.87 318 100.00 
Dłuższa nieobecność 124 34.35 237 65.65 361 100.00 
Nie przebywa pod 
wskazanym adresem 
20 43.48 26 56.52 46 100.00 
Inne 0 0.00 0 0.00 0 100.00 
Total 484 39.45 743 60.55 1227 100.00 
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Tabela 113 Efektywność – województwo zachodniopomorskie w podziale na płeć i status wywiadu 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 263 42.83 239 38.99 502 40.91 
Odmowa 163 26.55 155 25.29 318 25.92 
Dłuższa nieobecność 173 28.18 188 30.67 361 29.42 
Nie przebywa pod 
wskazanym adresem 
15 2.44 31 5.06 46 3.75 
Inne 0 0.00 0 0.00 0 0.00 
Total 614 100.00 613 100.00 1227 100.00 
 
Tabela 114 Efektywność –  województwo zachodniopomorskie w podziale na  status wywiadu i płeć 
 Kobiety Mężczyźni Total 
Status wywiadu (n) % (n) % (n) % 
Wywiad zrealizowany 263 52.39 239 47.61 502 100.00 
Odmowa 163 51.26 155 48.74 318 100.00 
Dłuższa nieobecność 173 47.92 188 52.08 361 100.00 
Nie przebywa pod 
wskazanym adresem 
15 32.61 31 67.39 46 100.00 
Inne 0 0.00 0 0.00 0 100.00 
Total 614 50.04 613 49.96 1227 100.00 
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Tabela 115 Efektywność – województwo zachodniopomorskie w podziale na grupy wieku i status 
wywiadu 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 84 38.18 319 37.78 99 48.29 502 40.91 
Odmowa 54 24.55 206 25.69 58 28.29 318 25.92 
Dłuższa nieobecność 73 33.18 243 30.30 45 21.95 361 29.42 
Nie przebywa pod 
wskazanym adresem 
9 4.09 34 4.24 3 1.46 46 3.75 
Inne 0 0.00 0 0.00 0 0.00 0 0.00 
Total 220 100.00 802 100.00 205 100.00 1227 100.00 
 
 
Tabela 116 Efektywność – województwo zachodniopomorskie w podziale na status wywiadu i grupy 
wieku 
 18-24 lata 25-59 lat 60 i więcej lat Total 
Status wywiadu (n) % (n) % (n) % (n) % 
Wywiad zrealizowany 84 16.73 319 63.55 99 19.72 502 100.00 
Odmowa 54 16.98. 206 64.78 58 18.24 318 100.00 
Dłuższa nieobecność 73 20.22 243 67.31 45 12.47 361 100.00 
Nie przebywa pod 
wskazanym adresem 
9 19.57 34 73.91 3 6.52 46 100.00 
Inne 0 0.00 0 0.00 0 0.00 0 100.00 
Total 220 17.93 802 65.36 205 16.71 1227 100.00 
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Wyniki 
Dane zostały przetworzone przy użyciu pakiety statystycznego SPSS ver 15.0.  
Wyniki zostały zaprezentowane w postaci tabel i wykresów, oddzielnie dla populacji 
ogólnopolskiej i dla poszczególnych województw.  
Dane prezentowane dla całej populacji zostały przeważone tak, aby struktura 
według płci, wieku i województwa odpowiadała strukturze ogólnopolskiej. 
Dane dla województwo zostały zaprezentowane w postaci surowej.  
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Appendix 4 Consent form (version translated from Polish to 
English) 
Declaration of Consent 
for survey completion and measurement of weight and height 
 
⇒ Good morning, my name is...................   .....................    I am an interviewer 
employed by PBS DGA.  
 
⇒ Your name has been drawn from national registry of adult Polish people for 
participation in a narionwide research study about health related knowlege and 
attitudes of Poles. 
 
The research relates to health of Polish people and is conducted as part of “The 
National Programme for Cancer Control” led by Ministry of Health. 
  
⇒ The aim of this study is to determine the level of knowledge and attitudes of 
Poles relating to elements of healthy lifestyle that are included in the European 
Code against Cancer.  
 
⇒ My task is to concuct an interview with you  and measure your weight and height.  
 
⇒ Information obtained from you will be used exclusively for medical research 
purposes in accordance with the Act on the Personal Data Protection. 
Therefore, I am requesting you for your written consent for your participation in  
this research. 
 
⇒ I would like to request you to dedicate some time for answering the questions as 
they are a source of important information. We will be very thenkful if you agree 
to take part in this research. 
 
 
Scientific coordinator of the study 
Jolanta Lissowska PhD 
tel: 022-546-2012 
fax:022-643-9234 
e-mail: lissowsj@coi.waw.pl 
 
Operational coordinator of the study 
Elżbieta Wołkiewicz MSc 
Tel. sł.    0-58 550 60 70 
Mob. 0-606 299 141 
e-mail: elzbieta.wolkiewicz@pbsdga.pl 
 
Department of Epidemiology and Cancer 
Prevention 
Institute of Oncology 
Roentgena 5 
02-781 Warsaw 
 
 
PBS DGA Ltd. 
Junaków 2 
81-812 Sopot 
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Declaration 
 
I agree to: 
⇒ participate in the survey, 
⇒ allow for measurement s of my weight and height, 
⇒ use of my data for scientific purposes. 
   
 
I declare that I was informed in detail of the purpose of this research.  
All questions related to these activities have been explained to me. 
 
City....................................  
 
 
 
Date..................................  
Respondent’s readable signature........................................... 
 
Respondent’s home or mobile phone......................................  
 
Interviewer’s readable signature.................. ............................. 
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Appendix 5 Scored items in breast and cervical cancer knowledge 
scales  
 
Breast cancer knowledge scale 
Questions included in the new scale Possible responses  Weighted score 
Have you ever heard about the need for 
regular breast self-examination (at home)?  
• Yes  
• No 
• I don’t know, it is difficult to 
say 
2 
0 
0 
Have you ever heard that regular 
mammography allows early detection of 
breast cancer 
• Yes  
• No 
• I don’t know, it is difficult to 
say 
2 
0 
0 
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Question: Do you think that changing certain habits and behaviours cancer can be 
prevented? Please indicate, which of the below described behaviours can influence the 
development of the below specified cancers 
 The weighted scoring applied to each of the responses 
Breast cancer A B C D E F 
1. Regular mammography below the age of 50  0 0 0 2 1 0 
2. Regular mammography above the age of 50 2 1 0 0 0 0 
3. Use of hormonal contraception 0 0 0 1 2 0 
4. Use of hormonal replacement therapy 0 0 0 1 2 0 
5. Increase of intake of fruits and vegetables 0 2 1 0 0 0 
6. Decrease of fat intake 2 1 0 0 0 0 
7. Limitation or avoidance of alcohol 2 1 0 0 0 0 
8. Smoking cessation 0 1 2 0 0 0 
9. Increase of physical activity  2 1 0 0 0 0 
10. Regular breast self-examination 2 1 0 0 0 0 
11. Frequent X-rays (various body parts) 0 0 0 0 2 0 
 
Key:  
To a large extent it can protect against cancer 
It can have protective influence against cancer 
It can have a somewhat protective influence against cancer 
It does not influence cancer development 
Contrarily, it can lead to cancer development 
I don’t know, it is difficult to say 
A 
B 
C 
D 
E 
F 
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Cervical cancer related knowledge scale 
Scoring applied to question on the knowledge of the usefulness of cervical screening 
Questions included in the new 
scale 
Possible responses  Weighted score 
Have you ever heard that regular 
cytology allows early detection of 
cervical cancer? 
• Yes 
• No 
• I don’t know, it is difficult to 
say 
2 
0 
0 
 
Question: Do you think that by changing certain habits and behaviours cancer can be 
prevented? Please indicate, which of the below described behaviours that can influence the 
development of the below specified cancers 
 The weighted scoring applied to each of the responses 
Cervical cancer A B C D E F 
1. Regular cytology 2 1 0 0 0 0 
2. Use of hormonal contraception 0 0 0 1 2 0 
3. Young age at sexual initiation 0 0 0 0 2 0 
4. High number of sexual partners 0 0 0 0 2 0 
5. Smoking cessation 2 1 0 0 0 0 
 
Key: 
To a large extent it can protect against cancer 
It can have protective influence against cancer 
It can have a somewhat protective influence against cancer 
It does not influence cancer development 
Contrarily, it can lead to cancer development 
I don’t know, it is difficult to say 
A 
B 
C 
D 
E 
F 
 
 
